<SEC-DOCUMENT>0001178913-22-002936.txt : 20241204
<SEC-HEADER>0001178913-22-002936.hdr.sgml : 20241204
<ACCEPTANCE-DATETIME>20220804093228
ACCESSION NUMBER:		0001178913-22-002936
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		40
CONFORMED PERIOD OF REPORT:	20220630
FILED AS OF DATE:		20220804
DATE AS OF CHANGE:		20220804

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Sol-Gel Technologies Ltd.
		CENTRAL INDEX KEY:			0001684693
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			L3
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38367
		FILM NUMBER:		221135127

	BUSINESS ADDRESS:	
		STREET 1:		7 GOLDA MEIR ST.
		STREET 2:		WEIZMANN SCIENCE PARK
		CITY:			NESS ZIONA
		STATE:			L3
		ZIP:			7403648
		BUSINESS PHONE:		97289313433

	MAIL ADDRESS:	
		STREET 1:		7 GOLDA MEIR ST.
		STREET 2:		WEIZMANN SCIENCE PARK
		CITY:			NESS ZIONA
		STATE:			L3
		ZIP:			7403648
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>zk2228238.htm
<DESCRIPTION>6-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>
<!--INTEGIX by Ez-XBRL--><html xmlns="http://www.w3.org/1999/xhtml" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2022-02-16" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:us-types="http://fasb.org/us-types/2021-01-31" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:currency="http://xbrl.sec.gov/currency/2022" xmlns:exch="http://xbrl.sec.gov/exch/2022" xmlns:naics="http://xbrl.sec.gov/naics/2022" xmlns:sic="http://xbrl.sec.gov/sic/2022" xmlns:stpr="http://xbrl.sec.gov/stpr/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:srt-types="http://fasb.org/srt-types/2022" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:slgl="http://www.sol-gel.co/20220630"  ><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/><title>Sol-Gel Technologies Ltd. - 1684693 - 2022</title></head><body style="font-size:10pt;font-family:Times New Roman;">
        <div style="display:none">
        <ix:header><ix:hidden><ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="C_20220101to20220630"  id="FFact_322" >0001684693</ix:nonNumeric><ix:nonNumeric name="dei:CurrentFiscalYearEndDate" contextRef="C_20220101to20220630"  id="FFact_323" >--12-31</ix:nonNumeric><ix:nonNumeric name="dei:AmendmentFlag" contextRef="C_20220101to20220630"  id="FFact_324" >false</ix:nonNumeric><ix:nonNumeric name="dei:DocumentType" contextRef="C_20220101to20220630"  id="FFact_325" >6-K</ix:nonNumeric><ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="C_20220101to20220630"  id="FFact_326" >2022-06-30</ix:nonNumeric><ix:nonNumeric name="dei:DocumentFiscalPeriodFocus" contextRef="C_20220101to20220630"  id="Fdei_DocumentFiscalPeriodFocus20220718125411444" >Q2</ix:nonNumeric></ix:hidden>
<ix:references>
        <link:schemaRef xlink:type="simple" xlink:href="slgl-20220630.xsd"/>
        </ix:references></ix:header></div><div>
  <div>
    <div>
      <hr style="border:none;border-bottom:1px solid black;border-top:4px solid black;height:10px;color:#ffffff;background-color:#ffffff;text-align:center;margin-left:auto;margin-right:auto;text-align:center" />
      <div>
        <div style="line-height:1.25">
          <div style="text-align:center;line-height:1.25;font-weight:bold"><br /><span style="font-family:Times New Roman,Times,serif"><span style="font-size:14pt"><span>&#160;<span style="background-color:rgb(255, 255, 255);font-weight:bold;color:rgb(0, 0, 0);font-style:normal;font-variant:normal;text-transform:none">UNITED STATES</span></span></span></span></div>
          <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-size:14pt;font-weight:bold;background-color:rgb(255, 255, 255);color:rgb(0, 0, 0);font-style:normal;font-variant:normal;text-transform:none"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:14pt"><span>SECURITIES AND EXCHANGE COMMISSION</span></span></span></div>
          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span>Washington, D.C. 20549</span></span></span></span></div>
        </div>
        <div style="line-height:1.25">
          <div style="line-height:1.25">&#160;</div>
        </div>
        <div style="line-height:1.25;background-color:rgb(255, 255, 255);font-weight:bold;color:rgb(0, 0, 0);font-family:'Times New Roman',Times,serif;font-size:14pt;font-style:normal;font-variant:normal;text-transform:none">
          <div style="text-align:center;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:14pt"><span>FORM <ix:nonNumeric id="F20220718063032973_0" name="dei:DocumentType" contextRef="C_20220101to20220630">6-K</ix:nonNumeric></span></span></span></div>
        </div>
        <div style="line-height:1.25">
          <div style="line-height:1.25">&#160;</div>
        </div>
        <div style="line-height:1.25">
          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span><span style="font-family:Times New Roman,Times,serif"><span>Report of Foreign Private Issuer</span></span></span></span></div>
          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span><span style="font-family:Times New Roman,Times,serif"><span>Pursuant to Rule 13a-16 or 15d-16</span></span></span></span></div>
          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span><span style="font-family:Times New Roman,Times,serif"><span>Under the Securities Exchange Act of 1934</span></span></span></span></div>
        </div>
        <div style="line-height:1.25">
          <div style="line-height:1.25">&#160;</div>
        </div>
        <div style="line-height:1.25">
          <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-size:16pt;font-weight:bold;background-color:rgb(255, 255, 255);color:rgb(0, 0, 0);font-style:normal;font-variant:normal;text-transform:none"><span style="font-size:16pt"><span style="font-family:Times New Roman,Times,serif"><span><ix:nonNumeric id="F20220718063032974_2" name="dei:EntityRegistrantName" contextRef="C_20220101to20220630">SOL-GEL TECHNOLOGIES LTD.</ix:nonNumeric></span></span></span></div>
          <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>(Translation of registrant&#8217;s name into English)</span></span></span></span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>For the month of August <ix:nonNumeric id="F20220718063032973_1" name="dei:DocumentFiscalYearFocus" contextRef="C_20220101to20220630">2022</ix:nonNumeric></span></span></span></span></span></div>
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><ix:nonNumeric id="F20220718063032974_3" name="dei:EntityAddressAddressLine1" contextRef="C_20220101to20220630">7 Golda Meir Street</ix:nonNumeric></span></span></span></span></span></div>
          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><ix:nonNumeric id="F20220718063032974_4" name="dei:EntityAddressCityOrTown" contextRef="C_20220101to20220630">Ness Ziona</ix:nonNumeric>&#160;<ix:nonNumeric id="F20220718063032975_5" name="dei:EntityAddressPostalZipCode" contextRef="C_20220101to20220630">7403650</ix:nonNumeric>, <ix:nonNumeric id="F20220718063032975_6" name="dei:EntityAddressCountry" contextRef="C_20220101to20220630" format="ixt-sec:countrynameen">Israel</ix:nonNumeric></span></span></span></span></span></div>
          <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span>(Address of principal executive offices)</span></span></span></span></span></div>
        </div>
        <div style="line-height:1.25">
          <div style="line-height:1.25">&#160;</div>
        </div>
        <div style="line-height:1.25">
          <div style="text-indent:24.5pt;line-height:1.25"><span style="font-size:10pt"><span><span style="font-family:Times New Roman,Times,serif"><span>Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.</span></span></span></span></div>
        </div>
        <div style="line-height:1.25">
          <div style="line-height:1.25">&#160;</div>
        </div>
        <div style="line-height:1.25">
          <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span><span style="font-family:Times New Roman,Times,serif"><span>Form 20-F <span>&#9746;</span>&#160; &#160; &#160; &#160; &#160; Form 40-F <span>&#9744;</span></span></span></span></span></div>
        </div>
        <div style="line-height:1.25">
          <div style="line-height:1.25">&#160;</div>
        </div>
        <div style="line-height:1.25">
          <div style="text-indent:24.5pt;line-height:1.25"><span style="font-size:10pt"><span><span style="font-family:Times New Roman,Times,serif"><span>Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): <span>&#9744;</span></span></span></span></span></div>
        </div>
        <div style="line-height:1.25">
          <div style="line-height:1.25">&#160;</div>
        </div>
        <div style="line-height:1.25">
          <div style="text-indent:24.5pt;line-height:1.25"><span style="font-size:10pt"><span><span style="font-family:Times New Roman,Times,serif"><span>Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): <span>&#9744;</span></span></span></span></span></div>
        </div>
        <div style="line-height:1.25">
          <div style="line-height:1.25">&#160;</div>
          <div style="clear:both;margin-top:10pt;margin-bottom:10pt">
            <div style="page-break-after:always">
              <hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" />
            </div>
          </div>
        </div>
        <div style="line-height:1.25">&#160;</div>
        <div style="line-height:1.25">
          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span>INFORMATION CONTAINED IN THIS REPORT ON FORM 6-K</span></span></span></span></span></div>
        </div>
        <div style="line-height:1.25">
          <div style="line-height:1.25">&#160;</div>
        </div>
        <div style="line-height:1.25">
          <div style="text-align:justify;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span>On August 4, 2022, Sol-Gel Technologies Ltd. (the &#8220;Company&#8221;) issued a press release announcing the Company&#8217;s financial results for the quarter ended June 30, 2022. In addition, the Company is submitting with this Form 6-K its unaudited condensed consolidated financial statements as of June 30, 2022 and for the three and six months then ended.</span></span></span></span></span></div>
          <div style="line-height:1.25">&#160;</div>
        </div>
        <div style="line-height:1.25">
          <div style="text-align:justify;text-indent:-72pt;margin-left:72pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span>Attached hereto are the following exhibits:</span></span></span></span></span></div>
          <div style="text-align:justify;text-indent:-72pt;margin-left:72pt;line-height:1.25">&#160;</div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:72pt;vertical-align:top;align:right"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span><a href="exhibit_99-1.htm">Exhibit 99.1</a></span></span></span></span></span></td>
                <td style="width:auto;vertical-align:top;text-align:justify">
                  <div><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span><a href="exhibit_99-1.htm">Press release dated August 4, 2022</a></span></span></span></span></span></div>
                </td>
              </tr>

          </table>
          <div style="line-height:1.25">&#160;</div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:72pt;vertical-align:top;align:right"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span><a href="exhibit_99-2.htm">Exhibit 99.2</a></span></span></span></span></span></td>
                <td style="width:auto;vertical-align:top;text-align:justify">
                  <div><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span><a href="exhibit_99-2.htm">Unaudited condensed consolidated financial statements as of June 30, 2022 and for the three and six months then ended</a></span></span></span></span></span></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="line-height:1.25">
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:justify;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span>Exhibits 99.1 (other than the two paragraphs immediately preceding the heading &#8220;Second Quarter 2022 and Recent Corporate Developments&#8221;) and 99.2 are hereby incorporated by reference into the Company's Registration Statement on Form S-8 (Registration No. 333-223915) and its Registration Statements on Form F-3 (Registration Nos. 333-230564 and 333-264190).</span></span></span></span></span></div>
        </div>
        <div style="line-height:1.25">
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span>2</span></span></span></span></span></div>
          <div style="clear:both;margin-top:10pt;margin-bottom:10pt">
            <div style="page-break-after:always">
              <hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" />
            </div>
          </div>
        </div>
        <div style="line-height:1.25">
          <div style="line-height:1.25">&#160;</div>
          <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span>SIGNATURES</span></span></span></span></span></div>
          <div style="line-height:1.25">&#160;</div>
        </div>
        <div style="line-height:1.25">
          <div style="text-align:justify;text-indent:24.5pt;line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span>Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</span></span></span></span></span></div>
          <div style="line-height:1.25">&#160;</div>
        </div>
        <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

            <tr>
              <td style="width:50%;vertical-align:top">
                <div style="line-height:1.25">&#160;</div>
              </td>
              <td colspan="2" style="vertical-align:top">
                <div style="line-height:1.25;font-weight:bold"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span>SOL-GEL TECHNOLOGIES LTD.</span></span></span></span></span></div>
              </td>
              <td colspan="1" style="width:20%;vertical-align:top">&#160;</td>
            </tr>
            <tr>
              <td style="width:50%;vertical-align:middle">
                <div style="line-height:1.25">&#160;</div>
              </td>
              <td style="width:3%;vertical-align:middle">&#160;</td>
              <td style="width:27%;vertical-align:middle">
                <div style="line-height:1.25">&#160;</div>
              </td>
              <td colspan="1" style="width:20%;vertical-align:middle">&#160;</td>
            </tr>
            <tr>
              <td style="width:50%;vertical-align:top;padding-bottom:2px">
                <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span>Date: August 4, 2022</span></span></span></span></span></div>
              </td>
              <td style="width:3%;vertical-align:top;padding-bottom:2px">
                <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span>By:</span></span></span></span></span></div>
              </td>
              <td style="width:27%;vertical-align:top;border-bottom:2px solid rgb(0, 0, 0)">
                <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span>/s/ Gilad Mamlok</span></span></span></span></span></div>
              </td>
              <td colspan="1" style="width:20%;vertical-align:top;padding-bottom:2px">&#160;</td>
            </tr>
            <tr>
              <td style="width:50%;vertical-align:top">
                <div style="line-height:1.25">&#160;</div>
              </td>
              <td style="width:3%;vertical-align:top">
                <div style="line-height:1.25">&#160;</div>
              </td>
              <td style="width:27%;vertical-align:top">
                <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span>Gilad Mamlok</span></span></span></span></span></div>
              </td>
              <td colspan="1" style="width:20%;vertical-align:top">&#160;</td>
            </tr>
            <tr>
              <td style="width:50%;vertical-align:top">
                <div style="line-height:1.25">&#160;</div>
              </td>
              <td style="width:3%;vertical-align:top">
                <div style="line-height:1.25">&#160;</div>
              </td>
              <td style="width:27%;vertical-align:top">
                <div style="line-height:1.25"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span>Chief Financial Officer</span></span></span></span></span></div>
              </td>
              <td colspan="1" style="width:20%;vertical-align:top">&#160;</td>
            </tr>

        </table>
        <div style="line-height:1.25">
          <div style="line-height:1.25">&#160;</div>
          <div style="line-height:1.25">
            <div style="text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span>3</span></span></span></span></span></div>
            <hr style="border:none;border-bottom:4px solid black;border-top:1px solid black;height:10px;color:#ffffff;background-color:#ffffff;text-align:center;margin-left:auto;margin-right:auto;text-align:center;page-break-after:always" />
          </div>
          <div style="line-height:1.25">&#160;</div>
        </div>
      </div>
    </div>
  </div>
</div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>exhibit_99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Z-K Global
         Document created using Broadridge PROfile 22.7.2.5063
         Copyright 1995 - 2022 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;">
    <div style="text-align: right;"> <u><font style="font-weight: bold;">Exhibit 99.1</font></u><br>
    </div>
    <div>
      <div id="DSPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
      <div style="line-height: 1.25"><font style="font-weight: bold; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-size: 14pt; font-style: normal; font-variant: normal; text-transform: none;">Sol-Gel
          Technologies Reports Second Quarter 2022 Financial Results and Provides Corporate Update </font><br>
      </div>
      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 12pt; margin-bottom: 6pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z829454df74ce4f1e89d6b5b2f02ed6bd">

            <tr>
              <td style="width: 22.5pt; vertical-align: top; align: right;">
                <div style="margin-left: 4.5pt; line-height: 1.25; font-style: italic;">&#8226;</div>
              </td>
              <td style="width: auto; vertical-align: top;">
                <div style="text-align: justify; line-height: 1.25; font-style: italic;">Prescription volumes to date indicate strong uptake, similar to successful dermatology launches</div>
              </td>
            </tr>

        </table>
      </div>
      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 12pt; margin-bottom: 6pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zed15ca4ed3a04b2e988b4e27d5a1cb72">

            <tr>
              <td style="width: 22.5pt; vertical-align: top; align: right;">
                <div style="margin-left: 4.5pt; line-height: 1.25; font-style: italic;">&#160;&#8226;</div>
              </td>
              <td style="width: auto; vertical-align: top;">
                <div style="text-align: justify; line-height: 1.25;">&#160;<font style="font-style: italic;">Sol-Gel receives $3.5 million milestone payment from commercial partner Galderma Holding SA (&#8220;Galderma&#8221;)</font>&#160;<font style="font-style: italic;">for
                    FDA approval of EPSOLAY</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 12pt; margin-bottom: 6pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z0f9787429f2f40a99b92a7b1bc407c0b">

            <tr>
              <td style="width: 22.5pt; vertical-align: top; align: right;">
                <div style="margin-left: 4.5pt; line-height: 1.25; font-style: italic;">&#8226;</div>
              </td>
              <td style="width: auto; vertical-align: top;">
                <div style="text-align: justify; line-height: 1.25; font-style: italic;">Sol-Gel&#8217;s cash runway expected to extend through the end of 2023</div>
              </td>
            </tr>

        </table>
      </div>
      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 12pt; margin-bottom: 6pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z0728f433f1c745d492b91e9bcf83bbfa">

            <tr>
              <td style="width: 22.5pt; vertical-align: top; align: right;">
                <div style="margin-left: 4.5pt; line-height: 1.25; font-style: italic;">&#8226;</div>
              </td>
              <td style="width: auto; vertical-align: top;">
                <div style="text-align: justify; line-height: 1.25; font-style: italic;">SGT-510 to enter clinical trial later this year</div>
              </td>
            </tr>

        </table>
      </div>
      <div style="line-height: 1.25;"> <br>
      </div>
      <div style="line-height: 1.25;">NESS ZIONA,&#160;Israel, August 4, 2022--&#160;Sol-Gel Technologies, Ltd.&#160;(NASDAQ: SLGL), a dermatology company focused on identifying, developing, commercializing or partnering branded and generic topical drug products for the
        treatment of skin diseases, announced today financial results for the second quarter ended June 30, 2022 and provided a corporate update.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="line-height: 1.25;">&#8220;We and our partner Galderma are very pleased to report that the launches in the U.S. of &#160;EPSOLAY&#174; and TWYNEO are going well and prescriber reception has been strong,&#8221; stated Alon Seri-Levy, PhD, Chief Executive
        Officer of Sol-Gel.&#160; &#8220;Prescription volume data<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">1</sup> also support our confidence in a strong dermatology launch trajectory. Galderma has an unparalleled track record of commercializing innovative drugs for acne and rosacea in the U.S. and has
        been using a mix of commercial strategies to drive adoption. Going forward, as they secure managed care access over the course of the year, we expect net sales and royalty income in line with volume growth.&#8221;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="line-height: 1.25;">Dr. Seri-Levy added, &#8220;Our next areas of focus are to advance our innovative pipeline assets into clinical trials, with SGT-510 planned to enter a clinical trial later this year, and to explore opportunities to extract
        additional value from our TWYNEO and EPSOLAY products.&#8221;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="line-height: 1.25; font-weight: bold;">Second Quarter 2022 and Recent Corporate Developments</div>
      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 12pt; margin-bottom: 12pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="ze16773666e0f4dc28053d44c236f8663">

            <tr>
              <td style="width: 36pt; vertical-align: top; align: right;">
                <div style="margin-left: 18pt; line-height: 1.25;">&#8226;</div>
                <div style="line-height: 1.25">&#160;</div>
              </td>
              <td style="width: auto; vertical-align: top;">
                <div style="line-height: 1.25;">On June 2, 2022, Galderma announced the availability in the U.S of EPSOLAY (benzoyl peroxide cream, 5%) for the treatment of inflammatory lesions of rosacea in adults. EPSOLAY is the first and only benzoyl
                  peroxide topical treatment proven to relieve the bumps and blemishes of rosacea and provides rapid, significant and sustained relief.</div>
              </td>
            </tr>

        </table>
        <div> <br>
          <hr noshade="noshade" align="left" style="background-color: #000000; border: 0px; height: 1px; width: 2in; margin-left: 0pt; margin-right: auto; color: #000000;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">1</sup> IQVIA data, July 2022 </div>
      </div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 12pt; margin-bottom: 12pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z41cc22f298e44467a0f795e7ea9ec59f">

            <tr>
              <td style="width: 36pt; vertical-align: top; align: right;">
                <div style="margin-left: 18pt; line-height: 1.25;">&#8226;</div>
                <div style="line-height: 1.25">&#160;</div>
              </td>
              <td style="width: auto; vertical-align: top;">
                <div style="line-height: 1.25;">On April 25, 2022, Sol-Gel announced FDA approval of EPSOLAY. Sol-Gel has granted to Galderma the exclusive rights to commercialize EPSOLAY in the U.S.&#160; A $3.5 million milestone payment was received by
                  Sol-Gel from Galderma related to the approval, in accordance with the U.S. commercialization agreement between the two companies and recorded as license revenue.</div>
              </td>
            </tr>

        </table>
      </div>
      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 12pt; margin-bottom: 12pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zc4dfe24728d5425e93f7d2e1ef055a63">

            <tr>
              <td style="width: 36pt; vertical-align: top; align: right;">
                <div style="margin-left: 18pt; line-height: 1.25;">&#8226;</div>
              </td>
              <td style="width: auto; vertical-align: top;">
                <div style="line-height: 1.25;">Following the introduction of TWYNEO by Galderma at the Annual Meeting of the American Academy of Dermatology, March 25-29 in Boston, MA, Sol-Gel announced TYWNEO was made commercially available to the U.S.
                  market.</div>
              </td>
            </tr>

        </table>
      </div>
      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 12pt; margin-bottom: 12pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z6997fcb08efc407eabaf7b0d5137ee21">

            <tr>
              <td style="width: 36pt; vertical-align: top; align: right;">
                <div style="margin-left: 18pt; line-height: 1.25;">&#8226;</div>
              </td>
              <td style="width: auto; vertical-align: top;">
                <div style="line-height: 1.25;">&#160;Both the launch of TWYNEO and the approval of EPSOLAY were covered by various trade media outlets in print, video and audio by major beauty, personal care and industry publications and media outlets
                  including <u>Allure</u> magazine, <u>Practical Dermatology</u>, <u>The Dermatologist</u>, <u>Medpagetoday.com,</u>&#160;<u>Healio.com</u>, <u>Personal Care Insights</u>, <u>Monthly Prescribing Reference (MPR)</u> and <u>Drug Topics</u>.</div>
              </td>
            </tr>

        </table>
      </div>
      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 12pt; margin-bottom: 12pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z2d509c9224fa4d33a52b7d65c8ac0846">

            <tr>
              <td style="width: 36pt; vertical-align: top; align: right;">
                <div style="margin-left: 18pt; line-height: 1.25; font-weight: bold;">&#8226;</div>
              </td>
              <td style="width: auto; vertical-align: top;">
                <div style="line-height: 1.25;">Sol-Gel plans to progress SGT-510 into a clinical trial later this year and to progress other proprietary assets into clinical studies in the first half of next year.</div>
              </td>
            </tr>

        </table>
      </div>
      <div style="line-height: 1.25; font-weight: bold;">Second Quarter Financial Results</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="line-height: 1.25;">Revenue was $3.5 million for the quarter ending June 30, 2022, received from the Company&#8217;s commercial partner, Galderma, resulting from the FDA approval of EPSOLAY and recorded as license revenue, compared to $0.9
        million of revenue for the same period in 2021 which was recorded as collaborative revenue and primarily related to sales of generic products by its partner Padagis.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="line-height: 1.25;">Research and development expenses were $2.4 million for the quarter ending June 30, 2022, compared to $6.9 million for the same period in 2021. The decrease of $4.5 million was mainly attributed to a decrease of $3.0
        million in professional expenses related to TWYNEO and EPSOLAY and a decrease of $1.5 million in research and development expenses related to previously partnered programs of generic product candidates which are now being developed by Padagis,
        offset by ongoing development of Sol-Gel&#8217;s proprietary assets.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="line-height: 1.25;">General and administrative expenses were $1.6 million for the quarter ending June 30, 2022, compared to $2.0 million for the same period in 2021. The decrease of $0.4 million was mainly attributed to winding down of
        pre-commercialization-related expenses for EPSOLAY and TWYNEO.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="line-height: 1.25;">Sol-Gel reported a loss of $0.1 million for the second quarter of 2022 compared to a loss of $8.0 million for the same period in 2021.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="line-height: 1.25;">As of June 30, 2022, Sol-Gel had $26.8 million in cash, cash equivalents and deposits, and $9.8 million in marketable securities for a total balance of $36.6 million. As a result of the Company&#8217;s agreements with
        Galderma regarding EPSOLAY and TWYNEO and the previously announced generics sale agreement with Padagis, the Company expects that its cash resources will enable funding of operational and capital expenditure requirements through the end of 2023.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="line-height: 1.25; font-weight: bold;">About&#160;EPSOLAY</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="line-height: 1.25;">EPSOLAY is a topical cream containing benzoyl peroxide, 5%, for the treatment of inflammatory lesions of rosacea in adults. EPSOLAY utilizes a proprietary technology to encapsulate benzoyl peroxide within silica-based
        microcapsules to create a barrier between the medication and the skin. The silica-based shell is designed to slowly release benzoyl peroxide over time to provide a favorable efficacy and safety profile. EPSOLAY is covered by granted patents until
        2040 as well as a pending patent application until 2041.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="line-height: 1.25;">Visit <u>www.epsolay.com</u> for further information, including full Prescribing Information.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="line-height: 1.25; font-weight: bold;">About&#160;TWYNEO</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="line-height: 1.25;">TWYNEO is a topical cream containing a fixed&#8209;dose combination of tretinoin, 0.1% and benzoyl peroxide, 3% cream for the treatment of acne vulgaris in adults and pediatric patients 9 years of age and older. TWYNEO is
        the first acne treatment that contains a fixed&#8209;dose combination of benzoyl peroxide and tretinoin. Tretinoin and benzoyl peroxide are widely prescribed separately for acne vulgaris; however, benzoyl peroxide causes degradation of the tretinoin
        molecule, thereby potentially reducing its effectiveness if used at the same time or combined in the same formulation. TWYNEO uses silica (silicon dioxide) core shell structures to separately micro-encapsulate tretinoin crystals and benzoyl
        peroxide crystals enabling inclusion of the two active ingredients in the cream. TWYNEO is patent protected until 2038.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25;">Visit <u>www.twyneo.com</u> for further information, including full Prescribing Information.</div>
      </div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="line-height: 1.25; font-weight: bold;">About&#160;Sol-Gel&#160;Technologies</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="line-height: 1.25;">Sol-Gel&#160;is a dermatology company focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. Sol-Gel leveraged its proprietary microencapsulation
        technology platform for TWYNEO, which is approved for the treatment of acne vulgaris in adults and pediatric patients nine years of age and older; and EPSOLAY, which is approved for the treatment of inflammatory lesions of rosacea in adults. Both
        drugs are exclusively licensed to Galderma for&#160;U.S.&#160;commercialization. Founded in 1981, Galderma is the world&#8217;s largest independent dermatology company.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="line-height: 1.25;">The Company&#8217;s pipeline also includes topical drug candidates SGT-210, SGT-310 and SGT-510 under investigation for the treatment of&#160;plaque psoriasis and other dermatologic indications.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="line-height: 1.25;">For additional information, please visit&#160;<u>www.sol-gel.com</u>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="line-height: 1.25; font-weight: bold;">Forward-Looking&#160;Statements</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="line-height: 1.25; font-style: italic;">This press release contains &#8220;forward-looking statements&#8221; within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this press release that do not relate
        to matters of historical fact should be considered forward-looking statements, including, but not limited to, statements regarding the benefits we expect to receive under our agreement with Galderma; expected net sales and royalty income in line
        with volume growth of EPSOLAY and/or TWYNEO; and our expected cash runway. These forward-looking statements include information about possible or assumed future results of our business, financial condition, results of operations, liquidity, plans
        and objectives. In some cases, you can identify forward-looking statements by terminology such as &#8220;believe,&#8221; &#8220;may,&#8221; &#8220;estimate,&#8221; &#8220;continue,&#8221; &#8220;anticipate,&#8221; &#8220;intend,&#8221; &#8220;should,&#8221; &#8220;plan,&#8221; &#8220;expect,&#8221; &#8220;predict,&#8221; &#8220;potential,&#8221; or the negative of these terms
        or other similar expressions. Forward-looking statements are based on information we have when those statements are made or our management&#8217;s current expectations and are subject to risks and uncertainties that could cause actual performance or
        results to differ materially from those expressed in or suggested by the forward-looking statements. Important factors that could cause such differences include, but are not limited to, the risk that we will not receive all of the anticipated
        benefits under our agreement with Galderma, the risk that EPSOLAY and/or TWYNEO will not provide treatment to the number of patients anticipated, risks relating to the effects of COVID-19 (coronavirus) as well as the following factors: (i) the
        adequacy of our financial and other resources, particularly in light of our history of recurring losses and the uncertainty regarding the adequacy of our liquidity to pursue our complete business objectives; (ii) our ability to complete the
        development of our product candidates; (iii) our ability to find suitable co-development partners; (iv) our ability to obtain and maintain regulatory approvals for our product candidates in our target markets, the potential delay in receiving such
        regulatory approvals and the possibility of adverse regulatory or legal actions relating to our product candidates even if regulatory approval is obtained; (v) our ability to commercialize our pharmaceutical product candidates; (vi) our ability to
        obtain and maintain adequate protection of our intellectual property; (vii) our ability to manufacture our product candidates in commercial quantities, at an adequate quality or at an acceptable cost; (viii) our ability to establish adequate sales,
        marketing and distribution channels; (ix) acceptance of our product candidates by healthcare professionals and patients; (x) the possibility that we may face third-party claims of intellectual property infringement; (xi) the timing and results of
        clinical trials that we may conduct or that our competitors and others may conduct relating to our or their products; (xii) intense competition in our industry, with competitors having substantially greater financial, technological, research and
        development, regulatory and clinical, manufacturing, marketing and sales, distribution and personnel resources than we do; (xiii) potential product liability claims; (xiv) potential adverse federal, state and local government regulation in the
        United States, Europe or Israel; and (xv) loss or retirement of key executives and research scientists. These and other important factors discussed in the Company's Annual Report on Form 20-F filed with the Securities and Exchange Commission
        (&#8220;SEC&#8221;) on April 4, 2022, as amended, and our other reports filed with the SEC could cause actual results to differ materially from those indicated by the forward-looking statements made in this press release. Except as required by law, we
        undertake no obligation to update any forward-looking statements in this press release.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="line-height: 1.25; font-weight: bold;">For further information, please contact:</div>
      <div style="line-height: 1.25">&#160; <br>
      </div>
      <div style="line-height: 1.25; font-weight: bold;">Investors:</div>
      <div style="line-height: 1.25">&#160; <br>
      </div>
      <div style="line-height: 1.25;">Irina Koffler<br>
        Investor relations, LifeSci Advisors<br>
        <u>ikoffler@lifesciadvisors.com</u><br>
        +1 917 734 7387</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="line-height: 1.25; font-weight: bold;">Sol-Gel Technologies</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="line-height: 1.25;">Gilad Mamlok<br>
        Chief Financial Officer<br>
        <u>gilad.mamlok@sol-gel.com</u></div>
      <div style="line-height: 1.25">&#160;</div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: center; line-height: 1.25;"><font style="font-weight: bold;">SOL-GEL TECHNOLOGIES LTD.</font><br>
        <font style="font-weight: bold;">CONSOLIDATED BALANCE SHEETS</font><br>
        (U.S. dollars in thousands, except share and per share data)<br>
        (Unaudited)</div>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" class="cfttable" id="zcfb9e4f0faf14cddbbb6bab8c974d4b1" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000; width: 100%;">

          <tr>
            <td valign="bottom" style="vertical-align: top;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom;">&#160;</td>
            <td valign="bottom" colspan="2" style="vertical-align: bottom;">
              <div style="text-align: center; line-height: 1.25; font-weight: bold;">December 31,</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom;">&#160;</td>
            <td valign="bottom" colspan="2" style="vertical-align: bottom;">
              <div style="text-align: center; line-height: 1.25; font-weight: bold;">June 30,</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: top; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;"><font style="line-height: 1.25;"> </font></div>
                <div style="text-align: center; line-height: 1.25; font-weight: bold;">2021</div>
                <div style="line-height: 1.25;"><font style="line-height: 1.25;"> </font></div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;"><font style="line-height: 1.25;"> </font></div>
                <div style="text-align: center; line-height: 1.25; font-weight: bold;">2022</div>
                <div style="line-height: 1.25;"><font style="line-height: 1.25;"> </font></div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: center; line-height: 1.25; font-weight: bold;">A s s e t s</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" colspan="2" style="vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" colspan="2" style="vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: top;">
              <div style="line-height: 1.25;"><font style="font-weight: bold;">CURRENT ASSETS</font>:</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom;">&#160;</td>
            <td valign="bottom" colspan="2" style="vertical-align: top;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom;">&#160;</td>
            <td valign="bottom" colspan="2" style="vertical-align: top;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);">
              <div style="text-indent: 14.2pt; line-height: 1.25;">Cash and cash equivalents</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">$</div>
            </td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">20,085</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">$</div>
            </td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">5,765</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: top; width: 76%;">
              <div style="text-indent: 14.2pt; line-height: 1.25;">Bank deposits</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div style="line-height: 1.25;">21,448</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div style="line-height: 1.25;">21,000</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);">
              <div style="text-indent: 14.2pt; line-height: 1.25;">Marketable securities</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">1,709</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">9,846</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 76%;">
              <div style="text-indent: 14.2pt; line-height: 1.25;">Receivables from collaborative arrangements</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div style="line-height: 1.25;">13,065</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div style="line-height: 1.25;">10,176</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
              <div style="text-indent: 14.2pt; line-height: 1.25;">Prepaid expenses and other current assets</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;"><font style="line-height: 1.25;"></font></div>
                <div style="line-height: 1.25;">800</div>
                <div style="line-height: 1.25;"><font style="line-height: 1.25;"></font></div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;"><font style="line-height: 1.25;"></font></div>
                <div style="line-height: 1.25;">1,691</div>
                <div style="line-height: 1.25;"><font style="line-height: 1.25;"></font></div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px;">
              <div style="line-height: 1.25; font-weight: bold;">TOTAL&#160; CURRENT ASSETS</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;"><font style="line-height: 1.25;"></font></div>
                <div style="line-height: 1.25;">57,107</div>
                <div style="line-height: 1.25;"><font style="line-height: 1.25;"></font></div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;"><font style="line-height: 1.25;"></font></div>
                <div style="line-height: 1.25;">48,478</div>
                <div style="line-height: 1.25;"><font style="line-height: 1.25;"></font></div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: top; width: 76%;">
              <div style="line-height: 1.25; font-weight: bold;">NON-CURRENT ASSETS:</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">&#160;&#160;&#160;&#160;&#160;&#160;Long-term receivables from collaborative arrangements</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">7,402</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">2,499</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 76%;">
              <div style="text-indent: 14.2pt; line-height: 1.25;">Restricted long-term deposits and cash</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div style="line-height: 1.25;">1,298</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div style="line-height: 1.25;">1,289</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);">
              <div style="text-indent: 14.2pt; line-height: 1.25;">Property and equipment, net</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">1,051</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">826</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 76%;">
              <div style="text-indent: 14.2pt; line-height: 1.25;">Operating lease right-of-use assets</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div style="line-height: 1.25;">1,501</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div style="line-height: 1.25;">1,153</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
              <div style="text-indent: 14.2pt; line-height: 1.25;">Funds in respect of employee rights upon retirement</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;"><font style="line-height: 1.25;"></font></div>
                <div style="line-height: 1.25;">830</div>
                <div style="line-height: 1.25;"><font style="line-height: 1.25;"></font></div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;"><font style="line-height: 1.25;"></font></div>
                <div style="line-height: 1.25;">738</div>
                <div style="line-height: 1.25;"><font style="line-height: 1.25;"></font></div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px;">
              <div style="line-height: 1.25; font-weight: bold;">TOTAL&#160; NON-CURRENT ASSETS</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;"><font style="line-height: 1.25;"></font></div>
                <div style="line-height: 1.25;">12,082</div>
                <div style="line-height: 1.25;"><font style="line-height: 1.25;"></font></div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;"><font style="line-height: 1.25;"></font></div>
                <div style="line-height: 1.25;">6,505</div>
                <div style="line-height: 1.25;"><font style="line-height: 1.25;"></font></div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 4px;">
              <div style="line-height: 1.25; font-weight: bold;">TOTAL&#160; ASSETS</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;">$</div>
              </div>
            </td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;">69,189</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;">$</div>
              </div>
            </td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;">54,983</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);">
              <div style="text-align: center; line-height: 1.25; font-weight: bold;">Liabilities and shareholders' equity</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: top; width: 76%;">
              <div style="line-height: 1.25; font-weight: bold;">CURRENT LIABILITIES:</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);">
              <div style="text-indent: 14.2pt; line-height: 1.25;">Accounts payable</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">$</div>
            </td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">766</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">$</div>
            </td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">860</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 76%;">
              <div style="text-indent: 14.2pt; line-height: 1.25;">Other accounts payable</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div style="line-height: 1.25;">10,145</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div style="line-height: 1.25;">1,664</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
              <div style="text-indent: 14.2pt; line-height: 1.25;">Current maturities of operating leases</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;"><font style="line-height: 1.25;"></font></div>
                <div style="line-height: 1.25;">781</div>
                <div style="line-height: 1.25;"><font style="line-height: 1.25;"></font></div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;"><font style="line-height: 1.25;"></font></div>
                <div style="line-height: 1.25;">701</div>
                <div style="line-height: 1.25;"><font style="line-height: 1.25;"></font></div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px;">
              <div style="line-height: 1.25; font-weight: bold;">TOTAL&#160; CURRENT LIABILITIES</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;"><font style="line-height: 1.25;"></font></div>
                <div style="line-height: 1.25;">11,692</div>
                <div style="line-height: 1.25;"><font style="line-height: 1.25;"></font></div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;"><font style="line-height: 1.25;"></font></div>
                <div style="line-height: 1.25;">3,225</div>
                <div style="line-height: 1.25;"><font style="line-height: 1.25;"></font></div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: top; width: 76%;">
              <div style="line-height: 1.25; font-weight: bold;">LONG-TERM LIABILITIES</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);">
              <div style="text-indent: 14.2pt; line-height: 1.25;">Operating leases liabilities</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">810</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">369</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px;">
              <div style="text-indent: 14.2pt; line-height: 1.25;">Liability for employee rights upon retirement</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;"><font style="line-height: 1.25;"></font></div>
                <div style="line-height: 1.25;">1,093</div>
                <div style="line-height: 1.25;"><font style="line-height: 1.25;"></font></div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;"><font style="line-height: 1.25;"></font></div>
                <div style="line-height: 1.25;">1,038</div>
                <div style="line-height: 1.25;"><font style="line-height: 1.25;"></font></div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25; font-weight: bold;">TOTAL&#160; LONG-TERM LIABILITIES</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;"><font style="line-height: 1.25;"></font></div>
                <div style="line-height: 1.25;">1,903</div>
                <div style="line-height: 1.25;"><font style="line-height: 1.25;"></font></div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;"><font style="line-height: 1.25;"></font></div>
                <div style="line-height: 1.25;">1,407</div>
                <div style="line-height: 1.25;"><font style="line-height: 1.25;"></font></div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px;">
              <div style="line-height: 1.25; font-weight: bold;">TOTAL&#160; LIABILITIES</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;">$</div>
              </div>
            </td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;">13,595</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;">$</div>
              </div>
            </td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;">4,632</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 76%;">
              <div style="text-indent: -16.149pt; margin-left: 16.149pt; line-height: 1.25; font-weight: bold;">SHAREHOLDERS' EQUITY:</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: top; width: 76%; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">Ordinary Shares, NIS 0.1 par value &#8211; authorized: 50,000,000 as of December 31, 2021 and June 30, 2022; issued and outstanding: 23,126,804 and 23,129,469 as of December 31, 2021 and June 30, 2022, respectively.</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">638</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">638</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: top; width: 76%;">
              <div style="text-indent: 14.2pt; line-height: 1.25;">Additional paid-in capital</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div style="line-height: 1.25;">233,098</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div style="line-height: 1.25;">233,586</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
              <div style="text-indent: 14.2pt; line-height: 1.25;">Accumulated deficit</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;">(178,142</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;">)</div>
              </div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;">(183,873</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;">)</div>
              </div>
            </td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 2px;">
              <div style="text-indent: -20.35pt; margin-left: 20.35pt; line-height: 1.25; font-weight: bold;">TOTAL SHAREHOLDERS' EQUITY</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;"><font style="line-height: 1.25;"></font></div>
                <div style="line-height: 1.25;">55,594</div>
                <div style="line-height: 1.25;"><font style="line-height: 1.25;"></font></div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;"><font style="line-height: 1.25;"></font></div>
                <div style="line-height: 1.25;">50,351</div>
                <div style="line-height: 1.25;"><font style="line-height: 1.25;"></font></div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: top; width: 76%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25; font-weight: bold;">TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;">$</div>
              </div>
            </td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;">69,189</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;">$</div>
              </div>
            </td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;">54,983</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: center; line-height: 1.25;"><font style="font-weight: bold;">SOL-GEL TECHNOLOGIES LTD.</font><br>
        <font style="font-weight: bold;">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</font><br>
        (U.S. dollars in thousands, except share and per share data)<br>
        (Unaudited)</div>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" class="cfttable" id="zb1edd298d4e44e3da91ed149671a5cdc" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000; width: 100%;">

          <tr>
            <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;"><font style="line-height: 1.25;"> </font></div>
                <div style="text-align: center; line-height: 1.25; font-weight: bold; text-indent: 1pt;">Six months ended</div>
                <div style="text-align: center; line-height: 1.25; font-weight: bold; text-indent: 1pt;">June 30</div>
                <div style="line-height: 1.25;"><font style="line-height: 1.25;"> </font></div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;"><font style="line-height: 1.25;"> </font></div>
                <div style="text-align: center; line-height: 1.25; font-weight: bold; text-indent: 1pt;">Three months ended</div>
                <div style="text-align: center; line-height: 1.25; font-weight: bold; text-indent: 1pt;">June 30</div>
                <div style="line-height: 1.25;"><font style="line-height: 1.25;"> </font></div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;"><font style="line-height: 1.25;"> </font></div>
                <div style="text-align: center; line-height: 1.25; font-weight: bold; text-indent: 1pt;">2021</div>
                <div style="line-height: 1.25;"><font style="line-height: 1.25;"> </font></div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;"><font style="line-height: 1.25;"> </font></div>
                <div style="text-align: center; line-height: 1.25; font-weight: bold; text-indent: 1pt;">2022</div>
                <div style="line-height: 1.25;"><font style="line-height: 1.25;"> </font></div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;"><font style="line-height: 1.25;"> </font></div>
                <div style="text-align: center; line-height: 1.25; font-weight: bold; text-indent: 1pt;">2021</div>
                <div style="line-height: 1.25;"><font style="line-height: 1.25;"> </font></div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;"><font style="line-height: 1.25;"> </font></div>
                <div style="text-align: center; line-height: 1.25; font-weight: bold; text-indent: 1pt;">2022</div>
                <div style="line-height: 1.25;"><font style="line-height: 1.25;"> </font></div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255);">
              <div style="text-indent: -14.2pt; margin-left: 15.9pt; line-height: 1.25; font-weight: bold;">COLLABORATION REVENUES</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">$</div>
            </td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">1,629</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">-</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">$</div>
            </td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">928</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">-</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 52%; padding-bottom: 2px;">
              <div style="text-indent: -14.2pt; margin-left: 15.9pt; line-height: 1.25; font-weight: bold;">LICENSE REVENUES</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;"><font style="line-height: 1.25;"></font></div>
                <div style="line-height: 1.25;">-</div>
                <div style="line-height: 1.25;"><font style="line-height: 1.25;"></font></div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;"><font style="line-height: 1.25;"></font></div>
                <div style="line-height: 1.25;">3,521</div>
                <div style="line-height: 1.25;"><font style="line-height: 1.25;"></font></div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;"><font style="line-height: 1.25;"></font></div>
                <div style="line-height: 1.25;">-</div>
                <div style="line-height: 1.25;"><font style="line-height: 1.25;"></font></div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;"><font style="line-height: 1.25;"></font></div>
                <div style="line-height: 1.25;">3,518</div>
                <div style="line-height: 1.25;"><font style="line-height: 1.25;"></font></div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255);">
              <div style="text-indent: -14.2pt; margin-left: 15.9pt; line-height: 1.25; font-weight: bold;">TOTAL REVENUES</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">$</div>
            </td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">1,629</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">$</div>
            </td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">3,521</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">$</div>
            </td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">928</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">$</div>
            </td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">3,518</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 52%;">
              <div style="text-indent: -14.2pt; margin-left: 15.9pt; line-height: 1.25; font-weight: bold;">RESEARCH AND DEVELOPMENT EXPENSES</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div style="line-height: 1.25;">9,399</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div style="line-height: 1.25;">6,422</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div style="line-height: 1.25;">6,933</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div style="line-height: 1.25;">2,380</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 52%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
              <div style="text-indent: -14.2pt; margin-left: 15.9pt; line-height: 1.25; font-weight: bold;">GENERAL AND ADMINISTRATIVE EXPENSES</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;"><font style="line-height: 1.25;"></font></div>
                <div style="line-height: 1.25;">4,496</div>
                <div style="line-height: 1.25;"><font style="line-height: 1.25;"></font></div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;"><font style="line-height: 1.25;"></font></div>
                <div style="line-height: 1.25;">3,512</div>
                <div style="line-height: 1.25;"><font style="line-height: 1.25;"></font></div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;"><font style="line-height: 1.25;"></font></div>
                <div style="line-height: 1.25;">2,037</div>
                <div style="line-height: 1.25;"><font style="line-height: 1.25;"></font></div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;"><font style="line-height: 1.25;"></font></div>
                <div style="line-height: 1.25;">1,601</div>
                <div style="line-height: 1.25;"><font style="line-height: 1.25;"></font></div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 52%;">
              <div style="text-indent: -14.2pt; margin-left: 15.9pt; line-height: 1.25; font-weight: bold;">TOTAL OPERATING LOSS</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div style="line-height: 1.25;">12,266</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div style="line-height: 1.25;">6,413</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div style="line-height: 1.25;">8,042</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div style="line-height: 1.25;">463</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 52%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
              <div style="text-indent: -14.2pt; margin-left: 15.9pt; line-height: 1.25;"><font style="font-weight: bold;">FINANCIAL INCOME, </font>net</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;">(170</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;">)</div>
              </div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;">(682</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;">)</div>
              </div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;">(9</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;">)</div>
              </div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;">(329</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;">)</div>
              </div>
            </td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 52%; padding-bottom: 4px;">
              <div style="text-indent: -14.2pt; margin-left: 15.9pt; line-height: 1.25; font-weight: bold;">LOSS FOR THE PERIOD</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;">$</div>
              </div>
            </td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;">12,096</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;">$</div>
              </div>
            </td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;">5,731</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;">$</div>
              </div>
            </td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;">8,033</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;">$</div>
              </div>
            </td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;">134</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 52%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">
              <div style="text-indent: -14.2pt; margin-left: 15.9pt; line-height: 1.25; font-weight: bold;">BASIC AND DILUTED LOSS PER ORDINARY SHARE</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;">$</div>
              </div>
            </td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;">0.53</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;">$</div>
              </div>
            </td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;">0.25</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;">$</div>
              </div>
            </td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;">0.35</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;">$</div>
              </div>
            </td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;">0.01</div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 52%; padding-bottom: 4px;">
              <div style="text-indent: -14.2pt; margin-left: 15.9pt; line-height: 1.25; font-weight: bold;">WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING USED IN COMPUTATION OF BASIC AND DILUTED LOSS PER SHARE</div>
            </td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;"><font style="line-height: 1.25;"></font></div>
                <div style="line-height: 1.25;">23,016,104</div>
                <div style="line-height: 1.25;"><font style="line-height: 1.25;"></font></div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;"><font style="line-height: 1.25;"></font></div>
                <div style="line-height: 1.25;">23,127,958</div>
                <div style="line-height: 1.25;"><font style="line-height: 1.25;"></font></div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;"><font style="line-height: 1.25;"></font></div>
                <div style="line-height: 1.25;">23,028,508</div>
                <div style="line-height: 1.25;"><font style="line-height: 1.25;"></font></div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
            <td valign="bottom" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
            <td valign="bottom" class="cftcurrcell" colspan="1" style="vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);">&#160;</td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;"><font style="line-height: 1.25;"></font></div>
                <div style="line-height: 1.25;">23,128,429</div>
                <div style="line-height: 1.25;"><font style="line-height: 1.25;"></font></div>
              </div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <div style="line-height: 1.25;">
        <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
      <div style="line-height: 1.25">&#160;</div>
    </div>
    <br>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>exhibit_99-2.htm
<DESCRIPTION>EXHIBIT 99.2
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>
<!--INTEGIX by Ez-XBRL--><html xmlns="http://www.w3.org/1999/xhtml" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2022-02-16" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:us-types="http://fasb.org/us-types/2021-01-31" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:currency="http://xbrl.sec.gov/currency/2022" xmlns:exch="http://xbrl.sec.gov/exch/2022" xmlns:naics="http://xbrl.sec.gov/naics/2022" xmlns:sic="http://xbrl.sec.gov/sic/2022" xmlns:stpr="http://xbrl.sec.gov/stpr/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:srt-types="http://fasb.org/srt-types/2022" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:slgl="http://www.sol-gel.co/20220630"  ><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/><title>Sol-Gel Technologies Ltd. - 1684693 - 2022</title></head><body style="font-size:10pt;font-family:Times New Roman;">
        <div style="display:none">
        <ix:header><ix:hidden><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="C_20220101to20220630_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"  id="Fxbrl_20220802203243985_Fact_126" unitRef="usd"  xsi:nil="true"></ix:nonFraction><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" contextRef="C_20210101to20210630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"  id="Fxbrl_20220802203330582" unitRef="usd"  xsi:nil="true"></ix:nonFraction><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" contextRef="C_20210101to20210630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"  id="Fxbrl_20220802203340661" unitRef="usd"  xsi:nil="true"></ix:nonFraction><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="C_20210101to20210630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"  id="Fxbrl_20220802203405739" unitRef="usd"  xsi:nil="true"></ix:nonFraction><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="C_20220101to20220630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"  id="Fxbrl_20220802203425221" unitRef="usd"  xsi:nil="true"></ix:nonFraction><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="C_20220401to20220630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"  id="Fxbrl_20220802203547323" unitRef="usd"  xsi:nil="true"></ix:nonFraction><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="C_20210401to20210630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"  id="Fxbrl_20220802203910105" unitRef="usd"  xsi:nil="true"></ix:nonFraction><ix:footnote id="FN20220721214244043" xml:lang="en-US">Investments in Corporate bonds rated A or higher.</ix:footnote>
</ix:hidden>
<ix:references>
        <link:schemaRef xlink:type="simple" xlink:href="slgl-20220630.xsd"/>
        </ix:references><ix:resources><xbrli:context id="C_20220630"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001684693</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20220630"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001684693</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001684693</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20210630_srtProductOrServiceAxis_slglCollabrationsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001684693</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">slgl:CollabrationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20220630_srtProductOrServiceAxis_slglCollabrationsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001684693</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">slgl:CollabrationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210401to20210630_srtProductOrServiceAxis_slglCollabrationsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001684693</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">slgl:CollabrationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220401to20220630_srtProductOrServiceAxis_slglCollabrationsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001684693</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">slgl:CollabrationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20210630"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001684693</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210401to20210630"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001684693</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220401to20220630"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001684693</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220401to20220630_srtProductOrServiceAxis_usgaapLicenseMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001684693</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210401to20210630_srtProductOrServiceAxis_usgaapLicenseMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001684693</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20220630_srtProductOrServiceAxis_usgaapLicenseMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001684693</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20210630_srtProductOrServiceAxis_usgaapLicenseMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001684693</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20070101to20071231_srtRangeAxis_srtMinimumMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001684693</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2007-01-01</xbrli:startDate>
        <xbrli:endDate>2007-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20070101to20071231_srtRangeAxis_srtMaximumMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001684693</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2007-01-01</xbrli:startDate>
        <xbrli:endDate>2007-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211101"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001684693</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-11-01</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211101to20211101"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001684693</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2021-11-01</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220401to20220425_srtProductOrServiceAxis_slglEpsolayMember_usgaapTypeOfArrangementAxis_slglLicenseAgreementsWithGaldermaMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001684693</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">slgl:EpsolayMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">slgl:LicenseAgreementsWithGaldermaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-04-25</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220531_usgaapTypeOfArrangementAxis_slglLicenseAgreementsWithGaldermaMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001684693</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">slgl:LicenseAgreementsWithGaldermaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-05-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210930_srtProductOrServiceAxis_slglTwyneoMember_usgaapTypeOfArrangementAxis_slglLicenseAgreementsWithGaldermaMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001684693</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">slgl:TwyneoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">slgl:LicenseAgreementsWithGaldermaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210930_srtProductOrServiceAxis_slglEpsolayMember_usgaapTypeOfArrangementAxis_slglLicenseAgreementsWithGaldermaMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001684693</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">slgl:EpsolayMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">slgl:LicenseAgreementsWithGaldermaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220301to20220331"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001684693</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-03-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20210630_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001684693</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20210630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001684693</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20210630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001684693</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210630"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001684693</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210630_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001684693</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001684693</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001684693</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20220630_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001684693</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20220630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001684693</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20220630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001684693</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220630_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001684693</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001684693</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001684693</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001684693</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001684693</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001684693</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210401to20210630_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001684693</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210401to20210630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001684693</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210401to20210630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001684693</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220401to20220630_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001684693</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220401to20220630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001684693</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220401to20220630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001684693</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220331"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001684693</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220331_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001684693</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220331_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001684693</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001684693</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20201231"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001684693</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20201231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001684693</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20201231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001684693</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20201231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001684693</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210331"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001684693</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-03-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210331_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001684693</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-03-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210331_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001684693</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-03-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001684693</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-03-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220101to20220630_srtTitleOfIndividualAxis_slglEmployeesAndExecutiveOfficersMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001684693</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">slgl:EmployeesAndExecutiveOfficersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220301to20220331_srtTitleOfIndividualAxis_slglEmployeesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001684693</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">slgl:EmployeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-03-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220331_srtTitleOfIndividualAxis_slglEmployeesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001684693</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">slgl:EmployeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220301to20220331_srtTitleOfIndividualAxis_srtExecutiveOfficerMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001684693</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ExecutiveOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-03-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220331_srtTitleOfIndividualAxis_srtExecutiveOfficerMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001684693</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ExecutiveOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220301to20220331_srtTitleOfIndividualAxis_srtChiefExecutiveOfficerMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001684693</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-03-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220331_srtTitleOfIndividualAxis_srtChiefExecutiveOfficerMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001684693</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210701to20210731_usgaapRelatedPartyTransactionsByRelatedPartyAxis_slglJefferiesLlcMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001684693</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">slgl:JefferiesLlcMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-07-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220401to20220430_usgaapRelatedPartyTransactionsByRelatedPartyAxis_slglJefferiesLlcMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001684693</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">slgl:JefferiesLlcMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:startDate>2022-04-01</xbrli:startDate>
        <xbrli:endDate>2022-04-30</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_usgaapInvestmentTypeAxis_usgaapUSGovernmentCorporationsAndAgenciesSecuritiesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001684693</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220630_usgaapInvestmentTypeAxis_usgaapUSGovernmentCorporationsAndAgenciesSecuritiesMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001684693</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_usgaapInvestmentTypeAxis_slglOtherForeignGovernmentBondsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001684693</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">slgl:OtherForeignGovernmentBondsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20211231_usgaapInvestmentTypeAxis_usgaapAllOtherCorporateBondsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001684693</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:AllOtherCorporateBondsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220630_usgaapInvestmentTypeAxis_usgaapAllOtherCorporateBondsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001684693</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:AllOtherCorporateBondsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:context id="C_20210101to20211231"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001684693</xbrli:identifier></xbrli:entity><xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
        </xbrli:period></xbrli:context><xbrli:context id="C_20220630_usgaapInvestmentTypeAxis_slglOtherForeignGovernmentBondsMember"><xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001684693</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">slgl:OtherForeignGovernmentBondsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
        </xbrli:period></xbrli:context><xbrli:unit id="Agreement"><xbrli:measure>slgl:Agreement</xbrli:measure></xbrli:unit>
<xbrli:unit id="Candidate"><xbrli:measure>slgl:Candidate</xbrli:measure></xbrli:unit>
<xbrli:unit id="ILSPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:ILS</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit>
<xbrli:unit id="Instalment"><xbrli:measure>slgl:Instalment</xbrli:measure></xbrli:unit>
<xbrli:unit id="Program"><xbrli:measure>slgl:Program</xbrli:measure></xbrli:unit>
<xbrli:unit id="Shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit>
<xbrli:unit id="USDPShares"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit>
<xbrli:unit id="pure"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit>
<xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit>
<ix:relationship fromRefs="Fxbrl_20220802203330582" toRefs="FN20220802204601537"/><ix:relationship fromRefs="Fxbrl_20220802203340661" toRefs="FN20220802204601537"/><ix:relationship fromRefs="Fxbrl_20220802203405739" toRefs="FN20220802204601537"/><ix:relationship fromRefs="Fxbrl_20220802203425221" toRefs="FN20220802204601537"/><ix:relationship fromRefs="Fxbrl_20220802203547323" toRefs="FN20220802204601537"/><ix:relationship fromRefs="Fxbrl_20220802203910105" toRefs="FN20220802204601537"/><ix:relationship fromRefs="FFact_257" toRefs="FN20220721214244043"/><ix:relationship fromRefs="FFact_258" toRefs="FN20220721214244043"/></ix:resources></ix:header></div><div><div><div><div style="line-height:1.25"><hr style="border:none;border-bottom:1px solid black;border-top:4px solid black;height:10px;color:#ffffff;background-color:#ffffff;text-align:center;margin-left:auto;margin-right:auto;text-align:center" /></div></div><div style="line-height:1.25;text-align:right"><p style="margin:0pt">&#160;</p><span style="text-decoration:underline"><strong><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exhibit 99.2</span></span></strong></span></div><div style="text-align:center;line-height:1.25;font-weight:bold"><p style="margin:0pt">&#160;</p><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">SOL-GEL TECHNOLOGIES LTD.</span></span></div><div style="line-height:1.25">&#160;</div><div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></span></div><div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">AS OF JUNE 30, 2022</span></span></div><div style="clear:both;margin-top:10pt;margin-bottom:10pt"><div style="page-break-after:always"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div><div style="line-height:1.25">&#160;</div><div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">SOL-GEL TECHNOLOGIES LTD.</span></span></div><div style="line-height:1.25">&#160;</div><div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">UNAUDITED CONDENSED</span></span></div><div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">CONSOLIDATED FINANCIAL STATEMENTS</span></span></div><div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">AS OF JUNE 30, 2022</span></span></div><div style="line-height:1.25">&#160;</div><div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">TABLE OF CONTENTS</span></span></div><div style="line-height:1.25">&#160;</div><table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"><tr><td style="width:86.63%;vertical-align:top">&#160;</td><td style="width:13.37%;vertical-align:top"><div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Page</span></span></div></td></tr><tr><td style="width:86.63%;vertical-align:top"><div style="text-indent:-14pt;margin-right:17pt;margin-left:14pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">CONDENSED CONSOLIDATED FINANCIAL STATEMENTS:</span></span></div></td><td style="width:13.37%;vertical-align:top">&#160;</td></tr><tr><td style="width:86.63%;vertical-align:top"><div style="text-indent:6.35pt;margin-right:17pt;margin-left:7.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="#BALANCESHEETS">Balance Sheets</a></span></span></div></td><td style="width:13.37%;vertical-align:top"><div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">F-2</span></span></div></td></tr><tr><td style="width:86.63%;vertical-align:top"><div style="text-indent:6.35pt;margin-right:17pt;margin-left:7.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="#STATEMENTSOFOPERATIONS">Statements of Operations</a></span></span></div></td><td style="width:13.37%;vertical-align:top"><div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">F-3</span></span></div></td></tr><tr><td style="width:86.63%;vertical-align:top"><div style="text-indent:6.35pt;margin-right:17pt;margin-left:7.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="#SHAREHOLDERSEQUITY">Statements of Changes in Shareholders' Equity</a></span></span></div></td><td style="width:13.37%;vertical-align:top"><div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">F-4 - F-5</span></span></div></td></tr><tr><td style="width:86.63%;vertical-align:top"><div style="text-indent:6.35pt;margin-right:17pt;margin-left:7.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="#CASHFLOWS">Statements of Cash Flows</a></span></span></div></td><td style="width:13.37%;vertical-align:top"><div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">F-6</span></span></div></td></tr><tr><td style="width:86.63%;vertical-align:top"><div style="text-indent:6.35pt;margin-right:17pt;margin-left:7.65pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><a href="#FINANCIALSTATEMENTS">Notes to the Financial Statements</a></span></span></div></td><td style="width:13.37%;vertical-align:top"><div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">F-7 - F-12</span></span></div></td></tr></table><div style="line-height:1.25">&#160;</div><div style="line-height:1.25"><hr style="height:1px;width:17%;color:#000000;background-color:#000000;text-align:center;margin-left:auto;margin-right:auto;border:none;text-align:center" /></div><div style="line-height:1.25"><hr style="height:1px;width:20%;color:#000000;background-color:#000000;text-align:center;margin-left:auto;margin-right:auto;border:none;text-align:center" /><div><hr style="height:1px;width:17%;color:#000000;background-color:#000000;text-align:center;margin-left:auto;margin-right:auto;border:none;text-align:center" /></div></div><div style="text-align:center;line-height:1.25">&#160;</div><div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The amounts are stated in U.S. dollars in thousands, except share and per share data</span></span></div><div style="clear:both;margin-top:10pt;margin-bottom:10pt"><div style="page-break-after:always"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" /></div></div><div><div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold">&#160;</div></div></div>
  <div>
    <div>
      <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">SOL-GEL TECHNOLOGIES LTD.</span></span></div>
      <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>
      <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif"><a id="BALANCESHEETS"></a> <span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">CONDENSED CONSOLIDATED BALANCE SHEETS</span></span></div>
      <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(U.S. dollars in thousands, except share and per share data)</span></span></div>
      <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>
      <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(Unaudited)</span></span></div>
      <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left;color:#000000;width:100%">

        <tr>
          <td rowspan="1" style="vertical-align:top;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" rowspan="1" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="2" rowspan="1" style="vertical-align:top;font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December 31,</span></span></div>
          </td>
          <td colspan="1" rowspan="1" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
          <td colspan="1" rowspan="1" style="font-weight:bold;vertical-align:bottom;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="2" rowspan="1" style="vertical-align:top;font-weight:bold;font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">June 30,</span></span></div>
          </td>
          <td colspan="1" rowspan="1" style="font-weight:bold;vertical-align:bottom;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td rowspan="1" style="vertical-align:top;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="2" rowspan="1" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
          </td>
          <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
          <td colspan="1" rowspan="1" style="font-weight:bold;vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="2" rowspan="1" style="vertical-align:top;font-weight:bold;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
          </td>
          <td colspan="1" rowspan="1" style="font-weight:bold;vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">A s s e t s</span></span></div>
          </td>
          <td colspan="1" style="font-weight:bold;text-align:center;vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="2" style="vertical-align:top;font-weight:bold;text-align:center;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="font-weight:bold;background-color:rgb(204, 238, 255);vertical-align:bottom;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="text-align:center;font-weight:bold;vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="2" style="vertical-align:top;text-align:center;font-weight:bold;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="font-weight:bold;background-color:rgb(204, 238, 255);vertical-align:bottom;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top" valign="bottom">
            <div style="text-align:justify;line-height:1.25;font-family:'Palatino Linotype', serif;font-size:9pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">CURRENT ASSETS</span><span>:</span></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="2" style="vertical-align:top;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="2" style="vertical-align:top;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;background-color:rgb(204, 238, 255);width:76%;font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="text-align:justify;text-indent:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash and cash equivalents</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
          </td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_1" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="C_20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">20,085</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
          </td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_2" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="C_20220630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,765</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:76%;font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="text-align:justify;text-indent:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Bank deposits</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_3" name="us-gaap:DepositsAssetsCurrent" contextRef="C_20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">21,448</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_4" name="us-gaap:DepositsAssetsCurrent" contextRef="C_20220630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">21,000</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;background-color:rgb(204, 238, 255);width:76%;font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="text-align:justify;text-indent:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Marketable securities</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_5" name="us-gaap:MarketableSecuritiesCurrent" contextRef="C_20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,709</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_6" name="us-gaap:MarketableSecuritiesCurrent" contextRef="C_20220630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,846</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:76%;font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="text-align:justify;text-indent:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Receivables from collaborative arrangements</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_7" name="us-gaap:ReceivablesNetCurrent" contextRef="C_20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,065</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_8" name="us-gaap:ReceivablesNetCurrent" contextRef="C_20220630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,176</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:76%;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="text-align:justify;text-indent:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Prepaid expenses and other current assets</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_9" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="C_20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">800</ix:nonFraction></span></span></div>
            </div>
          </td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_10" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="C_20220630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,691</ix:nonFraction></span></span></div>
            </div>
          </td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:76%;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="text-align:justify;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">TOTAL CURRENT ASSETS</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_11" name="us-gaap:AssetsCurrent" contextRef="C_20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">57,107</ix:nonFraction></span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_12" name="us-gaap:AssetsCurrent" contextRef="C_20220630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">48,478</ix:nonFraction></span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;background-color:rgb(204, 238, 255);width:76%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:76%;font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="text-align:justify;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NON-CURRENT ASSETS:</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;background-color:rgb(204, 238, 255);width:76%;font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="text-align:justify;text-indent:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Long-term receivables from collaborative arrangements</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220721161311389" name="us-gaap:AccountsReceivableNetNoncurrent" contextRef="C_20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,402</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220721161335019" name="us-gaap:AccountsReceivableNetNoncurrent" contextRef="C_20220630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,499</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:76%;font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="text-align:justify;text-indent:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Restricted long-term deposits and cash</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_13" name="us-gaap:RestrictedCashAndInvestmentsNoncurrent" contextRef="C_20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,298</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_14" name="us-gaap:RestrictedCashAndInvestmentsNoncurrent" contextRef="C_20220630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,289</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:76%;font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="text-align:justify;text-indent:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Property and equipment, net</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_15" name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="C_20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,051</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_16" name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="C_20220630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">826</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:76%;font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="text-align:justify;text-indent:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Operating lease right-of-use assets</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_17" name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="C_20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,501</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_18" name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="C_20220630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,153</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:76%;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="text-align:justify;text-indent:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Funds in respect of employee rights upon retirement</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_19" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" contextRef="C_20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">830</ix:nonFraction></span></span></div>
            </div>
          </td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_20" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" contextRef="C_20220630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">738</ix:nonFraction></span></span></div>
            </div>
          </td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:76%;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="text-align:justify;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">TOTAL NON-CURRENT ASSETS</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_21" name="us-gaap:AssetsNoncurrent" contextRef="C_20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,082</ix:nonFraction></span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_22" name="us-gaap:AssetsNoncurrent" contextRef="C_20220630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,505</ix:nonFraction></span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;background-color:rgb(204, 238, 255);width:76%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:76%;padding-bottom:4px;font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="text-align:justify;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">TOTAL ASSETS</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_23" name="us-gaap:Assets" contextRef="C_20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">69,189</ix:nonFraction></span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_24" name="us-gaap:Assets" contextRef="C_20220630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">54,983</ix:nonFraction></span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;background-color:rgb(204, 238, 255);width:76%;font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Liabilities and shareholders' equity</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:76%;font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="text-align:justify;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">CURRENT LIABILITIES:</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:76%;font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="text-align:justify;text-indent:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Accounts payable</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
          </td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_25" name="us-gaap:AccountsPayableCurrent" contextRef="C_20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">766</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
          </td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_26" name="us-gaap:AccountsPayableCurrent" contextRef="C_20220630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">860</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:76%;font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="text-align:justify;text-indent:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other accounts payable</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_27" name="us-gaap:OtherAccruedLiabilitiesCurrent" contextRef="C_20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,145</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_28" name="us-gaap:OtherAccruedLiabilitiesCurrent" contextRef="C_20220630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,664</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;background-color:rgb(204, 238, 255);width:76%;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="text-align:justify;text-indent:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Current maturities of operating leases</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_29" name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="C_20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">781</ix:nonFraction></span></span></div>
            </div>
          </td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_30" name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="C_20220630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">701</ix:nonFraction></span></span></div>
            </div>
          </td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:76%;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="text-align:justify;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">TOTAL CURRENT LIABILITIES</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_31" name="us-gaap:LiabilitiesCurrent" contextRef="C_20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,692</ix:nonFraction></span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_32" name="us-gaap:LiabilitiesCurrent" contextRef="C_20220630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,225</ix:nonFraction></span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;background-color:rgb(204, 238, 255);width:76%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:76%;font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="text-align:justify;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">LONG-TERM LIABILITIES</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;background-color:rgb(204, 238, 255);width:76%;font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="text-align:justify;text-indent:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Operating leases liabilities</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_33" name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="C_20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">810</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_34" name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="C_20220630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">369</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:76%;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="text-align:justify;text-indent:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Liability for employee rights upon retirement</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_35" name="us-gaap:DefinedBenefitPlanBenefitObligation" contextRef="C_20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,093</ix:nonFraction></span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_36" name="us-gaap:DefinedBenefitPlanBenefitObligation" contextRef="C_20220630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,038</ix:nonFraction></span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;background-color:rgb(204, 238, 255);width:76%;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="text-align:justify;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">TOTAL LONG-TERM LIABILITIES</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_37" name="us-gaap:LiabilitiesNoncurrent" contextRef="C_20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,903</ix:nonFraction></span></span></div>
            </div>
          </td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_38" name="us-gaap:LiabilitiesNoncurrent" contextRef="C_20220630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,407</ix:nonFraction></span></span></div>
            </div>
          </td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:76%;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="text-align:justify;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">TOTAL LIABILITIES</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_39" name="us-gaap:Liabilities" contextRef="C_20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,595</ix:nonFraction></span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_40" name="us-gaap:Liabilities" contextRef="C_20220630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,632</ix:nonFraction></span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;background-color:rgb(204, 238, 255);width:76%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:76%;font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="text-align:justify;text-indent:-16.149pt;margin-left:16.149pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">SHAREHOLDERS' EQUITY:</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;background-color:rgb(204, 238, 255);width:76%" valign="bottom">
            <div style="margin-left:14.2pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Ordinary Shares, NIS <ix:nonFraction id="Fxbrl_20220721225320013" name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="C_20211231" unitRef="ILSPerShare" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="FFact_42" name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="C_20220630" unitRef="ILSPerShare" decimals="INF" format="ixt:num-dot-decimal">0.1</ix:nonFraction></ix:nonFraction> par value &#8211; authorized: <ix:nonFraction id="Fxbrl_20220721225341350" name="us-gaap:CommonStockSharesAuthorized" contextRef="C_20211231" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="FFact_44" name="us-gaap:CommonStockSharesAuthorized" contextRef="C_20220630" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">50,000,000</ix:nonFraction></ix:nonFraction> as of December 31, 2021 and June 30, 2022; issued and outstanding: <ix:nonFraction id="Fxbrl_20220721225424766" name="us-gaap:CommonStockSharesIssued" contextRef="C_20211231" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="FFact_46" name="us-gaap:CommonStockSharesOutstanding" contextRef="C_20211231" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">23,126,804</ix:nonFraction></ix:nonFraction> and <ix:nonFraction id="Fxbrl_20220721225441982" name="us-gaap:CommonStockSharesIssued" contextRef="C_20220630" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="FFact_48" name="us-gaap:CommonStockSharesOutstanding" contextRef="C_20220630" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">23,129,469</ix:nonFraction></ix:nonFraction> as of December 31, 2021 and June 30, 2022, respectively.</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_49" name="us-gaap:CommonStockValue" contextRef="C_20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">638</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_50" name="us-gaap:CommonStockValue" contextRef="C_20220630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">638</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:76%;font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="text-align:justify;text-indent:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Additional paid-in capital</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_51" name="us-gaap:AdditionalPaidInCapitalCommonStock" contextRef="C_20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">233,098</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_52" name="us-gaap:AdditionalPaidInCapitalCommonStock" contextRef="C_20220630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">233,586</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;background-color:rgb(204, 238, 255);width:76%;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="text-align:justify;text-indent:14.2pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Accumulated deficit</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_53" name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="C_20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">178,142</ix:nonFraction></span></span></div>
            </div>
          </td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_54" name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="C_20220630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">183,873</ix:nonFraction></span></span></div>
            </div>
          </td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </div>
          </td>
        </tr>
        <tr>
          <td style="vertical-align:top;width:76%;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="text-align:justify;text-indent:-20.35pt;margin-left:20.35pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">TOTAL SHAREHOLDERS' EQUITY</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_55" name="us-gaap:StockholdersEquity" contextRef="C_20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">55,594</ix:nonFraction></span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_56" name="us-gaap:StockholdersEquity" contextRef="C_20220630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">50,351</ix:nonFraction></span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:top;background-color:rgb(204, 238, 255);width:76%;padding-bottom:4px;font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
            </div>
          </td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_57" name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="C_20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">69,189</ix:nonFraction></span></span></div>
            </div>
          </td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;padding-bottom:4px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
            </div>
          </td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_58" name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="C_20220630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">54,983</ix:nonFraction></span></span></div>
            </div>
          </td>
          <td colspan="1" style="background-color:rgb(204, 238, 255);vertical-align:bottom;width:1%;padding-bottom:4px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
        </tr>

    </table>
    <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>
    <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.</span></span></div>
    <div style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</div>
    <div style="clear:both;margin-top:0pt;margin-bottom:10pt">
      <div style="text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000;font-weight:normal;font-style:normal">F - 2</span></span></span></div>
      <div style="page-break-after:always">
        <hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" />
      </div>
    </div>
    <div>
      <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold">&#160;</div>
    </div>
  </div>

  <div>
    <div>
      <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">SOL-GEL TECHNOLOGIES LTD.</span></span></div>
      <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>
      <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif"><a id="STATEMENTSOFOPERATIONS"></a> <span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</span></span></div>
      <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(U.S. dollars in thousands, except share and per share data)</span></span></div>
      <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>
      <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(Unaudited)</span></span></div>
      <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left;color:#000000;width:100%">

        <tr>
          <td style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
            <div style="line-height:1.25">
              <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold;text-indent:1pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Six months ended</span></span></div>
              <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold;text-indent:1pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">June 30</span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
            <div style="line-height:1.25">
              <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold;text-indent:1pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Three months ended</span></span></div>
              <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold;text-indent:1pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">June 30</span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25">
              <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:1pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25">
              <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:1pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25">
              <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:1pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25">
              <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:1pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="text-indent:-14.2pt;margin-left:15.9pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">COLLABORATION REVENUES</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_59" name="us-gaap:Revenues" contextRef="C_20210101to20210630_srtProductOrServiceAxis_slglCollabrationsMember" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,629</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_60" name="us-gaap:Revenues" contextRef="C_20220101to20220630_srtProductOrServiceAxis_slglCollabrationsMember" unitRef="usd" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_61" name="us-gaap:Revenues" contextRef="C_20210401to20210630_srtProductOrServiceAxis_slglCollabrationsMember" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">928</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_62" name="us-gaap:Revenues" contextRef="C_20220401to20220630_srtProductOrServiceAxis_slglCollabrationsMember" unitRef="usd" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:52%;padding-bottom:2px" valign="bottom">
            <div style="text-indent:-14.2pt;margin-left:15.9pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>LICENSE REVENUES</span></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220721161146624" name="us-gaap:Revenues" contextRef="C_20210101to20210630_srtProductOrServiceAxis_usgaapLicenseMember" unitRef="usd" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220721161139299" name="us-gaap:Revenues" contextRef="C_20220101to20220630_srtProductOrServiceAxis_usgaapLicenseMember" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,521</ix:nonFraction></span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220721161133008" name="us-gaap:Revenues" contextRef="C_20210401to20210630_srtProductOrServiceAxis_usgaapLicenseMember" unitRef="usd" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220721161123723" name="us-gaap:Revenues" contextRef="C_20220401to20220630_srtProductOrServiceAxis_usgaapLicenseMember" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,518</ix:nonFraction></span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:52%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="text-indent:-14.2pt;margin-left:15.9pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">TOTAL REVENUES</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220721161033355" name="us-gaap:Revenues" contextRef="C_20210101to20210630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,629</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220721161043873" name="us-gaap:Revenues" contextRef="C_20220101to20220630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,521</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220721161051230" name="us-gaap:Revenues" contextRef="C_20210401to20210630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">928</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220721161057037" name="us-gaap:Revenues" contextRef="C_20220401to20220630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,518</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:52%;font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="text-indent:-14.2pt;margin-left:15.9pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">RESEARCH AND DEVELOPMENT EXPENSES</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_63" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="C_20210101to20210630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,399</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_64" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="C_20220101to20220630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,422</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_65" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="C_20210401to20210630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,933</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_66" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="C_20220401to20220630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,380</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:52%;padding-bottom:2px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="text-indent:-14.2pt;margin-left:15.9pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">GENERAL AND ADMINISTRATIVE EXPENSES</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_67" name="us-gaap:GeneralAndAdministrativeExpense" contextRef="C_20210101to20210630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,496</ix:nonFraction></span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_68" name="us-gaap:GeneralAndAdministrativeExpense" contextRef="C_20220101to20220630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,512</ix:nonFraction></span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_69" name="us-gaap:GeneralAndAdministrativeExpense" contextRef="C_20210401to20210630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,037</ix:nonFraction></span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_70" name="us-gaap:GeneralAndAdministrativeExpense" contextRef="C_20220401to20220630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,601</ix:nonFraction></span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:52%;font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="text-align:justify;text-indent:-14.2pt;margin-left:15.9pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">TOTAL OPERATING LOSS</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_71" name="us-gaap:OperatingIncomeLoss" contextRef="C_20210101to20210630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">12,266</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_72" name="us-gaap:OperatingIncomeLoss" contextRef="C_20220101to20220630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">6,413</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_73" name="us-gaap:OperatingIncomeLoss" contextRef="C_20210401to20210630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">8,042</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_74" name="us-gaap:OperatingIncomeLoss" contextRef="C_20220401to20220630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">463</ix:nonFraction></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:52%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">
            <div style="text-align:justify;text-indent:-14.2pt;margin-left:15.9pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">FINANCIAL INCOME, </span><span>net</span></span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_75" name="slgl:FinancialIncomeExpensesNet" contextRef="C_20210101to20210630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">170</ix:nonFraction></span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_76" name="slgl:FinancialIncomeExpensesNet" contextRef="C_20220101to20220630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">682</ix:nonFraction></span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_77" name="slgl:FinancialIncomeExpensesNet" contextRef="C_20210401to20210630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">9</ix:nonFraction></span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_78" name="slgl:FinancialIncomeExpensesNet" contextRef="C_20220401to20220630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">329</ix:nonFraction></span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </div>
          </td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:52%;padding-bottom:4px;font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="text-align:justify;text-indent:-14.2pt;margin-left:15.9pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">LOSS FOR THE PERIOD</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_79" name="us-gaap:NetIncomeLoss" contextRef="C_20210101to20210630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">12,096</ix:nonFraction></span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_80" name="us-gaap:NetIncomeLoss" contextRef="C_20220101to20220630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">5,731</ix:nonFraction></span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_81" name="us-gaap:NetIncomeLoss" contextRef="C_20210401to20210630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">8,033</ix:nonFraction></span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_82" name="us-gaap:NetIncomeLoss" contextRef="C_20220401to20220630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">134</ix:nonFraction></span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:52%;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="text-indent:-14.2pt;margin-left:15.9pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">BASIC AND DILUTED LOSS PER ORDINARY SHARE</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220721234223951" name="us-gaap:EarningsPerShareBasic" contextRef="C_20210101to20210630" unitRef="USDPShares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="FFact_83" name="us-gaap:EarningsPerShareDiluted" contextRef="C_20210101to20210630" unitRef="USDPShares" decimals="INF" format="ixt:num-dot-decimal">0.53</ix:nonFraction></ix:nonFraction></span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220721234245557" name="us-gaap:EarningsPerShareBasic" contextRef="C_20220101to20220630" unitRef="USDPShares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="FFact_84" name="us-gaap:EarningsPerShareDiluted" contextRef="C_20220101to20220630" unitRef="USDPShares" decimals="INF" format="ixt:num-dot-decimal">0.25</ix:nonFraction></ix:nonFraction></span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220721234258686" name="us-gaap:EarningsPerShareBasic" contextRef="C_20210401to20210630" unitRef="USDPShares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="FFact_85" name="us-gaap:EarningsPerShareDiluted" contextRef="C_20210401to20210630" unitRef="USDPShares" decimals="INF" format="ixt:num-dot-decimal">0.35</ix:nonFraction></ix:nonFraction></span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220721234313495" name="us-gaap:EarningsPerShareBasic" contextRef="C_20220401to20220630" unitRef="USDPShares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="FFact_86" name="us-gaap:EarningsPerShareDiluted" contextRef="C_20220401to20220630" unitRef="USDPShares" decimals="INF" format="ixt:num-dot-decimal">0.01</ix:nonFraction></ix:nonFraction></span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align:bottom;width:52%;padding-bottom:4px;font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="text-indent:-14.2pt;margin-left:15.9pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING USED IN COMPUTATION OF BASIC AND DILUTED LOSS PER SHARE</span></span></div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220721234332813" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="C_20210101to20210630" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="FFact_87" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="C_20210101to20210630" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">23,016,104</ix:nonFraction></ix:nonFraction></span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220721234354066" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="C_20220101to20220630" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="FFact_88" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="C_20220101to20220630" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">23,127,958</ix:nonFraction></ix:nonFraction></span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220721234405451" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="C_20210401to20210630" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="FFact_89" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="C_20210401to20210630" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">23,028,508</ix:nonFraction></ix:nonFraction></span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
          <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
            <div style="line-height:1.25">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220721234419394" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="C_20220401to20220630" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="FFact_90" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="C_20220401to20220630" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">23,128,429</ix:nonFraction></ix:nonFraction></span></span></div>
            </div>
          </td>
          <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
        </tr>

    </table>
    <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>
    <div style="line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.</span></span></div>
    <div style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</div>
    <div style="clear:both;margin-top:0pt;margin-bottom:10pt">
      <div style="text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000;font-weight:normal;font-style:normal">F - 3</span></span></span></div>
      <div style="page-break-after:always">
        <hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" />
      </div>
    </div>
    <div>
      <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold">&#160;</div>
    </div>
  </div>

      <div>
        <div>
          <div>
            <div>
              <div>
                <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">SOL-GEL TECHNOLOGIES LTD.</span></span></div>
                <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>
                <div style="text-align:center;line-height:1.25"><a id="SHAREHOLDERSEQUITY"></a> <span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>CONDENSED CONSOLIDATED</span><span style="font-weight:bold">&#160;</span><span>STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY</span></span></span></div>
                <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(U.S. dollars in thousands, except share and per share data)</span></span></div>
                <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>
                <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(Unaudited)</span></span></div>
              </div>
              <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left;color:#000000;width:100%">

                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="6" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Ordinary shares</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Additional</span></span><br /><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">paid-in</span><span>&#160;<span style="font-weight:bold">capital</span></span></span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Accumulated</span></span></div>
                        <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">deficit</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Number of<br />shares</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Amounts</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="10" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Amounts</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">
                      <div style="text-align:justify;text-indent:-13.8pt;margin-left:13.8pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">BALANCE AS OF JANUARY 1, 2021</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220802203723330_Fact_91" name="us-gaap:CommonStockSharesOutstanding" contextRef="C_20201231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">23,000,782</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220802203723330_Fact_92" name="us-gaap:StockholdersEquity" contextRef="C_20201231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">635</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220802203723330_Fact_93" name="us-gaap:StockholdersEquity" contextRef="C_20201231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">231,577</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220802203723330_Fact_94" name="us-gaap:StockholdersEquity" contextRef="C_20201231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">181,363</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220802203723330_Fact_95" name="us-gaap:StockholdersEquity" contextRef="C_20201231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">50,849</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:40%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">
                      <div style="text-indent:-16.1pt;margin-left:16.6pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">CHANGES DURING THE SIX MONTHS ENDED JUNE 30, 2021:</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">
                      <div style="text-align:justify;text-indent:-14.45pt;margin-left:31.95pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Loss for the period</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220802203243942_Fact_96" name="us-gaap:ProfitLoss" contextRef="C_20210101to20210630_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">12,096</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220802203243942_Fact_97" name="us-gaap:ProfitLoss" contextRef="C_20210101to20210630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">12,096</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:40%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">
                      <div style="text-align:justify;text-indent:-14.45pt;margin-left:31.95pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Vesting of restricted shares units</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220802203243945_Fact_106" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" contextRef="C_20210101to20210630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">15,333</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="-sec-ix-hidden:Fxbrl_20220802203330582">*</span></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<span style="-sec-ix-hidden:Fxbrl_20220802203340661">*</span></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">
                      <div style="text-align:justify;text-indent:-14.45pt;margin-left:31.95pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exercise of options</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220802203243947_Fact_110" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="C_20210101to20210630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">13,836</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="-sec-ix-hidden:Fxbrl_20220802203405739">*</span></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220802203243947_Fact_112" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="C_20210101to20210630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">83</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220802203243947_Fact_113" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="C_20210101to20210630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">83</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:40%;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">
                      <div style="text-align:justify;text-indent:-14.45pt;margin-left:31.95pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share-based compensation</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220802203243956_Fact_114" name="us-gaap:ShareBasedCompensation" contextRef="C_20210101to20210630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">411</ix:nonFraction></span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220802203243956_Fact_115" name="us-gaap:ShareBasedCompensation" contextRef="C_20210101to20210630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">411</ix:nonFraction></span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:40%;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">
                      <div style="text-indent:-15.9pt;margin-left:15.9pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">BALANCE AT JUNE 30, 2021</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220802203243958_Fact_116" name="us-gaap:CommonStockSharesOutstanding" contextRef="C_20210630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">23,029,951</ix:nonFraction></span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220802203243958_Fact_117" name="us-gaap:StockholdersEquity" contextRef="C_20210630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">635</ix:nonFraction></span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220802203243958_Fact_118" name="us-gaap:StockholdersEquity" contextRef="C_20210630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">232,071</ix:nonFraction></span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220802203243958_Fact_119" name="us-gaap:StockholdersEquity" contextRef="C_20210630_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">193,459</ix:nonFraction></span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220802203243958_Fact_120" name="us-gaap:StockholdersEquity" contextRef="C_20210630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">39,247</ix:nonFraction></span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:40%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">
                      <div style="text-align:justify;text-indent:-13.8pt;margin-left:13.8pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">BALANCE AS OF JANUARY 1, 2022</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220802203312766_Fact_121" name="us-gaap:CommonStockSharesOutstanding" contextRef="C_20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">23,126,804</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220802203312766_Fact_122" name="us-gaap:StockholdersEquity" contextRef="C_20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">638</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220802203312766_Fact_123" name="us-gaap:StockholdersEquity" contextRef="C_20211231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">233,098</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220802203312766_Fact_124" name="us-gaap:StockholdersEquity" contextRef="C_20211231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">178,142</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220802203312766_Fact_125" name="us-gaap:StockholdersEquity" contextRef="C_20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">55,594</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:40%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">
                      <div style="text-indent:-16.1pt;margin-left:16.6pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">CHANGES DURING THE SIX MONTHS ENDED JUNE 30, 2022:</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">
                      <div style="text-align:justify;text-indent:-14.45pt;margin-left:31.95pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Loss for the period</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<span style="-sec-ix-hidden:Fxbrl_20220802203243985_Fact_126">5,731</span></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220802203243985_Fact_127" name="us-gaap:ProfitLoss" contextRef="C_20220101to20220630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">5,731</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:40%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">
                      <div style="text-align:justify;text-indent:-14.45pt;margin-left:31.95pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exercise of options</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220802203243988_Fact_131" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="C_20220101to20220630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">2,665</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="-sec-ix-hidden:Fxbrl_20220802203425221">*</span></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220802203243988_Fact_133" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="C_20220101to20220630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">15</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220802203243988_Fact_134" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="C_20220101to20220630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">15</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:40%;padding-bottom:2px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">
                      <div style="text-align:justify;text-indent:-14.45pt;margin-left:31.95pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share-based compensation</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220802203243992_Fact_135" name="us-gaap:ShareBasedCompensation" contextRef="C_20220101to20220630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">473</ix:nonFraction></span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220802203243992_Fact_136" name="us-gaap:ShareBasedCompensation" contextRef="C_20220101to20220630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">473</ix:nonFraction></span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:40%;padding-bottom:4px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">
                      <div style="text-indent:-15.9pt;margin-left:15.9pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">BALANCE AT JUNE 30, 2022</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220802203243995_Fact_137" name="us-gaap:CommonStockSharesOutstanding" contextRef="C_20220630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">23,129,469</ix:nonFraction></span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220802203243995_Fact_138" name="us-gaap:StockholdersEquity" contextRef="C_20220630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">638</ix:nonFraction></span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220802203243995_Fact_139" name="us-gaap:StockholdersEquity" contextRef="C_20220630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">233,586</ix:nonFraction></span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220802203243995_Fact_140" name="us-gaap:StockholdersEquity" contextRef="C_20220630_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">183,873</ix:nonFraction></span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220802203243995_Fact_141" name="us-gaap:StockholdersEquity" contextRef="C_20220630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">50,351</ix:nonFraction></span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>

              </table>
              <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>
              <div style="clear:both;margin-top:0pt;margin-bottom:10pt">
                <div style="text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000;font-weight:normal;font-style:normal">F - 4</span></span></span></div>
                <div style="page-break-after:always">
                  <hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" />
                </div>
              </div>
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>&#160;</span></span></span>
                <div>
                  <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">SOL-GEL TECHNOLOGIES LTD.</span></span></div>
                  <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>
                  <div style="text-align:center;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>CONDENSED CONSOLIDATED</span><span style="font-weight:bold">&#160;</span><span>STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY</span></span></span></div>
                  <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(U.S. dollars in thousands, except share and per share data)</span></span></div>
                  <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>
                  <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(Unaudited)</span></span></div>
                  <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>
                </div>
              </div>
              <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left;color:#000000;width:100%">

                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="6" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);font-family:Times New Roman, Times, serif;width:22%" valign="bottom">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Ordinary shares</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:Times New Roman, Times, serif;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:Times New Roman, Times, serif;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);width:10%" valign="bottom">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Additional</span></span><br /><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">paid-in&#160;capital</span></span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);width:10%" valign="bottom">
                      <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Accumulated</span></span></div>
                      <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">deficit</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);font-family:Times New Roman, Times, serif;width:10%" valign="bottom">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);font-family:Times New Roman, Times, serif;width:10%" valign="bottom">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Number of<br />shares</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);font-family:Times New Roman, Times, serif;width:10%" valign="bottom">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Amounts</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:Times New Roman, Times, serif;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:Times New Roman, Times, serif;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                    <td colspan="10" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);font-family:Times New Roman, Times, serif;width:34%" valign="bottom">
                      <div style="line-height:1.25">
                        <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Amounts</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">
                      <div style="text-align:justify;text-indent:-13.8pt;margin-left:13.8pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">BALANCE AS OF APRIL 1, 2021</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220802203800507_Fact_142" name="us-gaap:CommonStockSharesOutstanding" contextRef="C_20210331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">23,028,264</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220802203800507_Fact_143" name="us-gaap:StockholdersEquity" contextRef="C_20210331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">635</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220802203800507_Fact_144" name="us-gaap:StockholdersEquity" contextRef="C_20210331_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">231,849</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220802203800507_Fact_145" name="us-gaap:StockholdersEquity" contextRef="C_20210331_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">185,426</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220802203800507_Fact_146" name="us-gaap:StockholdersEquity" contextRef="C_20210331" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">47,058</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:40%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">
                      <div style="text-indent:-16.1pt;margin-left:16.6pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">CHANGES DURING THE THREE MONTHS ENDED JUNE 30, 2021:</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">
                      <div style="text-align:justify;text-indent:-14.45pt;margin-left:31.95pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Loss for the period</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220802203512121_Fact_147" name="us-gaap:ProfitLoss" contextRef="C_20210401to20210630_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">8,033</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220802203512121_Fact_148" name="us-gaap:ProfitLoss" contextRef="C_20210401to20210630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">8,033</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:40%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">
                      <div style="text-align:justify;text-indent:-14.45pt;margin-left:31.95pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exercise of options</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220802203512123_Fact_157" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="C_20210401to20210630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">1,687</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="-sec-ix-hidden:Fxbrl_20220802203910105">*</span></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220802203512123_Fact_159" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="C_20210401to20210630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">9</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220802203512123_Fact_160" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="C_20210401to20210630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">9</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:40%;padding-bottom:2px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">
                      <div style="text-align:justify;text-indent:-14.45pt;margin-left:31.95pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share-based compensation</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220802203512134_Fact_161" name="us-gaap:ShareBasedCompensation" contextRef="C_20210401to20210630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">213</ix:nonFraction></span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220802203512134_Fact_162" name="us-gaap:ShareBasedCompensation" contextRef="C_20210401to20210630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">213</ix:nonFraction></span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:40%;padding-bottom:4px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">
                      <div style="text-indent:-15.9pt;margin-left:15.9pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">BALANCE AT JUNE 30, 2021</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220802203512143_Fact_163" name="us-gaap:CommonStockSharesOutstanding" contextRef="C_20210630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">23,029,951</ix:nonFraction></span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220802203512143_Fact_164" name="us-gaap:StockholdersEquity" contextRef="C_20210630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">635</ix:nonFraction></span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220802203512143_Fact_165" name="us-gaap:StockholdersEquity" contextRef="C_20210630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">232,071</ix:nonFraction></span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220802203512143_Fact_166" name="us-gaap:StockholdersEquity" contextRef="C_20210630_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">193,459</ix:nonFraction></span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220802203512143_Fact_167" name="us-gaap:StockholdersEquity" contextRef="C_20210630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">39,247</ix:nonFraction></span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:40%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">
                      <div style="text-align:justify;text-indent:-13.8pt;margin-left:13.8pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">BALANCE AS OF APRIL 1, 2022</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220802203522391_Fact_168" name="us-gaap:CommonStockSharesOutstanding" contextRef="C_20220331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">23,127,669</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220802203522391_Fact_169" name="us-gaap:StockholdersEquity" contextRef="C_20220331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">638</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220802203522391_Fact_170" name="us-gaap:StockholdersEquity" contextRef="C_20220331_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">233,224</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220802203522391_Fact_171" name="us-gaap:StockholdersEquity" contextRef="C_20220331_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">183,739</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220802203522391_Fact_172" name="us-gaap:StockholdersEquity" contextRef="C_20220331" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">50,123</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">
                      <div style="text-indent:-16.1pt;margin-left:16.6pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">CHANGES DURING THE THREE MONTHS ENDED JUNE 30, 2022:</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:40%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">
                      <div style="text-align:justify;text-indent:-14.45pt;margin-left:31.95pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Loss for the period</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220802203512165_Fact_173" name="us-gaap:ProfitLoss" contextRef="C_20220401to20220630_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">134</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220802203512165_Fact_174" name="us-gaap:ProfitLoss" contextRef="C_20220401to20220630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">134</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                    </td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:40%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">
                      <div style="text-align:justify;text-indent:-14.45pt;margin-left:31.95pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Exercise of options</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220802203512172_Fact_175" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="C_20220401to20220630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">1,800</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="-sec-ix-hidden:Fxbrl_20220802203547323">*</span></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220802203512172_Fact_177" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="C_20220401to20220630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">10</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220802203512172_Fact_178" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="C_20220401to20220630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">10</ix:nonFraction></span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:40%;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">
                      <div style="text-align:justify;text-indent:-14.45pt;margin-left:31.95pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share-based compensation</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220802203512178_Fact_179" name="us-gaap:ShareBasedCompensation" contextRef="C_20220401to20220630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">352</ix:nonFraction></span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220802203512178_Fact_180" name="us-gaap:ShareBasedCompensation" contextRef="C_20220401to20220630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">352</ix:nonFraction></span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>
                  <tr>
                    <td style="vertical-align:bottom;width:40%;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">
                      <div style="text-indent:-15.9pt;margin-left:15.9pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">BALANCE AT JUNE 30, 2022</span></span></div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220802203512181_Fact_181" name="us-gaap:CommonStockSharesOutstanding" contextRef="C_20220630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">23,129,469</ix:nonFraction></span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220802203512181_Fact_182" name="us-gaap:StockholdersEquity" contextRef="C_20220630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">638</ix:nonFraction></span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220802203512181_Fact_183" name="us-gaap:StockholdersEquity" contextRef="C_20220630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">233,586</ix:nonFraction></span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220802203512181_Fact_184" name="us-gaap:StockholdersEquity" contextRef="C_20220630_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">183,873</ix:nonFraction></span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                    <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">
                      <div style="line-height:1.25">
                        <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220802203512181_Fact_185" name="us-gaap:StockholdersEquity" contextRef="C_20220630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">50,351</ix:nonFraction></span></span></div>
                      </div>
                    </td>
                    <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                  </tr>

              </table>
              <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">&#160;</span></span></span></div>
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">* </span><span><ix:footnote id="FN20220802204601537" xml:lang="en-US">less than $1 thousand.</ix:footnote></span></span></span></div>
              <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>
              <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.</span></span></div>
              <div style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</div>
              <div style="clear:both;margin-top:0pt;margin-bottom:10pt">
                <div style="text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000;font-weight:normal;font-style:normal">F - 5</span></span></span></div>
                <div style="page-break-after:always">
                  <hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" />
                </div>
              </div>
              <div style="text-align:center;line-height:1.25;font-weight:bold">&#160;</div>
            </div>
          </div>
        </div>
      </div>

  <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="font-weight:bold">SOL-GEL TECHNOLOGIES LTD.</span></span></span></p>
  <div style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center;margin-top:11pt;margin-bottom:0pt"><a id="CASHFLOWS"></a><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</span></span></div>
  <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">(U.S. dollars in thousands, except share and per share data)</span></span></p>
  <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:center;margin-top:11pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">(Unaudited<span style="font-weight:bold">)</span></span></span></p>
  <div>&#160;</div>
  <div>
    <div>
      <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left;color:#000000;width:100%">

          <tr>
            <td style="vertical-align:bottom;font-family:'Times New Roman',Times,serif;padding-bottom:2px" valign="bottom">&#160;</td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
            <td colspan="6" style="vertical-align:bottom;border-bottom:#000000 solid 2px" valign="bottom">
              <div style="line-height:1.25">
                <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold;text-indent:1pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Six months ended</span></span></div>
                <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold;text-indent:1pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">June 30</span></span></div>
              </div>
            </td>
            <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;font-family:'Times New Roman',Times,serif;padding-bottom:2px" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
            <td colspan="2" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif;border-bottom:#000000 solid 2px" valign="bottom">
              <div style="line-height:1.25">
                <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:1pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
              </div>
            </td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;padding-bottom:2px" valign="bottom">&#160;</td>
            <td colspan="2" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif;border-bottom:#000000 solid 2px" valign="bottom">
              <div style="line-height:1.25">
                <div style="text-align:center;line-height:1.25;font-weight:bold;text-indent:1pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
              </div>
            </td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">CASH FLOWS FROM OPERATING ACTIVITIES:</span></span></div>
            </td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="2" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="2" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;font-family:'Times New Roman',Times,serif;width:76%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Loss for the period</span></span></div>
            </td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
            </td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220721165859137" name="us-gaap:ProfitLoss" contextRef="C_20210101to20210630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">12,096</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
            </td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220721165911882" name="us-gaap:ProfitLoss" contextRef="C_20220101to20220630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">5,731</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;font-family:'Times New Roman',Times,serif;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Adjustments required to reconcile loss to net cash used in operating activities:</span></span></div>
            </td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;font-family:'Times New Roman',Times,serif;width:76%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Depreciation</span></span></div>
            </td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_188" name="us-gaap:Depreciation" contextRef="C_20210101to20210630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">474</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_189" name="us-gaap:Depreciation" contextRef="C_20220101to20220630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">327</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;font-family:'Times New Roman',Times,serif;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Changes in accrued liability for employee rights upon retirement, net</span></span></div>
            </td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_190" name="slgl:ChangesInAccruedLiabilityForEmployeeRightsUponRetirement" contextRef="C_20210101to20210630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">3</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_191" name="slgl:ChangesInAccruedLiabilityForEmployeeRightsUponRetirement" contextRef="C_20220101to20220630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">37</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;font-family:'Times New Roman',Times,serif;width:76%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Share-based compensation expenses</span></span></div>
            </td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_192" name="us-gaap:ShareBasedCompensation" contextRef="C_20210101to20210630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">411</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_193" name="us-gaap:ShareBasedCompensation" contextRef="C_20220101to20220630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">473</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;font-family:'Times New Roman',Times,serif;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financial expenses (income), net</span></span></div>
            </td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_194" name="slgl:FinanceExpensesNet" contextRef="C_20210101to20210630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">15</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220721165945170" name="slgl:FinanceExpensesNet" contextRef="C_20220101to20220630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">126</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;font-family:'Times New Roman',Times,serif;width:76%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net changes in operating leases</span></span></div>
            </td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_196" name="slgl:NetChangesInOperatingLeases" contextRef="C_20210101to20210630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">48</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_197" name="slgl:NetChangesInOperatingLeases" contextRef="C_20220101to20220630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">173</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;font-family:'Times New Roman',Times,serif;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Changes in fair value of marketable securities</span></span></div>
            </td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220721165926561" name="slgl:ChangesInFairValueOfMarketableSecurities" contextRef="C_20210101to20210630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">59</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_199" name="slgl:ChangesInFairValueOfMarketableSecurities" contextRef="C_20220101to20220630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">135</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;font-family:'Times New Roman',Times,serif;width:76%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Changes in operating asset and liabilities:</span></span></div>
            </td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25;font-family:'Palatino Linotype', serif;font-size:9pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Receivables from collaborative arrangements (including long-term)</span></span></span></div>
            </td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_200" name="us-gaap:IncreaseDecreaseInLongTermReceivablesCurrent" contextRef="C_20210101to20210630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">1,197</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_201" name="us-gaap:IncreaseDecreaseInLongTermReceivablesCurrent" contextRef="C_20220101to20220630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">7,792</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;font-family:'Times New Roman',Times,serif;width:76%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Prepaid expenses and other current assets</span></span></div>
            </td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_202" name="us-gaap:IncreaseDecreaseInPrepaidExpensesOther" contextRef="C_20210101to20210630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">482</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_203" name="us-gaap:IncreaseDecreaseInPrepaidExpensesOther" contextRef="C_20220101to20220630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">891</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;font-family:'Times New Roman',Times,serif;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Accounts payable, accrued expenses and other</span></span></div>
            </td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220721170010362" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" contextRef="C_20210101to20210630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">782</ix:nonFraction></span></span></div>
              </div>
            </td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
              </div>
            </td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220721170023162" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" contextRef="C_20220101to20220630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">8,387</ix:nonFraction></span></span></div>
              </div>
            </td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
              </div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;font-family:'Times New Roman',Times,serif;width:76%;padding-bottom:2px" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net cash used in operating activities</span></span></div>
            </td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_206" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="C_20210101to20210630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">11,367</ix:nonFraction></span></span></div>
              </div>
            </td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
              </div>
            </td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_207" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="C_20220101to20220630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">6,544</ix:nonFraction></span></span></div>
              </div>
            </td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
              </div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;font-family:'Times New Roman',Times,serif;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">CASH FLOWS FROM INVESTING ACTIVITIES:</span></span></div>
            </td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;font-family:'Times New Roman',Times,serif;width:76%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Purchase of property and equipment</span></span></div>
            </td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_208" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="C_20210101to20210630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">54</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_209" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="C_20220101to20220630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">102</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;font-family:'Times New Roman',Times,serif;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Investment in marketable securities</span></span></div>
            </td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_210" name="us-gaap:PaymentsToAcquireMarketableSecurities" contextRef="C_20210101to20210630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,065</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_211" name="us-gaap:PaymentsToAcquireMarketableSecurities" contextRef="C_20220101to20220630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,006</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;font-family:'Times New Roman',Times,serif;width:76%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Proceeds from sales and maturity of marketable securities</span></span></div>
            </td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_212" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" contextRef="C_20210101to20210630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">18,946</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_213" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" contextRef="C_20220101to20220630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,734</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25;font-family:'Palatino Linotype', serif;font-size:9pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Proceeds from short-term deposits</span></span></span></div>
            </td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220721163559362" name="slgl:ProceedsFromShortTermDeposits" contextRef="C_20210101to20210630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">500</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220721163606650" name="slgl:ProceedsFromShortTermDeposits" contextRef="C_20220101to20220630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">448</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;width:76%;padding-bottom:2px" valign="bottom">
              <div style="line-height:1.25;font-family:'Palatino Linotype', serif;font-size:9pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Proceeds from long-term deposits</span></span></span></div>
            </td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220721163643329" name="slgl:ProceedsFromLongTermDeposits" contextRef="C_20210101to20210630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">2</ix:nonFraction></span></span></div>
              </div>
            </td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220721163650650" name="slgl:ProceedsFromLongTermDeposits" contextRef="C_20220101to20220630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">9</ix:nonFraction></span></span></div>
              </div>
            </td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;font-family:'Times New Roman',Times,serif;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net cash provided by (used in) investing activities</span></span></div>
            </td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_218" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="C_20210101to20210630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">15,329</ix:nonFraction></span></span></div>
              </div>
            </td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220721170501016" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="C_20220101to20220630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">7,917</ix:nonFraction></span></span></div>
              </div>
            </td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
              </div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;font-family:'Times New Roman',Times,serif;width:76%" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">CASH FLOWS FROM FINANCING ACTIVITIES:</span></span></div>
            </td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;font-family:'Times New Roman',Times,serif;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Proceeds from exercise of options</span></span></div>
            </td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_220" name="us-gaap:ProceedsFromStockOptionsExercised" contextRef="C_20210101to20210630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">83</ix:nonFraction></span></span></div>
              </div>
            </td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_221" name="us-gaap:ProceedsFromStockOptionsExercised" contextRef="C_20220101to20220630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">15</ix:nonFraction></span></span></div>
              </div>
            </td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;font-family:'Times New Roman',Times,serif;width:76%;padding-bottom:2px" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Net cash provided by financing activities</span></span></div>
            </td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_224" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="C_20210101to20210630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">83</ix:nonFraction></span></span></div>
              </div>
            </td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_225" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="C_20220101to20220630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">15</ix:nonFraction></span></span></div>
              </div>
            </td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;font-family:'Times New Roman',Times,serif;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">EFFECT OF EXCHANGE RATE ON CASH AND CASH EQUIVALENTS</span></span></div>
            </td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220721165808265" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="C_20210101to20210630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">15</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
            </td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_227" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="C_20220101to20220630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">126</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;font-family:'Times New Roman',Times,serif;width:76%;padding-bottom:2px" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS AND RESTRICTED CASH</span></span></div>
            </td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_228" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="C_20210101to20210630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,030</ix:nonFraction></span></span></div>
              </div>
            </td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220721165838498" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="C_20220101to20220630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">14,320</ix:nonFraction></span></span></div>
              </div>
            </td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
              </div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;font-family:'Times New Roman',Times,serif;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AT BEGINNING OF THE PERIOD</span></span></div>
            </td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220721180304367" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="C_20201231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,272</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_231" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="C_20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">21,235</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;width:76%;padding-bottom:4px" valign="bottom">
              <div style="line-height:1.25;font-family:'Palatino Linotype', serif;font-size:9pt;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AT END OF THE PERIODS</span></span></span></div>
            </td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
              </div>
            </td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_232" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="C_20210630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,302</ix:nonFraction></span></span></div>
              </div>
            </td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;padding-bottom:4px" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
              </div>
            </td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_233" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="C_20220630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,915</ix:nonFraction></span></span></div>
              </div>
            </td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;padding-bottom:4px;white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;font-family:'Times New Roman',Times,serif;width:76%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash and Cash equivalents</span></span></div>
            </td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_234" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="C_20210630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,152</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_235" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="C_20220630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,765</ix:nonFraction></span></span></div>
            </td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;font-family:'Times New Roman',Times,serif;width:76%;padding-bottom:2px" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Restricted cash</span></span></div>
            </td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_236" name="us-gaap:RestrictedCash" contextRef="C_20210630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,150</ix:nonFraction></span></span></div>
              </div>
            </td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;padding-bottom:2px" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0)" valign="bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_237" name="us-gaap:RestrictedCash" contextRef="C_20220630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,150</ix:nonFraction></span></span></div>
              </div>
            </td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;padding-bottom:2px;white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;font-family:'Times New Roman',Times,serif;width:76%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">CASH AND CASH EQUIVALENTS AND RESTRICTED CASH SHOWN IN STATEMENT OF CASH FLOWS</span></span></div>
            </td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_238" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="C_20210630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,302</ix:nonFraction></span></span></div>
              </div>
            </td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_239" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="C_20220630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,915</ix:nonFraction></span></span></div>
              </div>
            </td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;font-family:'Times New Roman',Times,serif;width:76%" valign="bottom">
              <div style="line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">SUPPLEMENTARY INFORMATION:</span></span></div>
            </td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;white-space:nowrap" valign="bottom">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align:bottom;font-family:'Times New Roman',Times,serif;width:76%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Interest received</span></span></div>
            </td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_240" name="us-gaap:ProceedsFromInterestReceived" contextRef="C_20210101to20210630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">582</ix:nonFraction></span></span></div>
              </div>
            </td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">&#160;</td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;text-align:right;width:9%;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255)" valign="bottom">
              <div style="line-height:1.25">
                <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_241" name="us-gaap:ProceedsFromInterestReceived" contextRef="C_20220101to20220630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">153</ix:nonFraction></span></span></div>
              </div>
            </td>
            <td colspan="1" style="font-family:'Times New Roman',Times,serif;vertical-align:bottom;width:1%;padding-bottom:2px;background-color:rgb(204, 238, 255);white-space:nowrap" valign="bottom">&#160;</td>
          </tr>

      </table>
    </div>
  </div>
  <div>
    <div>
      <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold">&#160;</div>
      <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.</span></span></div>
      <div style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</div>
      <div style="clear:both;margin-top:0pt;margin-bottom:10pt">
        <div style="text-align:center"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:#000000;font-weight:normal;font-style:normal">F - 6</span></span></span></div>
        <div style="page-break-after:always">
          <hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;height:2px;color:#000000;background-color:#000000" />
        </div>
      </div>
      <div style="text-align:justify;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>&#160;</span></span></span></div>
      <div>
        <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">SOL-GEL TECHNOLOGIES LTD.</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>
        <div style="text-align:center;line-height:1.25"><a id="FINANCIALSTATEMENTS"></a> <span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span><br /><span>(U.S. dollars in thousands, except share and per share data)</span></span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>
        <div style="text-align:center;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(Unaudited)</span></span></div>
      </div>
    </div>
  </div>
  <div style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</div>

  <div>
    <div>
      <ix:nonNumeric id="Fxbrl_20220721155105496" name="us-gaap:NatureOfOperations" contextRef="C_20220101to20220630" escape="true">
        <div>
          <div>
            <div>
              <div>
                <div style="text-align:justify;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NOTE 1 &#8211; NATURE OF OPERATIONS</span></span></div>
                <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>
                <div style="text-align:justify;margin-left:20pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Sol-Gel Technologies Ltd. (collectively with its U.S. subsidiary, the Company) is an Israeli Company incorporated in 1997.</span></span></div>
                <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>
                <div style="text-align:justify;margin-left:20pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>The Company is a clinical stage specialty pharmaceutical company focused on developing and commercializing topical dermatological drug products. The Company&#8217;s lead products candidates are based upon its proprietary microencapsulation delivery system, consisting of microcapsules made of precipitated silica. The Company has two approved drugs: (i) Twyneo&#174;, which was developed for the treatment of acne vulgaris and received marketing authourization by the U.S. Food and Durg Administration (the "FDA") on July 27, 2021 and (ii) Epsolay&#174;, a treatment for subtype II rosacea that received marketing authourization by the FDA on April 25, 2022. In June 2021, the Company entered into two exclusive license agreements with Galderma for the commercialization of Twyneo&#174; and Epsolay&#174;, in the United States, see note 5. On April 14, 2022, the Company announced that Twyneo&#174; is available for purchase by consumers who obtain a prescription from their physician. On June 2, 2022, the Company announced that Epsolay&#174; is available for purchase by consumers who obtain a prescription from their physician. In addition to the novel products, the Company&#8217;s products included the approved generic products Acyclovir, Ivermectin and other generic product candidates. In November 2021, the company entered into an agreement with Padagis, to sell its rights in relation to ten generic collaborative agreements between the parties, including the agreements for the two aforementioned approved generic drug products. Under the new agreement, the company has retained collaboration rights to two generic programs related to four generic drug candidates, see note 4b.</span></span></span></div>
                <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>
                <div style="text-align:justify;margin-left:20pt;line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Risk and Uncertainties</span></span></div>
                <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>
                <div style="text-align:justify;margin-left:20pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Since incorporation through June 30, 2022, the Company has an accumulated deficit of $<ix:nonFraction id="FFact_242" name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="C_20220630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">183,873</ix:nonFraction> and its activities have been funded mainly by its shareholders, collaboration revenues and license agreements, see also Notes 4 and 5. The Company expects to continue to incur significant research and development and other costs related to its ongoing operations.</span></span></span></div>
                <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>
                <div style="text-align:justify;margin-left:20pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In addition, management is continuing to analyze cash resources and considering raising additional funding from different sources, such as corporate collaborations, public or private equity offerings and/or debt financings, and/or selling shares under the Company's Open Market Sale Agreement with Jefferies LLC. Management expects that the Company's cash and cash equivalents, deposits and marketable securities as of June 30, 2022 will allow the Company to fund its operating plan through at least the next 12 months from the condensed financial statement issuance date.</span></span></div>
                <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>
                <div style="text-align:justify;margin-left:20pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>The Company is subject to risks and uncertainties as a result of the COVID-19 pandemic. To date, the impact of COVID-19 pandemic has been limited and resulted in delays with respect to pre-approval inspections.</span></span></span></div>
              </div>
            </div>
          </div>
          <div><ix:exclude>
            <p style="margin:0pt">&#160;</p>
            <div style="clear:both;margin-top:0pt;margin-bottom:0pt"><div style="text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:#000000;font-weight:normal;font-style:normal">F - 7</span></span></span></div><div style="page-break-after:always"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;margin-top:4pt;margin-bottom:10pt;height:2px;color:#000000;background-color:#000000" /></div></div><div style="text-align:center;line-height:1.25;margin-top:0px;margin-bottom:0px;color:rgb(0, 0, 0);font-family:Times New Roman, Times, serif"><p style="margin:0pt">&#160;</p><strong><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">SOL-GEL TECHNOLOGIES LTD.</span></span></strong></div><div style="text-align:center;line-height:1.25;color:#000000"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="font-family:'Times New Roman',Times,serif"><strong>NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</strong><br />(U.S. dollars in thousands, except share and per share data)</span></span></span></p></div><div style="text-align:center;margin-top:0px;margin-bottom:0px;line-height:1.25;color:rgb(0, 0, 0);font-family:Times New Roman, Times, serif"><p style="margin:0pt">&#160;</p><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">(Unaudited)</span></span></div><div style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</div>
            <p style="margin:0pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span><strong><span><span style="color:black">NOTE 1 </span></span></strong></span></span></span></span></span><span style="font-size:10pt;font-family:Times New Roman, Times, serif">&#8211;</span><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span><strong><span><span style="color:black"> NATURE OF OPERATIONS </span></span></strong><span><span style="color:black">(continued):</span></span></span></span></span></span></span></p>
          </ix:exclude></div>
          <div>
            <div>
              <div style="text-align:justify;line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:20pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The full extent to which the COVID-19 pandemic will directly or indirectly impact the Company's business, results of operations and financial condition, including revenues from collaboration arrangements, expenses, reserves and allowances, manufacturing, supply, regulatory approvals, clinical trials, commercial launch of branded and generic product candidates, research and development costs and employee-related amounts, will depend on future developments that are highly uncertain and cannot be predicted. The Company continues to monitor and assess new information related to the COVID-19 pandemic, the actions taken to contain or treat COVID-19, as well as the economic impact on various markets.</span></span></div>
              <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>
              <div style="text-align:justify;margin-left:20pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Furthermore, the estimation process required to prepare the Company&#8217;s consolidated financial statements requires assumptions to be made about future events and conditions and the impact of COVID-19 on its financial results, and while management believes such assumptions are reasonable, they are inherently subjective and uncertain. The Company&#8217;s actual results could differ materially from those estimates.</span></span></div>
            </div>
          </div>
        </div>
      </ix:nonNumeric>
    </div>
  </div>
  <div style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</div>

  <ix:nonNumeric id="FFact_250" name="us-gaap:SignificantAccountingPoliciesTextBlock" contextRef="C_20220101to20220630" escape="true">
    <div>
      <p style="margin-top:0pt;margin-bottom:0pt;text-align:left;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><strong><span>NOTE 2 </span></strong></span></span></span></span></span></span></span><span style="font-size:10pt;font-family:Times New Roman, Times, serif">&#8211;</span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><strong><span> SIGNIFICANT ACCOUNTING POLICIES:</span></strong></span></span></span></span></span></span></span></p>
      <p style="margin-top:0pt;margin-bottom:0pt;text-align:left;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:left">&#160;</p>
      <ix:nonNumeric id="Fxbrl_20220721161540027" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" contextRef="C_20220101to20220630" escape="true">
        <div>
          <div>
            <div>
              <div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:36pt;vertical-align:top;font-family:'Times New Roman',Times,serif">
                        <div style="margin-left:18pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">a.</span></span></div>
                      </td>
                      <td style="width:auto;vertical-align:top">
                        <div style="line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">Basis of Presentation</span><br /><span>&#160;<br />The unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") for interim financial statements. Accordingly, they do not include all of the information and notes required by U.S. GAAP for annual financial statements. In the opinion of management, these unaudited condensed consolidated financial statements reflect all adjustments, which include normal recurring adjustments, necessary for a fair statement of the Company&#8217;s consolidated financial position as of June 30, 2022, the consolidated results of operations for the six month and three month periods ended June 30, 2021 and 2022 and statements of changes in shareholders' equity and cash flows for the six month period ended June 30, 2021 and 2022.</span></span></span></div>
                      </td>
                    </tr>

                </table>
              </div>
              <div style="margin-left:36pt;line-height:1.25">&#160;</div>
              <div style="margin-left:36pt;line-height:1.25;font-family:Times New Roman, Times, serif;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The consolidated results for the six month period ended June 30, 2022 are not necessarily indicative of the results to be expected for the year ending December 31, 2022.</span></span></div>
              <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>
              <div style="margin-left:35.7pt;line-height:1.25;font-family:Times New Roman, Times, serif;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">These unaudited condensed consolidated financial statements should be read in conjunction with the audited financial statements of the Company for the year ended December 31, 2021. The comparative balance sheet at December 31, 2021 has been derived from the audited financial statements at that date but does not include all disclosures required by U.S. GAAP.</span></span></div>
            </div>
          </div>
        </div>
      </ix:nonNumeric>
      <ix:nonNumeric id="Fxbrl_20220721163418659" name="us-gaap:EarningsPerSharePolicyTextBlock" contextRef="C_20220101to20220630" escape="true">
        <div>
          <p style="margin-top:0pt;margin-left:48px;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p>
          <div style="text-align:justify">
            <div style="margin-top:0px">
              <div>
                <div>
                  <div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:36pt;vertical-align:top;font-family:'Times New Roman',Times,serif">
                            <div style="margin-left:18pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">b.</span></span></div>
                          </td>
                          <td style="width:auto;vertical-align:top">
                            <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">Loss per share</span><br /><span>&#160;<br />Basic loss per share is computed on the basis of the net loss for the period divided by the weighted average number of ordinary shares outstanding during the period. Diluted loss per share is based upon the weighted average number of ordinary shares and of ordinary shares equivalents outstanding when dilutive. Ordinary share equivalents include outstanding stock options, restricted shares and warrants, which are included under the treasury stock method when dilutive.</span></span></span></div>
                          </td>
                        </tr>

                    </table>
                  </div>
                  <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>
                  <div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The calculation of diluted loss per share does not include <ix:nonFraction id="Fxbrl_20220721163539988" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="C_20220101to20220630" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">3,713,296</ix:nonFraction> and <ix:nonFraction id="Fxbrl_20220721163551609" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="C_20220401to20220630" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">4,085,416</ix:nonFraction> options, restricted shares and warrants for the six and three months ended June 30, 2022 and <ix:nonFraction id="Fxbrl_20220721163630539" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="C_20210101to20210630" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">3,437,843</ix:nonFraction> and <ix:nonFraction id="Fxbrl_20220721163648033" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="C_20210401to20210630" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">3,463,710</ix:nonFraction> options and restricted shares for the six and the three months ended June 30, 2021, respectively, because the effect would be anti-dilutive.</span></span></div>
                </div>
              </div>
            </div>
          </div>
        </div>
      </ix:nonNumeric>
    </div>
  </ix:nonNumeric>
  <div>
    <div style="width:100%;clear:both">
      <p style="margin:0pt">&#160;</p>
      <div style="clear:both;margin-top:0pt;margin-bottom:0pt"><div style="text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:#000000;font-weight:normal;font-style:normal">F - 8</span></span></span></div><div style="page-break-after:always"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;margin-top:4pt;margin-bottom:10pt;height:2px;color:#000000;background-color:#000000" /></div></div><div style="text-align:center;line-height:1.25;margin-top:0px;margin-bottom:0px;color:rgb(0, 0, 0);font-family:Times New Roman, Times, serif"><p style="margin:0pt">&#160;</p><strong><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">SOL-GEL TECHNOLOGIES LTD.</span></span></strong></div><div style="text-align:center;line-height:1.25;color:#000000"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="font-family:'Times New Roman',Times,serif"><strong>NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</strong><br />(U.S. dollars in thousands, except share and per share data)</span></span></span></p></div><div style="text-align:center;margin-top:0px;margin-bottom:0px;line-height:1.25;color:rgb(0, 0, 0);font-family:Times New Roman, Times, serif"><p style="margin:0pt">&#160;</p><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">(Unaudited)</span></span></div><div style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</div>
    </div>
  </div>

  <ix:nonNumeric id="FFact_275" name="us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" contextRef="C_20220101to20220630" escape="true">
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0px;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">NOTE 3 </span></span></span><span style="font-size:10pt;font-family:Times New Roman, Times, serif">&#8211;</span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold"> MARKETABLE SECURITIES:</span></span></span></p>
    <ix:nonNumeric id="FFact_261" name="us-gaap:MarketableSecuritiesTextBlock" contextRef="C_20220101to20220630" escape="true">
      <p style="margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <div>
        <div>
          <div style="line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:20pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The following table sets forth the Company&#8217;s marketable securities for the indicated periods:</span></span></div>
          <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>
          <div style="margin-left:20pt">
            <table border="0" cellpadding="0" cellspacing="0" style="color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:left;width:90%" width="100%">

                <tr>
                  <td colspan="1" rowspan="1" style="vertical-align:top;padding-bottom:2px;font-family:Times New Roman, Times, serif" valign="bottom">&#160;</td>
                  <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                  <td colspan="2" rowspan="1" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,</span></span></div>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                  <td colspan="2" rowspan="1" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">June 30,</span></span></div>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="vertical-align:top;padding-bottom:2px;font-family:Times New Roman, Times, serif" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
                    <div style="line-height:1.25">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                    </div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
                    <div style="line-height:1.25">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                    </div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="vertical-align:middle;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Level 2 securities:</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                  <td colspan="6" style="vertical-align:top;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="vertical-align:middle;font-family:Times New Roman, Times, serif;width:76%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">U.S government and agency bonds</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;font-family:Times New Roman, Times, serif;width:9%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_251" name="us-gaap:MarketableSecuritiesCurrent" contextRef="C_20211231_usgaapInvestmentTypeAxis_usgaapUSGovernmentCorporationsAndAgenciesSecuritiesMember" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">275</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;font-family:Times New Roman, Times, serif;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;font-family:Times New Roman, Times, serif;width:9%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_252" name="us-gaap:MarketableSecuritiesCurrent" contextRef="C_20220630_usgaapInvestmentTypeAxis_usgaapUSGovernmentCorporationsAndAgenciesSecuritiesMember" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,174</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;font-family:Times New Roman, Times, serif;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="vertical-align:middle;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:76%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other foreign government bonds</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:9%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_255" name="us-gaap:MarketableSecuritiesCurrent" contextRef="C_20211231_usgaapInvestmentTypeAxis_slglOtherForeignGovernmentBondsMember" unitRef="usd" scale="3" decimals="-3" format="ixt:fixed-zero">-</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:9%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220721171136582" name="us-gaap:MarketableSecuritiesCurrent" contextRef="C_20220630_usgaapInvestmentTypeAxis_slglOtherForeignGovernmentBondsMember" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,507</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="vertical-align:middle;padding-bottom:2px;font-family:Times New Roman, Times, serif;width:76%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Corporate bonds*</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:2px solid rgb(0, 0, 0);font-family:Times New Roman, Times, serif;width:9%" valign="bottom">
                    <div style="line-height:1.25">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_257" name="us-gaap:MarketableSecuritiesCurrent" contextRef="C_20211231_usgaapInvestmentTypeAxis_usgaapAllOtherCorporateBondsMember" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,434</ix:nonFraction></span></span></div>
                    </div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:Times New Roman, Times, serif;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:2px solid rgb(0, 0, 0);font-family:Times New Roman, Times, serif;width:9%" valign="bottom">
                    <div style="line-height:1.25">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_258" name="us-gaap:MarketableSecuritiesCurrent" contextRef="C_20220630_usgaapInvestmentTypeAxis_usgaapAllOtherCorporateBondsMember" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,165</ix:nonFraction></span></span></div>
                    </div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:Times New Roman, Times, serif;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="vertical-align:middle;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:76%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:9%" valign="bottom">
                    <div style="line-height:1.25">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_259" name="us-gaap:MarketableSecuritiesCurrent" contextRef="C_20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,709</ix:nonFraction></span></span></div>
                    </div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:9%" valign="bottom">
                    <div style="line-height:1.25">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_260" name="us-gaap:MarketableSecuritiesCurrent" contextRef="C_20220630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,846</ix:nonFraction></span></span></div>
                    </div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                </tr>

            </table>
          </div>
        </div>
      </div>
      <div style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</div>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-left:20pt;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">* <span id="FN_60f774710b70e4ca22c9cb88">Investments in Corporate bonds rated A or higher.</span></span></span></p>
    </ix:nonNumeric>
    <p style="margin-top:0pt;margin-bottom:0pt">&#160;</p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-left:20pt;text-align:justify;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company&#8217;s debt securities are classified within Level 2 because it uses quoted market prices or alternative pricing sources and models utilizing market observable inputs to determine their fair value.</span></span></p>
    <ix:nonNumeric id="FFact_272" name="us-gaap:ScheduleOfDerivativeAssetsAtFairValueTableTextBlock" contextRef="C_20220101to20220630" escape="true">
      <p style="margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <div>
        <div>
          <div style="line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:20pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The table below sets forth a summary of the changes in the fair value of the Company&#8217;s marketable securities for the indicated periods:</span></span></div>
          <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>
          <div style="margin-left:20pt">
            <table border="0" cellpadding="0" cellspacing="0" style="color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:left;width:90%" width="100%">

                <tr>
                  <td style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                  <td colspan="6" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Marketable securities</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif" valign="bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">For&#160;the&#160;year&#160;ended</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif" valign="bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">For&#160;the&#160;Six&#160;Months</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,&#160;2021</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">ended&#160;June&#160;30,&#160;2022</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:top;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:top;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:76%" valign="bottom">
                    <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance at beginning of the period</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:9%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_262" name="us-gaap:MarketableSecuritiesCurrent" contextRef="C_20201231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">21,652</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:9%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_263" name="us-gaap:MarketableSecuritiesCurrent" contextRef="C_20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,709</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:76%" valign="bottom">
                    <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Additions</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;font-family:Times New Roman, Times, serif;width:9%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_264" name="us-gaap:PaymentsToAcquireMarketableSecurities" contextRef="C_20210101to20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,716</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;font-family:Times New Roman, Times, serif;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;font-family:Times New Roman, Times, serif;width:9%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_265" name="us-gaap:PaymentsToAcquireMarketableSecurities" contextRef="C_20220101to20220630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,006</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;font-family:Times New Roman, Times, serif;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:76%" valign="bottom">
                    <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Sale or maturity</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:9%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_266" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" contextRef="C_20210101to20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">26,784</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;white-space:nowrap;width:1%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:9%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="FFact_267" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" contextRef="C_20220101to20220630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,734</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;white-space:nowrap;width:1%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:top;padding-bottom:2px;font-family:Times New Roman, Times, serif;width:76%" valign="bottom">
                    <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Changes in fair value during the period</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:2px solid rgb(0, 0, 0);font-family:Times New Roman, Times, serif;width:9%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_268" name="slgl:ChangesInFairValueOfMarketableSecurities" contextRef="C_20210101to20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">125</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:Times New Roman, Times, serif;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:2px solid rgb(0, 0, 0);font-family:Times New Roman, Times, serif;width:9%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(<ix:nonFraction id="Fxbrl_20220721232906325" name="slgl:ChangesInFairValueOfMarketableSecurities" contextRef="C_20220101to20220630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal" sign="-">135</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:Times New Roman, Times, serif;white-space:nowrap;width:1%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:top;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:76%" valign="bottom">
                    <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance at end of the period</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:9%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_270" name="us-gaap:MarketableSecuritiesCurrent" contextRef="C_20211231" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,709</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:9%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_271" name="us-gaap:MarketableSecuritiesCurrent" contextRef="C_20220630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,846</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                </tr>

            </table>
          </div>
        </div>
      </div>
    </ix:nonNumeric>
    <ix:nonNumeric id="FFact_274" name="us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock" contextRef="C_20220101to20220630" escape="true">
      <p style="margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <div>
        <div>
          <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:20pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As of June 30, 2022, the Company&#8217;s debt securities had the following maturity dates:</span></span></div>
          <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>
          <div style="margin-left:20pt">
            <table border="0" cellpadding="0" cellspacing="0" style="color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:left;width:90%" width="100%">

                <tr>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
                    <div style="line-height:1.25">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Market value</span></span></div>
                    </div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif" valign="bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">June 30,</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
                    <div style="line-height:1.25">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                    </div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="vertical-align:middle;padding-bottom:2px;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:88%" valign="bottom">
                    <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Due within one year</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:9%" valign="bottom">
                    <div style="line-height:1.25">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_273" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" contextRef="C_20220630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,041</ix:nonFraction></span></span></div>
                    </div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="vertical-align:middle;padding-bottom:4px;font-family:Times New Roman, Times, serif;width:88%" valign="bottom">
                    <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Between 1-2 years</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:4px;font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0);font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:4px double rgb(0, 0, 0);font-family:Times New Roman, Times, serif;width:9%" valign="bottom">
                    <div style="line-height:1.25">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="Fxbrl_20220721174756543" name="slgl:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue" contextRef="C_20220630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">805</ix:nonFraction></span></span></div>
                    </div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:4px;font-family:Times New Roman, Times, serif;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                </tr>

            </table>
          </div>
        </div>
      </div>
    </ix:nonNumeric>
    <p style="margin-top:0pt;margin-bottom:0pt">&#160;</p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-left:20pt;text-align:justify;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span style="color:black">The carrying amount of the cash and cash equivalents, bank deposits, restricted cash, restricted long term deposits,</span></span>&#160;<span><span style="color:black">receivables from collaborative arrangements, accrued expenses and other liabilities approximates their fair value.</span></span></span></span></span></span></span></p>
  </ix:nonNumeric>
  <div>
    <div style="width:100%;clear:both">
      <p style="margin:0pt">&#160;</p>
      <div style="clear:both;margin-top:0pt;margin-bottom:0pt"><div style="text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:#000000;font-weight:normal;font-style:normal">F - 9</span></span></span></div><div style="page-break-after:always"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;margin-top:4pt;margin-bottom:10pt;height:2px;color:#000000;background-color:#000000" /></div></div><div style="text-align:center;line-height:1.25;margin-top:0px;margin-bottom:0px;color:rgb(0, 0, 0);font-family:Times New Roman, Times, serif"><p style="margin:0pt">&#160;</p><strong><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">SOL-GEL TECHNOLOGIES LTD.</span></span></strong></div><div style="text-align:center;line-height:1.25;color:#000000"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="font-family:'Times New Roman',Times,serif"><strong>NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</strong><br />(U.S. dollars in thousands, except share and per share data)</span></span></span></p></div><div style="text-align:center;margin-top:0px;margin-bottom:0px;line-height:1.25;color:rgb(0, 0, 0);font-family:Times New Roman, Times, serif"><p style="margin:0pt">&#160;</p><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">(Unaudited)</span></span></div><div style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</div>
    </div>
  </div>

  <ix:nonNumeric id="FFact_281" name="us-gaap:RevenueFromContractWithCustomerTextBlock" contextRef="C_20220101to20220630" escape="true">
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0px;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0px"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">NOTE 4 &#8211; COLLABORATION AGREEMENTS:<br />&#160;</span></span></span></p>
    <div>
      <div>
        <div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:36.55pt;vertical-align:top;font-family:'Times New Roman',Times,serif">
                  <div style="margin-left:20.55pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">a.</span></span></div>
                </td>
                <td style="width:auto;vertical-align:top;font-family:'Times New Roman',Times,serif">
                  <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In 2007, the Company granted rights to a third party for use and commercialization of a product for skin protection. Under this agreement, the Company is entitled to royalties during the years <ix:nonNumeric id="Fxbrl_20220721155340132" name="slgl:RoyaltiesMaturity" contextRef="C_20070101to20071231_srtRangeAxis_srtMinimumMember">2016</ix:nonNumeric> to <ix:nonNumeric id="Fxbrl_20220721155348640" name="slgl:RoyaltiesMaturity" contextRef="C_20070101to20071231_srtRangeAxis_srtMaximumMember">2024</ix:nonNumeric>. Based on current sales, royalties are not material.</span></span></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>
        <div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:36.55pt;vertical-align:top;font-family:'Times New Roman',Times,serif">
                  <div style="margin-left:20.55pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">b.</span></span></div>
                </td>
                <td style="width:auto;vertical-align:top;font-family:'Times New Roman',Times,serif">
                  <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In 2016 through 2020, the Company entered into several collaboration agreements mainly with one Partner for the development, manufacturing and commercialization of several generic product candidates. Under the agreements, the Partner is obligated to conduct regulatory, scientific, clinical and technical activities necessary to develop the product and prepare and file ANDA, with the FDA and gain regulatory approval. The Company participates in the development of the product candidates, including participation in joint steering committees and is obligated for sourcing the active pharmaceutical ingredient (API) during the development phase.</span></span></div>
                  <div style="text-align:justify;line-height:1.25">&#160;</div>
                  <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Upon FDA approval, the Partner has exclusive rights and is required to use diligent efforts to commercialize these products in territories defined under the agreements, including all required sales, marketing and distributing activities associated with the agreements. The Company is entitled to a share of the Partner's gross profits related to the sale of the products, as such term is defined in each of the agreements.</span></span></div>
                  <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>
                  <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>These Agreement are considered to be within the scope of ASC 808, as the parties are active participants and exposed to the risks and rewards of the collaborative activity.<br />&#160;</span></span></span></div>
                  <div style="text-align:justify;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company recognizes collaboration revenue when the related sales occur.</span></span></div>
                  <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>
                  <div style="text-align:justify;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In November 2021, the Company entered into a new agreement (the "New Agreement") with the Partner, to sell its rights in relation to <ix:nonFraction id="Fxbrl_20220721203035246" name="slgl:NumberOfGenericCollaborativeAgreementsToSellRights" contextRef="C_20211101" unitRef="Agreement" scale="0" decimals="0" format="ixt-sec:numwordsen">ten</ix:nonFraction> generic collaborative agreements between the parties, including the agreements for two approved generic drug products. Under the New Agreement, the Company has retained collaboration rights to <ix:nonFraction id="Fxbrl_20220721203021215" name="slgl:NumberOfGenericProgramsRetainedForCollaborationRights" contextRef="C_20211101" unitRef="Program" scale="0" decimals="0" format="ixt-sec:numwordsen">two</ix:nonFraction> generic programs related to <ix:nonFraction id="Fxbrl_20220721203017096" name="slgl:NumberOfGenericDrugCandidates" contextRef="C_20211101" unitRef="Candidate" scale="0" decimals="0" format="ixt-sec:numwordsen">four</ix:nonFraction> generic drug candidates. Following the signing of the New Agreement, the Company is no longer entitled to receive its share in profit as detailed above.</span></span></div>
                  <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>
                  <div style="text-align:justify;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Under the terms of the New Agreement, effective as of November 1, 2021, the Company will unconditionally receive $<ix:nonFraction id="Fxbrl_20220721163242015" name="slgl:ExpectedRevenueReceivableOverTwentyFourMonths" contextRef="C_20211101" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">21,500</ix:nonFraction> over 24 months, in lieu of its share in future gross profits for the <ix:nonFraction id="Fxbrl_20220802221729758" name="slgl:NumberOfApprovedGenericDrugProducts" contextRef="C_20211101" unitRef="Program" scale="0" decimals="0" format="ixt-sec:numwordsen">two</ix:nonFraction> approved generic drug products and its potential gross profits for <ix:nonFraction id="Fxbrl_20220721163429797" name="slgl:NumberOfUnapprovedGenericPrograms" contextRef="C_20211101" unitRef="Program" scale="0" decimals="0" format="ixt-sec:numwordsen">eight</ix:nonFraction> unapproved generic programs. The Company received $<ix:nonFraction id="Fxbrl_20220721163505699" name="slgl:UpfrontPaymentReceived" contextRef="C_20211101to20211101" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,250</ix:nonFraction> as an upfront payment and $<ix:nonFraction id="Fxbrl_20220721163600367" name="slgl:PaymentReceivableInInstalments" contextRef="C_20211101" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">20,250</ix:nonFraction> in <ix:nonFraction id="Fxbrl_20220721163635760" name="slgl:NumberOfEqualQuarterlyInstalments" contextRef="C_20211101" unitRef="Instalment" scale="0" decimals="0" format="ixt-sec:numwordsen">eight</ix:nonFraction> equal quarterly instalments. The New Agreement also provides that effective as of November 1, 2021, the Company will cease paying any outstanding and future operational costs related to these collaborative agreements.</span></span></div>
                </td>
              </tr>

          </table>
        </div>
        <div>
          <div style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</div>
        </div>
      </div>
    </div>
  </ix:nonNumeric>

  <ix:nonNumeric id="FFact_285" name="slgl:LicenseAgreementsTextBlock" contextRef="C_20220101to20220630" escape="true">
    <div>
      <div>
        <p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong><span>NOTE</span></strong><span>&#160;<strong>5 </strong></span></span></span></span><span style="font-size:10pt;font-family:Times New Roman, Times, serif">&#8211;</span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong> </strong></span><strong><span><span style="color:black">LICENSE AGREEMENTS</span></span></strong><strong><span>:</span></strong></span></span></span></p>
        <p style="margin-top:0pt;margin-left:24px;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p>
        <p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif;margin-left:20pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:black">In June 2021, the Company entered into two exclusive license agreements with Galderma for the commercialization of Twyneo&#174; and Epsolay&#174;, in the United States. According to the agreement, the Company has an option to regain commercialization rights five years following first commercialization. In the third quarter of 2021, the Company received $<ix:nonFraction id="Fxbrl_20220721220455933" name="slgl:RefundableUpfrontPayment" contextRef="C_20210930_srtProductOrServiceAxis_slglTwyneoMember_usgaapTypeOfArrangementAxis_slglLicenseAgreementsWithGaldermaMember" unitRef="usd" scale="6" decimals="-5" format="ixt:num-dot-decimal">7.5</ix:nonFraction> million for </span></span><span><span><span style="color:black">Twyneo&#174;</span></span></span><span><span style="color:black"> and $<ix:nonFraction id="Fxbrl_20220721220959228" name="slgl:RefundableUpfrontPayment" contextRef="C_20210930_srtProductOrServiceAxis_slglEpsolayMember_usgaapTypeOfArrangementAxis_slglLicenseAgreementsWithGaldermaMember" unitRef="usd" scale="6" decimals="-6" format="ixt:num-dot-decimal">4</ix:nonFraction> million for </span></span><span><span><span style="color:black">Epsolay&#174;</span></span></span><span><span style="color:black"> of upfront payments, which are refundable if FDA approval for each respective product is not received by December 31, 2021. </span></span><span><span style="color:black">On July 27, 2021, the Company announced that the FDA approved the Company&#8217;s first proprietary drug product, Twyneo&#174;</span></span><span><span style="color:black">.</span></span></span></span></span></p>
      </div>
      <div><ix:exclude>
        <div style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</div>
        <div style="clear:both;margin-top:0pt;margin-bottom:0pt"><div style="text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:#000000;font-weight:normal;font-style:normal">F - 10</span></span></span></div><div style="page-break-after:always"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;margin-top:4pt;margin-bottom:10pt;height:2px;color:#000000;background-color:#000000" /></div></div><div style="text-align:center;line-height:1.25;margin-top:0px;margin-bottom:0px;color:rgb(0, 0, 0);font-family:Times New Roman, Times, serif"><p style="margin:0pt">&#160;</p><strong><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">SOL-GEL TECHNOLOGIES LTD.</span></span></strong></div><div style="text-align:center;line-height:1.25;color:#000000"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="font-family:'Times New Roman',Times,serif"><strong>NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</strong><br />(U.S. dollars in thousands, except share and per share data)</span></span></span></p></div><div style="text-align:center;margin-top:0px;margin-bottom:0px;line-height:1.25;color:rgb(0, 0, 0);font-family:Times New Roman, Times, serif"><p style="margin:0pt">&#160;</p><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">(Unaudited)</span></span></div><div style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</div>
        <p style="margin:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong><span>NOTE</span></strong><span>&#160;<strong>5 </strong></span></span></span></span><span style="font-size:10pt;font-family:Times New Roman, Times, serif">&#8211;&#160;</span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong><span><span style="color:black">LICENSE AGREEMENTS</span></span></strong><strong>&#160;</strong><span><span style="color:black">(continued):</span></span></span></span></span></p>
      </ix:exclude></div>
      <p style="margin:0pt">&#160;</p>
      <div>
        <div>
          <div style="text-align:justify;margin-left:20pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>On April 14, 2022, the Company announced that Twyneo&#174; is available for purchase by consumers who obtain a prescription from their physician, See note 1. In March 2022, the Company has refunded the $<ix:nonFraction id="Fxbrl_20220721222124939" name="slgl:RefundUpFrontPayment" contextRef="C_20220301to20220331" unitRef="usd" scale="6" decimals="-6" format="ixt:num-dot-decimal">4</ix:nonFraction> million upfront payment to Galderma, since FDA approval for Epsolay&#174; had not been received as of December 31, 2021. On April 25, 2022, the Company announced that the FDA approved the drug product, Epsolay&#174;, which entitled the Company to $<ix:nonFraction id="Fxbrl_20220721170709301" name="slgl:SalesMilestonePayments" contextRef="C_20220401to20220425_srtProductOrServiceAxis_slglEpsolayMember_usgaapTypeOfArrangementAxis_slglLicenseAgreementsWithGaldermaMember" unitRef="usd" scale="6" decimals="-5" format="ixt:num-dot-decimal">3.5</ix:nonFraction> million milestone payment, according to the license agreement.<span style="font-weight:bold">&#160;</span>In May 2022, the Company has received the $<ix:nonFraction id="Fxbrl_20220721170733213" name="slgl:RefundableUpfrontPayment" contextRef="C_20220531_usgaapTypeOfArrangementAxis_slglLicenseAgreementsWithGaldermaMember" unitRef="usd" scale="6" decimals="-5" format="ixt:num-dot-decimal">3.5</ix:nonFraction> million payment from Galderma. On June 2, 2022, the Company announced that Epsolay&#174; is available for purchase by consumers who obtain a prescription from their physician, See note 1.</span></span></span></div>
        </div>
      </div>
    </div>
  </ix:nonNumeric>
  <div>
    <div style="width:100%;clear:both">
      <p style="margin:0pt">&#160;</p>
    </div>
  </div>

  <ix:nonNumeric id="FFact_317" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" contextRef="C_20220101to20220630" escape="true">
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0px;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">NOTE</span><span>&#160;<span style="font-weight:bold">6 &#8211; SHARE CAPITAL:</span></span></span></span></p>
    <div>
      <div>
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>
        <div style="text-align:justify;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold;margin-left:20pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Options grants</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>
        <div style="text-align:justify;margin-left:20pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">During the six months ended June 30, 2022, the Company granted <ix:nonFraction id="Fxbrl_20220721173057826" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="C_20220101to20220630_srtTitleOfIndividualAxis_slglEmployeesAndExecutiveOfficersMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">722,488</ix:nonFraction> options to employees and executive officers:</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>
        <div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:20pt">&#160;</td>
                <td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:15pt">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">i.</span></span></div>
                </td>
                <td style="width:auto;vertical-align:top;font-family:Times New Roman, Times, serif">
                  <div style="line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In March 2022, the Company granted a total of <ix:nonFraction id="Fxbrl_20220721173108962" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="C_20220301to20220331_srtTitleOfIndividualAxis_slglEmployeesMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">148,907</ix:nonFraction> options to several employees to purchase ordinary shares at an exercise price of $<ix:nonFraction id="Fxbrl_20220721173117602" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="C_20220331_srtTitleOfIndividualAxis_slglEmployeesMember" unitRef="USDPShares" decimals="INF" format="ixt:num-dot-decimal">7.38</ix:nonFraction> per share.</span></span><br /><br /><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The options vest over a period of <ix:nonNumeric id="Fxbrl_20220721173129398" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" contextRef="C_20220301to20220331_srtTitleOfIndividualAxis_slglEmployeesMember" format="ixt-sec:duryear">4</ix:nonNumeric> years; one quarter of the options vest on the first anniversary of the vesting commencement date (as described in each agreement) and the rest vest quarterly over the following three years. The options expire on the tenth anniversary of their grant date.</span></span></div>
                  <div style="line-height:1.25">&#160;</div>
                </td>
              </tr>

          </table>
        </div>
        <div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:20pt">&#160;</td>
                <td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:15pt">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">ii.</span></span></div>
                </td>
                <td style="width:auto;vertical-align:top;font-family:Times New Roman, Times, serif">
                  <div style="line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In March 2022, the Company granted a total of <ix:nonFraction id="Fxbrl_20220721173139898" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="C_20220301to20220331_srtTitleOfIndividualAxis_srtExecutiveOfficerMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">271,517</ix:nonFraction> options to several Executive Officers to purchase ordinary shares at an exercise price of $<ix:nonFraction id="Fxbrl_20220721173148339" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="C_20220331_srtTitleOfIndividualAxis_srtExecutiveOfficerMember" unitRef="USDPShares" decimals="INF" format="ixt:num-dot-decimal">10</ix:nonFraction> per share.</span></span><br /><br /><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The options vest over a period of <ix:nonNumeric id="Fxbrl_20220721173158462" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" contextRef="C_20220301to20220331_srtTitleOfIndividualAxis_srtExecutiveOfficerMember" format="ixt-sec:duryear">4</ix:nonNumeric> years; one quarter of the options vest on the first anniversary of the vesting commencement date (as described in each agreement) and the rest vest quarterly over the following three years. The options expire on the tenth anniversary of their grant date.</span></span></div>
                  <div style="text-indent:38.4pt;line-height:1.25">&#160;</div>
                </td>
              </tr>

          </table>
        </div>
        <div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:20pt">&#160;</td>
                <td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:15pt">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">iii.</span></span></div>
                </td>
                <td style="width:auto;vertical-align:top;font-family:Times New Roman, Times, serif">
                  <div style="line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In March 2022, the board of directors approved and recommended the Company shareholders to approve a grant of <ix:nonFraction id="Fxbrl_20220721173211662" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="C_20220301to20220331_srtTitleOfIndividualAxis_srtChiefExecutiveOfficerMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">302,064</ix:nonFraction> options to the Company's CEO to purchase ordinary shares at an exercise price of $<ix:nonFraction id="Fxbrl_20220721173220544" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="C_20220331_srtTitleOfIndividualAxis_srtChiefExecutiveOfficerMember" unitRef="USDPShares" decimals="INF" format="ixt:num-dot-decimal">10</ix:nonFraction> per share. The Company's shareholders approved the grant in June 2022.</span></span></div>
                  <div style="text-indent:38.4pt;line-height:1.25">&#160;</div>
                  <div style="line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The options vest over a period of <ix:nonNumeric id="Fxbrl_20220721173231456" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" contextRef="C_20220301to20220331_srtTitleOfIndividualAxis_srtChiefExecutiveOfficerMember" format="ixt-sec:duryear">4</ix:nonNumeric> years; one quarter of the options vest on the first anniversary of the vesting commencement date (as described in each agreement) and the rest vest quarterly over the following three years. The options expire on the tenth anniversary of their grant date.</span></span></div>
                </td>
              </tr>

          </table>
        </div>
      </div>
    </div>
    <ix:nonNumeric id="FFact_307" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" contextRef="C_20220101to20220630" escape="true">
      <div>
        <div>
          <div style="text-align:justify;margin-left:20pt;line-height:1.25;font-family:'Times New Roman',Times,serif">
            <p style="margin:0pt">&#160;</p><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The fair value of options granted in 2022 was $<ix:nonFraction id="FFact_297" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" contextRef="C_20220101to20220630" unitRef="usd" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,278</ix:nonFraction>. The underlying data used for computing the fair value of the options are as follows:</span></span>
          </div>
          <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>
          <div style="margin-left:20pt;margin-bottom:10pt">
            <table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                <tr>
                  <td style="vertical-align:top;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
                    <div style="text-align:center;text-indent:20pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;width:88%;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">
                    <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Value of one ordinary share</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_298" name="us-gaap:SharePrice" contextRef="C_20220630" unitRef="USDPShares" decimals="INF" format="ixt:num-dot-decimal">7.72</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;width:88%;padding-bottom:4px;font-family:'Times New Roman',Times,serif" valign="bottom">
                    <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Dividend yield</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_300" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="C_20220101to20220630" unitRef="pure" decimals="INF" format="ixt:num-dot-decimal">0</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:top;width:88%;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">
                    <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Expected volatility</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_301" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="C_20220101to20220630" unitRef="pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">62.6</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:top;width:88%;font-family:'Times New Roman',Times,serif;padding-bottom:4px" valign="bottom">
                    <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Risk-free interest rate</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;padding-bottom:4px" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonFraction id="FFact_303" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="C_20220101to20220630" unitRef="pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">2.5</ix:nonFraction></span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;padding-bottom:4px;white-space:nowrap" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:top;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">
                    <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Expected term</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:top;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">
                    <div style="text-align:center;text-indent:20pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><ix:nonNumeric id="FFact_306" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" contextRef="C_20220101to20220630" format="ixt-sec:duryear">7</ix:nonNumeric> years</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>

            </table>
          </div>
        </div>
      </div>
    </ix:nonNumeric>
    <div><ix:exclude>
      <div style="clear:both;margin-top:0pt;margin-bottom:0pt"><div style="text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="color:#000000;font-weight:normal;font-style:normal">F - 11</span></span></span></div><div style="page-break-after:always"><hr style="border-width:0px;clear:both;margin:4px 0px;width:100%;margin-top:4pt;margin-bottom:10pt;height:2px;color:#000000;background-color:#000000" /></div></div><div style="text-align:center;line-height:1.25;margin-top:0px;margin-bottom:0px;color:rgb(0, 0, 0);font-family:Times New Roman, Times, serif"><p style="margin:0pt">&#160;</p><strong><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">SOL-GEL TECHNOLOGIES LTD.</span></span></strong></div><div style="text-align:center;line-height:1.25;color:#000000"><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">&#160;</p><p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="font-family:'Times New Roman',Times,serif"><strong>NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</strong><br />(U.S. dollars in thousands, except share and per share data)</span></span></span></p></div><div style="text-align:center;margin-top:0px;margin-bottom:0px;line-height:1.25;color:rgb(0, 0, 0);font-family:Times New Roman, Times, serif"><p style="margin:0pt">&#160;</p><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">(Unaudited)</span></span></div><div style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</div>
      <p style="margin:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong><span>NOTE</span></strong><span>&#160;<strong>6 </strong></span></span></span></span><span style="font-size:10pt;font-family:Times New Roman, Times, serif">&#8211;</span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong> </strong></span><strong><span><span style="color:black">SHARE CAPITAL</span></span></strong><strong>&#160;</strong><span><span style="color:black">(continued):</span></span></span></span></span></p>
    </ix:exclude></div>
    <p style="margin-top:0pt;margin-left:27px;margin-bottom:0pt;text-align:left;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:left">&#160;</p>
    <p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif;margin-left:20pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong><span><span style="color:black">Ordinary shares</span></span></strong><br /><br /><span><span style="color:black">In July 2021, the Company entered into an ATM sales agreement with Jefferies LLC ("Jefferies"), pursuant to which the Company is entitled, at its sole discretion, to offer and sell through Jefferies, acting as sales agent, Shares having an aggregate offering price of up to $<ix:nonFraction id="Fxbrl_20220726213802308" name="slgl:AggregateOfferingPrice" contextRef="C_20210701to20210731_usgaapRelatedPartyTransactionsByRelatedPartyAxis_slglJefferiesLlcMember" unitRef="usd" scale="6" decimals="-6" format="ixt:num-dot-decimal">25</ix:nonFraction>.0&#160;million throughout the period during which the ATM facility remains in effect. The Company agreed to pay Jefferies a commission of&#160;<ix:nonFraction id="Fxbrl_20220721184050637" name="slgl:PercentageOfGrossProceedsFromSaleOfShares" contextRef="C_20210701to20210731_usgaapRelatedPartyTransactionsByRelatedPartyAxis_slglJefferiesLlcMember" unitRef="pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">3.0</ix:nonFraction>% of the gross proceeds from the sale of shares under the facility.</span></span></span></span></span></p>
    <p style="margin:0pt">&#160;</p>
    <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif;margin-left:20pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:black">From the effective date of the agreement through its expiration,&#160;<ix:nonFraction id="Fxbrl_20220721184154893" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="C_20210701to20210731_usgaapRelatedPartyTransactionsByRelatedPartyAxis_slglJefferiesLlcMember" unitRef="Shares" decimals="INF" format="ixt:num-dot-decimal">41,154</ix:nonFraction> shares were sold under the program for total gross proceeds of approximately $ </span></span><span><span style="color:black"><ix:nonFraction id="Fxbrl_20220721184235909" name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="C_20210701to20210731_usgaapRelatedPartyTransactionsByRelatedPartyAxis_slglJefferiesLlcMember" unitRef="usd" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.5</ix:nonFraction>&#160;</span></span><span><span style="color:black">million.</span></span></span></span></span></p>
    <p style="margin:0pt">&#160;</p>
    <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif;margin-left:20pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:black">In April 2022, the Company signed a new ATM agreement with Jefferies for total amount of $<ix:nonFraction id="Fxbrl_20220721184533343" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="C_20220401to20220430_usgaapRelatedPartyTransactionsByRelatedPartyAxis_slglJefferiesLlcMember" unitRef="usd" scale="6" decimals="-6" format="ixt:num-dot-decimal">23</ix:nonFraction> million. As of the issuance date of this report, no shares were sold under the new ATM agreement.</span></span></span></p>
  </ix:nonNumeric>
  <div>
    <div style="width:100%;clear:both">
      <p style="margin:0pt">&#160;</p>
    </div>
  </div>

  <ix:nonNumeric id="FFact_318" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock" contextRef="C_20220101to20220630" escape="true">
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0px;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="font-weight:bold">NOTE 7&#8201;</span><span>&#8211;</span><span style="font-weight:bold">&#8201;RELATED PARTIES:</span></span></span></p>
    <p style="margin:0pt">&#160;</p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:0pt;margin-left:35pt;text-indent:-16pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="font-weight:normal">a.</span><span style="padding-left:9pt">Related parties include the controlling shareholder and companies under his control, the board of directors and the executive officers of the Company.</span></span></span></p>
    <p style="margin:0pt">&#160;</p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt;margin-left:35pt;text-indent:-16pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span>b.</span><span style="padding-left:9pt"><span>As to options granted to executive officers, see note 6.&#160;</span></span></span></span></p>
  </ix:nonNumeric>
  <div>
    <div style="width:100%;clear:both">
      <p style="margin:0pt">&#160;</p>
      <p style="margin:0pt;text-align:center"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">F - 12</span></span></p>
      <hr style="border:none;border-bottom:4px solid black;border-top:1px solid black;height:10px;width:100%;color:#ffffff;background-color:#ffffff;text-align:center;margin-left:auto;margin-right:auto;text-align:center" />
    </div>
  </div>
</div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>slgl-20220630.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<schema xmlns:slgl="http://www.sol-gel.co/20220630" xmlns="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:currency="http://xbrl.sec.gov/currency/2022" xmlns:exch="http://xbrl.sec.gov/exch/2022" xmlns:naics="http://xbrl.sec.gov/naics/2022" xmlns:sic="http://xbrl.sec.gov/sic/2022" xmlns:stpr="http://xbrl.sec.gov/stpr/2022" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:srt-types="http://fasb.org/srt-types/2022" xmlns:us-gaap="http://fasb.org/us-gaap/2022" targetNamespace="http://www.sol-gel.co/20220630" elementFormDefault="qualified">
  <!-- INTEGIX by Ez-XBRL -->
  <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd"/>
  <import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd"/>
  <import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd"/>
  <import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd"/>
  <import namespace="http://xbrl.sec.gov/currency/2022" schemaLocation="https://xbrl.sec.gov/currency/2022/currency-2022.xsd"/>
  <import namespace="http://xbrl.sec.gov/exch/2022" schemaLocation="https://xbrl.sec.gov/exch/2022/exch-2022.xsd"/>
  <import namespace="http://xbrl.sec.gov/naics/2022" schemaLocation="https://xbrl.sec.gov/naics/2022/naics-2022.xsd"/>
  <import namespace="http://xbrl.sec.gov/sic/2022" schemaLocation="https://xbrl.sec.gov/sic/2022/sic-2022.xsd"/>
  <import namespace="http://xbrl.sec.gov/stpr/2022" schemaLocation="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd"/>
  <import namespace="http://fasb.org/us-types/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd"/>
  <import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd"/>
  <import namespace="http://fasb.org/srt-types/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd"/>
  <import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd"/>
  <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <annotation>
    <appinfo>
      <link:roleType roleURI="http://www.sol-gel.co/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>0001 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.sol-gel.co/role/CondensedConsolidatedBalanceSheets" id="CondensedConsolidatedBalanceSheets">
        <link:definition>0002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.sol-gel.co/role/CondensedConsolidatedBalanceSheetsParenthetical" id="CondensedConsolidatedBalanceSheetsParenthetical">
        <link:definition>0003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfOperations" id="CondensedConsolidatedStatementsOfOperations">
        <link:definition>0004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity" id="CondensedConsolidatedStatementsOfChangesInShareholdersEquity">
        <link:definition>0005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfCashFlows" id="CondensedConsolidatedStatementsOfCashFlows">
        <link:definition>0006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.sol-gel.co/role/NatureOfOperations" id="NatureOfOperations">
        <link:definition>0007 - Disclosure - NATURE OF OPERATIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.sol-gel.co/role/SignificantAccountingPolicies" id="SignificantAccountingPolicies">
        <link:definition>0008 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES:</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.sol-gel.co/role/MarketableSecurities" id="MarketableSecurities">
        <link:definition>0009 - Disclosure - MARKETABLE SECURITIES:</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.sol-gel.co/role/CollaborationAgreements" id="CollaborationAgreements">
        <link:definition>0010 - Disclosure - COLLABORATION AGREEMENTS:</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.sol-gel.co/role/LicenseAgreements" id="LicenseAgreements">
        <link:definition>0011 - Disclosure - LICENSE AGREEMENTS:</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.sol-gel.co/role/ShareCapital" id="ShareCapital">
        <link:definition>0012 - Disclosure - SHARE CAPITAL:</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.sol-gel.co/role/RelatedParties" id="RelatedParties">
        <link:definition>0013 - Disclosure - RELATED PARTIES:</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.sol-gel.co/role/SignificantAccountingPoliciesPolicies" id="SignificantAccountingPoliciesPolicies">
        <link:definition>0015 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES: (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.sol-gel.co/role/MarketableSecuritiesTables" id="MarketableSecuritiesTables">
        <link:definition>0016 - Disclosure - MARKETABLE SECURITIES: (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.sol-gel.co/role/ShareCapitalTables" id="ShareCapitalTables">
        <link:definition>0017 - Disclosure - SHARE CAPITAL: (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.sol-gel.co/role/NatureOfOperationsDetails" id="NatureOfOperationsDetails">
        <link:definition>0018 - Disclosure - NATURE OF OPERATIONS (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.sol-gel.co/role/SignificantAccountingPoliciesNarrativeDetails" id="SignificantAccountingPoliciesNarrativeDetails">
        <link:definition>0019 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES: (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.sol-gel.co/role/MarketableSecuritiesScheduleOfCompanysMarketableSecuritiesDetails" id="MarketableSecuritiesScheduleOfCompanysMarketableSecuritiesDetails">
        <link:definition>0020 - Disclosure - MARKETABLE SECURITIES: (Schedule of Company's Marketable Securities) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.sol-gel.co/role/MarketableSecuritiesSummaryOfChangesInFairValueOfCompanysMarketableSecuritiesDetails" id="MarketableSecuritiesSummaryOfChangesInFairValueOfCompanysMarketableSecuritiesDetails">
        <link:definition>0021 - Disclosure - MARKETABLE SECURITIES: (Schedule of Changes in Fair Value of Company's Marketable Securities) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.sol-gel.co/role/MarketableSecuritiesScheduleOfCompanysDebtMarketableSecuritiesDetails" id="MarketableSecuritiesScheduleOfCompanysDebtMarketableSecuritiesDetails">
        <link:definition>0022 - Disclosure - MARKETABLE SECURITIES: (Schedule of Company's debt marketable securities) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.sol-gel.co/role/CollaborationAgreementsDetails" id="CollaborationAgreementsDetails">
        <link:definition>0023 - Disclosure - COLLABORATION AGREEMENTS: (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.sol-gel.co/role/LicenseAgreementsDetails" id="LicenseAgreementsDetails">
        <link:definition>0024 - Disclosure - LICENSE AGREEMENTS: (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.sol-gel.co/role/ShareCapitalNarrativeDetails" id="ShareCapitalNarrativeDetails">
        <link:definition>0025 - Disclosure - SHARE CAPITAL: (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.sol-gel.co/role/ShareCapitalScheduleOfAssumptionsUsedToEstimateFairValueDetails" id="ShareCapitalScheduleOfAssumptionsUsedToEstimateFairValueDetails">
        <link:definition>0026 - Disclosure - SHARE CAPITAL: (Schedule of Assumptions Used to Estimate Fair Value) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:linkbaseRef xlink:type="simple" xlink:href="slgl-20220630_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="slgl-20220630_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="slgl-20220630_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="slgl-20220630_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
    </appinfo>
  </annotation>
  <element name="AggregateOfferingPrice" id="slgl_AggregateOfferingPrice" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue" id="slgl_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="CashAndCashEquivalentsAndRestrictedCashShownInStatementOfCashFlows" id="slgl_CashAndCashEquivalentsAndRestrictedCashShownInStatementOfCashFlows" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ChangesInAccruedLiabilityForEmployeeRightsUponRetirement" id="slgl_ChangesInAccruedLiabilityForEmployeeRightsUponRetirement" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="ChangesInFairValueOfMarketableSecurities" id="slgl_ChangesInFairValueOfMarketableSecurities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="CollabrationsMember" id="slgl_CollabrationsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="DocumentAndEntityInformation" id="slgl_DocumentAndEntityInformation" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="EmployeesAndExecutiveOfficersMember" id="slgl_EmployeesAndExecutiveOfficersMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="EmployeesMember" id="slgl_EmployeesMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="EpsolayMember" id="slgl_EpsolayMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ExpectedRevenueReceivableOverTwentyFourMonths" id="slgl_ExpectedRevenueReceivableOverTwentyFourMonths" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="FinanceExpensesNet" id="slgl_FinanceExpensesNet" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="FinancialIncomeExpensesNet" id="slgl_FinancialIncomeExpensesNet" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="IncreaseInOperatingLeaseRouAssetsAndLiabilities" id="slgl_IncreaseInOperatingLeaseRouAssetsAndLiabilities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="IssuanceOfSharesAndWarrantsThroughPrivatePlacement" id="slgl_IssuanceOfSharesAndWarrantsThroughPrivatePlacement" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="IssuanceOfSharesAndWarrantsThroughPrivatePlacementShares" id="slgl_IssuanceOfSharesAndWarrantsThroughPrivatePlacementShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="IssuanceOfSharesAndWarrantsThroughPublicOfferingNetOfIssuanceCosts" id="slgl_IssuanceOfSharesAndWarrantsThroughPublicOfferingNetOfIssuanceCosts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="IssuanceOfSharesAndWarrantsThroughPublicOfferingNetOfIssuanceCostsShares" id="slgl_IssuanceOfSharesAndWarrantsThroughPublicOfferingNetOfIssuanceCostsShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="JefferiesLlcMember" id="slgl_JefferiesLlcMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="LicenseAgreementsAbstract" id="slgl_LicenseAgreementsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="LicenseAgreementsTextBlock" id="slgl_LicenseAgreementsTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="LicenseAgreementsWithGaldermaMember" id="slgl_LicenseAgreementsWithGaldermaMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="LongTermDeposits" id="slgl_LongTermDeposits" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="NetChangesInOperatingLeases" id="slgl_NetChangesInOperatingLeases" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="NumberOfApprovedGenericDrugProducts" id="slgl_NumberOfApprovedGenericDrugProducts" type="xbrli:integerItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfEqualQuarterlyInstalments" id="slgl_NumberOfEqualQuarterlyInstalments" type="xbrli:integerItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfGenericCollaborativeAgreementsToSellRights" id="slgl_NumberOfGenericCollaborativeAgreementsToSellRights" type="xbrli:integerItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfGenericDrugCandidates" id="slgl_NumberOfGenericDrugCandidates" type="xbrli:integerItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfGenericProgramsRetainedForCollaborationRights" id="slgl_NumberOfGenericProgramsRetainedForCollaborationRights" type="xbrli:integerItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="NumberOfUnapprovedGenericPrograms" id="slgl_NumberOfUnapprovedGenericPrograms" type="xbrli:integerItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="OtherForeignGovernmentBondsMember" id="slgl_OtherForeignGovernmentBondsMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PaymentReceivableInInstalments" id="slgl_PaymentReceivableInInstalments" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="PercentageOfGrossProceedsFromSaleOfShares" id="slgl_PercentageOfGrossProceedsFromSaleOfShares" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="PercentageOfGrossProfitsRelatedToSaleProducts" id="slgl_PercentageOfGrossProfitsRelatedToSaleProducts" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ProceedsFromLongTermDeposits" id="slgl_ProceedsFromLongTermDeposits" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ProceedsFromShortTermDeposits" id="slgl_ProceedsFromShortTermDeposits" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="ProductAndService" id="slgl_ProductAndService" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="ReceiveFromThirdPartyUpfrontPayment" id="slgl_ReceiveFromThirdPartyUpfrontPayment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="RefundableUpfrontPayment" id="slgl_RefundableUpfrontPayment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="RefundUpFrontPayment" id="slgl_RefundUpFrontPayment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="RefundUpfrontPayment" id="slgl_RefundUpfrontPayment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="RoyaltiesCompanyIsEligibleToReceive" id="slgl_RoyaltiesCompanyIsEligibleToReceive" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit"/>
  <element name="RoyaltiesMaturity" id="slgl_RoyaltiesMaturity" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="SalesMilestonePayments" id="slgl_SalesMilestonePayments" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="ShortTermDeposits" id="slgl_ShortTermDeposits" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="TwyneoMember" id="slgl_TwyneoMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="UnderwrittenPublicOfferingMember" id="slgl_UnderwrittenPublicOfferingMember" type="dtr-types:domainItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true"/>
  <element name="UpfrontPaymentReceived" id="slgl_UpfrontPaymentReceived" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
  <element name="UpfrontPayments" id="slgl_UpfrontPayments" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit"/>
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>5
<FILENAME>slgl-20220630_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <!-- INTEGIX by Ez-XBRL -->
  <roleRef xlink:type="simple" xlink:href="slgl-20220630.xsd#CondensedConsolidatedBalanceSheets" roleURI="http://www.sol-gel.co/role/CondensedConsolidatedBalanceSheets"/>
  <roleRef xlink:type="simple" xlink:href="slgl-20220630.xsd#CondensedConsolidatedStatementsOfOperations" roleURI="http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfOperations"/>
  <roleRef xlink:type="simple" xlink:href="slgl-20220630.xsd#CondensedConsolidatedStatementsOfCashFlows" roleURI="http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfCashFlows"/>
  <calculationLink xlink:type="extended" xlink:role="http://www.sol-gel.co/role/CondensedConsolidatedBalanceSheets">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesCurrent" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesNetCurrent" xlink:label="loc_us-gaap_ReceivablesNetCurrent_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepositsAssetsCurrent" xlink:label="loc_us-gaap_DepositsAssetsCurrent_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNoncurrent" xlink:label="loc_us-gaap_AssetsNoncurrent_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndInvestmentsNoncurrent" xlink:label="loc_us-gaap_RestrictedCashAndInvestmentsNoncurrent_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetNoncurrent" xlink:label="loc_us-gaap_AccountsReceivableNetNoncurrent_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaap_AccountsPayableCurrent_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligation" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaap_CommitmentsAndContingencies_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_23"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_23"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_24"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_25"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_0" xlink:to="loc_us-gaap_AssetsCurrent_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_1" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_1" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_2" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_1" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_3" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_1" xlink:to="loc_us-gaap_ReceivablesNetCurrent_4" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_1" xlink:to="loc_us-gaap_DepositsAssetsCurrent_5" order="40" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_0" xlink:to="loc_us-gaap_AssetsNoncurrent_7" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent_7" xlink:to="loc_us-gaap_RestrictedCashAndInvestmentsNoncurrent_7" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent_7" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_8" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent_7" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_9" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent_7" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_10" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsNoncurrent_7" xlink:to="loc_us-gaap_AccountsReceivableNetNoncurrent_11" order="40" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_13" xlink:to="loc_us-gaap_Liabilities_14" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_14" xlink:to="loc_us-gaap_LiabilitiesCurrent_14" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_14" xlink:to="loc_us-gaap_AccountsPayableCurrent_14" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_14" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_15" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_14" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_16" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_14" xlink:to="loc_us-gaap_LiabilitiesNoncurrent_18" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesNoncurrent_18" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_18" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesNoncurrent_18" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_19" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_14" xlink:to="loc_us-gaap_CommitmentsAndContingencies_21" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_13" xlink:to="loc_us-gaap_StockholdersEquity_23" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_23" xlink:to="loc_us-gaap_CommonStockValue_23" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_23" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_24" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_23" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_25" order="20" use="optional" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfOperations">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_0"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_FinancialIncomeExpensesNet" xlink:label="loc_slgl_FinancialIncomeExpensesNet_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_4"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_0" xlink:to="loc_slgl_FinancialIncomeExpensesNet_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_0" xlink:to="loc_us-gaap_OperatingIncomeLoss_2" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_2" xlink:to="loc_us-gaap_Revenues_2" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_2" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_3" order="10" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_2" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_4" order="20" use="optional" weight="-1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfCashFlows">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInLongTermReceivablesCurrent" xlink:label="loc_us-gaap_IncreaseDecreaseInLongTermReceivablesCurrent_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaap_Depreciation_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_4"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_FinanceExpensesNet" xlink:label="loc_slgl_FinanceExpensesNet_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidExpensesOther" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidExpensesOther_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_7"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_ChangesInAccruedLiabilityForEmployeeRightsUponRetirement" xlink:label="loc_slgl_ChangesInAccruedLiabilityForEmployeeRightsUponRetirement_8"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_ChangesInFairValueOfMarketableSecurities" xlink:label="loc_slgl_ChangesInFairValueOfMarketableSecurities_9"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_NetChangesInOperatingLeases" xlink:label="loc_slgl_NetChangesInOperatingLeases_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireMarketableSecurities" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_14"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_ProceedsFromShortTermDeposits" xlink:label="loc_slgl_ProceedsFromShortTermDeposits_15"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_ProceedsFromLongTermDeposits" xlink:label="loc_slgl_ProceedsFromLongTermDeposits_16"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_ShortTermDeposits" xlink:label="loc_slgl_ShortTermDeposits_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_23"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCash" xlink:label="loc_us-gaap_RestrictedCash_24"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1" xlink:to="loc_us-gaap_IncreaseDecreaseInLongTermReceivablesCurrent_1" order="0" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1" xlink:to="loc_us-gaap_ProfitLoss_2" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1" xlink:to="loc_us-gaap_Depreciation_3" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1" xlink:to="loc_us-gaap_ShareBasedCompensation_4" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1" xlink:to="loc_slgl_FinanceExpensesNet_5" order="40" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidExpensesOther_6" order="50" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_7" order="60" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1" xlink:to="loc_slgl_ChangesInAccruedLiabilityForEmployeeRightsUponRetirement_8" order="70" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1" xlink:to="loc_slgl_ChangesInFairValueOfMarketableSecurities_9" order="80" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1" xlink:to="loc_slgl_NetChangesInOperatingLeases_10" order="90" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_12" order="10" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_12" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_12" order="0" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_12" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_13" order="10" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_12" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_14" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_12" xlink:to="loc_slgl_ProceedsFromShortTermDeposits_15" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_12" xlink:to="loc_slgl_ProceedsFromLongTermDeposits_16" order="40" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_12" xlink:to="loc_slgl_ShortTermDeposits_17" order="50" use="optional" weight="-1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_19" order="20" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_19" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_19" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_21" order="30" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_22" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_23" order="0" use="optional" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_22" xlink:to="loc_us-gaap_RestrictedCash_24" order="10" use="optional" weight="1"/>
  </calculationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>6
<FILENAME>slgl-20220630_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
  <!-- INTEGIX by Ez-XBRL -->
  <roleRef xlink:type="simple" xlink:href="slgl-20220630.xsd#CondensedConsolidatedStatementsOfOperations" roleURI="http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfOperations"/>
  <roleRef xlink:type="simple" xlink:href="slgl-20220630.xsd#CondensedConsolidatedStatementsOfChangesInShareholdersEquity" roleURI="http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity"/>
  <roleRef xlink:type="simple" xlink:href="slgl-20220630.xsd#MarketableSecuritiesScheduleOfCompanysMarketableSecuritiesDetails" roleURI="http://www.sol-gel.co/role/MarketableSecuritiesScheduleOfCompanysMarketableSecuritiesDetails"/>
  <roleRef xlink:type="simple" xlink:href="slgl-20220630.xsd#CollaborationAgreementsDetails" roleURI="http://www.sol-gel.co/role/CollaborationAgreementsDetails"/>
  <roleRef xlink:type="simple" xlink:href="slgl-20220630.xsd#LicenseAgreementsDetails" roleURI="http://www.sol-gel.co/role/LicenseAgreementsDetails"/>
  <roleRef xlink:type="simple" xlink:href="slgl-20220630.xsd#ShareCapitalNarrativeDetails" roleURI="http://www.sol-gel.co/role/ShareCapitalNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="slgl-20220630.xsd#ShareCapitalScheduleOfAssumptionsUsedToEstimateFairValueDetails" roleURI="http://www.sol-gel.co/role/ShareCapitalScheduleOfAssumptionsUsedToEstimateFairValueDetails"/>
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll"/>
  <definitionLink xlink:type="extended" xlink:role="http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfOperations">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srt_ProductOrServiceAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_1"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_CollabrationsMember" xlink:label="loc_slgl_CollabrationsMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicenseMember" xlink:label="loc_us-gaap_LicenseMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_10"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_FinancialIncomeExpensesNet" xlink:label="loc_slgl_FinancialIncomeExpensesNet_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaap_EarningsPerShareBasic_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaap_EarningsPerShareDiluted_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_16"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_StatementTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_srt_ProductOrServiceAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_1" xlink:to="loc_srt_ProductsAndServicesDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_1" xlink:to="loc_slgl_CollabrationsMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_1" xlink:to="loc_us-gaap_LicenseMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_1" xlink:to="loc_srt_ProductsAndServicesDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_Revenues_7" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_8" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_9" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_OperatingIncomeLoss_10" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_slgl_FinancialIncomeExpensesNet_11" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_NetIncomeLoss_12" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_EarningsPerShareBasic_13" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_EarningsPerShareDiluted_14" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_15" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_16" order="100" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaap_RetainedEarningsMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_16"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_StatementTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1" xlink:to="loc_us-gaap_EquityComponentDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_1" xlink:to="loc_us-gaap_CommonStockMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_1" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_1" xlink:to="loc_us-gaap_RetainedEarningsMember_3" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1" xlink:to="loc_us-gaap_EquityComponentDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_StockholdersEquity_8" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_9" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_ProfitLoss_10" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan_11" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_12" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_13" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_14" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_15" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_ShareBasedCompensation_16" order="90" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.sol-gel.co/role/MarketableSecuritiesScheduleOfCompanysMarketableSecuritiesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesAbstract" xlink:label="loc_us-gaap_MarketableSecuritiesAbstract_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesCurrent" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis" xlink:label="loc_us-gaap_InvestmentTypeAxis_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" xlink:label="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignGovernmentDebtMember" xlink:label="loc_us-gaap_ForeignGovernmentDebtMember_4"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_OtherForeignGovernmentBondsMember" xlink:label="loc_slgl_OtherForeignGovernmentBondsMember_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllOtherCorporateBondsMember" xlink:label="loc_us-gaap_AllOtherCorporateBondsMember_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_Default"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_MarketableSecuritiesAbstract_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MarketableSecuritiesAbstract_1" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_StatementTable_3" order="10" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_3" xlink:to="loc_us-gaap_InvestmentTypeAxis_3" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_3" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_3" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_3" xlink:to="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_3" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_3" xlink:to="loc_us-gaap_ForeignGovernmentDebtMember_4" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_3" xlink:to="loc_slgl_OtherForeignGovernmentBondsMember_5" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_3" xlink:to="loc_us-gaap_AllOtherCorporateBondsMember_6" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_3" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_Default" order="10" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.sol-gel.co/role/CollaborationAgreementsDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_Default"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_RoyaltiesMaturity" xlink:label="loc_slgl_RoyaltiesMaturity_7"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_NumberOfGenericCollaborativeAgreementsToSellRights" xlink:label="loc_slgl_NumberOfGenericCollaborativeAgreementsToSellRights_8"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_NumberOfGenericProgramsRetainedForCollaborationRights" xlink:label="loc_slgl_NumberOfGenericProgramsRetainedForCollaborationRights_9"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_NumberOfGenericDrugCandidates" xlink:label="loc_slgl_NumberOfGenericDrugCandidates_10"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_ExpectedRevenueReceivableOverTwentyFourMonths" xlink:label="loc_slgl_ExpectedRevenueReceivableOverTwentyFourMonths_11"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_NumberOfApprovedGenericDrugProducts" xlink:label="loc_slgl_NumberOfApprovedGenericDrugProducts_12"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_NumberOfUnapprovedGenericPrograms" xlink:label="loc_slgl_NumberOfUnapprovedGenericPrograms_13"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_UpfrontPaymentReceived" xlink:label="loc_slgl_UpfrontPaymentReceived_14"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_PaymentReceivableInInstalments" xlink:label="loc_slgl_PaymentReceivableInInstalments_15"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_NumberOfEqualQuarterlyInstalments" xlink:label="loc_slgl_NumberOfEqualQuarterlyInstalments_16"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_us-gaap_StatementTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_srt_RangeAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_1" xlink:to="loc_srt_RangeMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_1" xlink:to="loc_srt_MinimumMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_1" xlink:to="loc_srt_MaximumMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_1" xlink:to="loc_srt_RangeMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_slgl_RoyaltiesMaturity_7" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_slgl_NumberOfGenericCollaborativeAgreementsToSellRights_8" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_slgl_NumberOfGenericProgramsRetainedForCollaborationRights_9" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_slgl_NumberOfGenericDrugCandidates_10" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_slgl_ExpectedRevenueReceivableOverTwentyFourMonths_11" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_slgl_NumberOfApprovedGenericDrugProducts_12" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_slgl_NumberOfUnapprovedGenericPrograms_13" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_slgl_UpfrontPaymentReceived_14" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_slgl_PaymentReceivableInInstalments_15" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0" xlink:to="loc_slgl_NumberOfEqualQuarterlyInstalments_16" order="100" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.sol-gel.co/role/LicenseAgreementsDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srt_ProductOrServiceAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_1"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_TwyneoMember" xlink:label="loc_slgl_TwyneoMember_1"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_EpsolayMember" xlink:label="loc_slgl_EpsolayMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaap_TypeOfArrangementAxis_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_6"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_LicenseAgreementsWithGaldermaMember" xlink:label="loc_slgl_LicenseAgreementsWithGaldermaMember_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_Default"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_UpfrontPayments" xlink:label="loc_slgl_UpfrontPayments_15"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_RoyaltiesCompanyIsEligibleToReceive" xlink:label="loc_slgl_RoyaltiesCompanyIsEligibleToReceive_16"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_RefundableUpfrontPayment" xlink:label="loc_slgl_RefundableUpfrontPayment_17"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_SalesMilestonePayments" xlink:label="loc_slgl_SalesMilestonePayments_18"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_RefundUpFrontPayment" xlink:label="loc_slgl_RefundUpFrontPayment_19"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_0" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_1" xlink:to="loc_srt_ProductOrServiceAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_1" xlink:to="loc_srt_ProductsAndServicesDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_1" xlink:to="loc_slgl_TwyneoMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_1" xlink:to="loc_slgl_EpsolayMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_1" xlink:to="loc_srt_ProductsAndServicesDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_1" xlink:to="loc_us-gaap_TypeOfArrangementAxis_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_6" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_6" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_6" xlink:to="loc_slgl_LicenseAgreementsWithGaldermaMember_6" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_6" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_1" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_10" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_10" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_10" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_10" xlink:to="loc_us-gaap_SubsequentEventMember_10" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_10" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_0" xlink:to="loc_slgl_UpfrontPayments_15" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_0" xlink:to="loc_slgl_RoyaltiesCompanyIsEligibleToReceive_16" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_0" xlink:to="loc_slgl_RefundableUpfrontPayment_17" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_0" xlink:to="loc_slgl_SalesMilestonePayments_18" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_0" xlink:to="loc_slgl_RefundUpFrontPayment_19" order="50" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.sol-gel.co/role/ShareCapitalNarrativeDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_1"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_JefferiesLlcMember" xlink:label="loc_slgl_JefferiesLlcMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srt_TitleOfIndividualAxis_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_5"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_EmployeesAndExecutiveOfficersMember" xlink:label="loc_slgl_EmployeesAndExecutiveOfficersMember_5"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_EmployeesMember" xlink:label="loc_slgl_EmployeesMember_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ExecutiveOfficerMember" xlink:label="loc_srt_ExecutiveOfficerMember_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ChiefExecutiveOfficerMember" xlink:label="loc_srt_ChiefExecutiveOfficerMember_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_DirectorMember" xlink:label="loc_srt_DirectorMember_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_us-gaap_PrivatePlacementMember_13"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_UnderwrittenPublicOfferingMember" xlink:label="loc_slgl_UnderwrittenPublicOfferingMember_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_23"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssued" xlink:label="loc_us-gaap_SharesIssued_24"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_25"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_26"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_27"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_28"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_29"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_30"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_AggregateOfferingPrice" xlink:label="loc_slgl_AggregateOfferingPrice_31"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_PercentageOfGrossProceedsFromSaleOfShares" xlink:label="loc_slgl_PercentageOfGrossProceedsFromSaleOfShares_32"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_33"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_34"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_35"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1" xlink:to="loc_us-gaap_RelatedPartyDomain_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_1" xlink:to="loc_slgl_JefferiesLlcMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1" xlink:to="loc_us-gaap_RelatedPartyDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_srt_TitleOfIndividualAxis_5" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_TitleOfIndividualAxis_5" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_5" xlink:to="loc_slgl_EmployeesAndExecutiveOfficersMember_5" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_5" xlink:to="loc_slgl_EmployeesMember_6" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_5" xlink:to="loc_srt_ExecutiveOfficerMember_7" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_5" xlink:to="loc_srt_ChiefExecutiveOfficerMember_8" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_5" xlink:to="loc_srt_DirectorMember_9" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_TitleOfIndividualAxis_5" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_13" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_13" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_13" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_13" xlink:to="loc_us-gaap_PrivatePlacementMember_13" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_13" xlink:to="loc_slgl_UnderwrittenPublicOfferingMember_14" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_13" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_19" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_20" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_21" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_22" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_23" order="50" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_SharesIssued_24" order="60" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_25" order="70" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_26" order="80" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_27" order="90" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_28" order="100" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_29" order="110" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_30" order="120" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_slgl_AggregateOfferingPrice_31" order="130" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_slgl_PercentageOfGrossProceedsFromSaleOfShares_32" order="140" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_33" order="150" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_34" order="160" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_35" order="170" use="optional"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.sol-gel.co/role/ShareCapitalScheduleOfAssumptionsUsedToEstimateFairValueDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_Default"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaap_SharePrice_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_11"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" order="0" use="optional" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_srt_RangeAxis_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_1" xlink:to="loc_srt_RangeMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_1" xlink:to="loc_srt_MinimumMember_1" order="0" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_1" xlink:to="loc_srt_MaximumMember_2" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_1" xlink:to="loc_srt_RangeMember_Default" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_SharePrice_7" order="10" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_8" order="20" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_9" order="30" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_10" order="40" use="optional"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_11" order="50" use="optional"/>
  </definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>7
<FILENAME>slgl-20220630_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <!-- INTEGIX by Ez-XBRL -->
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel"/>
  <labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_AggregateOfferingPrice" xlink:label="loc_slgl_AggregateOfferingPrice_1"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_AggregateOfferingPrice" xlink:label="loc_slgl_AggregateOfferingPrice_2"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_AggregateOfferingPrice" xlink:label="loc_slgl_AggregateOfferingPrice_3"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue" xlink:label="loc_slgl_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue_4"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue" xlink:label="loc_slgl_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue_5"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue" xlink:label="loc_slgl_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue_6"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_CashAndCashEquivalentsAndRestrictedCashShownInStatementOfCashFlows" xlink:label="loc_slgl_CashAndCashEquivalentsAndRestrictedCashShownInStatementOfCashFlows_7"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_CashAndCashEquivalentsAndRestrictedCashShownInStatementOfCashFlows" xlink:label="loc_slgl_CashAndCashEquivalentsAndRestrictedCashShownInStatementOfCashFlows_8"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_ChangesInAccruedLiabilityForEmployeeRightsUponRetirement" xlink:label="loc_slgl_ChangesInAccruedLiabilityForEmployeeRightsUponRetirement_9"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_ChangesInAccruedLiabilityForEmployeeRightsUponRetirement" xlink:label="loc_slgl_ChangesInAccruedLiabilityForEmployeeRightsUponRetirement_10"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_ChangesInAccruedLiabilityForEmployeeRightsUponRetirement" xlink:label="loc_slgl_ChangesInAccruedLiabilityForEmployeeRightsUponRetirement_11"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_ChangesInFairValueOfMarketableSecurities" xlink:label="loc_slgl_ChangesInFairValueOfMarketableSecurities_12"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_ChangesInFairValueOfMarketableSecurities" xlink:label="loc_slgl_ChangesInFairValueOfMarketableSecurities_13"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_ChangesInFairValueOfMarketableSecurities" xlink:label="loc_slgl_ChangesInFairValueOfMarketableSecurities_14"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_ChangesInFairValueOfMarketableSecurities" xlink:label="loc_slgl_ChangesInFairValueOfMarketableSecurities_15"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_CollabrationsMember" xlink:label="loc_slgl_CollabrationsMember_16"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_CollabrationsMember" xlink:label="loc_slgl_CollabrationsMember_17"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_CollabrationsMember" xlink:label="loc_slgl_CollabrationsMember_18"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_EmployeesAndExecutiveOfficersMember" xlink:label="loc_slgl_EmployeesAndExecutiveOfficersMember_19"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_EmployeesAndExecutiveOfficersMember" xlink:label="loc_slgl_EmployeesAndExecutiveOfficersMember_20"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_EmployeesAndExecutiveOfficersMember" xlink:label="loc_slgl_EmployeesAndExecutiveOfficersMember_21"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_EmployeesAndExecutiveOfficersMember" xlink:label="loc_slgl_EmployeesAndExecutiveOfficersMember_22"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_EmployeesMember" xlink:label="loc_slgl_EmployeesMember_23"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_EmployeesMember" xlink:label="loc_slgl_EmployeesMember_24"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_EpsolayMember" xlink:label="loc_slgl_EpsolayMember_25"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_EpsolayMember" xlink:label="loc_slgl_EpsolayMember_26"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_ExpectedRevenueReceivableOverTwentyFourMonths" xlink:label="loc_slgl_ExpectedRevenueReceivableOverTwentyFourMonths_27"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_ExpectedRevenueReceivableOverTwentyFourMonths" xlink:label="loc_slgl_ExpectedRevenueReceivableOverTwentyFourMonths_28"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_ExpectedRevenueReceivableOverTwentyFourMonths" xlink:label="loc_slgl_ExpectedRevenueReceivableOverTwentyFourMonths_29"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_FinanceExpensesNet" xlink:label="loc_slgl_FinanceExpensesNet_30"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_FinanceExpensesNet" xlink:label="loc_slgl_FinanceExpensesNet_31"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_FinanceExpensesNet" xlink:label="loc_slgl_FinanceExpensesNet_32"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_FinancialIncomeExpensesNet" xlink:label="loc_slgl_FinancialIncomeExpensesNet_33"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_FinancialIncomeExpensesNet" xlink:label="loc_slgl_FinancialIncomeExpensesNet_34"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_FinancialIncomeExpensesNet" xlink:label="loc_slgl_FinancialIncomeExpensesNet_35"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_FinancialIncomeExpensesNet" xlink:label="loc_slgl_FinancialIncomeExpensesNet_36"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_IncreaseInOperatingLeaseRouAssetsAndLiabilities" xlink:label="loc_slgl_IncreaseInOperatingLeaseRouAssetsAndLiabilities_37"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_IncreaseInOperatingLeaseRouAssetsAndLiabilities" xlink:label="loc_slgl_IncreaseInOperatingLeaseRouAssetsAndLiabilities_38"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_IssuanceOfSharesAndWarrantsThroughPrivatePlacement" xlink:label="loc_slgl_IssuanceOfSharesAndWarrantsThroughPrivatePlacement_39"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_IssuanceOfSharesAndWarrantsThroughPrivatePlacement" xlink:label="loc_slgl_IssuanceOfSharesAndWarrantsThroughPrivatePlacement_40"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_IssuanceOfSharesAndWarrantsThroughPrivatePlacement" xlink:label="loc_slgl_IssuanceOfSharesAndWarrantsThroughPrivatePlacement_41"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_IssuanceOfSharesAndWarrantsThroughPrivatePlacementShares" xlink:label="loc_slgl_IssuanceOfSharesAndWarrantsThroughPrivatePlacementShares_42"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_IssuanceOfSharesAndWarrantsThroughPrivatePlacementShares" xlink:label="loc_slgl_IssuanceOfSharesAndWarrantsThroughPrivatePlacementShares_43"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_IssuanceOfSharesAndWarrantsThroughPrivatePlacementShares" xlink:label="loc_slgl_IssuanceOfSharesAndWarrantsThroughPrivatePlacementShares_44"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_IssuanceOfSharesAndWarrantsThroughPublicOfferingNetOfIssuanceCosts" xlink:label="loc_slgl_IssuanceOfSharesAndWarrantsThroughPublicOfferingNetOfIssuanceCosts_45"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_IssuanceOfSharesAndWarrantsThroughPublicOfferingNetOfIssuanceCosts" xlink:label="loc_slgl_IssuanceOfSharesAndWarrantsThroughPublicOfferingNetOfIssuanceCosts_46"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_IssuanceOfSharesAndWarrantsThroughPublicOfferingNetOfIssuanceCostsShares" xlink:label="loc_slgl_IssuanceOfSharesAndWarrantsThroughPublicOfferingNetOfIssuanceCostsShares_47"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_IssuanceOfSharesAndWarrantsThroughPublicOfferingNetOfIssuanceCostsShares" xlink:label="loc_slgl_IssuanceOfSharesAndWarrantsThroughPublicOfferingNetOfIssuanceCostsShares_48"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_JefferiesLlcMember" xlink:label="loc_slgl_JefferiesLlcMember_49"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_JefferiesLlcMember" xlink:label="loc_slgl_JefferiesLlcMember_50"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_LicenseAgreementsTextBlock" xlink:label="loc_slgl_LicenseAgreementsTextBlock_51"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_LicenseAgreementsTextBlock" xlink:label="loc_slgl_LicenseAgreementsTextBlock_52"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_LicenseAgreementsTextBlock" xlink:label="loc_slgl_LicenseAgreementsTextBlock_53"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_LicenseAgreementsWithGaldermaMember" xlink:label="loc_slgl_LicenseAgreementsWithGaldermaMember_54"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_LicenseAgreementsWithGaldermaMember" xlink:label="loc_slgl_LicenseAgreementsWithGaldermaMember_55"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_LongTermDeposits" xlink:label="loc_slgl_LongTermDeposits_56"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_LongTermDeposits" xlink:label="loc_slgl_LongTermDeposits_57"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_LongTermDeposits" xlink:label="loc_slgl_LongTermDeposits_58"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_NetChangesInOperatingLeases" xlink:label="loc_slgl_NetChangesInOperatingLeases_59"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_NetChangesInOperatingLeases" xlink:label="loc_slgl_NetChangesInOperatingLeases_60"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_NetChangesInOperatingLeases" xlink:label="loc_slgl_NetChangesInOperatingLeases_61"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_NumberOfApprovedGenericDrugProducts" xlink:label="loc_slgl_NumberOfApprovedGenericDrugProducts_62"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_NumberOfApprovedGenericDrugProducts" xlink:label="loc_slgl_NumberOfApprovedGenericDrugProducts_63"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_NumberOfApprovedGenericDrugProducts" xlink:label="loc_slgl_NumberOfApprovedGenericDrugProducts_64"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_NumberOfEqualQuarterlyInstalments" xlink:label="loc_slgl_NumberOfEqualQuarterlyInstalments_65"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_NumberOfEqualQuarterlyInstalments" xlink:label="loc_slgl_NumberOfEqualQuarterlyInstalments_66"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_NumberOfEqualQuarterlyInstalments" xlink:label="loc_slgl_NumberOfEqualQuarterlyInstalments_67"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_NumberOfGenericCollaborativeAgreementsToSellRights" xlink:label="loc_slgl_NumberOfGenericCollaborativeAgreementsToSellRights_68"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_NumberOfGenericCollaborativeAgreementsToSellRights" xlink:label="loc_slgl_NumberOfGenericCollaborativeAgreementsToSellRights_69"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_NumberOfGenericCollaborativeAgreementsToSellRights" xlink:label="loc_slgl_NumberOfGenericCollaborativeAgreementsToSellRights_70"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_NumberOfGenericDrugCandidates" xlink:label="loc_slgl_NumberOfGenericDrugCandidates_71"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_NumberOfGenericDrugCandidates" xlink:label="loc_slgl_NumberOfGenericDrugCandidates_72"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_NumberOfGenericDrugCandidates" xlink:label="loc_slgl_NumberOfGenericDrugCandidates_73"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_NumberOfGenericProgramsRetainedForCollaborationRights" xlink:label="loc_slgl_NumberOfGenericProgramsRetainedForCollaborationRights_74"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_NumberOfGenericProgramsRetainedForCollaborationRights" xlink:label="loc_slgl_NumberOfGenericProgramsRetainedForCollaborationRights_75"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_NumberOfGenericProgramsRetainedForCollaborationRights" xlink:label="loc_slgl_NumberOfGenericProgramsRetainedForCollaborationRights_76"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_NumberOfUnapprovedGenericPrograms" xlink:label="loc_slgl_NumberOfUnapprovedGenericPrograms_77"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_NumberOfUnapprovedGenericPrograms" xlink:label="loc_slgl_NumberOfUnapprovedGenericPrograms_78"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_NumberOfUnapprovedGenericPrograms" xlink:label="loc_slgl_NumberOfUnapprovedGenericPrograms_79"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_OtherForeignGovernmentBondsMember" xlink:label="loc_slgl_OtherForeignGovernmentBondsMember_80"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_OtherForeignGovernmentBondsMember" xlink:label="loc_slgl_OtherForeignGovernmentBondsMember_81"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_PaymentReceivableInInstalments" xlink:label="loc_slgl_PaymentReceivableInInstalments_82"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_PaymentReceivableInInstalments" xlink:label="loc_slgl_PaymentReceivableInInstalments_83"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_PaymentReceivableInInstalments" xlink:label="loc_slgl_PaymentReceivableInInstalments_84"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_PercentageOfGrossProceedsFromSaleOfShares" xlink:label="loc_slgl_PercentageOfGrossProceedsFromSaleOfShares_85"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_PercentageOfGrossProceedsFromSaleOfShares" xlink:label="loc_slgl_PercentageOfGrossProceedsFromSaleOfShares_86"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_PercentageOfGrossProceedsFromSaleOfShares" xlink:label="loc_slgl_PercentageOfGrossProceedsFromSaleOfShares_87"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_PercentageOfGrossProfitsRelatedToSaleProducts" xlink:label="loc_slgl_PercentageOfGrossProfitsRelatedToSaleProducts_88"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_PercentageOfGrossProfitsRelatedToSaleProducts" xlink:label="loc_slgl_PercentageOfGrossProfitsRelatedToSaleProducts_89"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_ProceedsFromLongTermDeposits" xlink:label="loc_slgl_ProceedsFromLongTermDeposits_90"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_ProceedsFromLongTermDeposits" xlink:label="loc_slgl_ProceedsFromLongTermDeposits_91"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_ProceedsFromLongTermDeposits" xlink:label="loc_slgl_ProceedsFromLongTermDeposits_92"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_ProceedsFromShortTermDeposits" xlink:label="loc_slgl_ProceedsFromShortTermDeposits_93"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_ProceedsFromShortTermDeposits" xlink:label="loc_slgl_ProceedsFromShortTermDeposits_94"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_ProceedsFromShortTermDeposits" xlink:label="loc_slgl_ProceedsFromShortTermDeposits_95"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_ProductAndService" xlink:label="loc_slgl_ProductAndService_96"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_ProductAndService" xlink:label="loc_slgl_ProductAndService_97"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_ReceiveFromThirdPartyUpfrontPayment" xlink:label="loc_slgl_ReceiveFromThirdPartyUpfrontPayment_98"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_ReceiveFromThirdPartyUpfrontPayment" xlink:label="loc_slgl_ReceiveFromThirdPartyUpfrontPayment_99"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_RefundableUpfrontPayment" xlink:label="loc_slgl_RefundableUpfrontPayment_100"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_RefundableUpfrontPayment" xlink:label="loc_slgl_RefundableUpfrontPayment_101"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_RefundableUpfrontPayment" xlink:label="loc_slgl_RefundableUpfrontPayment_102"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_RefundUpFrontPayment" xlink:label="loc_slgl_RefundUpFrontPayment_103"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_RefundUpFrontPayment" xlink:label="loc_slgl_RefundUpFrontPayment_104"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_RefundUpFrontPayment" xlink:label="loc_slgl_RefundUpFrontPayment_105"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_RoyaltiesCompanyIsEligibleToReceive" xlink:label="loc_slgl_RoyaltiesCompanyIsEligibleToReceive_106"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_RoyaltiesCompanyIsEligibleToReceive" xlink:label="loc_slgl_RoyaltiesCompanyIsEligibleToReceive_107"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_RoyaltiesMaturity" xlink:label="loc_slgl_RoyaltiesMaturity_108"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_RoyaltiesMaturity" xlink:label="loc_slgl_RoyaltiesMaturity_109"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_RoyaltiesMaturity" xlink:label="loc_slgl_RoyaltiesMaturity_110"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_SalesMilestonePayments" xlink:label="loc_slgl_SalesMilestonePayments_111"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_SalesMilestonePayments" xlink:label="loc_slgl_SalesMilestonePayments_112"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_SalesMilestonePayments" xlink:label="loc_slgl_SalesMilestonePayments_113"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_ShortTermDeposits" xlink:label="loc_slgl_ShortTermDeposits_114"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_ShortTermDeposits" xlink:label="loc_slgl_ShortTermDeposits_115"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_ShortTermDeposits" xlink:label="loc_slgl_ShortTermDeposits_116"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_TwyneoMember" xlink:label="loc_slgl_TwyneoMember_117"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_TwyneoMember" xlink:label="loc_slgl_TwyneoMember_118"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_UnderwrittenPublicOfferingMember" xlink:label="loc_slgl_UnderwrittenPublicOfferingMember_119"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_UnderwrittenPublicOfferingMember" xlink:label="loc_slgl_UnderwrittenPublicOfferingMember_120"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_UpfrontPaymentReceived" xlink:label="loc_slgl_UpfrontPaymentReceived_121"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_UpfrontPaymentReceived" xlink:label="loc_slgl_UpfrontPaymentReceived_122"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_UpfrontPaymentReceived" xlink:label="loc_slgl_UpfrontPaymentReceived_123"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_UpfrontPayments" xlink:label="loc_slgl_UpfrontPayments_124"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_UpfrontPayments" xlink:label="loc_slgl_UpfrontPayments_125"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_UpfrontPayments" xlink:label="loc_slgl_UpfrontPayments_126"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInLongTermReceivablesCurrent" xlink:label="loc_us-gaap_IncreaseDecreaseInLongTermReceivablesCurrent_127"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInLongTermReceivablesCurrent" xlink:label="loc_us-gaap_IncreaseDecreaseInLongTermReceivablesCurrent_128"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidExpensesOther" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidExpensesOther_129"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidExpensesOther" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidExpensesOther_130"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireMarketableSecurities" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_131"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireMarketableSecurities" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_132"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_133"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_134"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_135"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_136"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_137"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_138"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_139"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_140"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_141"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_142"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_143"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_144"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_145"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_146"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_147"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_148"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_149"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_150"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_151"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_152"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_153"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_154"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_155"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_156"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_157"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_158"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_159"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_160"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesCurrent" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_161"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesCurrent" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_162"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesCurrent" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_163"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCash" xlink:label="loc_us-gaap_RestrictedCash_164"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCash" xlink:label="loc_us-gaap_RestrictedCash_165"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_166"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_167"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_168"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_169"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_170"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="loc_dei_CoverAbstract_171"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_dei_CurrentFiscalYearEndDate_172"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_dei_DocumentFiscalPeriodFocus_173"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_dei_DocumentFiscalYearFocus_174"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_175"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_176"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_dei_EntityAddressAddressLine1_177"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_dei_EntityAddressCityOrTown_178"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="loc_dei_EntityAddressCountry_179"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_dei_EntityAddressPostalZipCode_180"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_181"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="loc_dei_EntityFileNumber_182"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_183"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_DocumentAndEntityInformation" xlink:label="loc_slgl_DocumentAndEntityInformation_184"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_LicenseAgreementsAbstract" xlink:label="loc_slgl_LicenseAgreementsAbstract_185"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ChiefExecutiveOfficerMember" xlink:label="loc_srt_ChiefExecutiveOfficerMember_186"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_DirectorMember" xlink:label="loc_srt_DirectorMember_187"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ExecutiveOfficerMember" xlink:label="loc_srt_ExecutiveOfficerMember_188"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ExecutiveOfficerMember" xlink:label="loc_srt_ExecutiveOfficerMember_189"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_190"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_191"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srt_ProductOrServiceAxis_192"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_193"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_194"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_195"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srt_TitleOfIndividualAxis_196"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_197"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaap_AccountsPayableCurrent_198"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetNoncurrent" xlink:label="loc_us-gaap_AccountsReceivableNetNoncurrent_199"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetNoncurrent" xlink:label="loc_us-gaap_AccountsReceivableNetNoncurrent_200"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_201"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_202"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_203"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllOtherCorporateBondsMember" xlink:label="loc_us-gaap_AllOtherCorporateBondsMember_204"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_205"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_206"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_207"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_208"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaap_AssetsAbstract_209"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent_210"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent_211"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaap_AssetsCurrentAbstract_212"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNoncurrent" xlink:label="loc_us-gaap_AssetsNoncurrent_213"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNoncurrent" xlink:label="loc_us-gaap_AssetsNoncurrent_214"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNoncurrentAbstract" xlink:label="loc_us-gaap_AssetsNoncurrentAbstract_215"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_216"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_217"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_218"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_219"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_220"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_221"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_222"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaap_CommitmentsAndContingencies_223"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_224"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsDisclosureTextBlock" xlink:label="loc_us-gaap_CommitmentsDisclosureTextBlock_225"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_226"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_227"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_228"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_229"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_230"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_231"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligation" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_232"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_233"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepositsAssetsCurrent" xlink:label="loc_us-gaap_DepositsAssetsCurrent_234"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaap_Depreciation_235"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaap_EarningsPerShareBasic_236"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaap_EarningsPerShareBasic_237"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaap_EarningsPerShareDiluted_238"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaap_EarningsPerShareDiluted_239"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_240"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_241"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignGovernmentDebtMember" xlink:label="loc_us-gaap_ForeignGovernmentDebtMember_242"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_243"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaap_IncomeStatementAbstract_244"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_245"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_246"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_247"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_248"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_249"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis" xlink:label="loc_us-gaap_InvestmentTypeAxis_250"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_251"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities_252"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities_253"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_254"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_255"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_256"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent_257"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent_258"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_259"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_260"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_261"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="loc_us-gaap_LiabilitiesNoncurrentAbstract_262"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="loc_us-gaap_LiabilitiesNoncurrentAbstract_263"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicenseMember" xlink:label="loc_us-gaap_LicenseMember_264"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicenseMember" xlink:label="loc_us-gaap_LicenseMember_265"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesAbstract" xlink:label="loc_us-gaap_MarketableSecuritiesAbstract_266"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesTextBlock" xlink:label="loc_us-gaap_MarketableSecuritiesTextBlock_267"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NatureOfOperations" xlink:label="loc_us-gaap_NatureOfOperations_268"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_269"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_270"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_271"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_272"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_273"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_274"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_275"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_276"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_277"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_278"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_279"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_280"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_281"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_282"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_283"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_284"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_us-gaap_PrivatePlacementMember_285"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromInterestReceived" xlink:label="loc_us-gaap_ProceedsFromInterestReceived_286"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_287"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_288"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_289"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_290"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_291"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_292"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_293"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesNetCurrent" xlink:label="loc_us-gaap_ReceivablesNetCurrent_294"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_295"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_296"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_297"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_298"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_299"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndInvestmentsNoncurrent" xlink:label="loc_us-gaap_RestrictedCashAndInvestmentsNoncurrent_300"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaap_RetainedEarningsMember_301"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_302"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_303"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock_304"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_305"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_306"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_307"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_308"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_309"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock_310"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_311"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_312"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_313"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_314"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_315"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_316"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_317"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_318"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_319"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_320"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_321"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_322"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_323"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_324"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaap_SharePrice_325"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssued" xlink:label="loc_us-gaap_SharesIssued_326"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_327"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_328"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_329"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_330"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_331"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_332"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_333"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaap_StockholdersEquityAbstract_334"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_335"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_336"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan_337"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_338"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_339"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_340"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_341"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_342"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_343"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_344"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember_345"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaap_SubsequentEventsAbstract_346"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_347"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_348"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_349"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_350"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_351"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_352"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaap_TypeOfArrangementAxis_353"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" xlink:label="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_354"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_355"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_356"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_357"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_358"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_slgl_AggregateOfferingPrice_0" xml:lang="en-US">Represents the amount of aggregate offering price.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_slgl_AggregateOfferingPrice_1" xml:lang="en-US">Aggregate Offering Price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_slgl_AggregateOfferingPrice_2" xml:lang="en-US">Aggregate offering price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_slgl_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue_0" xml:lang="en-US">Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), maturing in two fiscal year following latest fiscal year. Excludes interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_slgl_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue_1" xml:lang="en-US">Available For Sale Securities Debt Maturities After One Through Two Years Fair Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_slgl_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue_2" xml:lang="en-US">Between 1-2 years</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_slgl_CashAndCashEquivalentsAndRestrictedCashShownInStatementOfCashFlows_0" xml:lang="en-US">Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_slgl_CashAndCashEquivalentsAndRestrictedCashShownInStatementOfCashFlows_1" xml:lang="en-US">Cash And Cash Equivalents And Restricted Cash Shown In Statement Of Cash Flows</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_slgl_ChangesInAccruedLiabilityForEmployeeRightsUponRetirement_0" xml:lang="en-US">Changes in accrued liability for employee rights upon retirement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_slgl_ChangesInAccruedLiabilityForEmployeeRightsUponRetirement_1" xml:lang="en-US">Changes in accrued liability for employee rights upon retirement, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_slgl_ChangesInAccruedLiabilityForEmployeeRightsUponRetirement_2" xml:lang="en-US">Changes In Accrued Liability For Employee Rights Upon Retirement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_slgl_ChangesInFairValueOfMarketableSecurities_0" xml:lang="en-US">Cash inflow from changes in fair value of marketable securities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_slgl_ChangesInFairValueOfMarketableSecurities_1" xml:lang="en-US">Changes in fair value of marketable securities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_slgl_ChangesInFairValueOfMarketableSecurities_2" xml:lang="en-US">Changes In Fair Value Of Marketable Securities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_slgl_ChangesInFairValueOfMarketableSecurities_3" xml:lang="en-US">Change in fair value during the period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_slgl_CollabrationsMember_0" xml:lang="en-US">This member stands for collabrations.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_slgl_CollabrationsMember_1" xml:lang="en-US">Collabrations [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_slgl_CollabrationsMember_2" xml:lang="en-US">COLLABORATION REVENUES [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_slgl_EmployeesAndExecutiveOfficersMember_0" xml:lang="en-US">Employees And Executive Officers [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_slgl_EmployeesAndExecutiveOfficersMember_1" xml:lang="en-US">Employees And Executive Officers [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_slgl_EmployeesAndExecutiveOfficersMember_2" xml:lang="en-US">Employees and Director [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_slgl_EmployeesAndExecutiveOfficersMember_3" xml:lang="en-US">Employees And Executive Officers [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_slgl_EmployeesMember_0" xml:lang="en-US">Employees Member [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_slgl_EmployeesMember_1" xml:lang="en-US">Employees [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_slgl_EpsolayMember_0" xml:lang="en-US">Epsolay</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_slgl_EpsolayMember_1" xml:lang="en-US">Epsolay [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_slgl_ExpectedRevenueReceivableOverTwentyFourMonths_0" xml:lang="en-US">Represents the value of expected revenue receivable over twenty four months.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_slgl_ExpectedRevenueReceivableOverTwentyFourMonths_1" xml:lang="en-US">Expected Revenue Receivable Over Twenty Four Months</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_slgl_ExpectedRevenueReceivableOverTwentyFourMonths_2" xml:lang="en-US">Expected revenue receivable over twenty four months</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_slgl_FinanceExpensesNet_0" xml:lang="en-US">Finance expenses, net.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_slgl_FinanceExpensesNet_1" xml:lang="en-US">Finance Expenses Net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_slgl_FinanceExpensesNet_2" xml:lang="en-US">Financial expenses (income), net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_slgl_FinancialIncomeExpensesNet_0" xml:lang="en-US">Financial expenses (income), net.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_slgl_FinancialIncomeExpensesNet_1" xml:lang="en-US">FINANCIAL INCOME, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_slgl_FinancialIncomeExpensesNet_2" xml:lang="en-US">Financial Income Expenses Net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_slgl_FinancialIncomeExpensesNet_3" xml:lang="en-US">FINANCIAL INCOME, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_slgl_IncreaseInOperatingLeaseRouAssetsAndLiabilities_0" xml:lang="en-US">Increase in Operating lease ROU assets and liabilities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_slgl_IncreaseInOperatingLeaseRouAssetsAndLiabilities_1" xml:lang="en-US">Increase in Operating lease ROU assets and liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_slgl_IssuanceOfSharesAndWarrantsThroughPrivatePlacement_0" xml:lang="en-US">Issuance of shares and warrants throught private placement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_slgl_IssuanceOfSharesAndWarrantsThroughPrivatePlacement_1" xml:lang="en-US">Issuance Of Shares And Warrants Through Private Placement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_slgl_IssuanceOfSharesAndWarrantsThroughPrivatePlacement_2" xml:lang="en-US">Issuance of shares and warrants through private placement from the controlling shareholder</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_slgl_IssuanceOfSharesAndWarrantsThroughPrivatePlacementShares_0" xml:lang="en-US">Number of issuance of shares and warrants throught private placement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_slgl_IssuanceOfSharesAndWarrantsThroughPrivatePlacementShares_1" xml:lang="en-US">Issuance Of Shares And Warrants Through Private Placement Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_slgl_IssuanceOfSharesAndWarrantsThroughPrivatePlacementShares_2" xml:lang="en-US">Issuance of shares and warrants through private placement from the controlling shareholder, shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_slgl_IssuanceOfSharesAndWarrantsThroughPublicOfferingNetOfIssuanceCosts_0" xml:lang="en-US">Issuance of shares and warrants through public offering, net of issuance costs.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_slgl_IssuanceOfSharesAndWarrantsThroughPublicOfferingNetOfIssuanceCosts_1" xml:lang="en-US">Issuance of shares and warrants through public offering, net of issuance costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_slgl_IssuanceOfSharesAndWarrantsThroughPublicOfferingNetOfIssuanceCostsShares_0" xml:lang="en-US">Issuance of shares and warrants through public offering, net of issuance costs, shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_slgl_IssuanceOfSharesAndWarrantsThroughPublicOfferingNetOfIssuanceCostsShares_1" xml:lang="en-US">Issuance of shares and warrants through public offering, net of issuance costs, shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_slgl_JefferiesLlcMember_0" xml:lang="en-US">Jefferies Llc.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_slgl_JefferiesLlcMember_1" xml:lang="en-US">Jefferies Llc [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_slgl_LicenseAgreementsTextBlock_0" xml:lang="en-US">The entire disclosure for license agreements information.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_slgl_LicenseAgreementsTextBlock_1" xml:lang="en-US">License Agreements Text Block</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_slgl_LicenseAgreementsTextBlock_2" xml:lang="en-US">LICENSE AGREEMENTS:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_slgl_LicenseAgreementsWithGaldermaMember_0" xml:lang="en-US">License Agreements With Galderma</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_slgl_LicenseAgreementsWithGaldermaMember_1" xml:lang="en-US">License Agreements With Galderma [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_slgl_LongTermDeposits_0" xml:lang="en-US">Long-term deposits.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_slgl_LongTermDeposits_1" xml:lang="en-US">Long-term deposits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_slgl_LongTermDeposits_2" xml:lang="en-US">Long Term Deposits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_slgl_NetChangesInOperatingLeases_0" xml:lang="en-US">Net changes in operating leases.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_slgl_NetChangesInOperatingLeases_1" xml:lang="en-US">Net changes in operating leases</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_slgl_NetChangesInOperatingLeases_2" xml:lang="en-US">Net Changes In Operating Leases</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_slgl_NumberOfApprovedGenericDrugProducts_0" xml:lang="en-US">Represents the number of approved generic drug products.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_slgl_NumberOfApprovedGenericDrugProducts_1" xml:lang="en-US">Number Of Approved Generic Drug Products</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_slgl_NumberOfApprovedGenericDrugProducts_2" xml:lang="en-US">Number of approved generic drug products</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_slgl_NumberOfEqualQuarterlyInstalments_0" xml:lang="en-US">Represents the number of equal quarterly instalments.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_slgl_NumberOfEqualQuarterlyInstalments_1" xml:lang="en-US">Number Of Equal Quarterly Instalments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_slgl_NumberOfEqualQuarterlyInstalments_2" xml:lang="en-US">Number of equal quarterly instalments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_slgl_NumberOfGenericCollaborativeAgreementsToSellRights_0" xml:lang="en-US">Number of generic collaborative agreements to sell the rights.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_slgl_NumberOfGenericCollaborativeAgreementsToSellRights_1" xml:lang="en-US">Number Of Generic Collaborative Agreements To Sell Rights</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_slgl_NumberOfGenericCollaborativeAgreementsToSellRights_2" xml:lang="en-US">Number of generic collaborative agreements to sell rights</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_slgl_NumberOfGenericDrugCandidates_0" xml:lang="en-US">Number of generic drug candidates.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_slgl_NumberOfGenericDrugCandidates_1" xml:lang="en-US">Number Of Generic Drug Candidates</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_slgl_NumberOfGenericDrugCandidates_2" xml:lang="en-US">Number of generic drug candidates</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_slgl_NumberOfGenericProgramsRetainedForCollaborationRights_0" xml:lang="en-US">Number of generic programs retained for collaboration rights.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_slgl_NumberOfGenericProgramsRetainedForCollaborationRights_1" xml:lang="en-US">Number Of Generic Programs Retained For Collaboration Rights</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_slgl_NumberOfGenericProgramsRetainedForCollaborationRights_2" xml:lang="en-US">Number of generic programs retained for collaboration rights</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_slgl_NumberOfUnapprovedGenericPrograms_0" xml:lang="en-US">Represents the number of unapproved generic programs.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_slgl_NumberOfUnapprovedGenericPrograms_1" xml:lang="en-US">Number Of Unapproved Generic Programs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_slgl_NumberOfUnapprovedGenericPrograms_2" xml:lang="en-US">Number of unapproved generic programs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_slgl_OtherForeignGovernmentBondsMember_0" xml:lang="en-US">Other foreign government bonds [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_slgl_OtherForeignGovernmentBondsMember_1" xml:lang="en-US">Other foreign government bonds [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_slgl_PaymentReceivableInInstalments_0" xml:lang="en-US">Represents the value of payment receivable in instalments.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_slgl_PaymentReceivableInInstalments_1" xml:lang="en-US">Payment Receivable In Instalments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_slgl_PaymentReceivableInInstalments_2" xml:lang="en-US">Payment receivable in instalments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_slgl_PercentageOfGrossProceedsFromSaleOfShares_0" xml:lang="en-US">Represents the of Percentage of gross proceeds from sale of shares.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_slgl_PercentageOfGrossProceedsFromSaleOfShares_1" xml:lang="en-US">Percentage Of Gross Proceeds From Sale Of Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_slgl_PercentageOfGrossProceedsFromSaleOfShares_2" xml:lang="en-US">Percentage of gross proceeds from sale of shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_slgl_PercentageOfGrossProfitsRelatedToSaleProducts_0" xml:lang="en-US">Percentage of gross profits related to sale products.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_slgl_PercentageOfGrossProfitsRelatedToSaleProducts_1" xml:lang="en-US">Percentage of gross profits related to sale products</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_slgl_ProceedsFromLongTermDeposits_0" xml:lang="en-US">Represents the amount of proceeds from long-term deposits.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_slgl_ProceedsFromLongTermDeposits_1" xml:lang="en-US">Proceeds From Long Term Deposits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_slgl_ProceedsFromLongTermDeposits_2" xml:lang="en-US">Proceeds from long-term deposits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_slgl_ProceedsFromShortTermDeposits_0" xml:lang="en-US">Represents the amount of proceeds from short term deposits.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_slgl_ProceedsFromShortTermDeposits_1" xml:lang="en-US">Proceeds From Short Term Deposits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_slgl_ProceedsFromShortTermDeposits_2" xml:lang="en-US">Proceeds from short-term deposits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_slgl_ProductAndService_0" xml:lang="en-US">Information by product and service, or group of similar products and similar services.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_slgl_ProductAndService_1" xml:lang="en-US">Product And Service</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_slgl_ReceiveFromThirdPartyUpfrontPayment_0" xml:lang="en-US">Receive from third party upfront payment.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_slgl_ReceiveFromThirdPartyUpfrontPayment_1" xml:lang="en-US">Receive from third party upfront payment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_slgl_RefundableUpfrontPayment_0" xml:lang="en-US">Represent the amount of refundable upfront payment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_slgl_RefundableUpfrontPayment_1" xml:lang="en-US">Refundable Upfront Payment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_slgl_RefundableUpfrontPayment_2" xml:lang="en-US">Refundable upfront payment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_slgl_RefundUpFrontPayment_0" xml:lang="en-US">The amount of refund upfront payment.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_slgl_RefundUpFrontPayment_1" xml:lang="en-US">Refund Up Front Payment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_slgl_RefundUpFrontPayment_2" xml:lang="en-US">Refunded Upfront Payment To Galderma</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_slgl_RoyaltiesCompanyIsEligibleToReceive_0" xml:lang="en-US">Royalties company is eligible to receive.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_slgl_RoyaltiesCompanyIsEligibleToReceive_1" xml:lang="en-US">Royalties company is eligible to receive</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_slgl_RoyaltiesMaturity_0" xml:lang="en-US">Royalties Maturity.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_slgl_RoyaltiesMaturity_1" xml:lang="en-US">Royalties Maturity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_slgl_RoyaltiesMaturity_2" xml:lang="en-US">Royalties maturity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_slgl_SalesMilestonePayments_0" xml:lang="en-US">Represent of amount the sales milestone payments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_slgl_SalesMilestonePayments_1" xml:lang="en-US">Sales Milestone Payments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_slgl_SalesMilestonePayments_2" xml:lang="en-US">Sales milestone payments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_slgl_ShortTermDeposits_0" xml:lang="en-US">Short-term deposits.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_slgl_ShortTermDeposits_1" xml:lang="en-US">short-term deposits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_slgl_ShortTermDeposits_2" xml:lang="en-US">Short Term Deposits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_slgl_TwyneoMember_0" xml:lang="en-US">Twyneo</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_slgl_TwyneoMember_1" xml:lang="en-US">Twyneo [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_slgl_UnderwrittenPublicOfferingMember_0" xml:lang="en-US">Underwritten Public Offering Member</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_slgl_UnderwrittenPublicOfferingMember_1" xml:lang="en-US">Underwritten Public Offering [member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_slgl_UpfrontPaymentReceived_0" xml:lang="en-US">Represents the value of upfront payment received.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_slgl_UpfrontPaymentReceived_1" xml:lang="en-US">Upfront Payment Received</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_slgl_UpfrontPaymentReceived_2" xml:lang="en-US">Upfront payment received</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_slgl_UpfrontPayments_0" xml:lang="en-US">Upfront payments.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_slgl_UpfrontPayments_1" xml:lang="en-US">Upfront payments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_slgl_UpfrontPayments_2" xml:lang="en-US">Upfront payments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_IncreaseDecreaseInLongTermReceivablesCurrent_0" xml:lang="en-US">Receivables from collaborative arrangements (including long-term)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncreaseDecreaseInLongTermReceivablesCurrent_1" xml:lang="en-US">Increase (Decrease) in Long-Term Receivables, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidExpensesOther_0" xml:lang="en-US">Prepaid expenses and other current assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidExpensesOther_1" xml:lang="en-US">Increase (Decrease) in Prepaid Expenses, Other</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_PaymentsToAcquireMarketableSecurities_0" xml:lang="en-US">Investment in marketable securities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PaymentsToAcquireMarketableSecurities_1" xml:lang="en-US">Additions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_0" xml:lang="en-US">Purchase of property and equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_1" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_0" xml:lang="en-US">Sale or maturity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_1" xml:lang="en-US">Proceeds from sales and maturity of marketable securities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit_0" xml:lang="en-US">Accumulated deficit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit_1" xml:lang="en-US">Accumulated deficit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit_2" xml:lang="en-US">Accumulated deficit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="lab_us-gaap_NetIncomeLoss_0" xml:lang="en-US">LOSS FOR THE PERIOD</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetIncomeLoss_1" xml:lang="en-US">Loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_NetIncomeLoss_2" xml:lang="en-US">Loss for the period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_NetIncomeLoss_3" xml:lang="en-US">LOSS FOR THE PERIOD</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="lab_us-gaap_OperatingIncomeLoss_0" xml:lang="en-US">TOTAL OPERATING LOSS</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingIncomeLoss_1" xml:lang="en-US">Operating Income (Loss)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_OperatingIncomeLoss_2" xml:lang="en-US">TOTAL OPERATING LOSS</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="lab_us-gaap_ProfitLoss_0" xml:lang="en-US">LOSS FOR THE PERIOD</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ProfitLoss_1" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ProfitLoss_2" xml:lang="en-US">Loss for the period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_ProfitLoss_3" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Total</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_0" xml:lang="en-US">Cash and Cash equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_1" xml:lang="en-US">Cash and cash equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0" xml:lang="en-US">CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AT END OF THE PERIODS</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1" xml:lang="en-US">CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AT BEGINNING OF THE PERIOD</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3" xml:lang="en-US">CASH AND CASH EQUIVALENTS AND RESTRICTED CASH SHOWN IN STATEMENT OF CASH FLOWS</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4" xml:lang="en-US">CASH AND CASH EQUIVALENTS AND RESTRICTED CASH SHOWN IN STATEMENT OF CASH FLOWS</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_us-gaap_CommonStockSharesOutstanding_0" xml:lang="en-US">Balance, shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_us-gaap_CommonStockSharesOutstanding_1" xml:lang="en-US">Balance, shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommonStockSharesOutstanding_2" xml:lang="en-US">Ordinary shares, shares outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_us-gaap_MarketableSecuritiesCurrent_0" xml:lang="en-US">Balance at end of the period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_us-gaap_MarketableSecuritiesCurrent_1" xml:lang="en-US">Balance at beginning of the period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_MarketableSecuritiesCurrent_2" xml:lang="en-US">Marketable securities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_us-gaap_RestrictedCash_0" xml:lang="en-US">Restricted cash</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RestrictedCash_1" xml:lang="en-US">Restricted Cash</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_us-gaap_StockholdersEquity_0" xml:lang="en-US">Balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_us-gaap_StockholdersEquity_1" xml:lang="en-US">Balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockholdersEquity_2" xml:lang="en-US">Stockholders' Equity Attributable to Parent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_StockholdersEquity_3" xml:lang="en-US">TOTAL SHAREHOLDERS' EQUITY</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_AmendmentFlag_0" xml:lang="en-US">Amendment Flag</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_CoverAbstract_0" xml:lang="en-US">Cover [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_CurrentFiscalYearEndDate_0" xml:lang="en-US">Current Fiscal Year End Date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentFiscalPeriodFocus_0" xml:lang="en-US">Document Fiscal Period Focus</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentFiscalYearFocus_0" xml:lang="en-US">Document Fiscal Year Focus</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentPeriodEndDate_0" xml:lang="en-US">Document Period End Date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentType_0" xml:lang="en-US">Document Type</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityAddressAddressLine1_0" xml:lang="en-US">Entity Address, Address Line One</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityAddressCityOrTown_0" xml:lang="en-US">Entity Address, City or Town</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityAddressCountry_0" xml:lang="en-US">Entity Address, Country</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityAddressPostalZipCode_0" xml:lang="en-US">Entity Address, Postal Zip Code</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityCentralIndexKey_0" xml:lang="en-US">Entity Central Index Key</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityFileNumber_0" xml:lang="en-US">Entity File Number</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityRegistrantName_0" xml:lang="en-US">Entity Registrant Name</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_slgl_DocumentAndEntityInformation_0" xml:lang="en-US">Document And Entity Information</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_slgl_LicenseAgreementsAbstract_0" xml:lang="en-US">License Agreements [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_ChiefExecutiveOfficerMember_0" xml:lang="en-US">Chief Executive Officer [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_DirectorMember_0" xml:lang="en-US">Director [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_ExecutiveOfficerMember_0" xml:lang="en-US">Executive Officer [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_srt_ExecutiveOfficerMember_1" xml:lang="en-US">Executive Officers [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_MaximumMember_0" xml:lang="en-US">Maximum [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_MinimumMember_0" xml:lang="en-US">Minimum [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_ProductOrServiceAxis_0" xml:lang="en-US">Product and Service [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_ProductsAndServicesDomain_0" xml:lang="en-US">Product and Service [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_RangeAxis_0" xml:lang="en-US">Range [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_srt_RangeAxis_1" xml:lang="en-US">Statistical Measurement [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_TitleOfIndividualAxis_0" xml:lang="en-US">Title of Individual [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccountingPoliciesAbstract_0" xml:lang="en-US">Accounting Policies [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccountsPayableCurrent_0" xml:lang="en-US">Accounts payable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccountsReceivableNetNoncurrent_0" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Noncurrent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AccountsReceivableNetNoncurrent_1" xml:lang="en-US">Long-term receivables from collaborative arrangements</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock_0" xml:lang="en-US">Additional paid-in capital</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember_0" xml:lang="en-US">Additional Paid-In Capital [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0" xml:lang="en-US">Adjustments required to reconcile loss to net cash used in operating activities:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AllOtherCorporateBondsMember_0" xml:lang="en-US">Corporate bonds [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_0" xml:lang="en-US">Anti-dilutive shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_0" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_Assets_0" xml:lang="en-US">Assets [Default Label]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_Assets_1" xml:lang="en-US">TOTAL ASSETS</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AssetsAbstract_0" xml:lang="en-US">Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AssetsCurrent_0" xml:lang="en-US">Assets, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_AssetsCurrent_1" xml:lang="en-US">TOTAL CURRENT ASSETS</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AssetsCurrentAbstract_0" xml:lang="en-US">CURRENT ASSETS:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AssetsNoncurrent_0" xml:lang="en-US">Assets, Noncurrent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_AssetsNoncurrent_1" xml:lang="en-US">TOTAL NON-CURRENT ASSETS</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AssetsNoncurrentAbstract_0" xml:lang="en-US">NON-CURRENT ASSETS:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_0" xml:lang="en-US">Due within one year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_0" xml:lang="en-US">Basis of presentation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_1" xml:lang="en-US">Basis of Presentation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1" xml:lang="en-US">INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS AND RESTRICTED CASH</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_0" xml:lang="en-US">Warrants to purchase ordinary shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_0" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommitmentsAndContingencies_0" xml:lang="en-US">COMMITMENTS</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommitmentsDisclosureTextBlock_0" xml:lang="en-US">COMMITMENTS:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommonStockMember_0" xml:lang="en-US">Ordinary shares [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare_0" xml:lang="en-US">Ordinary shares, par value per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommonStockSharesAuthorized_0" xml:lang="en-US">Ordinary shares, shares authorized</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommonStockSharesIssued_0" xml:lang="en-US">Ordinary shares, shares issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommonStockValue_0" xml:lang="en-US">Ordinary Shares, NIS 0.1 par value - authorized: 50,000,000 as of December 31, 2021 and June 30, 2022; issued and outstanding: 23,000,782 and 23,029,951 as of December 31, 2021 and June 30, 2022, respectively.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_CommonStockValue_1" xml:lang="en-US">Ordinary Shares, NIS 0.1 par value &#8211; authorized: 50,000,000 as of December 31, 2021 and June 30, 2022; issued and outstanding: 23,126,804 and 23,129,469 as of December 31, 2021 and June 30, 2022, respectively.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation_0" xml:lang="en-US">Liability for employee rights upon retirement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_0" xml:lang="en-US">Funds in respect of employee rights upon retirement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DepositsAssetsCurrent_0" xml:lang="en-US">Bank deposits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_Depreciation_0" xml:lang="en-US">Depreciation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EarningsPerShareBasic_0" xml:lang="en-US">Earnings Per Share, Basic</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_EarningsPerShareBasic_1" xml:lang="en-US">BASIC LOSS PER ORDINARY SHARE</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EarningsPerShareDiluted_0" xml:lang="en-US">BASIC AND DILUTED LOSS PER ORDINARY SHARE</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_EarningsPerShareDiluted_1" xml:lang="en-US">DILUTED LOSS PER ORDINARY SHARE</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock_0" xml:lang="en-US">Loss per share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0" xml:lang="en-US">EFFECT OF EXCHANGE RATE ON CASH AND CASH EQUIVALENTS</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ForeignGovernmentDebtMember_0" xml:lang="en-US">Canada government bonds [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense_0" xml:lang="en-US">GENERAL AND ADMINISTRATIVE EXPENSES</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeStatementAbstract_0" xml:lang="en-US">Income Statement [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_0" xml:lang="en-US">Accounts payable, accrued expenses and other</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_0" xml:lang="en-US">Changes in operating asset and liabilities:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_0" xml:lang="en-US">Schedule of Debt Securities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_0" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_0" xml:lang="en-US">MARKETABLE SECURITIES</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_InvestmentTypeAxis_0" xml:lang="en-US">Investment Type [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock_0" xml:lang="en-US">Leases</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_Liabilities_0" xml:lang="en-US">Liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_Liabilities_1" xml:lang="en-US">TOTAL LIABILITIES</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity_0" xml:lang="en-US">Liabilities and Equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity_1" xml:lang="en-US">TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0" xml:lang="en-US">Liabilities and shareholders' equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LiabilitiesCurrent_0" xml:lang="en-US">Liabilities, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_LiabilitiesCurrent_1" xml:lang="en-US">TOTAL CURRENT LIABILITIES</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract_0" xml:lang="en-US">CURRENT LIABILITIES:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LiabilitiesNoncurrent_0" xml:lang="en-US">Liabilities, Noncurrent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_LiabilitiesNoncurrent_1" xml:lang="en-US">TOTAL LONG-TERM LIABILITIES</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LiabilitiesNoncurrentAbstract_0" xml:lang="en-US">LONG-TERM LIABILITIES -</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LiabilitiesNoncurrentAbstract_1" xml:lang="en-US">LONG-TERM LIABILITIES</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LicenseMember_0" xml:lang="en-US">License [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_LicenseMember_1" xml:lang="en-US">LICENSE REVENUES [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_MarketableSecuritiesAbstract_0" xml:lang="en-US">Level 2 securities:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_MarketableSecuritiesTextBlock_0" xml:lang="en-US">Schedule of Marketable Securities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NatureOfOperations_0" xml:lang="en-US">NATURE OF OPERATIONS</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_0" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_1" xml:lang="en-US">Net cash provided by financing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0" xml:lang="en-US">CASH FLOWS FROM FINANCING ACTIVITIES:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_0" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_1" xml:lang="en-US">Net cash provided by (used in) investing activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_0" xml:lang="en-US">CASH FLOWS FROM INVESTING ACTIVITIES:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_0" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_1" xml:lang="en-US">Net cash used in operating activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_0" xml:lang="en-US">CASH FLOWS FROM OPERATING ACTIVITIES:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_0" xml:lang="en-US">Newly issued and recently adopted accounting pronouncements:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent_0" xml:lang="en-US">Current maturities of operating leases</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_0" xml:lang="en-US">Operating leases liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset_0" xml:lang="en-US">Operating lease right-of-use assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent_0" xml:lang="en-US">Other accounts payable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_0" xml:lang="en-US">Prepaid expenses and other current assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PrivatePlacementMember_0" xml:lang="en-US">Private Placement [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ProceedsFromInterestReceived_0" xml:lang="en-US">Interest received</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ProceedsFromIssuanceInitialPublicOffering_0" xml:lang="en-US">Procceds from Initial public offering, net of issuance costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_0" xml:lang="en-US">Proceeds from Issuance of Common Stock</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_1" xml:lang="en-US">Net proceeds</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_0" xml:lang="en-US">Proceeds from private placement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised_0" xml:lang="en-US">Proceed from exercise of options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised_1" xml:lang="en-US">Proceeds from exercise of options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet_0" xml:lang="en-US">Property and equipment, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ReceivablesNetCurrent_0" xml:lang="en-US">Receivables from collaborative arrangements</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RelatedPartyDomain_0" xml:lang="en-US">Related Party [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract_0" xml:lang="en-US">Related Party Transactions [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_0" xml:lang="en-US">Related Party [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_0" xml:lang="en-US">RELATED PARTIES:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense_0" xml:lang="en-US">RESEARCH AND DEVELOPMENT EXPENSES</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RestrictedCashAndInvestmentsNoncurrent_0" xml:lang="en-US">Restricted long-term deposits and cash</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RetainedEarningsMember_0" xml:lang="en-US">Accumulated Deficit [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract_0" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_0" xml:lang="en-US">COLLABORATION AGREEMENTS:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock_0" xml:lang="en-US">Revenue recognition</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_Revenues_0" xml:lang="en-US">Revenues</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_Revenues_1" xml:lang="en-US">TOTAL REVENUES</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_0" xml:lang="en-US">Sale of Stock, Number of Shares Issued in Transaction</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_1" xml:lang="en-US">Issuance of share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_0" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock_0" xml:lang="en-US">Summary of Changes in Fair Value of Marketable Securities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_0" xml:lang="en-US">Schedule of Assumptions Used to Estimate Fair Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensation_0" xml:lang="en-US">Share-based compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ShareBasedCompensation_1" xml:lang="en-US">Share-based compensation expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_0" xml:lang="en-US">Option vesting period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_0" xml:lang="en-US">Percentage of option vesting</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_0" xml:lang="en-US">Dividend yield</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_0" xml:lang="en-US">Expected term</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_0" xml:lang="en-US">Expected volatility</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_0" xml:lang="en-US">Risk-free interest rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_0" xml:lang="en-US">Option grants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0" xml:lang="en-US">Exercise price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_0" xml:lang="en-US">Fair value of options granted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SharePrice_0" xml:lang="en-US">Value of one ordinary share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SharesIssued_0" xml:lang="en-US">Ordinary shares issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SharesIssuedPricePerShare_0" xml:lang="en-US">Per share price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock_0" xml:lang="en-US">SIGNIFICANT ACCOUNTING POLICIES:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StatementEquityComponentsAxis_0" xml:lang="en-US">Equity Components [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StatementLineItems_0" xml:lang="en-US">Statement [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract_0" xml:lang="en-US">Statement of Cash Flows [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract_0" xml:lang="en-US">Statement of Financial Position [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StatementTable_0" xml:lang="en-US">Statement [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockholdersEquityAbstract_0" xml:lang="en-US">SHAREHOLDERS' EQUITY:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract_0" xml:lang="en-US">Stockholders' Equity Note [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_0" xml:lang="en-US">SHARE CAPITAL:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan_0" xml:lang="en-US">Exercise of options granted to an employee, shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_0" xml:lang="en-US">Shares issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_0" xml:lang="en-US">Vesting of restricted shares units, shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_0" xml:lang="en-US">Exercise of options, shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_0" xml:lang="en-US">Stock Issued During Period, Value, New Issues</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_1" xml:lang="en-US">Available balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_0" xml:lang="en-US">Vesting of restricted shares units</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_0" xml:lang="en-US">Exercise of options</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SubsequentEventMember_0" xml:lang="en-US">Subsequent Event [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SubsequentEventsAbstract_0" xml:lang="en-US">Subsequent Events [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SubsequentEventsTextBlock_0" xml:lang="en-US">SUBSEQUENT EVENT:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SubsequentEventTypeAxis_0" xml:lang="en-US">Subsequent Event Type [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SubsequentEventTypeDomain_0" xml:lang="en-US">Subsequent Event Type [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis_0" xml:lang="en-US">Subsidiary Sale Of Stock [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis_1" xml:lang="en-US">Sale of Stock [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract_0" xml:lang="en-US">SUPPLEMENTARY INFORMATION:</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_TypeOfArrangementAxis_0" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_0" xml:lang="en-US">U.S government and agency bonds [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_0" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1" xml:lang="en-US">WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING USED IN COMPUTATION OF DILUTED LOSS PER SHARE</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_0" xml:lang="en-US">WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING USED IN COMPUTATION OF BASIC AND DILUTED LOSS PER SHARE</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_1" xml:lang="en-US">WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING USED IN COMPUTATION OF BASIC LOSS PER SHARE</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_AggregateOfferingPrice_1" xlink:to="lab_slgl_AggregateOfferingPrice_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_AggregateOfferingPrice_2" xlink:to="lab_slgl_AggregateOfferingPrice_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_AggregateOfferingPrice_3" xlink:to="lab_slgl_AggregateOfferingPrice_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue_4" xlink:to="lab_slgl_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue_5" xlink:to="lab_slgl_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue_6" xlink:to="lab_slgl_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_CashAndCashEquivalentsAndRestrictedCashShownInStatementOfCashFlows_7" xlink:to="lab_slgl_CashAndCashEquivalentsAndRestrictedCashShownInStatementOfCashFlows_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_CashAndCashEquivalentsAndRestrictedCashShownInStatementOfCashFlows_8" xlink:to="lab_slgl_CashAndCashEquivalentsAndRestrictedCashShownInStatementOfCashFlows_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_ChangesInAccruedLiabilityForEmployeeRightsUponRetirement_9" xlink:to="lab_slgl_ChangesInAccruedLiabilityForEmployeeRightsUponRetirement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_ChangesInAccruedLiabilityForEmployeeRightsUponRetirement_10" xlink:to="lab_slgl_ChangesInAccruedLiabilityForEmployeeRightsUponRetirement_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_ChangesInAccruedLiabilityForEmployeeRightsUponRetirement_11" xlink:to="lab_slgl_ChangesInAccruedLiabilityForEmployeeRightsUponRetirement_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_ChangesInFairValueOfMarketableSecurities_12" xlink:to="lab_slgl_ChangesInFairValueOfMarketableSecurities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_ChangesInFairValueOfMarketableSecurities_13" xlink:to="lab_slgl_ChangesInFairValueOfMarketableSecurities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_ChangesInFairValueOfMarketableSecurities_14" xlink:to="lab_slgl_ChangesInFairValueOfMarketableSecurities_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_ChangesInFairValueOfMarketableSecurities_15" xlink:to="lab_slgl_ChangesInFairValueOfMarketableSecurities_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_CollabrationsMember_16" xlink:to="lab_slgl_CollabrationsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_CollabrationsMember_17" xlink:to="lab_slgl_CollabrationsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_CollabrationsMember_18" xlink:to="lab_slgl_CollabrationsMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_EmployeesAndExecutiveOfficersMember_19" xlink:to="lab_slgl_EmployeesAndExecutiveOfficersMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_EmployeesAndExecutiveOfficersMember_20" xlink:to="lab_slgl_EmployeesAndExecutiveOfficersMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_EmployeesAndExecutiveOfficersMember_21" xlink:to="lab_slgl_EmployeesAndExecutiveOfficersMember_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_EmployeesAndExecutiveOfficersMember_22" xlink:to="lab_slgl_EmployeesAndExecutiveOfficersMember_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_EmployeesMember_23" xlink:to="lab_slgl_EmployeesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_EmployeesMember_24" xlink:to="lab_slgl_EmployeesMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_EpsolayMember_25" xlink:to="lab_slgl_EpsolayMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_EpsolayMember_26" xlink:to="lab_slgl_EpsolayMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_ExpectedRevenueReceivableOverTwentyFourMonths_27" xlink:to="lab_slgl_ExpectedRevenueReceivableOverTwentyFourMonths_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_ExpectedRevenueReceivableOverTwentyFourMonths_28" xlink:to="lab_slgl_ExpectedRevenueReceivableOverTwentyFourMonths_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_ExpectedRevenueReceivableOverTwentyFourMonths_29" xlink:to="lab_slgl_ExpectedRevenueReceivableOverTwentyFourMonths_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_FinanceExpensesNet_30" xlink:to="lab_slgl_FinanceExpensesNet_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_FinanceExpensesNet_31" xlink:to="lab_slgl_FinanceExpensesNet_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_FinanceExpensesNet_32" xlink:to="lab_slgl_FinanceExpensesNet_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_FinancialIncomeExpensesNet_33" xlink:to="lab_slgl_FinancialIncomeExpensesNet_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_FinancialIncomeExpensesNet_34" xlink:to="lab_slgl_FinancialIncomeExpensesNet_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_FinancialIncomeExpensesNet_35" xlink:to="lab_slgl_FinancialIncomeExpensesNet_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_FinancialIncomeExpensesNet_36" xlink:to="lab_slgl_FinancialIncomeExpensesNet_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_IncreaseInOperatingLeaseRouAssetsAndLiabilities_37" xlink:to="lab_slgl_IncreaseInOperatingLeaseRouAssetsAndLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_IncreaseInOperatingLeaseRouAssetsAndLiabilities_38" xlink:to="lab_slgl_IncreaseInOperatingLeaseRouAssetsAndLiabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_IssuanceOfSharesAndWarrantsThroughPrivatePlacement_39" xlink:to="lab_slgl_IssuanceOfSharesAndWarrantsThroughPrivatePlacement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_IssuanceOfSharesAndWarrantsThroughPrivatePlacement_40" xlink:to="lab_slgl_IssuanceOfSharesAndWarrantsThroughPrivatePlacement_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_IssuanceOfSharesAndWarrantsThroughPrivatePlacement_41" xlink:to="lab_slgl_IssuanceOfSharesAndWarrantsThroughPrivatePlacement_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_IssuanceOfSharesAndWarrantsThroughPrivatePlacementShares_42" xlink:to="lab_slgl_IssuanceOfSharesAndWarrantsThroughPrivatePlacementShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_IssuanceOfSharesAndWarrantsThroughPrivatePlacementShares_43" xlink:to="lab_slgl_IssuanceOfSharesAndWarrantsThroughPrivatePlacementShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_IssuanceOfSharesAndWarrantsThroughPrivatePlacementShares_44" xlink:to="lab_slgl_IssuanceOfSharesAndWarrantsThroughPrivatePlacementShares_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_IssuanceOfSharesAndWarrantsThroughPublicOfferingNetOfIssuanceCosts_45" xlink:to="lab_slgl_IssuanceOfSharesAndWarrantsThroughPublicOfferingNetOfIssuanceCosts_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_IssuanceOfSharesAndWarrantsThroughPublicOfferingNetOfIssuanceCosts_46" xlink:to="lab_slgl_IssuanceOfSharesAndWarrantsThroughPublicOfferingNetOfIssuanceCosts_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_IssuanceOfSharesAndWarrantsThroughPublicOfferingNetOfIssuanceCostsShares_47" xlink:to="lab_slgl_IssuanceOfSharesAndWarrantsThroughPublicOfferingNetOfIssuanceCostsShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_IssuanceOfSharesAndWarrantsThroughPublicOfferingNetOfIssuanceCostsShares_48" xlink:to="lab_slgl_IssuanceOfSharesAndWarrantsThroughPublicOfferingNetOfIssuanceCostsShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_JefferiesLlcMember_49" xlink:to="lab_slgl_JefferiesLlcMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_JefferiesLlcMember_50" xlink:to="lab_slgl_JefferiesLlcMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_LicenseAgreementsTextBlock_51" xlink:to="lab_slgl_LicenseAgreementsTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_LicenseAgreementsTextBlock_52" xlink:to="lab_slgl_LicenseAgreementsTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_LicenseAgreementsTextBlock_53" xlink:to="lab_slgl_LicenseAgreementsTextBlock_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_LicenseAgreementsWithGaldermaMember_54" xlink:to="lab_slgl_LicenseAgreementsWithGaldermaMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_LicenseAgreementsWithGaldermaMember_55" xlink:to="lab_slgl_LicenseAgreementsWithGaldermaMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_LongTermDeposits_56" xlink:to="lab_slgl_LongTermDeposits_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_LongTermDeposits_57" xlink:to="lab_slgl_LongTermDeposits_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_LongTermDeposits_58" xlink:to="lab_slgl_LongTermDeposits_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_NetChangesInOperatingLeases_59" xlink:to="lab_slgl_NetChangesInOperatingLeases_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_NetChangesInOperatingLeases_60" xlink:to="lab_slgl_NetChangesInOperatingLeases_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_NetChangesInOperatingLeases_61" xlink:to="lab_slgl_NetChangesInOperatingLeases_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_NumberOfApprovedGenericDrugProducts_62" xlink:to="lab_slgl_NumberOfApprovedGenericDrugProducts_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_NumberOfApprovedGenericDrugProducts_63" xlink:to="lab_slgl_NumberOfApprovedGenericDrugProducts_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_NumberOfApprovedGenericDrugProducts_64" xlink:to="lab_slgl_NumberOfApprovedGenericDrugProducts_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_NumberOfEqualQuarterlyInstalments_65" xlink:to="lab_slgl_NumberOfEqualQuarterlyInstalments_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_NumberOfEqualQuarterlyInstalments_66" xlink:to="lab_slgl_NumberOfEqualQuarterlyInstalments_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_NumberOfEqualQuarterlyInstalments_67" xlink:to="lab_slgl_NumberOfEqualQuarterlyInstalments_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_NumberOfGenericCollaborativeAgreementsToSellRights_68" xlink:to="lab_slgl_NumberOfGenericCollaborativeAgreementsToSellRights_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_NumberOfGenericCollaborativeAgreementsToSellRights_69" xlink:to="lab_slgl_NumberOfGenericCollaborativeAgreementsToSellRights_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_NumberOfGenericCollaborativeAgreementsToSellRights_70" xlink:to="lab_slgl_NumberOfGenericCollaborativeAgreementsToSellRights_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_NumberOfGenericDrugCandidates_71" xlink:to="lab_slgl_NumberOfGenericDrugCandidates_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_NumberOfGenericDrugCandidates_72" xlink:to="lab_slgl_NumberOfGenericDrugCandidates_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_NumberOfGenericDrugCandidates_73" xlink:to="lab_slgl_NumberOfGenericDrugCandidates_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_NumberOfGenericProgramsRetainedForCollaborationRights_74" xlink:to="lab_slgl_NumberOfGenericProgramsRetainedForCollaborationRights_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_NumberOfGenericProgramsRetainedForCollaborationRights_75" xlink:to="lab_slgl_NumberOfGenericProgramsRetainedForCollaborationRights_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_NumberOfGenericProgramsRetainedForCollaborationRights_76" xlink:to="lab_slgl_NumberOfGenericProgramsRetainedForCollaborationRights_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_NumberOfUnapprovedGenericPrograms_77" xlink:to="lab_slgl_NumberOfUnapprovedGenericPrograms_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_NumberOfUnapprovedGenericPrograms_78" xlink:to="lab_slgl_NumberOfUnapprovedGenericPrograms_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_NumberOfUnapprovedGenericPrograms_79" xlink:to="lab_slgl_NumberOfUnapprovedGenericPrograms_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_OtherForeignGovernmentBondsMember_80" xlink:to="lab_slgl_OtherForeignGovernmentBondsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_OtherForeignGovernmentBondsMember_81" xlink:to="lab_slgl_OtherForeignGovernmentBondsMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_PaymentReceivableInInstalments_82" xlink:to="lab_slgl_PaymentReceivableInInstalments_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_PaymentReceivableInInstalments_83" xlink:to="lab_slgl_PaymentReceivableInInstalments_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_PaymentReceivableInInstalments_84" xlink:to="lab_slgl_PaymentReceivableInInstalments_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_PercentageOfGrossProceedsFromSaleOfShares_85" xlink:to="lab_slgl_PercentageOfGrossProceedsFromSaleOfShares_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_PercentageOfGrossProceedsFromSaleOfShares_86" xlink:to="lab_slgl_PercentageOfGrossProceedsFromSaleOfShares_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_PercentageOfGrossProceedsFromSaleOfShares_87" xlink:to="lab_slgl_PercentageOfGrossProceedsFromSaleOfShares_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_PercentageOfGrossProfitsRelatedToSaleProducts_88" xlink:to="lab_slgl_PercentageOfGrossProfitsRelatedToSaleProducts_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_PercentageOfGrossProfitsRelatedToSaleProducts_89" xlink:to="lab_slgl_PercentageOfGrossProfitsRelatedToSaleProducts_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_ProceedsFromLongTermDeposits_90" xlink:to="lab_slgl_ProceedsFromLongTermDeposits_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_ProceedsFromLongTermDeposits_91" xlink:to="lab_slgl_ProceedsFromLongTermDeposits_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_ProceedsFromLongTermDeposits_92" xlink:to="lab_slgl_ProceedsFromLongTermDeposits_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_ProceedsFromShortTermDeposits_93" xlink:to="lab_slgl_ProceedsFromShortTermDeposits_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_ProceedsFromShortTermDeposits_94" xlink:to="lab_slgl_ProceedsFromShortTermDeposits_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_ProceedsFromShortTermDeposits_95" xlink:to="lab_slgl_ProceedsFromShortTermDeposits_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_ProductAndService_96" xlink:to="lab_slgl_ProductAndService_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_ProductAndService_97" xlink:to="lab_slgl_ProductAndService_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_ReceiveFromThirdPartyUpfrontPayment_98" xlink:to="lab_slgl_ReceiveFromThirdPartyUpfrontPayment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_ReceiveFromThirdPartyUpfrontPayment_99" xlink:to="lab_slgl_ReceiveFromThirdPartyUpfrontPayment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_RefundableUpfrontPayment_100" xlink:to="lab_slgl_RefundableUpfrontPayment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_RefundableUpfrontPayment_101" xlink:to="lab_slgl_RefundableUpfrontPayment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_RefundableUpfrontPayment_102" xlink:to="lab_slgl_RefundableUpfrontPayment_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_RefundUpFrontPayment_103" xlink:to="lab_slgl_RefundUpFrontPayment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_RefundUpFrontPayment_104" xlink:to="lab_slgl_RefundUpFrontPayment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_RefundUpFrontPayment_105" xlink:to="lab_slgl_RefundUpFrontPayment_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_RoyaltiesCompanyIsEligibleToReceive_106" xlink:to="lab_slgl_RoyaltiesCompanyIsEligibleToReceive_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_RoyaltiesCompanyIsEligibleToReceive_107" xlink:to="lab_slgl_RoyaltiesCompanyIsEligibleToReceive_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_RoyaltiesMaturity_108" xlink:to="lab_slgl_RoyaltiesMaturity_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_RoyaltiesMaturity_109" xlink:to="lab_slgl_RoyaltiesMaturity_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_RoyaltiesMaturity_110" xlink:to="lab_slgl_RoyaltiesMaturity_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_SalesMilestonePayments_111" xlink:to="lab_slgl_SalesMilestonePayments_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_SalesMilestonePayments_112" xlink:to="lab_slgl_SalesMilestonePayments_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_SalesMilestonePayments_113" xlink:to="lab_slgl_SalesMilestonePayments_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_ShortTermDeposits_114" xlink:to="lab_slgl_ShortTermDeposits_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_ShortTermDeposits_115" xlink:to="lab_slgl_ShortTermDeposits_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_ShortTermDeposits_116" xlink:to="lab_slgl_ShortTermDeposits_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_TwyneoMember_117" xlink:to="lab_slgl_TwyneoMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_TwyneoMember_118" xlink:to="lab_slgl_TwyneoMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_UnderwrittenPublicOfferingMember_119" xlink:to="lab_slgl_UnderwrittenPublicOfferingMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_UnderwrittenPublicOfferingMember_120" xlink:to="lab_slgl_UnderwrittenPublicOfferingMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_UpfrontPaymentReceived_121" xlink:to="lab_slgl_UpfrontPaymentReceived_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_UpfrontPaymentReceived_122" xlink:to="lab_slgl_UpfrontPaymentReceived_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_UpfrontPaymentReceived_123" xlink:to="lab_slgl_UpfrontPaymentReceived_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_UpfrontPayments_124" xlink:to="lab_slgl_UpfrontPayments_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_UpfrontPayments_125" xlink:to="lab_slgl_UpfrontPayments_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_UpfrontPayments_126" xlink:to="lab_slgl_UpfrontPayments_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInLongTermReceivablesCurrent_127" xlink:to="lab_us-gaap_IncreaseDecreaseInLongTermReceivablesCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInLongTermReceivablesCurrent_128" xlink:to="lab_us-gaap_IncreaseDecreaseInLongTermReceivablesCurrent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidExpensesOther_129" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidExpensesOther_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidExpensesOther_130" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidExpensesOther_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireMarketableSecurities_131" xlink:to="lab_us-gaap_PaymentsToAcquireMarketableSecurities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireMarketableSecurities_132" xlink:to="lab_us-gaap_PaymentsToAcquireMarketableSecurities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_133" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_134" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_135" xlink:to="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_136" xlink:to="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit_137" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit_138" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit_139" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss_140" xlink:to="lab_us-gaap_NetIncomeLoss_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss_141" xlink:to="lab_us-gaap_NetIncomeLoss_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss_142" xlink:to="lab_us-gaap_NetIncomeLoss_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss_143" xlink:to="lab_us-gaap_NetIncomeLoss_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss_144" xlink:to="lab_us-gaap_OperatingIncomeLoss_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss_145" xlink:to="lab_us-gaap_OperatingIncomeLoss_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss_146" xlink:to="lab_us-gaap_OperatingIncomeLoss_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss_147" xlink:to="lab_us-gaap_ProfitLoss_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss_148" xlink:to="lab_us-gaap_ProfitLoss_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss_149" xlink:to="lab_us-gaap_ProfitLoss_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss_150" xlink:to="lab_us-gaap_ProfitLoss_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_151" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_152" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_153" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_154" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_155" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_156" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_157" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding_158" xlink:to="lab_us-gaap_CommonStockSharesOutstanding_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding_159" xlink:to="lab_us-gaap_CommonStockSharesOutstanding_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding_160" xlink:to="lab_us-gaap_CommonStockSharesOutstanding_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesCurrent_161" xlink:to="lab_us-gaap_MarketableSecuritiesCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesCurrent_162" xlink:to="lab_us-gaap_MarketableSecuritiesCurrent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesCurrent_163" xlink:to="lab_us-gaap_MarketableSecuritiesCurrent_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCash_164" xlink:to="lab_us-gaap_RestrictedCash_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCash_165" xlink:to="lab_us-gaap_RestrictedCash_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity_166" xlink:to="lab_us-gaap_StockholdersEquity_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity_167" xlink:to="lab_us-gaap_StockholdersEquity_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity_168" xlink:to="lab_us-gaap_StockholdersEquity_2"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity_169" xlink:to="lab_us-gaap_StockholdersEquity_3"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag_170" xlink:to="lab_dei_AmendmentFlag_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract_171" xlink:to="lab_dei_CoverAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate_172" xlink:to="lab_dei_CurrentFiscalYearEndDate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus_173" xlink:to="lab_dei_DocumentFiscalPeriodFocus_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus_174" xlink:to="lab_dei_DocumentFiscalYearFocus_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate_175" xlink:to="lab_dei_DocumentPeriodEndDate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType_176" xlink:to="lab_dei_DocumentType_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1_177" xlink:to="lab_dei_EntityAddressAddressLine1_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown_178" xlink:to="lab_dei_EntityAddressCityOrTown_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCountry_179" xlink:to="lab_dei_EntityAddressCountry_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode_180" xlink:to="lab_dei_EntityAddressPostalZipCode_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey_181" xlink:to="lab_dei_EntityCentralIndexKey_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber_182" xlink:to="lab_dei_EntityFileNumber_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName_183" xlink:to="lab_dei_EntityRegistrantName_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_DocumentAndEntityInformation_184" xlink:to="lab_slgl_DocumentAndEntityInformation_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_slgl_LicenseAgreementsAbstract_185" xlink:to="lab_slgl_LicenseAgreementsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ChiefExecutiveOfficerMember_186" xlink:to="lab_srt_ChiefExecutiveOfficerMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_DirectorMember_187" xlink:to="lab_srt_DirectorMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ExecutiveOfficerMember_188" xlink:to="lab_srt_ExecutiveOfficerMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ExecutiveOfficerMember_189" xlink:to="lab_srt_ExecutiveOfficerMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember_190" xlink:to="lab_srt_MaximumMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember_191" xlink:to="lab_srt_MinimumMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis_192" xlink:to="lab_srt_ProductOrServiceAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain_193" xlink:to="lab_srt_ProductsAndServicesDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis_194" xlink:to="lab_srt_RangeAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis_195" xlink:to="lab_srt_RangeAxis_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualAxis_196" xlink:to="lab_srt_TitleOfIndividualAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_197" xlink:to="lab_us-gaap_AccountingPoliciesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent_198" xlink:to="lab_us-gaap_AccountsPayableCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetNoncurrent_199" xlink:to="lab_us-gaap_AccountsReceivableNetNoncurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetNoncurrent_200" xlink:to="lab_us-gaap_AccountsReceivableNetNoncurrent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock_201" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember_202" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_203" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllOtherCorporateBondsMember_204" xlink:to="lab_us-gaap_AllOtherCorporateBondsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_205" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_206" xlink:to="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets_207" xlink:to="lab_us-gaap_Assets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets_208" xlink:to="lab_us-gaap_Assets_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract_209" xlink:to="lab_us-gaap_AssetsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent_210" xlink:to="lab_us-gaap_AssetsCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent_211" xlink:to="lab_us-gaap_AssetsCurrent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract_212" xlink:to="lab_us-gaap_AssetsCurrentAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsNoncurrent_213" xlink:to="lab_us-gaap_AssetsNoncurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsNoncurrent_214" xlink:to="lab_us-gaap_AssetsNoncurrent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_215" xlink:to="lab_us-gaap_AssetsNoncurrentAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_216" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_217" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_218" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_219" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_220" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_221" xlink:to="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_222" xlink:to="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies_223" xlink:to="lab_us-gaap_CommitmentsAndContingencies_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_224" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsDisclosureTextBlock_225" xlink:to="lab_us-gaap_CommitmentsDisclosureTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember_226" xlink:to="lab_us-gaap_CommonStockMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare_227" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized_228" xlink:to="lab_us-gaap_CommonStockSharesAuthorized_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued_229" xlink:to="lab_us-gaap_CommonStockSharesIssued_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue_230" xlink:to="lab_us-gaap_CommonStockValue_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue_231" xlink:to="lab_us-gaap_CommonStockValue_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBenefitObligation_232" xlink:to="lab_us-gaap_DefinedBenefitPlanBenefitObligation_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_233" xlink:to="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepositsAssetsCurrent_234" xlink:to="lab_us-gaap_DepositsAssetsCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation_235" xlink:to="lab_us-gaap_Depreciation_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic_236" xlink:to="lab_us-gaap_EarningsPerShareBasic_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic_237" xlink:to="lab_us-gaap_EarningsPerShareBasic_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted_238" xlink:to="lab_us-gaap_EarningsPerShareDiluted_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted_239" xlink:to="lab_us-gaap_EarningsPerShareDiluted_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock_240" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_241" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignGovernmentDebtMember_242" xlink:to="lab_us-gaap_ForeignGovernmentDebtMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense_243" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract_244" xlink:to="lab_us-gaap_IncomeStatementAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_245" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_246" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_247" xlink:to="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_248" xlink:to="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_249" xlink:to="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeAxis_250" xlink:to="lab_us-gaap_InvestmentTypeAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeasesPolicyTextBlock_251" xlink:to="lab_us-gaap_LesseeLeasesPolicyTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities_252" xlink:to="lab_us-gaap_Liabilities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities_253" xlink:to="lab_us-gaap_Liabilities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_254" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_255" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_256" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent_257" xlink:to="lab_us-gaap_LiabilitiesCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent_258" xlink:to="lab_us-gaap_LiabilitiesCurrent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_259" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesNoncurrent_260" xlink:to="lab_us-gaap_LiabilitiesNoncurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesNoncurrent_261" xlink:to="lab_us-gaap_LiabilitiesNoncurrent_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_262" xlink:to="lab_us-gaap_LiabilitiesNoncurrentAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_263" xlink:to="lab_us-gaap_LiabilitiesNoncurrentAbstract_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LicenseMember_264" xlink:to="lab_us-gaap_LicenseMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LicenseMember_265" xlink:to="lab_us-gaap_LicenseMember_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesAbstract_266" xlink:to="lab_us-gaap_MarketableSecuritiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesTextBlock_267" xlink:to="lab_us-gaap_MarketableSecuritiesTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NatureOfOperations_268" xlink:to="lab_us-gaap_NatureOfOperations_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_269" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_270" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_271" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_272" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_273" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_274" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_275" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_276" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_277" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_278" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent_279" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_280" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset_281" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_282" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent_283" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_284" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrivatePlacementMember_285" xlink:to="lab_us-gaap_PrivatePlacementMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromInterestReceived_286" xlink:to="lab_us-gaap_ProceedsFromInterestReceived_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_287" xlink:to="lab_us-gaap_ProceedsFromIssuanceInitialPublicOffering_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_288" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_289" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_290" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised_291" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised_292" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_293" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesNetCurrent_294" xlink:to="lab_us-gaap_ReceivablesNetCurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyDomain_295" xlink:to="lab_us-gaap_RelatedPartyDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_296" xlink:to="lab_us-gaap_RelatedPartyTransactionsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_297" xlink:to="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_298" xlink:to="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense_299" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndInvestmentsNoncurrent_300" xlink:to="lab_us-gaap_RestrictedCashAndInvestmentsNoncurrent_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember_301" xlink:to="lab_us-gaap_RetainedEarningsMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_302" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_303" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRecognitionPolicyTextBlock_304" xlink:to="lab_us-gaap_RevenueRecognitionPolicyTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues_305" xlink:to="lab_us-gaap_Revenues_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues_306" xlink:to="lab_us-gaap_Revenues_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_307" xlink:to="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_308" xlink:to="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_309" xlink:to="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock_310" xlink:to="lab_us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_311" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_312" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation_313" xlink:to="lab_us-gaap_ShareBasedCompensation_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation_314" xlink:to="lab_us-gaap_ShareBasedCompensation_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_315" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_316" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_317" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_318" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_319" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_320" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_321" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_322" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_323" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_324" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharePrice_325" xlink:to="lab_us-gaap_SharePrice_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesIssued_326" xlink:to="lab_us-gaap_SharesIssued_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesIssuedPricePerShare_327" xlink:to="lab_us-gaap_SharesIssuedPricePerShare_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock_328" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_329" xlink:to="lab_us-gaap_StatementEquityComponentsAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems_330" xlink:to="lab_us-gaap_StatementLineItems_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_331" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_332" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable_333" xlink:to="lab_us-gaap_StatementTable_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract_334" xlink:to="lab_us-gaap_StockholdersEquityAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_335" xlink:to="lab_us-gaap_StockholdersEquityNoteAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_336" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan_337" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_338" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_339" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_340" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_341" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_342" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_343" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_344" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember_345" xlink:to="lab_us-gaap_SubsequentEventMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsAbstract_346" xlink:to="lab_us-gaap_SubsequentEventsAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsTextBlock_347" xlink:to="lab_us-gaap_SubsequentEventsTextBlock_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_348" xlink:to="lab_us-gaap_SubsequentEventTypeAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_349" xlink:to="lab_us-gaap_SubsequentEventTypeDomain_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_350" xlink:to="lab_us-gaap_SubsidiarySaleOfStockAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_351" xlink:to="lab_us-gaap_SubsidiarySaleOfStockAxis_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_352" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfArrangementAxis_353" xlink:to="lab_us-gaap_TypeOfArrangementAxis_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_354" xlink:to="lab_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_355" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_356" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_357" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_0"/>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_358" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_1"/>
  </labelLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>8
<FILENAME>slgl-20220630_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <!-- INTEGIX by Ez-XBRL -->
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel"/>
  <roleRef xlink:type="simple" xlink:href="slgl-20220630.xsd#DocumentAndEntityInformation" roleURI="http://www.sol-gel.co/role/DocumentAndEntityInformation"/>
  <roleRef xlink:type="simple" xlink:href="slgl-20220630.xsd#CondensedConsolidatedBalanceSheets" roleURI="http://www.sol-gel.co/role/CondensedConsolidatedBalanceSheets"/>
  <roleRef xlink:type="simple" xlink:href="slgl-20220630.xsd#CondensedConsolidatedBalanceSheetsParenthetical" roleURI="http://www.sol-gel.co/role/CondensedConsolidatedBalanceSheetsParenthetical"/>
  <roleRef xlink:type="simple" xlink:href="slgl-20220630.xsd#CondensedConsolidatedStatementsOfOperations" roleURI="http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfOperations"/>
  <roleRef xlink:type="simple" xlink:href="slgl-20220630.xsd#CondensedConsolidatedStatementsOfChangesInShareholdersEquity" roleURI="http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity"/>
  <roleRef xlink:type="simple" xlink:href="slgl-20220630.xsd#CondensedConsolidatedStatementsOfCashFlows" roleURI="http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfCashFlows"/>
  <roleRef xlink:type="simple" xlink:href="slgl-20220630.xsd#NatureOfOperations" roleURI="http://www.sol-gel.co/role/NatureOfOperations"/>
  <roleRef xlink:type="simple" xlink:href="slgl-20220630.xsd#SignificantAccountingPolicies" roleURI="http://www.sol-gel.co/role/SignificantAccountingPolicies"/>
  <roleRef xlink:type="simple" xlink:href="slgl-20220630.xsd#MarketableSecurities" roleURI="http://www.sol-gel.co/role/MarketableSecurities"/>
  <roleRef xlink:type="simple" xlink:href="slgl-20220630.xsd#CollaborationAgreements" roleURI="http://www.sol-gel.co/role/CollaborationAgreements"/>
  <roleRef xlink:type="simple" xlink:href="slgl-20220630.xsd#LicenseAgreements" roleURI="http://www.sol-gel.co/role/LicenseAgreements"/>
  <roleRef xlink:type="simple" xlink:href="slgl-20220630.xsd#ShareCapital" roleURI="http://www.sol-gel.co/role/ShareCapital"/>
  <roleRef xlink:type="simple" xlink:href="slgl-20220630.xsd#RelatedParties" roleURI="http://www.sol-gel.co/role/RelatedParties"/>
  <roleRef xlink:type="simple" xlink:href="slgl-20220630.xsd#SignificantAccountingPoliciesPolicies" roleURI="http://www.sol-gel.co/role/SignificantAccountingPoliciesPolicies"/>
  <roleRef xlink:type="simple" xlink:href="slgl-20220630.xsd#MarketableSecuritiesTables" roleURI="http://www.sol-gel.co/role/MarketableSecuritiesTables"/>
  <roleRef xlink:type="simple" xlink:href="slgl-20220630.xsd#ShareCapitalTables" roleURI="http://www.sol-gel.co/role/ShareCapitalTables"/>
  <roleRef xlink:type="simple" xlink:href="slgl-20220630.xsd#NatureOfOperationsDetails" roleURI="http://www.sol-gel.co/role/NatureOfOperationsDetails"/>
  <roleRef xlink:type="simple" xlink:href="slgl-20220630.xsd#SignificantAccountingPoliciesNarrativeDetails" roleURI="http://www.sol-gel.co/role/SignificantAccountingPoliciesNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="slgl-20220630.xsd#MarketableSecuritiesScheduleOfCompanysMarketableSecuritiesDetails" roleURI="http://www.sol-gel.co/role/MarketableSecuritiesScheduleOfCompanysMarketableSecuritiesDetails"/>
  <roleRef xlink:type="simple" xlink:href="slgl-20220630.xsd#MarketableSecuritiesSummaryOfChangesInFairValueOfCompanysMarketableSecuritiesDetails" roleURI="http://www.sol-gel.co/role/MarketableSecuritiesSummaryOfChangesInFairValueOfCompanysMarketableSecuritiesDetails"/>
  <roleRef xlink:type="simple" xlink:href="slgl-20220630.xsd#MarketableSecuritiesScheduleOfCompanysDebtMarketableSecuritiesDetails" roleURI="http://www.sol-gel.co/role/MarketableSecuritiesScheduleOfCompanysDebtMarketableSecuritiesDetails"/>
  <roleRef xlink:type="simple" xlink:href="slgl-20220630.xsd#CollaborationAgreementsDetails" roleURI="http://www.sol-gel.co/role/CollaborationAgreementsDetails"/>
  <roleRef xlink:type="simple" xlink:href="slgl-20220630.xsd#LicenseAgreementsDetails" roleURI="http://www.sol-gel.co/role/LicenseAgreementsDetails"/>
  <roleRef xlink:type="simple" xlink:href="slgl-20220630.xsd#ShareCapitalNarrativeDetails" roleURI="http://www.sol-gel.co/role/ShareCapitalNarrativeDetails"/>
  <roleRef xlink:type="simple" xlink:href="slgl-20220630.xsd#ShareCapitalScheduleOfAssumptionsUsedToEstimateFairValueDetails" roleURI="http://www.sol-gel.co/role/ShareCapitalScheduleOfAssumptionsUsedToEstimateFairValueDetails"/>
  <presentationLink xlink:type="extended" xlink:role="http://www.sol-gel.co/role/DocumentAndEntityInformation">
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="loc_dei_CoverAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_dei_CurrentFiscalYearEndDate_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_dei_DocumentFiscalYearFocus_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_dei_DocumentFiscalPeriodFocus_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="loc_dei_EntityFileNumber_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_dei_EntityAddressAddressLine1_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_dei_EntityAddressCityOrTown_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_dei_EntityAddressPostalZipCode_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="loc_dei_EntityAddressCountry_13"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0" xlink:to="loc_dei_EntityCentralIndexKey_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0" xlink:to="loc_dei_CurrentFiscalYearEndDate_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0" xlink:to="loc_dei_DocumentFiscalYearFocus_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0" xlink:to="loc_dei_DocumentFiscalPeriodFocus_4" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0" xlink:to="loc_dei_AmendmentFlag_5" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0" xlink:to="loc_dei_DocumentType_6" order="50" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0" xlink:to="loc_dei_DocumentPeriodEndDate_7" order="60" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0" xlink:to="loc_dei_EntityFileNumber_8" order="70" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0" xlink:to="loc_dei_EntityRegistrantName_9" order="80" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0" xlink:to="loc_dei_EntityAddressAddressLine1_10" order="90" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0" xlink:to="loc_dei_EntityAddressCityOrTown_11" order="100" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0" xlink:to="loc_dei_EntityAddressPostalZipCode_12" order="110" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0" xlink:to="loc_dei_EntityAddressCountry_13" order="120" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.sol-gel.co/role/CondensedConsolidatedBalanceSheets">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaap_AssetsAbstract_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaap_AssetsCurrentAbstract_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepositsAssetsCurrent" xlink:label="loc_us-gaap_DepositsAssetsCurrent_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesCurrent" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesNetCurrent" xlink:label="loc_us-gaap_ReceivablesNetCurrent_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNoncurrentAbstract" xlink:label="loc_us-gaap_AssetsNoncurrentAbstract_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetNoncurrent" xlink:label="loc_us-gaap_AccountsReceivableNetNoncurrent_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndInvestmentsNoncurrent" xlink:label="loc_us-gaap_RestrictedCashAndInvestmentsNoncurrent_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNoncurrent" xlink:label="loc_us-gaap_AssetsNoncurrent_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaap_AccountsPayableCurrent_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="loc_us-gaap_LiabilitiesNoncurrentAbstract_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligation" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_23"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_24"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaap_CommitmentsAndContingencies_25"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities_27"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaap_StockholdersEquityAbstract_28"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_28"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_29"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_30"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_31"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_33"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0" xlink:to="loc_us-gaap_AssetsAbstract_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1" xlink:to="loc_us-gaap_AssetsCurrentAbstract_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_1" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_1" xlink:to="loc_us-gaap_DepositsAssetsCurrent_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_1" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_1" xlink:to="loc_us-gaap_ReceivablesNetCurrent_4" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_1" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_5" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_1" xlink:to="loc_us-gaap_AssetsCurrent_6" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1" xlink:to="loc_us-gaap_AssetsNoncurrentAbstract_8" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_8" xlink:to="loc_us-gaap_AccountsReceivableNetNoncurrent_8" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_8" xlink:to="loc_us-gaap_RestrictedCashAndInvestmentsNoncurrent_9" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_8" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_10" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_8" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_11" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_8" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_12" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_8" xlink:to="loc_us-gaap_AssetsNoncurrent_13" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1" xlink:to="loc_us-gaap_Assets_15" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_17" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_17" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_17" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_17" xlink:to="loc_us-gaap_AccountsPayableCurrent_17" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_17" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_18" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_17" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_19" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_17" xlink:to="loc_us-gaap_LiabilitiesCurrent_20" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_17" xlink:to="loc_us-gaap_LiabilitiesNoncurrentAbstract_22" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_22" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_22" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_22" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_23" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_22" xlink:to="loc_us-gaap_LiabilitiesNoncurrent_24" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_22" xlink:to="loc_us-gaap_CommitmentsAndContingencies_25" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_17" xlink:to="loc_us-gaap_Liabilities_27" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_17" xlink:to="loc_us-gaap_StockholdersEquityAbstract_28" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_28" xlink:to="loc_us-gaap_CommonStockValue_28" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_28" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_29" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_28" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_30" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_28" xlink:to="loc_us-gaap_StockholdersEquity_31" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_17" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_33" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.sol-gel.co/role/CondensedConsolidatedBalanceSheetsParenthetical">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_4"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0" xlink:to="loc_us-gaap_CommonStockSharesIssued_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_4" order="30" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfOperations">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaap_IncomeStatementAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srt_ProductOrServiceAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_1"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_CollabrationsMember" xlink:label="loc_slgl_CollabrationsMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicenseMember" xlink:label="loc_us-gaap_LicenseMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_8"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_FinancialIncomeExpensesNet" xlink:label="loc_slgl_FinancialIncomeExpensesNet_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaap_EarningsPerShareBasic_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaap_EarningsPerShareDiluted_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_14"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0" xlink:to="loc_us-gaap_StatementTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_srt_ProductOrServiceAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_1" xlink:to="loc_srt_ProductsAndServicesDomain_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_1" xlink:to="loc_slgl_CollabrationsMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_1" xlink:to="loc_us-gaap_LicenseMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_StatementLineItems_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_us-gaap_Revenues_5" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_6" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_7" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_us-gaap_OperatingIncomeLoss_8" order="30" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_slgl_FinancialIncomeExpensesNet_9" order="40" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_us-gaap_NetIncomeLoss_10" order="50" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_us-gaap_EarningsPerShareBasic_11" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_us-gaap_EarningsPerShareDiluted_12" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_13" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_14" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaap_RetainedEarningsMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_13"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_14"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_16"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_0" xlink:to="loc_us-gaap_StatementTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1" xlink:to="loc_us-gaap_CommonStockMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1" xlink:to="loc_us-gaap_RetainedEarningsMember_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1" xlink:to="loc_us-gaap_EquityComponentDomain_4" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_StatementLineItems_6" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6" xlink:to="loc_us-gaap_StockholdersEquity_6" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_7" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6" xlink:to="loc_us-gaap_ProfitLoss_8" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan_9" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_10" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_11" order="50" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_12" order="60" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_13" order="70" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6" xlink:to="loc_us-gaap_ShareBasedCompensation_14" order="80" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6" xlink:to="loc_us-gaap_StockholdersEquity_15" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_16" order="100" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfCashFlows">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaap_Depreciation_2"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_ChangesInAccruedLiabilityForEmployeeRightsUponRetirement" xlink:label="loc_slgl_ChangesInAccruedLiabilityForEmployeeRightsUponRetirement_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_4"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_FinanceExpensesNet" xlink:label="loc_slgl_FinanceExpensesNet_5"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_NetChangesInOperatingLeases" xlink:label="loc_slgl_NetChangesInOperatingLeases_6"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_ChangesInFairValueOfMarketableSecurities" xlink:label="loc_slgl_ChangesInFairValueOfMarketableSecurities_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInLongTermReceivablesCurrent" xlink:label="loc_us-gaap_IncreaseDecreaseInLongTermReceivablesCurrent_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidExpensesOther" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidExpensesOther_9"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_10"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireMarketableSecurities" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_17"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_ProceedsFromShortTermDeposits" xlink:label="loc_slgl_ProceedsFromShortTermDeposits_18"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_ProceedsFromLongTermDeposits" xlink:label="loc_slgl_ProceedsFromLongTermDeposits_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_23"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_24"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_25"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_26"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_27"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_28"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCash" xlink:label="loc_us-gaap_RestrictedCash_29"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_30"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_32"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromInterestReceived" xlink:label="loc_us-gaap_ProceedsFromInterestReceived_32"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1" xlink:to="loc_us-gaap_ProfitLoss_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2" xlink:to="loc_us-gaap_Depreciation_2" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2" xlink:to="loc_slgl_ChangesInAccruedLiabilityForEmployeeRightsUponRetirement_3" order="10" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2" xlink:to="loc_us-gaap_ShareBasedCompensation_4" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2" xlink:to="loc_slgl_FinanceExpensesNet_5" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2" xlink:to="loc_slgl_NetChangesInOperatingLeases_6" order="40" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2" xlink:to="loc_slgl_ChangesInFairValueOfMarketableSecurities_7" order="50" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_8" order="60" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_8" xlink:to="loc_us-gaap_IncreaseDecreaseInLongTermReceivablesCurrent_8" order="0" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_8" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidExpensesOther_9" order="10" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_8" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_10" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_12" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_15" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_15" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_15" order="0" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_15" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_16" order="10" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_15" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_17" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_15" xlink:to="loc_slgl_ProceedsFromShortTermDeposits_18" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_15" xlink:to="loc_slgl_ProceedsFromLongTermDeposits_19" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_15" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_20" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_22" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_22" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_22" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_22" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_23" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_22" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_24" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_22" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_25" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_22" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_26" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_22" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_27" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_22" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_28" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_22" xlink:to="loc_us-gaap_RestrictedCash_29" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_22" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_30" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_0" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_32" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_32" xlink:to="loc_us-gaap_ProceedsFromInterestReceived_32" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.sol-gel.co/role/NatureOfOperations">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NatureOfOperations" xlink:label="loc_us-gaap_NatureOfOperations_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0" xlink:to="loc_us-gaap_NatureOfOperations_1" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.sol-gel.co/role/SignificantAccountingPolicies">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_1" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.sol-gel.co/role/MarketableSecurities">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_0" xlink:to="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_1" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.sol-gel.co/role/CollaborationAgreements">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_0" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_1" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.sol-gel.co/role/LicenseAgreements">
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_LicenseAgreementsAbstract" xlink:label="loc_slgl_LicenseAgreementsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_LicenseAgreementsTextBlock" xlink:label="loc_slgl_LicenseAgreementsTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_slgl_LicenseAgreementsAbstract_0" xlink:to="loc_slgl_LicenseAgreementsTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.sol-gel.co/role/ShareCapital">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_0" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_1" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.sol-gel.co/role/RelatedParties">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_0" xlink:to="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_1" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.sol-gel.co/role/SignificantAccountingPoliciesPolicies">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_5"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_RevenueRecognitionPolicyTextBlock_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_LesseeLeasesPolicyTextBlock_4" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_5" order="40" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.sol-gel.co/role/MarketableSecuritiesTables">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesTextBlock" xlink:label="loc_us-gaap_MarketableSecuritiesTextBlock_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_3"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_0" xlink:to="loc_us-gaap_MarketableSecuritiesTextBlock_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_0" xlink:to="loc_us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_0" xlink:to="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_3" order="20" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.sol-gel.co/role/ShareCapitalTables">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_0" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_1" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.sol-gel.co/role/NatureOfOperationsDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.sol-gel.co/role/SignificantAccountingPoliciesNarrativeDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_IncreaseInOperatingLeaseRouAssetsAndLiabilities" xlink:label="loc_slgl_IncreaseInOperatingLeaseRouAssetsAndLiabilities_2"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0" xlink:to="loc_slgl_IncreaseInOperatingLeaseRouAssetsAndLiabilities_2" order="10" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.sol-gel.co/role/MarketableSecuritiesScheduleOfCompanysMarketableSecuritiesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis" xlink:label="loc_us-gaap_InvestmentTypeAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" xlink:label="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignGovernmentDebtMember" xlink:label="loc_us-gaap_ForeignGovernmentDebtMember_2"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_OtherForeignGovernmentBondsMember" xlink:label="loc_slgl_OtherForeignGovernmentBondsMember_3"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllOtherCorporateBondsMember" xlink:label="loc_us-gaap_AllOtherCorporateBondsMember_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesAbstract" xlink:label="loc_us-gaap_MarketableSecuritiesAbstract_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesCurrent" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_7"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_0" xlink:to="loc_us-gaap_StatementTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_InvestmentTypeAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_1" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_1" xlink:to="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_1" xlink:to="loc_us-gaap_ForeignGovernmentDebtMember_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_1" xlink:to="loc_slgl_OtherForeignGovernmentBondsMember_3" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_1" xlink:to="loc_us-gaap_AllOtherCorporateBondsMember_4" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_StatementLineItems_7" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7" xlink:to="loc_us-gaap_MarketableSecuritiesAbstract_7" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesAbstract_7" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_7" order="0" use="optional"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.sol-gel.co/role/MarketableSecuritiesSummaryOfChangesInFairValueOfCompanysMarketableSecuritiesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesCurrent" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireMarketableSecurities" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_3"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_ChangesInFairValueOfMarketableSecurities" xlink:label="loc_slgl_ChangesInFairValueOfMarketableSecurities_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesCurrent" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_5"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_0" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_0" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_0" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_3" order="20" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_0" xlink:to="loc_slgl_ChangesInFairValueOfMarketableSecurities_4" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_0" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_5" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.sol-gel.co/role/MarketableSecuritiesScheduleOfCompanysDebtMarketableSecuritiesDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_1"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue" xlink:label="loc_slgl_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue_2"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_0" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_0" xlink:to="loc_slgl_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.sol-gel.co/role/CollaborationAgreementsDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_5"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_RoyaltiesMaturity" xlink:label="loc_slgl_RoyaltiesMaturity_5"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_NumberOfGenericCollaborativeAgreementsToSellRights" xlink:label="loc_slgl_NumberOfGenericCollaborativeAgreementsToSellRights_6"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_NumberOfGenericProgramsRetainedForCollaborationRights" xlink:label="loc_slgl_NumberOfGenericProgramsRetainedForCollaborationRights_7"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_NumberOfGenericDrugCandidates" xlink:label="loc_slgl_NumberOfGenericDrugCandidates_8"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_ExpectedRevenueReceivableOverTwentyFourMonths" xlink:label="loc_slgl_ExpectedRevenueReceivableOverTwentyFourMonths_9"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_NumberOfApprovedGenericDrugProducts" xlink:label="loc_slgl_NumberOfApprovedGenericDrugProducts_10"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_NumberOfUnapprovedGenericPrograms" xlink:label="loc_slgl_NumberOfUnapprovedGenericPrograms_11"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_UpfrontPaymentReceived" xlink:label="loc_slgl_UpfrontPaymentReceived_12"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_PaymentReceivableInInstalments" xlink:label="loc_slgl_PaymentReceivableInInstalments_13"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_NumberOfEqualQuarterlyInstalments" xlink:label="loc_slgl_NumberOfEqualQuarterlyInstalments_14"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_0" xlink:to="loc_us-gaap_StatementTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_srt_RangeAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_1" xlink:to="loc_srt_RangeMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_1" xlink:to="loc_srt_MinimumMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_1" xlink:to="loc_srt_MaximumMember_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1" xlink:to="loc_us-gaap_StatementLineItems_5" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_slgl_RoyaltiesMaturity_5" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_slgl_NumberOfGenericCollaborativeAgreementsToSellRights_6" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_slgl_NumberOfGenericProgramsRetainedForCollaborationRights_7" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_slgl_NumberOfGenericDrugCandidates_8" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_slgl_ExpectedRevenueReceivableOverTwentyFourMonths_9" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_slgl_NumberOfApprovedGenericDrugProducts_10" order="50" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_slgl_NumberOfUnapprovedGenericPrograms_11" order="60" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_slgl_UpfrontPaymentReceived_12" order="70" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_slgl_PaymentReceivableInInstalments_13" order="80" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5" xlink:to="loc_slgl_NumberOfEqualQuarterlyInstalments_14" order="90" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.sol-gel.co/role/LicenseAgreementsDetails">
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_LicenseAgreementsAbstract" xlink:label="loc_slgl_LicenseAgreementsAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srt_ProductOrServiceAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_1"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_TwyneoMember" xlink:label="loc_slgl_TwyneoMember_1"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_EpsolayMember" xlink:label="loc_slgl_EpsolayMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaap_TypeOfArrangementAxis_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_5"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_LicenseAgreementsWithGaldermaMember" xlink:label="loc_slgl_LicenseAgreementsWithGaldermaMember_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_11"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_UpfrontPayments" xlink:label="loc_slgl_UpfrontPayments_11"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_RoyaltiesCompanyIsEligibleToReceive" xlink:label="loc_slgl_RoyaltiesCompanyIsEligibleToReceive_12"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_RefundableUpfrontPayment" xlink:label="loc_slgl_RefundableUpfrontPayment_13"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_SalesMilestonePayments" xlink:label="loc_slgl_SalesMilestonePayments_14"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_RefundUpFrontPayment" xlink:label="loc_slgl_RefundUpFrontPayment_15"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_slgl_LicenseAgreementsAbstract_0" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_1" xlink:to="loc_srt_ProductOrServiceAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_1" xlink:to="loc_srt_ProductsAndServicesDomain_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_1" xlink:to="loc_slgl_TwyneoMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_1" xlink:to="loc_slgl_EpsolayMember_2" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_1" xlink:to="loc_us-gaap_TypeOfArrangementAxis_5" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_5" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_5" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_5" xlink:to="loc_slgl_LicenseAgreementsWithGaldermaMember_5" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_1" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_8" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_8" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_8" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_8" xlink:to="loc_us-gaap_SubsequentEventMember_8" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_1" xlink:to="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_11" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_11" xlink:to="loc_slgl_UpfrontPayments_11" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_11" xlink:to="loc_slgl_RoyaltiesCompanyIsEligibleToReceive_12" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_11" xlink:to="loc_slgl_RefundableUpfrontPayment_13" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_11" xlink:to="loc_slgl_SalesMilestonePayments_14" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_11" xlink:to="loc_slgl_RefundUpFrontPayment_15" order="40" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.sol-gel.co/role/ShareCapitalNarrativeDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_1"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_JefferiesLlcMember" xlink:label="loc_slgl_JefferiesLlcMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srt_TitleOfIndividualAxis_4"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_4"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_EmployeesAndExecutiveOfficersMember" xlink:label="loc_slgl_EmployeesAndExecutiveOfficersMember_4"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_EmployeesMember" xlink:label="loc_slgl_EmployeesMember_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ExecutiveOfficerMember" xlink:label="loc_srt_ExecutiveOfficerMember_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ChiefExecutiveOfficerMember" xlink:label="loc_srt_ChiefExecutiveOfficerMember_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_DirectorMember" xlink:label="loc_srt_DirectorMember_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_11"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_us-gaap_PrivatePlacementMember_11"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_UnderwrittenPublicOfferingMember" xlink:label="loc_slgl_UnderwrittenPublicOfferingMember_12"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_15"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_16"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_17"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_18"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_19"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_20"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssued" xlink:label="loc_us-gaap_SharesIssued_21"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_22"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_23"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_24"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_25"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_26"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_27"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_AggregateOfferingPrice" xlink:label="loc_slgl_AggregateOfferingPrice_28"/>
    <loc xlink:type="locator" xlink:href="slgl-20220630.xsd#slgl_PercentageOfGrossProceedsFromSaleOfShares" xlink:label="loc_slgl_PercentageOfGrossProceedsFromSaleOfShares_29"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_30"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_31"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_32"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1" xlink:to="loc_us-gaap_RelatedPartyDomain_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_1" xlink:to="loc_slgl_JefferiesLlcMember_1" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_srt_TitleOfIndividualAxis_4" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_4" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_4" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_4" xlink:to="loc_slgl_EmployeesAndExecutiveOfficersMember_4" order="0" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_4" xlink:to="loc_slgl_EmployeesMember_5" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_4" xlink:to="loc_srt_ExecutiveOfficerMember_6" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_4" xlink:to="loc_srt_ChiefExecutiveOfficerMember_7" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_4" xlink:to="loc_srt_DirectorMember_8" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_11" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_11" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_11" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_11" xlink:to="loc_us-gaap_PrivatePlacementMember_11" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_11" xlink:to="loc_slgl_UnderwrittenPublicOfferingMember_12" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_RelatedPartyDomain_15" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_16" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_16" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_16" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_16" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_17" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_16" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_18" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_16" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_19" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_16" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_20" order="40" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_16" xlink:to="loc_us-gaap_SharesIssued_21" order="50" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_16" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_22" order="60" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_16" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_23" order="70" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_16" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_24" order="80" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_16" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_25" order="90" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_16" xlink:to="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_26" order="100" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_16" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_27" order="110" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_16" xlink:to="loc_slgl_AggregateOfferingPrice_28" order="120" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_16" xlink:to="loc_slgl_PercentageOfGrossProceedsFromSaleOfShares_29" order="130" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_16" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_30" order="140" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_16" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_31" order="150" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_16" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_32" order="160" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.sol-gel.co/role/ShareCapitalScheduleOfAssumptionsUsedToEstimateFairValueDetails">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_0"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_1"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_2"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaap_SharePrice_5"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_6"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_7"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_8"/>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_9"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_srt_RangeAxis_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_1" xlink:to="loc_srt_RangeMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_1" xlink:to="loc_srt_MinimumMember_1" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_1" xlink:to="loc_srt_MaximumMember_2" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5" xlink:to="loc_us-gaap_SharePrice_5" order="0" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_6" order="10" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_7" order="20" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_8" order="30" use="optional"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_9" order="40" use="optional"/>
  </presentationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140393901806528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001684693<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">6-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 30,  2022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">SOL-GEL TECHNOLOGIES LTD.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">7 Golda Meir Street<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Ness Ziona<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">7403650<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">IL<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140393901147888">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>CURRENT ASSETS:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 5,765<span></span>
</td>
<td class="nump">$ 20,085<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepositsAssetsCurrent', window );">Bank deposits</a></td>
<td class="nump">21,000<span></span>
</td>
<td class="nump">21,448<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Marketable securities</a></td>
<td class="nump">9,846<span></span>
</td>
<td class="nump">1,709<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesNetCurrent', window );">Receivables from collaborative arrangements</a></td>
<td class="nump">10,176<span></span>
</td>
<td class="nump">13,065<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">1,691<span></span>
</td>
<td class="nump">800<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">TOTAL CURRENT ASSETS</a></td>
<td class="nump">48,478<span></span>
</td>
<td class="nump">57,107<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsNoncurrentAbstract', window );"><strong>NON-CURRENT ASSETS:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetNoncurrent', window );">Long-term receivables from collaborative arrangements</a></td>
<td class="nump">2,499<span></span>
</td>
<td class="nump">7,402<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndInvestmentsNoncurrent', window );">Restricted long-term deposits and cash</a></td>
<td class="nump">1,289<span></span>
</td>
<td class="nump">1,298<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">826<span></span>
</td>
<td class="nump">1,051<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">1,153<span></span>
</td>
<td class="nump">1,501<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Funds in respect of employee rights upon retirement</a></td>
<td class="nump">738<span></span>
</td>
<td class="nump">830<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsNoncurrent', window );">TOTAL NON-CURRENT ASSETS</a></td>
<td class="nump">6,505<span></span>
</td>
<td class="nump">12,082<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">TOTAL ASSETS</a></td>
<td class="nump">54,983<span></span>
</td>
<td class="nump">69,189<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>CURRENT LIABILITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">860<span></span>
</td>
<td class="nump">766<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other accounts payable</a></td>
<td class="nump">1,664<span></span>
</td>
<td class="nump">10,145<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current maturities of operating leases</a></td>
<td class="nump">701<span></span>
</td>
<td class="nump">781<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">TOTAL CURRENT LIABILITIES</a></td>
<td class="nump">3,225<span></span>
</td>
<td class="nump">11,692<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>LONG-TERM LIABILITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating leases liabilities</a></td>
<td class="nump">369<span></span>
</td>
<td class="nump">810<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Liability for employee rights upon retirement</a></td>
<td class="nump">1,038<span></span>
</td>
<td class="nump">1,093<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrent', window );">TOTAL LONG-TERM LIABILITIES</a></td>
<td class="nump">1,407<span></span>
</td>
<td class="nump">1,903<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">TOTAL LIABILITIES</a></td>
<td class="nump">4,632<span></span>
</td>
<td class="nump">13,595<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>SHAREHOLDERS' EQUITY:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Ordinary Shares, NIS 0.1 par value &#8211; authorized: 50,000,000 as of December 31, 2021 and June 30, 2022; issued and outstanding: 23,126,804 and 23,129,469 as of December 31, 2021 and June 30, 2022, respectively.</a></td>
<td class="nump">638<span></span>
</td>
<td class="nump">638<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">233,586<span></span>
</td>
<td class="nump">233,098<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(183,873)<span></span>
</td>
<td class="num">(178,142)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">TOTAL SHAREHOLDERS' EQUITY</a></td>
<td class="nump">50,351<span></span>
</td>
<td class="nump">55,594<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY</a></td>
<td class="nump">$ 54,983<span></span>
</td>
<td class="nump">$ 69,189<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepositsAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment within one year or during the operating cycle, if shorter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepositsAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-06(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401414&amp;loc=d3e604059-122996<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndInvestmentsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The noncurrent cash, cash equivalents and investments that is restricted as to withdrawal or usage. Restrictions may include legally restricted deposits held as compensating balances against borrowing arrangements, contracts entered into with others, or entity statements of intention with regard to particular deposits classified as long-term; that is not expected to be released from such existing restrictions within one year of the balance sheet date or operating cycle, whichever is longer. Excludes compensating balance arrangements that are not agreements which legally restrict the use of cash amounts shown on the balance sheet. Includes noncurrent cash equivalents and investments that are similarly restricted as to withdrawal, usage or disposal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL6242262-115580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=127002003&amp;loc=SL6242269-115581<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndInvestmentsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140393903148368">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) - &#8362; / shares<br></strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Ordinary shares, par value per share</a></td>
<td class="nump">&#8362; 0.1<span></span>
</td>
<td class="nump">&#8362; 0.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Ordinary shares, shares authorized</a></td>
<td class="nump">50,000,000<span></span>
</td>
<td class="nump">50,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ordinary shares, shares issued</a></td>
<td class="nump">23,129,469<span></span>
</td>
<td class="nump">23,126,804<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ordinary shares, shares outstanding</a></td>
<td class="nump">23,129,469<span></span>
</td>
<td class="nump">23,126,804<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140393901209392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">TOTAL REVENUES</a></td>
<td class="nump">$ 3,518<span></span>
</td>
<td class="nump">$ 928<span></span>
</td>
<td class="nump">$ 3,521<span></span>
</td>
<td class="nump">$ 1,629<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">RESEARCH AND DEVELOPMENT EXPENSES</a></td>
<td class="nump">2,380<span></span>
</td>
<td class="nump">6,933<span></span>
</td>
<td class="nump">6,422<span></span>
</td>
<td class="nump">9,399<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">GENERAL AND ADMINISTRATIVE EXPENSES</a></td>
<td class="nump">1,601<span></span>
</td>
<td class="nump">2,037<span></span>
</td>
<td class="nump">3,512<span></span>
</td>
<td class="nump">4,496<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">TOTAL OPERATING LOSS</a></td>
<td class="nump">463<span></span>
</td>
<td class="nump">8,042<span></span>
</td>
<td class="nump">6,413<span></span>
</td>
<td class="nump">12,266<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_slgl_FinancialIncomeExpensesNet', window );">FINANCIAL INCOME, net</a></td>
<td class="num">(329)<span></span>
</td>
<td class="num">(9)<span></span>
</td>
<td class="num">(682)<span></span>
</td>
<td class="num">(170)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">LOSS FOR THE PERIOD</a></td>
<td class="nump">$ 134<span></span>
</td>
<td class="nump">$ 8,033<span></span>
</td>
<td class="nump">$ 5,731<span></span>
</td>
<td class="nump">$ 12,096<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">BASIC LOSS PER ORDINARY SHARE</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.35<span></span>
</td>
<td class="nump">$ 0.25<span></span>
</td>
<td class="nump">$ 0.53<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">DILUTED LOSS PER ORDINARY SHARE</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.35<span></span>
</td>
<td class="nump">$ 0.25<span></span>
</td>
<td class="nump">$ 0.53<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING USED IN COMPUTATION OF BASIC LOSS PER SHARE</a></td>
<td class="nump">23,128,429<span></span>
</td>
<td class="nump">23,028,508<span></span>
</td>
<td class="nump">23,127,958<span></span>
</td>
<td class="nump">23,016,104<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING USED IN COMPUTATION OF DILUTED LOSS PER SHARE</a></td>
<td class="nump">23,128,429<span></span>
</td>
<td class="nump">23,028,508<span></span>
</td>
<td class="nump">23,127,958<span></span>
</td>
<td class="nump">23,016,104<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=slgl_CollabrationsMember', window );">COLLABORATION REVENUES [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">TOTAL REVENUES</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 928<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1,629<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_LicenseMember', window );">LICENSE REVENUES [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">TOTAL REVENUES</a></td>
<td class="nump">$ 3,518<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 3,521<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_slgl_FinancialIncomeExpensesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Financial expenses (income), net.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">slgl_FinancialIncomeExpensesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>slgl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=slgl_CollabrationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=slgl_CollabrationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_LicenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_LicenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140393900284688">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (Unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2"><div>Ordinary shares [Member]</div></th>
<th class="th"><div>Additional Paid-In Capital [Member]</div></th>
<th class="th"><div>Accumulated Deficit [Member]</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 635<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 231,577<span></span>
</td>
<td class="num">$ (181,363)<span></span>
</td>
<td class="nump">$ 50,849<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, shares at Dec. 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">23,000,782<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Loss for the period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12,096)<span></span>
</td>
<td class="num">(12,096)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross', window );">Vesting of restricted shares units</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Vesting of restricted shares units, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">15,333<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of options</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">83<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">83<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of options, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">13,836<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">411<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">411<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Jun. 30, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 635<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">232,071<span></span>
</td>
<td class="num">(193,459)<span></span>
</td>
<td class="nump">39,247<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, shares at Jun. 30, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">23,029,951<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Mar. 31, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 635<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">231,849<span></span>
</td>
<td class="num">(185,426)<span></span>
</td>
<td class="nump">47,058<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, shares at Mar. 31, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">23,028,264<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Loss for the period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,033)<span></span>
</td>
<td class="num">(8,033)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of options</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of options, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,687<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">213<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">213<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Jun. 30, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 635<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">232,071<span></span>
</td>
<td class="num">(193,459)<span></span>
</td>
<td class="nump">39,247<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, shares at Jun. 30, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">23,029,951<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 638<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">233,098<span></span>
</td>
<td class="num">(178,142)<span></span>
</td>
<td class="nump">$ 55,594<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, shares at Dec. 31, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">23,126,804<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,126,804<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Loss for the period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">$ (5,731)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of options</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of options, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,665<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">473<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">473<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Jun. 30, 2022</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 638<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">233,586<span></span>
</td>
<td class="num">(183,873)<span></span>
</td>
<td class="nump">$ 50,351<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, shares at Jun. 30, 2022</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">23,129,469<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,129,469<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Mar. 31, 2022</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 638<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">233,224<span></span>
</td>
<td class="num">(183,739)<span></span>
</td>
<td class="nump">$ 50,123<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, shares at Mar. 31, 2022</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">23,127,669<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Loss for the period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(134)<span></span>
</td>
<td class="num">(134)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of options</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of options, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,800<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">352<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">352<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Jun. 30, 2022</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 638<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 233,586<span></span>
</td>
<td class="num">$ (183,873)<span></span>
</td>
<td class="nump">$ 50,351<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, shares at Jun. 30, 2022</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">23,129,469<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,129,469<span></span>
</td>
</tr>
<tr><td colspan="6"></td></tr>
<tr><td colspan="6"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">less than $1 thousand.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate value of stock related to Restricted Stock Awards issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140393901064432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>CASH FLOWS FROM OPERATING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Loss for the period</a></td>
<td class="num">$ (134)<span></span>
</td>
<td class="num">$ (8,033)<span></span>
</td>
<td class="num">$ (5,731)<span></span>
</td>
<td class="num">$ (12,096)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments required to reconcile loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">327<span></span>
</td>
<td class="nump">474<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_slgl_ChangesInAccruedLiabilityForEmployeeRightsUponRetirement', window );">Changes in accrued liability for employee rights upon retirement, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation expenses</a></td>
<td class="nump">352<span></span>
</td>
<td class="nump">213<span></span>
</td>
<td class="nump">473<span></span>
</td>
<td class="nump">411<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_slgl_FinanceExpensesNet', window );">Financial expenses (income), net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(126)<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_slgl_NetChangesInOperatingLeases', window );">Net changes in operating leases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(173)<span></span>
</td>
<td class="num">(48)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_slgl_ChangesInFairValueOfMarketableSecurities', window );">Changes in fair value of marketable securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">135<span></span>
</td>
<td class="num">(59)<span></span>
</td>
<td class="num">$ (125)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating asset and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInLongTermReceivablesCurrent', window );">Receivables from collaborative arrangements (including long-term)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,792<span></span>
</td>
<td class="nump">1,197<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidExpensesOther', window );">Prepaid expenses and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(891)<span></span>
</td>
<td class="num">(482)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable, accrued expenses and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,387)<span></span>
</td>
<td class="num">(782)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,544)<span></span>
</td>
<td class="num">(11,367)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>CASH FLOWS FROM INVESTING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of property and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(102)<span></span>
</td>
<td class="num">(54)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireMarketableSecurities', window );">Investment in marketable securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10,006)<span></span>
</td>
<td class="num">(4,065)<span></span>
</td>
<td class="num">(6,716)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities', window );">Proceeds from sales and maturity of marketable securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,734<span></span>
</td>
<td class="nump">18,946<span></span>
</td>
<td class="nump">26,784<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_slgl_ProceedsFromShortTermDeposits', window );">Proceeds from short-term deposits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">448<span></span>
</td>
<td class="nump">500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_slgl_ProceedsFromLongTermDeposits', window );">Proceeds from long-term deposits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by (used in) investing activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7,917)<span></span>
</td>
<td class="nump">15,329<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>CASH FLOWS FROM FINANCING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from exercise of options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="nump">83<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="nump">83<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">EFFECT OF EXCHANGE RATE ON CASH AND CASH EQUIVALENTS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">126<span></span>
</td>
<td class="num">(15)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS AND RESTRICTED CASH</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14,320)<span></span>
</td>
<td class="nump">4,030<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AT BEGINNING OF THE PERIOD</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,235<span></span>
</td>
<td class="nump">8,272<span></span>
</td>
<td class="nump">8,272<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AT END OF THE PERIODS</a></td>
<td class="nump">6,915<span></span>
</td>
<td class="nump">12,302<span></span>
</td>
<td class="nump">6,915<span></span>
</td>
<td class="nump">12,302<span></span>
</td>
<td class="nump">21,235<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and Cash equivalents</a></td>
<td class="nump">5,765<span></span>
</td>
<td class="nump">11,152<span></span>
</td>
<td class="nump">5,765<span></span>
</td>
<td class="nump">11,152<span></span>
</td>
<td class="nump">20,085<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCash', window );">Restricted cash</a></td>
<td class="nump">1,150<span></span>
</td>
<td class="nump">1,150<span></span>
</td>
<td class="nump">1,150<span></span>
</td>
<td class="nump">1,150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">CASH AND CASH EQUIVALENTS AND RESTRICTED CASH SHOWN IN STATEMENT OF CASH FLOWS</a></td>
<td class="nump">$ 6,915<span></span>
</td>
<td class="nump">$ 12,302<span></span>
</td>
<td class="nump">6,915<span></span>
</td>
<td class="nump">12,302<span></span>
</td>
<td class="nump">$ 21,235<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>SUPPLEMENTARY INFORMATION:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromInterestReceived', window );">Interest received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 153<span></span>
</td>
<td class="nump">$ 582<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_slgl_ChangesInAccruedLiabilityForEmployeeRightsUponRetirement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Changes in accrued liability for employee rights upon retirement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">slgl_ChangesInAccruedLiabilityForEmployeeRightsUponRetirement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>slgl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_slgl_ChangesInFairValueOfMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash inflow from changes in fair value of marketable securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">slgl_ChangesInFairValueOfMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>slgl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_slgl_FinanceExpensesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finance expenses, net.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">slgl_FinanceExpensesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>slgl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_slgl_NetChangesInOperatingLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net changes in operating leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">slgl_NetChangesInOperatingLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>slgl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_slgl_ProceedsFromLongTermDeposits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of proceeds from long-term deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">slgl_ProceedsFromLongTermDeposits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>slgl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_slgl_ProceedsFromShortTermDeposits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of proceeds from short term deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">slgl_ProceedsFromShortTermDeposits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>slgl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInLongTermReceivablesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount due within one year (or one business cycle) of receivables that were originally due beyond one year (or one business cycle).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInLongTermReceivablesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidExpensesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of consideration paid in advance for other costs that provide economic benefits in future periods.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidExpensesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for purchase of marketable security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromInterestReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Interest received on loans and other debt instruments during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3337-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromInterestReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140393905265216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NATURE OF OPERATIONS<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NatureOfOperations', window );">NATURE OF OPERATIONS</a></td>
<td class="text">
        <div>
          <div>
            <div>
              <div>
                <div style="text-align:justify;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">NOTE 1 &#8211; NATURE OF OPERATIONS</span></span></div>
                <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>
                <div style="text-align:justify;margin-left:20pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Sol-Gel Technologies Ltd. (collectively with its U.S. subsidiary, the Company) is an Israeli Company incorporated in 1997.</span></span></div>
                <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>
                <div style="text-align:justify;margin-left:20pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>The Company is a clinical stage specialty pharmaceutical company focused on developing and commercializing topical dermatological drug products. The Company&#8217;s lead products candidates are based upon its proprietary microencapsulation delivery system, consisting of microcapsules made of precipitated silica. The Company has two approved drugs: (i) Twyneo&#174;, which was developed for the treatment of acne vulgaris and received marketing authourization by the U.S. Food and Durg Administration (the "FDA") on July 27, 2021 and (ii) Epsolay&#174;, a treatment for subtype II rosacea that received marketing authourization by the FDA on April 25, 2022. In June 2021, the Company entered into two exclusive license agreements with Galderma for the commercialization of Twyneo&#174; and Epsolay&#174;, in the United States, see note 5. On April 14, 2022, the Company announced that Twyneo&#174; is available for purchase by consumers who obtain a prescription from their physician. On June 2, 2022, the Company announced that Epsolay&#174; is available for purchase by consumers who obtain a prescription from their physician. In addition to the novel products, the Company&#8217;s products included the approved generic products Acyclovir, Ivermectin and other generic product candidates. In November 2021, the company entered into an agreement with Padagis, to sell its rights in relation to ten generic collaborative agreements between the parties, including the agreements for the two aforementioned approved generic drug products. Under the new agreement, the company has retained collaboration rights to two generic programs related to four generic drug candidates, see note 4b.</span></span></span></div>
                <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>
                <div style="text-align:justify;margin-left:20pt;line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Risk and Uncertainties</span></span></div>
                <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>
                <div style="text-align:justify;margin-left:20pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>Since incorporation through June 30, 2022, the Company has an accumulated deficit of $183,873 and its activities have been funded mainly by its shareholders, collaboration revenues and license agreements, see also Notes 4 and 5. The Company expects to continue to incur significant research and development and other costs related to its ongoing operations.</span></span></span></div>
                <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>
                <div style="text-align:justify;margin-left:20pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In addition, management is continuing to analyze cash resources and considering raising additional funding from different sources, such as corporate collaborations, public or private equity offerings and/or debt financings, and/or selling shares under the Company's Open Market Sale Agreement with Jefferies LLC. Management expects that the Company's cash and cash equivalents, deposits and marketable securities as of June 30, 2022 will allow the Company to fund its operating plan through at least the next 12 months from the condensed financial statement issuance date.</span></span></div>
                <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>
                <div style="text-align:justify;margin-left:20pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>The Company is subject to risks and uncertainties as a result of the COVID-19 pandemic. To date, the impact of COVID-19 pandemic has been limited and resulted in delays with respect to pre-approval inspections.</span></span></span></div>
              </div>
            </div>
          </div>
          <div/>
          <div>
            <div>
              <div style="text-align:justify;line-height:1.25">&#160;</div>
              <div style="text-align:justify;margin-left:20pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The full extent to which the COVID-19 pandemic will directly or indirectly impact the Company's business, results of operations and financial condition, including revenues from collaboration arrangements, expenses, reserves and allowances, manufacturing, supply, regulatory approvals, clinical trials, commercial launch of branded and generic product candidates, research and development costs and employee-related amounts, will depend on future developments that are highly uncertain and cannot be predicted. The Company continues to monitor and assess new information related to the COVID-19 pandemic, the actions taken to contain or treat COVID-19, as well as the economic impact on various markets.</span></span></div>
              <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>
              <div style="text-align:justify;margin-left:20pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Furthermore, the estimation process required to prepare the Company&#8217;s consolidated financial statements requires assumptions to be made about future events and conditions and the impact of COVID-19 on its financial results, and while management believes such assumptions are reasonable, they are inherently subjective and uncertain. The Company&#8217;s actual results could differ materially from those estimates.</span></span></div>
            </div>
          </div>
        </div>
      <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI https://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140393905541088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES:<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">SIGNIFICANT ACCOUNTING POLICIES:</a></td>
<td class="text">
    <div>
      <p style="margin-top:0pt;margin-bottom:0pt;text-align:left;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:left"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><strong><span>NOTE 2 </span></strong></span></span></span></span></span></span></span><span style="font-size:10pt;font-family:Times New Roman, Times, serif">&#8211;</span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span><strong><span> SIGNIFICANT ACCOUNTING POLICIES:</span></strong></span></span></span></span></span></span></span></p>
      <p style="margin-top:0pt;margin-bottom:0pt;text-align:left;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:left">&#160;</p>

        <div>
          <div>
            <div>
              <div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:36pt;vertical-align:top;font-family:'Times New Roman',Times,serif">
                        <div style="margin-left:18pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">a.</span></span></div>
                      </td>
                      <td style="width:auto;vertical-align:top">
                        <div style="line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">Basis of Presentation</span><br/><span>&#160;<br/>The unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") for interim financial statements. Accordingly, they do not include all of the information and notes required by U.S. GAAP for annual financial statements. In the opinion of management, these unaudited condensed consolidated financial statements reflect all adjustments, which include normal recurring adjustments, necessary for a fair statement of the Company&#8217;s consolidated financial position as of June 30, 2022, the consolidated results of operations for the six month and three month periods ended June 30, 2021 and 2022 and statements of changes in shareholders' equity and cash flows for the six month period ended June 30, 2021 and 2022.</span></span></span></div>
                      </td>
                    </tr>

                </table>
              </div>
              <div style="margin-left:36pt;line-height:1.25">&#160;</div>
              <div style="margin-left:36pt;line-height:1.25;font-family:Times New Roman, Times, serif;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The consolidated results for the six month period ended June 30, 2022 are not necessarily indicative of the results to be expected for the year ending December 31, 2022.</span></span></div>
              <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>
              <div style="margin-left:35.7pt;line-height:1.25;font-family:Times New Roman, Times, serif;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">These unaudited condensed consolidated financial statements should be read in conjunction with the audited financial statements of the Company for the year ended December 31, 2021. The comparative balance sheet at December 31, 2021 has been derived from the audited financial statements at that date but does not include all disclosures required by U.S. GAAP.</span></span></div>
            </div>
          </div>
        </div>


        <div>
          <p style="margin-top:0pt;margin-left:48px;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p>
          <div style="text-align:justify">
            <div style="margin-top:0px">
              <div>
                <div>
                  <div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:36pt;vertical-align:top;font-family:'Times New Roman',Times,serif">
                            <div style="margin-left:18pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">b.</span></span></div>
                          </td>
                          <td style="width:auto;vertical-align:top">
                            <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">Loss per share</span><br/><span>&#160;<br/>Basic loss per share is computed on the basis of the net loss for the period divided by the weighted average number of ordinary shares outstanding during the period. Diluted loss per share is based upon the weighted average number of ordinary shares and of ordinary shares equivalents outstanding when dilutive. Ordinary share equivalents include outstanding stock options, restricted shares and warrants, which are included under the treasury stock method when dilutive.</span></span></span></div>
                          </td>
                        </tr>

                    </table>
                  </div>
                  <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>
                  <div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The calculation of diluted loss per share does not include 3,713,296 and 4,085,416 options, restricted shares and warrants for the six and three months ended June 30, 2022 and 3,437,843 and 3,463,710 options and restricted shares for the six and the three months ended June 30, 2021, respectively, because the effect would be anti-dilutive.</span></span></div>
                </div>
              </div>
            </div>
          </div>
        </div>

    </div>
  <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140393905926928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>MARKETABLE SECURITIES:<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock', window );">MARKETABLE SECURITIES</a></td>
<td class="text">
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0px;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">NOTE 3 </span></span></span><span style="font-size:10pt;font-family:Times New Roman, Times, serif">&#8211;</span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold"> MARKETABLE SECURITIES:</span></span></span></p>

      <p style="margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <div>
        <div>
          <div style="line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:20pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The following table sets forth the Company&#8217;s marketable securities for the indicated periods:</span></span></div>
          <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>
          <div style="margin-left:20pt">
            <table border="0" cellpadding="0" cellspacing="0" style="color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:left;width:90%" width="100%">

                <tr>
                  <td colspan="1" rowspan="1" style="vertical-align:top;padding-bottom:2px;font-family:Times New Roman, Times, serif" valign="bottom">&#160;</td>
                  <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                  <td colspan="2" rowspan="1" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,</span></span></div>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                  <td colspan="2" rowspan="1" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">June 30,</span></span></div>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="vertical-align:top;padding-bottom:2px;font-family:Times New Roman, Times, serif" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
                    <div style="line-height:1.25">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                    </div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
                    <div style="line-height:1.25">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                    </div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="vertical-align:middle;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Level 2 securities:</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                  <td colspan="6" style="vertical-align:top;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="vertical-align:middle;font-family:Times New Roman, Times, serif;width:76%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">U.S government and agency bonds</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;font-family:Times New Roman, Times, serif;width:9%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">275</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;font-family:Times New Roman, Times, serif;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;font-family:Times New Roman, Times, serif;width:9%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,174</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;font-family:Times New Roman, Times, serif;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="vertical-align:middle;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:76%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other foreign government bonds</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:9%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:9%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,507</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="vertical-align:middle;padding-bottom:2px;font-family:Times New Roman, Times, serif;width:76%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Corporate bonds*</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:2px solid rgb(0, 0, 0);font-family:Times New Roman, Times, serif;width:9%" valign="bottom">
                    <div style="line-height:1.25">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,434</span></span></div>
                    </div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:Times New Roman, Times, serif;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:2px solid rgb(0, 0, 0);font-family:Times New Roman, Times, serif;width:9%" valign="bottom">
                    <div style="line-height:1.25">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7,165</span></span></div>
                    </div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:Times New Roman, Times, serif;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="vertical-align:middle;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:76%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:9%" valign="bottom">
                    <div style="line-height:1.25">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,709</span></span></div>
                    </div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:9%" valign="bottom">
                    <div style="line-height:1.25">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">9,846</span></span></div>
                    </div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                </tr>

            </table>
          </div>
        </div>
      </div>
      <div style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</div>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-left:20pt;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">* <span id="FN_60f774710b70e4ca22c9cb88">Investments in Corporate bonds rated A or higher.</span></span></span></p>

    <p style="margin-top:0pt;margin-bottom:0pt">&#160;</p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-left:20pt;text-align:justify;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company&#8217;s debt securities are classified within Level 2 because it uses quoted market prices or alternative pricing sources and models utilizing market observable inputs to determine their fair value.</span></span></p>

      <p style="margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <div>
        <div>
          <div style="line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:20pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The table below sets forth a summary of the changes in the fair value of the Company&#8217;s marketable securities for the indicated periods:</span></span></div>
          <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>
          <div style="margin-left:20pt">
            <table border="0" cellpadding="0" cellspacing="0" style="color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:left;width:90%" width="100%">

                <tr>
                  <td style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                  <td colspan="6" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Marketable securities</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif" valign="bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">For&#160;the&#160;year&#160;ended</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif" valign="bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">For&#160;the&#160;Six&#160;Months</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,&#160;2021</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">ended&#160;June&#160;30,&#160;2022</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:top;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:top;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:76%" valign="bottom">
                    <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance at beginning of the period</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:9%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">21,652</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:9%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,709</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:76%" valign="bottom">
                    <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Additions</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;font-family:Times New Roman, Times, serif;width:9%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6,716</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;font-family:Times New Roman, Times, serif;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;font-family:Times New Roman, Times, serif;width:9%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10,006</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;font-family:Times New Roman, Times, serif;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:76%" valign="bottom">
                    <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Sale or maturity</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:9%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(26,784</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;white-space:nowrap;width:1%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:9%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,734</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;white-space:nowrap;width:1%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:top;padding-bottom:2px;font-family:Times New Roman, Times, serif;width:76%" valign="bottom">
                    <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Changes in fair value during the period</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:2px solid rgb(0, 0, 0);font-family:Times New Roman, Times, serif;width:9%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">125</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:Times New Roman, Times, serif;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:2px solid rgb(0, 0, 0);font-family:Times New Roman, Times, serif;width:9%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(135</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:Times New Roman, Times, serif;white-space:nowrap;width:1%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:top;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:76%" valign="bottom">
                    <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance at end of the period</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:9%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,709</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:9%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">9,846</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                </tr>

            </table>
          </div>
        </div>
      </div>


      <p style="margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <div>
        <div>
          <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:20pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As of June 30, 2022, the Company&#8217;s debt securities had the following maturity dates:</span></span></div>
          <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>
          <div style="margin-left:20pt">
            <table border="0" cellpadding="0" cellspacing="0" style="color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:left;width:90%" width="100%">

                <tr>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
                    <div style="line-height:1.25">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Market value</span></span></div>
                    </div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif" valign="bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">June 30,</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
                    <div style="line-height:1.25">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                    </div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="vertical-align:middle;padding-bottom:2px;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:88%" valign="bottom">
                    <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Due within one year</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:9%" valign="bottom">
                    <div style="line-height:1.25">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">9,041</span></span></div>
                    </div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="vertical-align:middle;padding-bottom:4px;font-family:Times New Roman, Times, serif;width:88%" valign="bottom">
                    <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Between 1-2 years</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:4px;font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0);font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:4px double rgb(0, 0, 0);font-family:Times New Roman, Times, serif;width:9%" valign="bottom">
                    <div style="line-height:1.25">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">805</span></span></div>
                    </div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:4px;font-family:Times New Roman, Times, serif;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                </tr>

            </table>
          </div>
        </div>
      </div>

    <p style="margin-top:0pt;margin-bottom:0pt">&#160;</p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-left:20pt;text-align:justify;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span><span><span style="color:black">The carrying amount of the cash and cash equivalents, bank deposits, restricted cash, restricted long term deposits,</span></span>&#160;<span><span style="color:black">receivables from collaborative arrangements, accrued expenses and other liabilities approximates their fair value.</span></span></span></span></span></span></span></p>
  <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for investments in certain debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -URI https://asc.fasb.org/subtopic&amp;trid=2209399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -URI https://asc.fasb.org/subtopic&amp;trid=2324412<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI https://asc.fasb.org/topic&amp;trid=2196928<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 320<br> -URI https://asc.fasb.org/subtopic&amp;trid=2176304<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1403<br> -Paragraph (b)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140393906739344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COLLABORATION AGREEMENTS:<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">COLLABORATION AGREEMENTS:</a></td>
<td class="text">
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0px;margin-bottom:0pt"><span style="font-size:10pt;margin-top:0px"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">NOTE 4 &#8211; COLLABORATION AGREEMENTS:<br/>&#160;</span></span></span></p>
    <div>
      <div>
        <div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:36.55pt;vertical-align:top;font-family:'Times New Roman',Times,serif">
                  <div style="margin-left:20.55pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">a.</span></span></div>
                </td>
                <td style="width:auto;vertical-align:top;font-family:'Times New Roman',Times,serif">
                  <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In 2007, the Company granted rights to a third party for use and commercialization of a product for skin protection. Under this agreement, the Company is entitled to royalties during the years 2016 to 2024. Based on current sales, royalties are not material.</span></span></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>
        <div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:36.55pt;vertical-align:top;font-family:'Times New Roman',Times,serif">
                  <div style="margin-left:20.55pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">b.</span></span></div>
                </td>
                <td style="width:auto;vertical-align:top;font-family:'Times New Roman',Times,serif">
                  <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In 2016 through 2020, the Company entered into several collaboration agreements mainly with one Partner for the development, manufacturing and commercialization of several generic product candidates. Under the agreements, the Partner is obligated to conduct regulatory, scientific, clinical and technical activities necessary to develop the product and prepare and file ANDA, with the FDA and gain regulatory approval. The Company participates in the development of the product candidates, including participation in joint steering committees and is obligated for sourcing the active pharmaceutical ingredient (API) during the development phase.</span></span></div>
                  <div style="text-align:justify;line-height:1.25">&#160;</div>
                  <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Upon FDA approval, the Partner has exclusive rights and is required to use diligent efforts to commercialize these products in territories defined under the agreements, including all required sales, marketing and distributing activities associated with the agreements. The Company is entitled to a share of the Partner's gross profits related to the sale of the products, as such term is defined in each of the agreements.</span></span></div>
                  <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>
                  <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>These Agreement are considered to be within the scope of ASC 808, as the parties are active participants and exposed to the risks and rewards of the collaborative activity.<br/>&#160;</span></span></span></div>
                  <div style="text-align:justify;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company recognizes collaboration revenue when the related sales occur.</span></span></div>
                  <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>
                  <div style="text-align:justify;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In November 2021, the Company entered into a new agreement (the "New Agreement") with the Partner, to sell its rights in relation to ten generic collaborative agreements between the parties, including the agreements for two approved generic drug products. Under the New Agreement, the Company has retained collaboration rights to two generic programs related to four generic drug candidates. Following the signing of the New Agreement, the Company is no longer entitled to receive its share in profit as detailed above.</span></span></div>
                  <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>
                  <div style="text-align:justify;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Under the terms of the New Agreement, effective as of November 1, 2021, the Company will unconditionally receive $21,500 over 24 months, in lieu of its share in future gross profits for the two approved generic drug products and its potential gross profits for eight unapproved generic programs. The Company received $1,250 as an upfront payment and $20,250 in eight equal quarterly instalments. The New Agreement also provides that effective as of November 1, 2021, the Company will cease paying any outstanding and future operational costs related to these collaborative agreements.</span></span></div>
                </td>
              </tr>

          </table>
        </div>
        <div>
          <div style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</div>
        </div>
      </div>
    </div>
  <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI https://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140393906621600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LICENSE AGREEMENTS:<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_slgl_LicenseAgreementsAbstract', window );"><strong>License Agreements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_slgl_LicenseAgreementsTextBlock', window );">LICENSE AGREEMENTS:</a></td>
<td class="text">
    <div>
      <div>
        <p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong><span>NOTE</span></strong><span>&#160;<strong>5 </strong></span></span></span></span><span style="font-size:10pt;font-family:Times New Roman, Times, serif">&#8211;</span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><strong> </strong></span><strong><span><span style="color:black">LICENSE AGREEMENTS</span></span></strong><strong><span>:</span></strong></span></span></span></p>
        <p style="margin-top:0pt;margin-left:24px;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p>
        <p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif;margin-left:20pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:black">In June 2021, the Company entered into two exclusive license agreements with Galderma for the commercialization of Twyneo&#174; and Epsolay&#174;, in the United States. According to the agreement, the Company has an option to regain commercialization rights five years following first commercialization. In the third quarter of 2021, the Company received $7.5 million for </span></span><span><span><span style="color:black">Twyneo&#174;</span></span></span><span><span style="color:black"> and $4 million for </span></span><span><span><span style="color:black">Epsolay&#174;</span></span></span><span><span style="color:black"> of upfront payments, which are refundable if FDA approval for each respective product is not received by December 31, 2021. </span></span><span><span style="color:black">On July 27, 2021, the Company announced that the FDA approved the Company&#8217;s first proprietary drug product, Twyneo&#174;</span></span><span><span style="color:black">.</span></span></span></span></span></p>
      </div>
      <div/>
      <p style="margin:0pt">&#160;</p>
      <div>
        <div>
          <div style="text-align:justify;margin-left:20pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span>On April 14, 2022, the Company announced that Twyneo&#174; is available for purchase by consumers who obtain a prescription from their physician, See note 1. In March 2022, the Company has refunded the $4 million upfront payment to Galderma, since FDA approval for Epsolay&#174; had not been received as of December 31, 2021. On April 25, 2022, the Company announced that the FDA approved the drug product, Epsolay&#174;, which entitled the Company to $3.5 million milestone payment, according to the license agreement.<span style="font-weight:bold">&#160;</span>In May 2022, the Company has received the $3.5 million payment from Galderma. On June 2, 2022, the Company announced that Epsolay&#174; is available for purchase by consumers who obtain a prescription from their physician, See note 1.</span></span></span></div>
        </div>
      </div>
    </div>
  <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_slgl_LicenseAgreementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">slgl_LicenseAgreementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>slgl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_slgl_LicenseAgreementsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for license agreements information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">slgl_LicenseAgreementsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>slgl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140393993530224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHARE CAPITAL:<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">SHARE CAPITAL:</a></td>
<td class="text">
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0px;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">NOTE</span><span>&#160;<span style="font-weight:bold">6 &#8211; SHARE CAPITAL:</span></span></span></span></p>
    <div>
      <div>
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>
        <div style="text-align:justify;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold;margin-left:20pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Options grants</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>
        <div style="text-align:justify;margin-left:20pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">During the six months ended June 30, 2022, the Company granted 722,488 options to employees and executive officers:</span></span></div>
        <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>
        <div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:20pt">&#160;</td>
                <td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:15pt">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">i.</span></span></div>
                </td>
                <td style="width:auto;vertical-align:top;font-family:Times New Roman, Times, serif">
                  <div style="line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In March 2022, the Company granted a total of 148,907 options to several employees to purchase ordinary shares at an exercise price of $7.38 per share.</span></span><br/><br/><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The options vest over a period of 4 years; one quarter of the options vest on the first anniversary of the vesting commencement date (as described in each agreement) and the rest vest quarterly over the following three years. The options expire on the tenth anniversary of their grant date.</span></span></div>
                  <div style="line-height:1.25">&#160;</div>
                </td>
              </tr>

          </table>
        </div>
        <div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:20pt">&#160;</td>
                <td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:15pt">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">ii.</span></span></div>
                </td>
                <td style="width:auto;vertical-align:top;font-family:Times New Roman, Times, serif">
                  <div style="line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In March 2022, the Company granted a total of 271,517 options to several Executive Officers to purchase ordinary shares at an exercise price of $10 per share.</span></span><br/><br/><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The options vest over a period of 4 years; one quarter of the options vest on the first anniversary of the vesting commencement date (as described in each agreement) and the rest vest quarterly over the following three years. The options expire on the tenth anniversary of their grant date.</span></span></div>
                  <div style="text-indent:38.4pt;line-height:1.25">&#160;</div>
                </td>
              </tr>

          </table>
        </div>
        <div>
          <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

              <tr>
                <td style="width:20pt">&#160;</td>
                <td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:15pt">
                  <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">iii.</span></span></div>
                </td>
                <td style="width:auto;vertical-align:top;font-family:Times New Roman, Times, serif">
                  <div style="line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In March 2022, the board of directors approved and recommended the Company shareholders to approve a grant of 302,064 options to the Company's CEO to purchase ordinary shares at an exercise price of $10 per share. The Company's shareholders approved the grant in June 2022.</span></span></div>
                  <div style="text-indent:38.4pt;line-height:1.25">&#160;</div>
                  <div style="line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The options vest over a period of 4 years; one quarter of the options vest on the first anniversary of the vesting commencement date (as described in each agreement) and the rest vest quarterly over the following three years. The options expire on the tenth anniversary of their grant date.</span></span></div>
                </td>
              </tr>

          </table>
        </div>
      </div>
    </div>

      <div>
        <div>
          <div style="text-align:justify;margin-left:20pt;line-height:1.25;font-family:'Times New Roman',Times,serif">
            <p style="margin:0pt">&#160;</p><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The fair value of options granted in 2022 was $3,278. The underlying data used for computing the fair value of the options are as follows:</span></span>
          </div>
          <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>
          <div style="margin-left:20pt;margin-bottom:10pt">
            <table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                <tr>
                  <td style="vertical-align:top;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
                    <div style="text-align:center;text-indent:20pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;width:88%;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">
                    <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Value of one ordinary share</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7.72</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;width:88%;padding-bottom:4px;font-family:'Times New Roman',Times,serif" valign="bottom">
                    <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Dividend yield</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">0</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:top;width:88%;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">
                    <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Expected volatility</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">62.6</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:top;width:88%;font-family:'Times New Roman',Times,serif;padding-bottom:4px" valign="bottom">
                    <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Risk-free interest rate</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;padding-bottom:4px" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.5</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;padding-bottom:4px;white-space:nowrap" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:top;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">
                    <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Expected term</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:top;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">
                    <div style="text-align:center;text-indent:20pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7 years</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>

            </table>
          </div>
        </div>
      </div>

    <div/>
    <p style="margin-top:0pt;margin-left:27px;margin-bottom:0pt;text-align:left;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:left">&#160;</p>
    <p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif;margin-left:20pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><strong><span><span style="color:black">Ordinary shares</span></span></strong><br/><br/><span><span style="color:black">In July 2021, the Company entered into an ATM sales agreement with Jefferies LLC ("Jefferies"), pursuant to which the Company is entitled, at its sole discretion, to offer and sell through Jefferies, acting as sales agent, Shares having an aggregate offering price of up to $25.0&#160;million throughout the period during which the ATM facility remains in effect. The Company agreed to pay Jefferies a commission of&#160;3.0% of the gross proceeds from the sale of shares under the facility.</span></span></span></span></span></p>
    <p style="margin:0pt">&#160;</p>
    <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif;margin-left:20pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span><span><span style="color:black">From the effective date of the agreement through its expiration,&#160;41,154 shares were sold under the program for total gross proceeds of approximately $ </span></span><span><span style="color:black">0.5&#160;</span></span><span><span style="color:black">million.</span></span></span></span></span></p>
    <p style="margin:0pt">&#160;</p>
    <p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif;margin-left:20pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="color:black">In April 2022, the Company signed a new ATM agreement with Jefferies for total amount of $23 million. As of the issuance date of this report, no shares were sold under the new ATM agreement.</span></span></span></p>
  <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI https://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=SL126733271-114008<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140393906857872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTIES:<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">RELATED PARTIES:</a></td>
<td class="text">
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0px;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="font-weight:bold">NOTE 7&#8201;</span><span>&#8211;</span><span style="font-weight:bold">&#8201;RELATED PARTIES:</span></span></span></p>
    <p style="margin:0pt">&#160;</p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:0pt;margin-left:35pt;text-indent:-16pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span style="font-weight:normal">a.</span><span style="padding-left:9pt">Related parties include the controlling shareholder and companies under his control, the board of directors and the executive officers of the Company.</span></span></span></p>
    <p style="margin:0pt">&#160;</p>
    <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt;margin-left:35pt;text-indent:-16pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span>b.</span><span style="padding-left:9pt"><span>As to options granted to executive officers, see note 6.&#160;</span></span></span></span></p>
  <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -URI https://asc.fasb.org/topic&amp;trid=2122745<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140393905336832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES: (Policies)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text">
        <div>
          <div>
            <div>
              <div>
                <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                    <tr>
                      <td style="width:36pt;vertical-align:top;font-family:'Times New Roman',Times,serif">
                        <div style="margin-left:18pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">a.</span></span></div>
                      </td>
                      <td style="width:auto;vertical-align:top">
                        <div style="line-height:1.25;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">Basis of Presentation</span><br/><span>&#160;<br/>The unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") for interim financial statements. Accordingly, they do not include all of the information and notes required by U.S. GAAP for annual financial statements. In the opinion of management, these unaudited condensed consolidated financial statements reflect all adjustments, which include normal recurring adjustments, necessary for a fair statement of the Company&#8217;s consolidated financial position as of June 30, 2022, the consolidated results of operations for the six month and three month periods ended June 30, 2021 and 2022 and statements of changes in shareholders' equity and cash flows for the six month period ended June 30, 2021 and 2022.</span></span></span></div>
                      </td>
                    </tr>

                </table>
              </div>
              <div style="margin-left:36pt;line-height:1.25">&#160;</div>
              <div style="margin-left:36pt;line-height:1.25;font-family:Times New Roman, Times, serif;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The consolidated results for the six month period ended June 30, 2022 are not necessarily indicative of the results to be expected for the year ending December 31, 2022.</span></span></div>
              <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>
              <div style="margin-left:35.7pt;line-height:1.25;font-family:Times New Roman, Times, serif;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">These unaudited condensed consolidated financial statements should be read in conjunction with the audited financial statements of the Company for the year ended December 31, 2021. The comparative balance sheet at December 31, 2021 has been derived from the audited financial statements at that date but does not include all disclosures required by U.S. GAAP.</span></span></div>
            </div>
          </div>
        </div>
      <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Loss per share</a></td>
<td class="text">
        <div>
          <p style="margin-top:0pt;margin-left:48px;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif">&#160;</p>
          <div style="text-align:justify">
            <div style="margin-top:0px">
              <div>
                <div>
                  <div>
                    <table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000">

                        <tr>
                          <td style="width:36pt;vertical-align:top;font-family:'Times New Roman',Times,serif">
                            <div style="margin-left:18pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">b.</span></span></div>
                          </td>
                          <td style="width:auto;vertical-align:top">
                            <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-weight:bold">Loss per share</span><br/><span>&#160;<br/>Basic loss per share is computed on the basis of the net loss for the period divided by the weighted average number of ordinary shares outstanding during the period. Diluted loss per share is based upon the weighted average number of ordinary shares and of ordinary shares equivalents outstanding when dilutive. Ordinary share equivalents include outstanding stock options, restricted shares and warrants, which are included under the treasury stock method when dilutive.</span></span></span></div>
                          </td>
                        </tr>

                    </table>
                  </div>
                  <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>
                  <div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The calculation of diluted loss per share does not include 3,713,296 and 4,085,416 options, restricted shares and warrants for the six and three months ended June 30, 2022 and 3,437,843 and 3,463,710 options and restricted shares for the six and the three months ended June 30, 2021, respectively, because the effect would be anti-dilutive.</span></span></div>
                </div>
              </div>
            </div>
          </div>
        </div>
      <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140393901873072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>MARKETABLE SECURITIES: (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesTextBlock', window );">Schedule of Marketable Securities</a></td>
<td class="text">
      <p style="margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <div>
        <div>
          <div style="line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:20pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The following table sets forth the Company&#8217;s marketable securities for the indicated periods:</span></span></div>
          <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>
          <div style="margin-left:20pt">
            <table border="0" cellpadding="0" cellspacing="0" style="color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:left;width:90%" width="100%">

                <tr>
                  <td colspan="1" rowspan="1" style="vertical-align:top;padding-bottom:2px;font-family:Times New Roman, Times, serif" valign="bottom">&#160;</td>
                  <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                  <td colspan="2" rowspan="1" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,</span></span></div>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                  <td colspan="2" rowspan="1" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">June 30,</span></span></div>
                  </td>
                  <td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="vertical-align:top;padding-bottom:2px;font-family:Times New Roman, Times, serif" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
                    <div style="line-height:1.25">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2021</span></span></div>
                    </div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
                    <div style="line-height:1.25">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                    </div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="vertical-align:middle;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Level 2 securities:</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                  <td colspan="6" style="vertical-align:top;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="vertical-align:middle;font-family:Times New Roman, Times, serif;width:76%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">U.S government and agency bonds</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;font-family:Times New Roman, Times, serif;width:9%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">275</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;font-family:Times New Roman, Times, serif;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;font-family:Times New Roman, Times, serif;width:9%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,174</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;font-family:Times New Roman, Times, serif;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="vertical-align:middle;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:76%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Other foreign government bonds</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:9%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">-</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:9%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,507</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="vertical-align:middle;padding-bottom:2px;font-family:Times New Roman, Times, serif;width:76%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Corporate bonds*</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:2px solid rgb(0, 0, 0);font-family:Times New Roman, Times, serif;width:9%" valign="bottom">
                    <div style="line-height:1.25">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,434</span></span></div>
                    </div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:Times New Roman, Times, serif;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:2px solid rgb(0, 0, 0);font-family:Times New Roman, Times, serif;width:9%" valign="bottom">
                    <div style="line-height:1.25">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7,165</span></span></div>
                    </div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:Times New Roman, Times, serif;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="vertical-align:middle;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:76%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Total</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:9%" valign="bottom">
                    <div style="line-height:1.25">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,709</span></span></div>
                    </div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:9%" valign="bottom">
                    <div style="line-height:1.25">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">9,846</span></span></div>
                    </div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                </tr>

            </table>
          </div>
        </div>
      </div>
      <div style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif">&#160;</div>
      <p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-left:20pt;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">* <span id="FN_60f774710b70e4ca22c9cb88">Investments in Corporate bonds rated A or higher.</span></span></span></p>
    <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock', window );">Summary of Changes in Fair Value of Marketable Securities</a></td>
<td class="text">
      <p style="margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <div>
        <div>
          <div style="line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:20pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The table below sets forth a summary of the changes in the fair value of the Company&#8217;s marketable securities for the indicated periods:</span></span></div>
          <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>
          <div style="margin-left:20pt">
            <table border="0" cellpadding="0" cellspacing="0" style="color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:left;width:90%" width="100%">

                <tr>
                  <td style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                  <td colspan="6" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Marketable securities</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif" valign="bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">For&#160;the&#160;year&#160;ended</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif" valign="bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">For&#160;the&#160;Six&#160;Months</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">December&#160;31,&#160;2021</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">ended&#160;June&#160;30,&#160;2022</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:top;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:top;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:76%" valign="bottom">
                    <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance at beginning of the period</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:9%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">21,652</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:9%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,709</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:76%" valign="bottom">
                    <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Additions</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;font-family:Times New Roman, Times, serif;width:9%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">6,716</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;font-family:Times New Roman, Times, serif;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;font-family:Times New Roman, Times, serif;width:9%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">10,006</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;font-family:Times New Roman, Times, serif;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:76%" valign="bottom">
                    <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Sale or maturity</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:9%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(26,784</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;white-space:nowrap;width:1%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:9%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(1,734</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;white-space:nowrap;width:1%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:top;padding-bottom:2px;font-family:Times New Roman, Times, serif;width:76%" valign="bottom">
                    <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Changes in fair value during the period</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:2px solid rgb(0, 0, 0);font-family:Times New Roman, Times, serif;width:9%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">125</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:Times New Roman, Times, serif;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:2px solid rgb(0, 0, 0);font-family:Times New Roman, Times, serif;width:9%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">(135</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:Times New Roman, Times, serif;white-space:nowrap;width:1%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">)</span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:top;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:76%" valign="bottom">
                    <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Balance at end of the period</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:9%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">1,709</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">$</span></span></td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:9%" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">9,846</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                </tr>

            </table>
          </div>
        </div>
      </div>
    <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock', window );">Schedule of Debt Securities</a></td>
<td class="text">
      <p style="margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <div>
        <div>
          <div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:20pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As of June 30, 2022, the Company&#8217;s debt securities had the following maturity dates:</span></span></div>
          <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>
          <div style="margin-left:20pt">
            <table border="0" cellpadding="0" cellspacing="0" style="color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:left;width:90%" width="100%">

                <tr>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
                    <div style="line-height:1.25">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Market value</span></span></div>
                    </div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif" valign="bottom">
                    <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">June 30,</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
                    <div style="line-height:1.25">
                      <div style="text-align:center;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                    </div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="vertical-align:middle;padding-bottom:2px;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:88%" valign="bottom">
                    <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Due within one year</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:9%" valign="bottom">
                    <div style="line-height:1.25">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">9,041</span></span></div>
                    </div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td colspan="1" style="vertical-align:middle;padding-bottom:4px;font-family:Times New Roman, Times, serif;width:88%" valign="bottom">
                    <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Between 1-2 years</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:4px;font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0);font-family:Times New Roman, Times, serif;width:1%" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:4px double rgb(0, 0, 0);font-family:Times New Roman, Times, serif;width:9%" valign="bottom">
                    <div style="line-height:1.25">
                      <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">805</span></span></div>
                    </div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:4px;font-family:Times New Roman, Times, serif;white-space:nowrap;width:1%" valign="bottom">&#160;</td>
                </tr>

            </table>
          </div>
        </div>
      </div>
    <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of marketable securities. This may consist of investments in certain debt and equity securities, short-term investments and other assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of derivative assets at fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140393906857872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHARE CAPITAL: (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Assumptions Used to Estimate Fair Value</a></td>
<td class="text">
      <div>
        <div>
          <div style="text-align:justify;margin-left:20pt;line-height:1.25;font-family:'Times New Roman',Times,serif">
            <p style="margin:0pt">&#160;</p><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The fair value of options granted in 2022 was $3,278. The underlying data used for computing the fair value of the options are as follows:</span></span>
          </div>
          <div style="line-height:1.25;font-family:'Times New Roman',Times,serif">&#160;</div>
          <div style="margin-left:20pt;margin-bottom:10pt">
            <table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left">

                <tr>
                  <td style="vertical-align:top;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
                    <div style="text-align:center;text-indent:20pt;line-height:1.25;font-weight:bold"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2022</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;width:88%;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">
                    <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Value of one ordinary share</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">$</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7.72</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>
                <tr>
                  <td style="vertical-align:top;width:88%;padding-bottom:4px;font-family:'Times New Roman',Times,serif" valign="bottom">
                    <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Dividend yield</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">0</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:top;width:88%;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">
                    <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Expected volatility</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">62.6</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:top;width:88%;font-family:'Times New Roman',Times,serif;padding-bottom:4px" valign="bottom">
                    <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Risk-free interest rate</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;padding-bottom:4px" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">&#160;</td>
                  <td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif;border-bottom:4px double rgb(0, 0, 0)" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">2.5</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;padding-bottom:4px;white-space:nowrap" valign="bottom">
                    <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">%</span></span></div>
                  </td>
                </tr>
                <tr>
                  <td style="vertical-align:top;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">
                    <div style="text-align:justify;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Expected term</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">&#160;</td>
                  <td colspan="2" style="vertical-align:top;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom">
                    <div style="text-align:center;text-indent:20pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">7 years</span></span></div>
                  </td>
                  <td colspan="1" style="vertical-align:bottom;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom">&#160;</td>
                </tr>

            </table>
          </div>
        </div>
      </div>
    <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140393905320448">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>NATURE OF OPERATIONS (Narrative) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="nump">$ 183,873<span></span>
</td>
<td class="nump">$ 178,142<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140393900275072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES: (Narrative) (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive shares</a></td>
<td class="nump">4,085,416<span></span>
</td>
<td class="nump">3,463,710<span></span>
</td>
<td class="nump">3,713,296<span></span>
</td>
<td class="nump">3,437,843<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140393902774768">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>MARKETABLE SECURITIES: (Schedule of Company's Marketable Securities) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesAbstract', window );"><strong>Level 2 securities:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Marketable securities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 9,846<span></span>
</td>
<td class="nump">$ 1,709<span></span>
</td>
<td class="nump">$ 21,652<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember', window );">U.S government and agency bonds [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesAbstract', window );"><strong>Level 2 securities:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Marketable securities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,174<span></span>
</td>
<td class="nump">275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=slgl_OtherForeignGovernmentBondsMember', window );">Other foreign government bonds [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesAbstract', window );"><strong>Level 2 securities:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Marketable securities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,507<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_AllOtherCorporateBondsMember', window );">Corporate bonds [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesAbstract', window );"><strong>Level 2 securities:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Marketable securities</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 7,165<span></span>
</td>
<td class="nump">$ 1,434<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Investments in Corporate bonds rated A or higher.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=slgl_OtherForeignGovernmentBondsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=slgl_OtherForeignGovernmentBondsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_AllOtherCorporateBondsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_AllOtherCorporateBondsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140393903105744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>MARKETABLE SECURITIES: (Schedule of Changes in Fair Value of Company's Marketable Securities) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Balance at beginning of the period</a></td>
<td class="nump">$ 1,709<span></span>
</td>
<td class="nump">$ 21,652<span></span>
</td>
<td class="nump">$ 21,652<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireMarketableSecurities', window );">Additions</a></td>
<td class="nump">10,006<span></span>
</td>
<td class="nump">4,065<span></span>
</td>
<td class="nump">6,716<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities', window );">Sale or maturity</a></td>
<td class="num">(1,734)<span></span>
</td>
<td class="num">(18,946)<span></span>
</td>
<td class="num">(26,784)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_slgl_ChangesInFairValueOfMarketableSecurities', window );">Change in fair value during the period</a></td>
<td class="num">(135)<span></span>
</td>
<td class="nump">$ 59<span></span>
</td>
<td class="nump">125<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Balance at end of the period</a></td>
<td class="nump">$ 9,846<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,709<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_slgl_ChangesInFairValueOfMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash inflow from changes in fair value of marketable securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">slgl_ChangesInFairValueOfMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>slgl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for purchase of marketable security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140393901764896">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>MARKETABLE SECURITIES: (Schedule of Company's debt marketable securities) (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue', window );">Due within one year</a></td>
<td class="nump">$ 9,041<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_slgl_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue', window );">Between 1-2 years</a></td>
<td class="nump">$ 805<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_slgl_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), maturing in two fiscal year following latest fiscal year. Excludes interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">slgl_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>slgl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980459&amp;loc=SL120269850-112803<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140393901763552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COLLABORATION AGREEMENTS: (Narrative) (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Nov. 01, 2021 </div>
<div>USD ($) </div>
<div>Agreement </div>
<div>Candidate </div>
<div>Instalment </div>
<div>Program</div>
</th>
<th class="th"><div>Dec. 31, 2007</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_slgl_NumberOfGenericCollaborativeAgreementsToSellRights', window );">Number of generic collaborative agreements to sell rights | Agreement</a></td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_slgl_NumberOfGenericProgramsRetainedForCollaborationRights', window );">Number of generic programs retained for collaboration rights | Program</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_slgl_NumberOfGenericDrugCandidates', window );">Number of generic drug candidates | Candidate</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_slgl_ExpectedRevenueReceivableOverTwentyFourMonths', window );">Expected revenue receivable over twenty four months | $</a></td>
<td class="nump">$ 21,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_slgl_NumberOfApprovedGenericDrugProducts', window );">Number of approved generic drug products | Program</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_slgl_NumberOfUnapprovedGenericPrograms', window );">Number of unapproved generic programs | Program</a></td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_slgl_UpfrontPaymentReceived', window );">Upfront payment received | $</a></td>
<td class="nump">$ 1,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_slgl_PaymentReceivableInInstalments', window );">Payment receivable in instalments | $</a></td>
<td class="nump">$ 20,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_slgl_NumberOfEqualQuarterlyInstalments', window );">Number of equal quarterly instalments | Instalment</a></td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_slgl_RoyaltiesMaturity', window );">Royalties maturity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2016<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_slgl_RoyaltiesMaturity', window );">Royalties maturity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2024<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_slgl_ExpectedRevenueReceivableOverTwentyFourMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the value of expected revenue receivable over twenty four months.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">slgl_ExpectedRevenueReceivableOverTwentyFourMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>slgl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_slgl_NumberOfApprovedGenericDrugProducts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the number of approved generic drug products.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">slgl_NumberOfApprovedGenericDrugProducts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>slgl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_slgl_NumberOfEqualQuarterlyInstalments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the number of equal quarterly instalments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">slgl_NumberOfEqualQuarterlyInstalments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>slgl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_slgl_NumberOfGenericCollaborativeAgreementsToSellRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of generic collaborative agreements to sell the rights.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">slgl_NumberOfGenericCollaborativeAgreementsToSellRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>slgl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_slgl_NumberOfGenericDrugCandidates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of generic drug candidates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">slgl_NumberOfGenericDrugCandidates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>slgl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_slgl_NumberOfGenericProgramsRetainedForCollaborationRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of generic programs retained for collaboration rights.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">slgl_NumberOfGenericProgramsRetainedForCollaborationRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>slgl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_slgl_NumberOfUnapprovedGenericPrograms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the number of unapproved generic programs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">slgl_NumberOfUnapprovedGenericPrograms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>slgl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_slgl_PaymentReceivableInInstalments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the value of payment receivable in instalments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">slgl_PaymentReceivableInInstalments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>slgl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_slgl_RoyaltiesMaturity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Royalties Maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">slgl_RoyaltiesMaturity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>slgl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_slgl_UpfrontPaymentReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the value of upfront payment received.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">slgl_UpfrontPaymentReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>slgl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140393902734416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LICENSE AGREEMENTS: (Narrative) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 25, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>May 31, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_slgl_RefundUpFrontPayment', window );">Refunded Upfront Payment To Galderma</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=slgl_LicenseAgreementsWithGaldermaMember', window );">License Agreements With Galderma [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_slgl_RefundableUpfrontPayment', window );">Refundable upfront payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=slgl_TwyneoMember', window );">Twyneo [Member] | License Agreements With Galderma [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_slgl_RefundableUpfrontPayment', window );">Refundable upfront payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=slgl_EpsolayMember', window );">Epsolay [Member] | License Agreements With Galderma [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_slgl_RefundableUpfrontPayment', window );">Refundable upfront payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_slgl_SalesMilestonePayments', window );">Sales milestone payments</a></td>
<td class="nump">$ 3.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_slgl_RefundUpFrontPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of refund upfront payment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">slgl_RefundUpFrontPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>slgl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_slgl_RefundableUpfrontPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represent the amount of refundable upfront payment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">slgl_RefundableUpfrontPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>slgl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_slgl_SalesMilestonePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represent of amount the sales milestone payments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">slgl_SalesMilestonePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>slgl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=slgl_LicenseAgreementsWithGaldermaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=slgl_LicenseAgreementsWithGaldermaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=slgl_TwyneoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=slgl_TwyneoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=slgl_EpsolayMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=slgl_EpsolayMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140393902850176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHARE CAPITAL: (Narrative) (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="3">1 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Jul. 31, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1', window );">Fair value of options granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,278<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=slgl_EmployeesAndExecutiveOfficersMember', window );">Employees And Executive Officers [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Option grants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">722,488<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=slgl_EmployeesMember', window );">Employees [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Option grants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">148,907<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.38<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Option vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_ExecutiveOfficerMember', window );">Executive Officers [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Option grants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">271,517<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Option vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember', window );">Chief Executive Officer [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Option grants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">302,064<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Option vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=slgl_JefferiesLlcMember', window );">Jefferies Llc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_slgl_AggregateOfferingPrice', window );">Aggregate offering price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_slgl_PercentageOfGrossProceedsFromSaleOfShares', window );">Percentage of gross proceeds from sale of shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Issuance of share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41,154<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Net proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Available balance</a></td>
<td class="nump">$ 23,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_slgl_AggregateOfferingPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of aggregate offering price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">slgl_AggregateOfferingPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>slgl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_slgl_PercentageOfGrossProceedsFromSaleOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the of Percentage of gross proceeds from sale of shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">slgl_PercentageOfGrossProceedsFromSaleOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>slgl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=slgl_EmployeesAndExecutiveOfficersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=slgl_EmployeesAndExecutiveOfficersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=slgl_EmployeesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=slgl_EmployeesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_ExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_ExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=slgl_JefferiesLlcMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=slgl_JefferiesLlcMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140393903129088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHARE CAPITAL: (Schedule of Assumptions Used to Estimate Fair Value) (Details)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2022 </div>
<div>$ / shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Value of one ordinary share</a></td>
<td class="nump">$ 7.72<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">62.60%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">2.50%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term</a></td>
<td class="text">7 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>zk2228238_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:slgl="http://www.sol-gel.co/20220630"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="slgl-20220630.xsd" xlink:type="simple"/>
    <context id="C_20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001684693</identifier>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="C_20220101to20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001684693</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="C_20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001684693</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20210101to20210630_srtProductOrServiceAxis_slglCollabrationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001684693</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">slgl:CollabrationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="C_20220101to20220630_srtProductOrServiceAxis_slglCollabrationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001684693</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">slgl:CollabrationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="C_20210401to20210630_srtProductOrServiceAxis_slglCollabrationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001684693</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">slgl:CollabrationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="C_20220401to20220630_srtProductOrServiceAxis_slglCollabrationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001684693</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">slgl:CollabrationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="C_20210101to20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001684693</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="C_20210401to20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001684693</identifier>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="C_20220401to20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001684693</identifier>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="C_20220401to20220630_srtProductOrServiceAxis_usgaapLicenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001684693</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="C_20210401to20210630_srtProductOrServiceAxis_usgaapLicenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001684693</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="C_20220101to20220630_srtProductOrServiceAxis_usgaapLicenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001684693</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="C_20210101to20210630_srtProductOrServiceAxis_usgaapLicenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001684693</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="C_20070101to20071231_srtRangeAxis_srtMinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001684693</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2007-01-01</startDate>
            <endDate>2007-12-31</endDate>
        </period>
    </context>
    <context id="C_20070101to20071231_srtRangeAxis_srtMaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001684693</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2007-01-01</startDate>
            <endDate>2007-12-31</endDate>
        </period>
    </context>
    <context id="C_20211101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001684693</identifier>
        </entity>
        <period>
            <instant>2021-11-01</instant>
        </period>
    </context>
    <context id="C_20211101to20211101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001684693</identifier>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2021-11-01</endDate>
        </period>
    </context>
    <context id="C_20220401to20220425_srtProductOrServiceAxis_slglEpsolayMember_usgaapTypeOfArrangementAxis_slglLicenseAgreementsWithGaldermaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001684693</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">slgl:EpsolayMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">slgl:LicenseAgreementsWithGaldermaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-04-25</endDate>
        </period>
    </context>
    <context id="C_20220531_usgaapTypeOfArrangementAxis_slglLicenseAgreementsWithGaldermaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001684693</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">slgl:LicenseAgreementsWithGaldermaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-31</instant>
        </period>
    </context>
    <context id="C_20210930_srtProductOrServiceAxis_slglTwyneoMember_usgaapTypeOfArrangementAxis_slglLicenseAgreementsWithGaldermaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001684693</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">slgl:TwyneoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">slgl:LicenseAgreementsWithGaldermaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="C_20210930_srtProductOrServiceAxis_slglEpsolayMember_usgaapTypeOfArrangementAxis_slglLicenseAgreementsWithGaldermaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001684693</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">slgl:EpsolayMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">slgl:LicenseAgreementsWithGaldermaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="C_20220301to20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001684693</identifier>
        </entity>
        <period>
            <startDate>2022-03-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="C_20210101to20210630_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001684693</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="C_20210101to20210630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001684693</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="C_20210101to20210630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001684693</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="C_20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001684693</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="C_20210630_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001684693</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="C_20210630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001684693</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="C_20210630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001684693</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="C_20220101to20220630_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001684693</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="C_20220101to20220630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001684693</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="C_20220101to20220630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001684693</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="C_20220630_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001684693</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="C_20220630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001684693</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="C_20220630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001684693</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="C_20211231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001684693</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001684693</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001684693</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20210401to20210630_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001684693</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="C_20210401to20210630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001684693</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="C_20210401to20210630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001684693</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="C_20220401to20220630_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001684693</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="C_20220401to20220630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001684693</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="C_20220401to20220630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001684693</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="C_20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001684693</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="C_20220331_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001684693</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="C_20220331_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001684693</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="C_20220331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001684693</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="C_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001684693</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_20201231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001684693</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_20201231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001684693</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_20201231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001684693</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001684693</identifier>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="C_20210331_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001684693</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="C_20210331_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001684693</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="C_20210331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001684693</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="C_20220101to20220630_srtTitleOfIndividualAxis_slglEmployeesAndExecutiveOfficersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001684693</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">slgl:EmployeesAndExecutiveOfficersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="C_20220301to20220331_srtTitleOfIndividualAxis_slglEmployeesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001684693</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">slgl:EmployeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="C_20220331_srtTitleOfIndividualAxis_slglEmployeesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001684693</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">slgl:EmployeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="C_20220301to20220331_srtTitleOfIndividualAxis_srtExecutiveOfficerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001684693</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ExecutiveOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="C_20220331_srtTitleOfIndividualAxis_srtExecutiveOfficerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001684693</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ExecutiveOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="C_20220301to20220331_srtTitleOfIndividualAxis_srtChiefExecutiveOfficerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001684693</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="C_20220331_srtTitleOfIndividualAxis_srtChiefExecutiveOfficerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001684693</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="C_20210701to20210731_usgaapRelatedPartyTransactionsByRelatedPartyAxis_slglJefferiesLlcMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001684693</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">slgl:JefferiesLlcMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-07-31</endDate>
        </period>
    </context>
    <context id="C_20220401to20220430_usgaapRelatedPartyTransactionsByRelatedPartyAxis_slglJefferiesLlcMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001684693</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">slgl:JefferiesLlcMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="C_20211231_usgaapInvestmentTypeAxis_usgaapUSGovernmentCorporationsAndAgenciesSecuritiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001684693</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20220630_usgaapInvestmentTypeAxis_usgaapUSGovernmentCorporationsAndAgenciesSecuritiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001684693</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="C_20211231_usgaapInvestmentTypeAxis_slglOtherForeignGovernmentBondsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001684693</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">slgl:OtherForeignGovernmentBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20211231_usgaapInvestmentTypeAxis_usgaapAllOtherCorporateBondsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001684693</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:AllOtherCorporateBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20220630_usgaapInvestmentTypeAxis_usgaapAllOtherCorporateBondsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001684693</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:AllOtherCorporateBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="C_20210101to20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001684693</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_20220630_usgaapInvestmentTypeAxis_slglOtherForeignGovernmentBondsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001684693</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">slgl:OtherForeignGovernmentBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <unit id="Agreement">
        <measure>slgl:Agreement</measure>
    </unit>
    <unit id="Candidate">
        <measure>slgl:Candidate</measure>
    </unit>
    <unit id="ILSPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:ILS</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Instalment">
        <measure>slgl:Instalment</measure>
    </unit>
    <unit id="Program">
        <measure>slgl:Program</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="pure">
        <measure>pure</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <dei:EntityCentralIndexKey contextRef="C_20220101to20220630" id="FFact_322">0001684693</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate contextRef="C_20220101to20220630" id="FFact_323">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:AmendmentFlag contextRef="C_20220101to20220630" id="FFact_324">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="C_20220101to20220630" id="FFact_325">6-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="C_20220101to20220630" id="FFact_326">2022-06-30</dei:DocumentPeriodEndDate>
    <dei:DocumentFiscalPeriodFocus
      contextRef="C_20220101to20220630"
      id="Fdei_DocumentFiscalPeriodFocus20220718125411444">Q2</dei:DocumentFiscalPeriodFocus>
    <dei:DocumentType contextRef="C_20220101to20220630" id="F20220718063032973_0">6-K</dei:DocumentType>
    <dei:EntityRegistrantName contextRef="C_20220101to20220630" id="F20220718063032974_2">SOL-GEL TECHNOLOGIES LTD.</dei:EntityRegistrantName>
    <dei:DocumentFiscalYearFocus contextRef="C_20220101to20220630" id="F20220718063032973_1">2022</dei:DocumentFiscalYearFocus>
    <dei:EntityAddressAddressLine1 contextRef="C_20220101to20220630" id="F20220718063032974_3">7 Golda Meir Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="C_20220101to20220630" id="F20220718063032974_4">Ness Ziona</dei:EntityAddressCityOrTown>
    <dei:EntityAddressPostalZipCode contextRef="C_20220101to20220630" id="F20220718063032975_5">7403650</dei:EntityAddressPostalZipCode>
    <dei:EntityAddressCountry contextRef="C_20220101to20220630" id="F20220718063032975_6">IL</dei:EntityAddressCountry>
    <us-gaap:ProfitLoss
      contextRef="C_20220101to20220630_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      id="Fxbrl_20220802203243985_Fact_126"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="C_20210101to20210630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      id="Fxbrl_20220802203330582"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="C_20210101to20210630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      id="Fxbrl_20220802203340661"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_20210101to20210630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      id="Fxbrl_20220802203405739"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_20220101to20220630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      id="Fxbrl_20220802203425221"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_20220401to20220630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      id="Fxbrl_20220802203547323"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_20210401to20210630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      id="Fxbrl_20220802203910105"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_20211231"
      decimals="-3"
      id="FFact_1"
      unitRef="usd">20085000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_20220630"
      decimals="-3"
      id="FFact_2"
      unitRef="usd">5765000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:DepositsAssetsCurrent
      contextRef="C_20211231"
      decimals="-3"
      id="FFact_3"
      unitRef="usd">21448000</us-gaap:DepositsAssetsCurrent>
    <us-gaap:DepositsAssetsCurrent
      contextRef="C_20220630"
      decimals="-3"
      id="FFact_4"
      unitRef="usd">21000000</us-gaap:DepositsAssetsCurrent>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="C_20211231"
      decimals="-3"
      id="FFact_5"
      unitRef="usd">1709000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="C_20220630"
      decimals="-3"
      id="FFact_6"
      unitRef="usd">9846000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:ReceivablesNetCurrent
      contextRef="C_20211231"
      decimals="-3"
      id="FFact_7"
      unitRef="usd">13065000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:ReceivablesNetCurrent
      contextRef="C_20220630"
      decimals="-3"
      id="FFact_8"
      unitRef="usd">10176000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_20211231"
      decimals="-3"
      id="FFact_9"
      unitRef="usd">800000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_20220630"
      decimals="-3"
      id="FFact_10"
      unitRef="usd">1691000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="C_20211231"
      decimals="-3"
      id="FFact_11"
      unitRef="usd">57107000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="C_20220630"
      decimals="-3"
      id="FFact_12"
      unitRef="usd">48478000</us-gaap:AssetsCurrent>
    <us-gaap:AccountsReceivableNetNoncurrent
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20220721161311389"
      unitRef="usd">7402000</us-gaap:AccountsReceivableNetNoncurrent>
    <us-gaap:AccountsReceivableNetNoncurrent
      contextRef="C_20220630"
      decimals="-3"
      id="Fxbrl_20220721161335019"
      unitRef="usd">2499000</us-gaap:AccountsReceivableNetNoncurrent>
    <us-gaap:RestrictedCashAndInvestmentsNoncurrent
      contextRef="C_20211231"
      decimals="-3"
      id="FFact_13"
      unitRef="usd">1298000</us-gaap:RestrictedCashAndInvestmentsNoncurrent>
    <us-gaap:RestrictedCashAndInvestmentsNoncurrent
      contextRef="C_20220630"
      decimals="-3"
      id="FFact_14"
      unitRef="usd">1289000</us-gaap:RestrictedCashAndInvestmentsNoncurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_20211231"
      decimals="-3"
      id="FFact_15"
      unitRef="usd">1051000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_20220630"
      decimals="-3"
      id="FFact_16"
      unitRef="usd">826000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_20211231"
      decimals="-3"
      id="FFact_17"
      unitRef="usd">1501000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_20220630"
      decimals="-3"
      id="FFact_18"
      unitRef="usd">1153000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="C_20211231"
      decimals="-3"
      id="FFact_19"
      unitRef="usd">830000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="C_20220630"
      decimals="-3"
      id="FFact_20"
      unitRef="usd">738000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:AssetsNoncurrent
      contextRef="C_20211231"
      decimals="-3"
      id="FFact_21"
      unitRef="usd">12082000</us-gaap:AssetsNoncurrent>
    <us-gaap:AssetsNoncurrent
      contextRef="C_20220630"
      decimals="-3"
      id="FFact_22"
      unitRef="usd">6505000</us-gaap:AssetsNoncurrent>
    <us-gaap:Assets
      contextRef="C_20211231"
      decimals="-3"
      id="FFact_23"
      unitRef="usd">69189000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="C_20220630"
      decimals="-3"
      id="FFact_24"
      unitRef="usd">54983000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="C_20211231"
      decimals="-3"
      id="FFact_25"
      unitRef="usd">766000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="C_20220630"
      decimals="-3"
      id="FFact_26"
      unitRef="usd">860000</us-gaap:AccountsPayableCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="C_20211231"
      decimals="-3"
      id="FFact_27"
      unitRef="usd">10145000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="C_20220630"
      decimals="-3"
      id="FFact_28"
      unitRef="usd">1664000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="C_20211231"
      decimals="-3"
      id="FFact_29"
      unitRef="usd">781000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="C_20220630"
      decimals="-3"
      id="FFact_30"
      unitRef="usd">701000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="C_20211231"
      decimals="-3"
      id="FFact_31"
      unitRef="usd">11692000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="C_20220630"
      decimals="-3"
      id="FFact_32"
      unitRef="usd">3225000</us-gaap:LiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="C_20211231"
      decimals="-3"
      id="FFact_33"
      unitRef="usd">810000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="C_20220630"
      decimals="-3"
      id="FFact_34"
      unitRef="usd">369000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="C_20211231"
      decimals="-3"
      id="FFact_35"
      unitRef="usd">1093000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="C_20220630"
      decimals="-3"
      id="FFact_36"
      unitRef="usd">1038000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="C_20211231"
      decimals="-3"
      id="FFact_37"
      unitRef="usd">1903000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="C_20220630"
      decimals="-3"
      id="FFact_38"
      unitRef="usd">1407000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="C_20211231"
      decimals="-3"
      id="FFact_39"
      unitRef="usd">13595000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="C_20220630"
      decimals="-3"
      id="FFact_40"
      unitRef="usd">4632000</us-gaap:Liabilities>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_20211231"
      decimals="INF"
      id="Fxbrl_20220721225320013"
      unitRef="ILSPerShare">0.1</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_20220630"
      decimals="INF"
      id="FFact_42"
      unitRef="ILSPerShare">0.1</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_20211231"
      decimals="INF"
      id="Fxbrl_20220721225341350"
      unitRef="Shares">50000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_20220630"
      decimals="INF"
      id="FFact_44"
      unitRef="Shares">50000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_20211231"
      decimals="INF"
      id="Fxbrl_20220721225424766"
      unitRef="Shares">23126804</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_20211231"
      decimals="INF"
      id="FFact_46"
      unitRef="Shares">23126804</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_20220630"
      decimals="INF"
      id="Fxbrl_20220721225441982"
      unitRef="Shares">23129469</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_20220630"
      decimals="INF"
      id="FFact_48"
      unitRef="Shares">23129469</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="C_20211231"
      decimals="-3"
      id="FFact_49"
      unitRef="usd">638000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="C_20220630"
      decimals="-3"
      id="FFact_50"
      unitRef="usd">638000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="C_20211231"
      decimals="-3"
      id="FFact_51"
      unitRef="usd">233098000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="C_20220630"
      decimals="-3"
      id="FFact_52"
      unitRef="usd">233586000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="C_20211231"
      decimals="-3"
      id="FFact_53"
      unitRef="usd">-178142000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="C_20220630"
      decimals="-3"
      id="FFact_54"
      unitRef="usd">-183873000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="C_20211231"
      decimals="-3"
      id="FFact_55"
      unitRef="usd">55594000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20220630"
      decimals="-3"
      id="FFact_56"
      unitRef="usd">50351000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="C_20211231"
      decimals="-3"
      id="FFact_57"
      unitRef="usd">69189000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="C_20220630"
      decimals="-3"
      id="FFact_58"
      unitRef="usd">54983000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:Revenues
      contextRef="C_20210101to20210630_srtProductOrServiceAxis_slglCollabrationsMember"
      decimals="-3"
      id="FFact_59"
      unitRef="usd">1629000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="C_20220101to20220630_srtProductOrServiceAxis_slglCollabrationsMember"
      decimals="-3"
      id="FFact_60"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="C_20210401to20210630_srtProductOrServiceAxis_slglCollabrationsMember"
      decimals="-3"
      id="FFact_61"
      unitRef="usd">928000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="C_20220401to20220630_srtProductOrServiceAxis_slglCollabrationsMember"
      decimals="-3"
      id="FFact_62"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="C_20210101to20210630_srtProductOrServiceAxis_usgaapLicenseMember"
      decimals="-3"
      id="Fxbrl_20220721161146624"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="C_20220101to20220630_srtProductOrServiceAxis_usgaapLicenseMember"
      decimals="-3"
      id="Fxbrl_20220721161139299"
      unitRef="usd">3521000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="C_20210401to20210630_srtProductOrServiceAxis_usgaapLicenseMember"
      decimals="-3"
      id="Fxbrl_20220721161133008"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="C_20220401to20220630_srtProductOrServiceAxis_usgaapLicenseMember"
      decimals="-3"
      id="Fxbrl_20220721161123723"
      unitRef="usd">3518000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="C_20210101to20210630"
      decimals="-3"
      id="Fxbrl_20220721161033355"
      unitRef="usd">1629000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="Fxbrl_20220721161043873"
      unitRef="usd">3521000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="C_20210401to20210630"
      decimals="-3"
      id="Fxbrl_20220721161051230"
      unitRef="usd">928000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="C_20220401to20220630"
      decimals="-3"
      id="Fxbrl_20220721161057037"
      unitRef="usd">3518000</us-gaap:Revenues>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_20210101to20210630"
      decimals="-3"
      id="FFact_63"
      unitRef="usd">9399000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="FFact_64"
      unitRef="usd">6422000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_20210401to20210630"
      decimals="-3"
      id="FFact_65"
      unitRef="usd">6933000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_20220401to20220630"
      decimals="-3"
      id="FFact_66"
      unitRef="usd">2380000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_20210101to20210630"
      decimals="-3"
      id="FFact_67"
      unitRef="usd">4496000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="FFact_68"
      unitRef="usd">3512000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_20210401to20210630"
      decimals="-3"
      id="FFact_69"
      unitRef="usd">2037000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_20220401to20220630"
      decimals="-3"
      id="FFact_70"
      unitRef="usd">1601000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_20210101to20210630"
      decimals="-3"
      id="FFact_71"
      unitRef="usd">-12266000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="FFact_72"
      unitRef="usd">-6413000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_20210401to20210630"
      decimals="-3"
      id="FFact_73"
      unitRef="usd">-8042000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_20220401to20220630"
      decimals="-3"
      id="FFact_74"
      unitRef="usd">-463000</us-gaap:OperatingIncomeLoss>
    <slgl:FinancialIncomeExpensesNet
      contextRef="C_20210101to20210630"
      decimals="-3"
      id="FFact_75"
      unitRef="usd">170000</slgl:FinancialIncomeExpensesNet>
    <slgl:FinancialIncomeExpensesNet
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="FFact_76"
      unitRef="usd">682000</slgl:FinancialIncomeExpensesNet>
    <slgl:FinancialIncomeExpensesNet
      contextRef="C_20210401to20210630"
      decimals="-3"
      id="FFact_77"
      unitRef="usd">9000</slgl:FinancialIncomeExpensesNet>
    <slgl:FinancialIncomeExpensesNet
      contextRef="C_20220401to20220630"
      decimals="-3"
      id="FFact_78"
      unitRef="usd">329000</slgl:FinancialIncomeExpensesNet>
    <us-gaap:NetIncomeLoss
      contextRef="C_20210101to20210630"
      decimals="-3"
      id="FFact_79"
      unitRef="usd">-12096000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="FFact_80"
      unitRef="usd">-5731000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20210401to20210630"
      decimals="-3"
      id="FFact_81"
      unitRef="usd">-8033000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_20220401to20220630"
      decimals="-3"
      id="FFact_82"
      unitRef="usd">-134000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_20210101to20210630"
      decimals="INF"
      id="Fxbrl_20220721234223951"
      unitRef="USDPShares">0.53</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_20210101to20210630"
      decimals="INF"
      id="FFact_83"
      unitRef="USDPShares">0.53</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_20220101to20220630"
      decimals="INF"
      id="Fxbrl_20220721234245557"
      unitRef="USDPShares">0.25</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_20220101to20220630"
      decimals="INF"
      id="FFact_84"
      unitRef="USDPShares">0.25</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_20210401to20210630"
      decimals="INF"
      id="Fxbrl_20220721234258686"
      unitRef="USDPShares">0.35</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_20210401to20210630"
      decimals="INF"
      id="FFact_85"
      unitRef="USDPShares">0.35</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_20220401to20220630"
      decimals="INF"
      id="Fxbrl_20220721234313495"
      unitRef="USDPShares">0.01</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_20220401to20220630"
      decimals="INF"
      id="FFact_86"
      unitRef="USDPShares">0.01</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_20210101to20210630"
      decimals="INF"
      id="Fxbrl_20220721234332813"
      unitRef="Shares">23016104</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_20210101to20210630"
      decimals="INF"
      id="FFact_87"
      unitRef="Shares">23016104</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_20220101to20220630"
      decimals="INF"
      id="Fxbrl_20220721234354066"
      unitRef="Shares">23127958</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_20220101to20220630"
      decimals="INF"
      id="FFact_88"
      unitRef="Shares">23127958</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_20210401to20210630"
      decimals="INF"
      id="Fxbrl_20220721234405451"
      unitRef="Shares">23028508</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_20210401to20210630"
      decimals="INF"
      id="FFact_89"
      unitRef="Shares">23028508</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_20220401to20220630"
      decimals="INF"
      id="Fxbrl_20220721234419394"
      unitRef="Shares">23128429</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_20220401to20220630"
      decimals="INF"
      id="FFact_90"
      unitRef="Shares">23128429</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_20201231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20220802203723330_Fact_91"
      unitRef="Shares">23000782</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_20201231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20220802203723330_Fact_92"
      unitRef="usd">635000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20201231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20220802203723330_Fact_93"
      unitRef="usd">231577000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20201231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220802203723330_Fact_94"
      unitRef="usd">-181363000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20201231"
      decimals="-3"
      id="Fxbrl_20220802203723330_Fact_95"
      unitRef="usd">50849000</us-gaap:StockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="C_20210101to20210630_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220802203243942_Fact_96"
      unitRef="usd">-12096000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_20210101to20210630"
      decimals="-3"
      id="Fxbrl_20220802203243942_Fact_97"
      unitRef="usd">-12096000</us-gaap:ProfitLoss>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="C_20210101to20210630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20220802203243945_Fact_106"
      unitRef="Shares">15333</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="C_20210101to20210630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20220802203243947_Fact_110"
      unitRef="Shares">13836</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_20210101to20210630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20220802203243947_Fact_112"
      unitRef="usd">83000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_20210101to20210630"
      decimals="-3"
      id="Fxbrl_20220802203243947_Fact_113"
      unitRef="usd">83000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:ShareBasedCompensation
      contextRef="C_20210101to20210630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20220802203243956_Fact_114"
      unitRef="usd">411000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="C_20210101to20210630"
      decimals="-3"
      id="Fxbrl_20220802203243956_Fact_115"
      unitRef="usd">411000</us-gaap:ShareBasedCompensation>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_20210630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20220802203243958_Fact_116"
      unitRef="Shares">23029951</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_20210630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20220802203243958_Fact_117"
      unitRef="usd">635000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20210630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20220802203243958_Fact_118"
      unitRef="usd">232071000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20210630_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220802203243958_Fact_119"
      unitRef="usd">-193459000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20210630"
      decimals="-3"
      id="Fxbrl_20220802203243958_Fact_120"
      unitRef="usd">39247000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20220802203312766_Fact_121"
      unitRef="Shares">23126804</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_20211231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20220802203312766_Fact_122"
      unitRef="usd">638000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20211231_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20220802203312766_Fact_123"
      unitRef="usd">233098000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20211231_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220802203312766_Fact_124"
      unitRef="usd">-178142000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20211231"
      decimals="-3"
      id="Fxbrl_20220802203312766_Fact_125"
      unitRef="usd">55594000</us-gaap:StockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="Fxbrl_20220802203243985_Fact_127"
      unitRef="usd">-5731000</us-gaap:ProfitLoss>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="C_20220101to20220630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20220802203243988_Fact_131"
      unitRef="Shares">2665</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_20220101to20220630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20220802203243988_Fact_133"
      unitRef="usd">15000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="Fxbrl_20220802203243988_Fact_134"
      unitRef="usd">15000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:ShareBasedCompensation
      contextRef="C_20220101to20220630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20220802203243992_Fact_135"
      unitRef="usd">473000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="Fxbrl_20220802203243992_Fact_136"
      unitRef="usd">473000</us-gaap:ShareBasedCompensation>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_20220630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20220802203243995_Fact_137"
      unitRef="Shares">23129469</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_20220630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20220802203243995_Fact_138"
      unitRef="usd">638000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20220630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20220802203243995_Fact_139"
      unitRef="usd">233586000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20220630_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220802203243995_Fact_140"
      unitRef="usd">-183873000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20220630"
      decimals="-3"
      id="Fxbrl_20220802203243995_Fact_141"
      unitRef="usd">50351000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_20210331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20220802203800507_Fact_142"
      unitRef="Shares">23028264</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_20210331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20220802203800507_Fact_143"
      unitRef="usd">635000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20210331_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20220802203800507_Fact_144"
      unitRef="usd">231849000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20210331_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220802203800507_Fact_145"
      unitRef="usd">-185426000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20210331"
      decimals="-3"
      id="Fxbrl_20220802203800507_Fact_146"
      unitRef="usd">47058000</us-gaap:StockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="C_20210401to20210630_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220802203512121_Fact_147"
      unitRef="usd">-8033000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_20210401to20210630"
      decimals="-3"
      id="Fxbrl_20220802203512121_Fact_148"
      unitRef="usd">-8033000</us-gaap:ProfitLoss>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="C_20210401to20210630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20220802203512123_Fact_157"
      unitRef="Shares">1687</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_20210401to20210630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20220802203512123_Fact_159"
      unitRef="usd">9000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_20210401to20210630"
      decimals="-3"
      id="Fxbrl_20220802203512123_Fact_160"
      unitRef="usd">9000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:ShareBasedCompensation
      contextRef="C_20210401to20210630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20220802203512134_Fact_161"
      unitRef="usd">213000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="C_20210401to20210630"
      decimals="-3"
      id="Fxbrl_20220802203512134_Fact_162"
      unitRef="usd">213000</us-gaap:ShareBasedCompensation>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_20210630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20220802203512143_Fact_163"
      unitRef="Shares">23029951</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_20210630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20220802203512143_Fact_164"
      unitRef="usd">635000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20210630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20220802203512143_Fact_165"
      unitRef="usd">232071000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20210630_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220802203512143_Fact_166"
      unitRef="usd">-193459000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20210630"
      decimals="-3"
      id="Fxbrl_20220802203512143_Fact_167"
      unitRef="usd">39247000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_20220331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20220802203522391_Fact_168"
      unitRef="Shares">23127669</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_20220331_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20220802203522391_Fact_169"
      unitRef="usd">638000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20220331_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20220802203522391_Fact_170"
      unitRef="usd">233224000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20220331_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220802203522391_Fact_171"
      unitRef="usd">-183739000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20220331"
      decimals="-3"
      id="Fxbrl_20220802203522391_Fact_172"
      unitRef="usd">50123000</us-gaap:StockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="C_20220401to20220630_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220802203512165_Fact_173"
      unitRef="usd">-134000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_20220401to20220630"
      decimals="-3"
      id="Fxbrl_20220802203512165_Fact_174"
      unitRef="usd">-134000</us-gaap:ProfitLoss>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="C_20220401to20220630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20220802203512172_Fact_175"
      unitRef="Shares">1800</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_20220401to20220630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20220802203512172_Fact_177"
      unitRef="usd">10000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_20220401to20220630"
      decimals="-3"
      id="Fxbrl_20220802203512172_Fact_178"
      unitRef="usd">10000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:ShareBasedCompensation
      contextRef="C_20220401to20220630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20220802203512178_Fact_179"
      unitRef="usd">352000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="C_20220401to20220630"
      decimals="-3"
      id="Fxbrl_20220802203512178_Fact_180"
      unitRef="usd">352000</us-gaap:ShareBasedCompensation>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_20220630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="INF"
      id="Fxbrl_20220802203512181_Fact_181"
      unitRef="Shares">23129469</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_20220630_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember"
      decimals="-3"
      id="Fxbrl_20220802203512181_Fact_182"
      unitRef="usd">638000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20220630_usgaapStatementEquityComponentsAxis_usgaapAdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fxbrl_20220802203512181_Fact_183"
      unitRef="usd">233586000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20220630_usgaapStatementEquityComponentsAxis_usgaapRetainedEarningsMember"
      decimals="-3"
      id="Fxbrl_20220802203512181_Fact_184"
      unitRef="usd">-183873000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_20220630"
      decimals="-3"
      id="Fxbrl_20220802203512181_Fact_185"
      unitRef="usd">50351000</us-gaap:StockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="C_20210101to20210630"
      decimals="-3"
      id="Fxbrl_20220721165859137"
      unitRef="usd">-12096000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="Fxbrl_20220721165911882"
      unitRef="usd">-5731000</us-gaap:ProfitLoss>
    <us-gaap:Depreciation
      contextRef="C_20210101to20210630"
      decimals="-3"
      id="FFact_188"
      unitRef="usd">474000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="FFact_189"
      unitRef="usd">327000</us-gaap:Depreciation>
    <slgl:ChangesInAccruedLiabilityForEmployeeRightsUponRetirement
      contextRef="C_20210101to20210630"
      decimals="-3"
      id="FFact_190"
      unitRef="usd">-3000</slgl:ChangesInAccruedLiabilityForEmployeeRightsUponRetirement>
    <slgl:ChangesInAccruedLiabilityForEmployeeRightsUponRetirement
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="FFact_191"
      unitRef="usd">-37000</slgl:ChangesInAccruedLiabilityForEmployeeRightsUponRetirement>
    <us-gaap:ShareBasedCompensation
      contextRef="C_20210101to20210630"
      decimals="-3"
      id="FFact_192"
      unitRef="usd">411000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="FFact_193"
      unitRef="usd">473000</us-gaap:ShareBasedCompensation>
    <slgl:FinanceExpensesNet
      contextRef="C_20210101to20210630"
      decimals="-3"
      id="FFact_194"
      unitRef="usd">15000</slgl:FinanceExpensesNet>
    <slgl:FinanceExpensesNet
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="Fxbrl_20220721165945170"
      unitRef="usd">-126000</slgl:FinanceExpensesNet>
    <slgl:NetChangesInOperatingLeases
      contextRef="C_20210101to20210630"
      decimals="-3"
      id="FFact_196"
      unitRef="usd">48000</slgl:NetChangesInOperatingLeases>
    <slgl:NetChangesInOperatingLeases
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="FFact_197"
      unitRef="usd">173000</slgl:NetChangesInOperatingLeases>
    <slgl:ChangesInFairValueOfMarketableSecurities
      contextRef="C_20210101to20210630"
      decimals="-3"
      id="Fxbrl_20220721165926561"
      unitRef="usd">59000</slgl:ChangesInFairValueOfMarketableSecurities>
    <slgl:ChangesInFairValueOfMarketableSecurities
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="FFact_199"
      unitRef="usd">-135000</slgl:ChangesInFairValueOfMarketableSecurities>
    <us-gaap:IncreaseDecreaseInLongTermReceivablesCurrent
      contextRef="C_20210101to20210630"
      decimals="-3"
      id="FFact_200"
      unitRef="usd">-1197000</us-gaap:IncreaseDecreaseInLongTermReceivablesCurrent>
    <us-gaap:IncreaseDecreaseInLongTermReceivablesCurrent
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="FFact_201"
      unitRef="usd">-7792000</us-gaap:IncreaseDecreaseInLongTermReceivablesCurrent>
    <us-gaap:IncreaseDecreaseInPrepaidExpensesOther
      contextRef="C_20210101to20210630"
      decimals="-3"
      id="FFact_202"
      unitRef="usd">482000</us-gaap:IncreaseDecreaseInPrepaidExpensesOther>
    <us-gaap:IncreaseDecreaseInPrepaidExpensesOther
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="FFact_203"
      unitRef="usd">891000</us-gaap:IncreaseDecreaseInPrepaidExpensesOther>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="C_20210101to20210630"
      decimals="-3"
      id="Fxbrl_20220721170010362"
      unitRef="usd">-782000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="Fxbrl_20220721170023162"
      unitRef="usd">-8387000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="C_20210101to20210630"
      decimals="-3"
      id="FFact_206"
      unitRef="usd">-11367000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="FFact_207"
      unitRef="usd">-6544000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="C_20210101to20210630"
      decimals="-3"
      id="FFact_208"
      unitRef="usd">54000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="FFact_209"
      unitRef="usd">102000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="C_20210101to20210630"
      decimals="-3"
      id="FFact_210"
      unitRef="usd">4065000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="FFact_211"
      unitRef="usd">10006000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="C_20210101to20210630"
      decimals="-3"
      id="FFact_212"
      unitRef="usd">18946000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="FFact_213"
      unitRef="usd">1734000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <slgl:ProceedsFromShortTermDeposits
      contextRef="C_20210101to20210630"
      decimals="-3"
      id="Fxbrl_20220721163559362"
      unitRef="usd">500000</slgl:ProceedsFromShortTermDeposits>
    <slgl:ProceedsFromShortTermDeposits
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="Fxbrl_20220721163606650"
      unitRef="usd">448000</slgl:ProceedsFromShortTermDeposits>
    <slgl:ProceedsFromLongTermDeposits
      contextRef="C_20210101to20210630"
      decimals="-3"
      id="Fxbrl_20220721163643329"
      unitRef="usd">2000</slgl:ProceedsFromLongTermDeposits>
    <slgl:ProceedsFromLongTermDeposits
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="Fxbrl_20220721163650650"
      unitRef="usd">9000</slgl:ProceedsFromLongTermDeposits>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="C_20210101to20210630"
      decimals="-3"
      id="FFact_218"
      unitRef="usd">15329000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="Fxbrl_20220721170501016"
      unitRef="usd">-7917000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="C_20210101to20210630"
      decimals="-3"
      id="FFact_220"
      unitRef="usd">83000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="FFact_221"
      unitRef="usd">15000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="C_20210101to20210630"
      decimals="-3"
      id="FFact_224"
      unitRef="usd">83000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="FFact_225"
      unitRef="usd">15000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="C_20210101to20210630"
      decimals="-3"
      id="Fxbrl_20220721165808265"
      unitRef="usd">-15000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="FFact_227"
      unitRef="usd">126000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="C_20210101to20210630"
      decimals="-3"
      id="FFact_228"
      unitRef="usd">4030000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="Fxbrl_20220721165838498"
      unitRef="usd">-14320000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_20201231"
      decimals="-3"
      id="Fxbrl_20220721180304367"
      unitRef="usd">8272000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_20211231"
      decimals="-3"
      id="FFact_231"
      unitRef="usd">21235000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_20210630"
      decimals="-3"
      id="FFact_232"
      unitRef="usd">12302000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_20220630"
      decimals="-3"
      id="FFact_233"
      unitRef="usd">6915000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_20210630"
      decimals="-3"
      id="FFact_234"
      unitRef="usd">11152000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_20220630"
      decimals="-3"
      id="FFact_235"
      unitRef="usd">5765000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCash
      contextRef="C_20210630"
      decimals="-3"
      id="FFact_236"
      unitRef="usd">1150000</us-gaap:RestrictedCash>
    <us-gaap:RestrictedCash
      contextRef="C_20220630"
      decimals="-3"
      id="FFact_237"
      unitRef="usd">1150000</us-gaap:RestrictedCash>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_20210630"
      decimals="-3"
      id="FFact_238"
      unitRef="usd">12302000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_20220630"
      decimals="-3"
      id="FFact_239"
      unitRef="usd">6915000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:ProceedsFromInterestReceived
      contextRef="C_20210101to20210630"
      decimals="-3"
      id="FFact_240"
      unitRef="usd">582000</us-gaap:ProceedsFromInterestReceived>
    <us-gaap:ProceedsFromInterestReceived
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="FFact_241"
      unitRef="usd">153000</us-gaap:ProceedsFromInterestReceived>
    <us-gaap:NatureOfOperations
      contextRef="C_20220101to20220630"
      id="Fxbrl_20220721155105496">
        &lt;div&gt;
          &lt;div&gt;
            &lt;div&gt;
              &lt;div&gt;
                &lt;div style="text-align:justify;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;NOTE 1 &#x2013; NATURE OF OPERATIONS&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&#160;&lt;/div&gt;
                &lt;div style="text-align:justify;margin-left:20pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Sol-Gel Technologies Ltd. (collectively with its U.S. subsidiary, the Company) is an Israeli Company incorporated in 1997.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&#160;&lt;/div&gt;
                &lt;div style="text-align:justify;margin-left:20pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;The Company is a clinical stage specialty pharmaceutical company focused on developing and commercializing topical dermatological drug products. The Company&#x2019;s lead products candidates are based upon its proprietary microencapsulation delivery system, consisting of microcapsules made of precipitated silica. The Company has two approved drugs: (i) Twyneo&#xae;, which was developed for the treatment of acne vulgaris and received marketing authourization by the U.S. Food and Durg Administration (the "FDA") on July 27, 2021 and (ii) Epsolay&#xae;, a treatment for subtype II rosacea that received marketing authourization by the FDA on April 25, 2022. In June 2021, the Company entered into two exclusive license agreements with Galderma for the commercialization of Twyneo&#xae; and Epsolay&#xae;, in the United States, see note 5. On April 14, 2022, the Company announced that Twyneo&#xae; is available for purchase by consumers who obtain a prescription from their physician. On June 2, 2022, the Company announced that Epsolay&#xae; is available for purchase by consumers who obtain a prescription from their physician. In addition to the novel products, the Company&#x2019;s products included the approved generic products Acyclovir, Ivermectin and other generic product candidates. In November 2021, the company entered into an agreement with Padagis, to sell its rights in relation to ten generic collaborative agreements between the parties, including the agreements for the two aforementioned approved generic drug products. Under the new agreement, the company has retained collaboration rights to two generic programs related to four generic drug candidates, see note 4b.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&#160;&lt;/div&gt;
                &lt;div style="text-align:justify;margin-left:20pt;line-height:1.25;font-family:'Times New Roman',Times,serif;font-style:italic;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Risk and Uncertainties&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&#160;&lt;/div&gt;
                &lt;div style="text-align:justify;margin-left:20pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;Since incorporation through June 30, 2022, the Company has an accumulated deficit of $183,873 and its activities have been funded mainly by its shareholders, collaboration revenues and license agreements, see also Notes 4 and 5. The Company expects to continue to incur significant research and development and other costs related to its ongoing operations.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&#160;&lt;/div&gt;
                &lt;div style="text-align:justify;margin-left:20pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In addition, management is continuing to analyze cash resources and considering raising additional funding from different sources, such as corporate collaborations, public or private equity offerings and/or debt financings, and/or selling shares under the Company's Open Market Sale Agreement with Jefferies LLC. Management expects that the Company's cash and cash equivalents, deposits and marketable securities as of June 30, 2022 will allow the Company to fund its operating plan through at least the next 12 months from the condensed financial statement issuance date.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&#160;&lt;/div&gt;
                &lt;div style="text-align:justify;margin-left:20pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;The Company is subject to risks and uncertainties as a result of the COVID-19 pandemic. To date, the impact of COVID-19 pandemic has been limited and resulted in delays with respect to pre-approval inspections.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/div&gt;
          &lt;div/&gt;
          &lt;div&gt;
            &lt;div&gt;
              &lt;div style="text-align:justify;line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:20pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The full extent to which the COVID-19 pandemic will directly or indirectly impact the Company's business, results of operations and financial condition, including revenues from collaboration arrangements, expenses, reserves and allowances, manufacturing, supply, regulatory approvals, clinical trials, commercial launch of branded and generic product candidates, research and development costs and employee-related amounts, will depend on future developments that are highly uncertain and cannot be predicted. The Company continues to monitor and assess new information related to the COVID-19 pandemic, the actions taken to contain or treat COVID-19, as well as the economic impact on various markets.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&#160;&lt;/div&gt;
              &lt;div style="text-align:justify;margin-left:20pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Furthermore, the estimation process required to prepare the Company&#x2019;s consolidated financial statements requires assumptions to be made about future events and conditions and the impact of COVID-19 on its financial results, and while management believes such assumptions are reasonable, they are inherently subjective and uncertain. The Company&#x2019;s actual results could differ materially from those estimates.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/div&gt;
          &lt;/div&gt;
        &lt;/div&gt;
      </us-gaap:NatureOfOperations>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="C_20220630"
      decimals="-3"
      id="FFact_242"
      unitRef="usd">-183873000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="C_20220101to20220630" id="FFact_250">
    &lt;div&gt;
      &lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:left;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:left"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&lt;span&gt;NOTE 2 &lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&#x2013;&lt;/span&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt;&lt;span&gt; SIGNIFICANT ACCOUNTING POLICIES:&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:left;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:left"&gt;&#160;&lt;/p&gt;

        &lt;div&gt;
          &lt;div&gt;
            &lt;div&gt;
              &lt;div&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="width:36pt;vertical-align:top;font-family:'Times New Roman',Times,serif"&gt;
                        &lt;div style="margin-left:18pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;a.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td style="width:auto;vertical-align:top"&gt;
                        &lt;div style="line-height:1.25;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;Basis of Presentation&lt;/span&gt;&lt;br/&gt;&lt;span&gt;&#160;&lt;br/&gt;The unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") for interim financial statements. Accordingly, they do not include all of the information and notes required by U.S. GAAP for annual financial statements. In the opinion of management, these unaudited condensed consolidated financial statements reflect all adjustments, which include normal recurring adjustments, necessary for a fair statement of the Company&#x2019;s consolidated financial position as of June 30, 2022, the consolidated results of operations for the six month and three month periods ended June 30, 2021 and 2022 and statements of changes in shareholders' equity and cash flows for the six month period ended June 30, 2021 and 2022.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
              &lt;div style="margin-left:36pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="margin-left:36pt;line-height:1.25;font-family:Times New Roman, Times, serif;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The consolidated results for the six month period ended June 30, 2022 are not necessarily indicative of the results to be expected for the year ending December 31, 2022.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&#160;&lt;/div&gt;
              &lt;div style="margin-left:35.7pt;line-height:1.25;font-family:Times New Roman, Times, serif;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;These unaudited condensed consolidated financial statements should be read in conjunction with the audited financial statements of the Company for the year ended December 31, 2021. The comparative balance sheet at December 31, 2021 has been derived from the audited financial statements at that date but does not include all disclosures required by U.S. GAAP.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/div&gt;
          &lt;/div&gt;
        &lt;/div&gt;


        &lt;div&gt;
          &lt;p style="margin-top:0pt;margin-left:48px;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&#160;&lt;/p&gt;
          &lt;div style="text-align:justify"&gt;
            &lt;div style="margin-top:0px"&gt;
              &lt;div&gt;
                &lt;div&gt;
                  &lt;div&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:36pt;vertical-align:top;font-family:'Times New Roman',Times,serif"&gt;
                            &lt;div style="margin-left:18pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;b.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top"&gt;
                            &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;Loss per share&lt;/span&gt;&lt;br/&gt;&lt;span&gt;&#160;&lt;br/&gt;Basic loss per share is computed on the basis of the net loss for the period divided by the weighted average number of ordinary shares outstanding during the period. Diluted loss per share is based upon the weighted average number of ordinary shares and of ordinary shares equivalents outstanding when dilutive. Ordinary share equivalents include outstanding stock options, restricted shares and warrants, which are included under the treasury stock method when dilutive.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                  &lt;/div&gt;
                  &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&#160;&lt;/div&gt;
                  &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The calculation of diluted loss per share does not include 3,713,296 and 4,085,416 options, restricted shares and warrants for the six and three months ended June 30, 2022 and 3,437,843 and 3,463,710 options and restricted shares for the six and the three months ended June 30, 2021, respectively, because the effect would be anti-dilutive.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/div&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/div&gt;
        &lt;/div&gt;

    &lt;/div&gt;
  </us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="C_20220101to20220630"
      id="Fxbrl_20220721161540027">
        &lt;div&gt;
          &lt;div&gt;
            &lt;div&gt;
              &lt;div&gt;
                &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                    &lt;tr&gt;
                      &lt;td style="width:36pt;vertical-align:top;font-family:'Times New Roman',Times,serif"&gt;
                        &lt;div style="margin-left:18pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;a.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                      &lt;td style="width:auto;vertical-align:top"&gt;
                        &lt;div style="line-height:1.25;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;Basis of Presentation&lt;/span&gt;&lt;br/&gt;&lt;span&gt;&#160;&lt;br/&gt;The unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") for interim financial statements. Accordingly, they do not include all of the information and notes required by U.S. GAAP for annual financial statements. In the opinion of management, these unaudited condensed consolidated financial statements reflect all adjustments, which include normal recurring adjustments, necessary for a fair statement of the Company&#x2019;s consolidated financial position as of June 30, 2022, the consolidated results of operations for the six month and three month periods ended June 30, 2021 and 2022 and statements of changes in shareholders' equity and cash flows for the six month period ended June 30, 2021 and 2022.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                      &lt;/td&gt;
                    &lt;/tr&gt;

                &lt;/table&gt;
              &lt;/div&gt;
              &lt;div style="margin-left:36pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
              &lt;div style="margin-left:36pt;line-height:1.25;font-family:Times New Roman, Times, serif;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The consolidated results for the six month period ended June 30, 2022 are not necessarily indicative of the results to be expected for the year ending December 31, 2022.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
              &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&#160;&lt;/div&gt;
              &lt;div style="margin-left:35.7pt;line-height:1.25;font-family:Times New Roman, Times, serif;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;These unaudited condensed consolidated financial statements should be read in conjunction with the audited financial statements of the Company for the year ended December 31, 2021. The comparative balance sheet at December 31, 2021 has been derived from the audited financial statements at that date but does not include all disclosures required by U.S. GAAP.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
            &lt;/div&gt;
          &lt;/div&gt;
        &lt;/div&gt;
      </us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="C_20220101to20220630"
      id="Fxbrl_20220721163418659">
        &lt;div&gt;
          &lt;p style="margin-top:0pt;margin-left:48px;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&#160;&lt;/p&gt;
          &lt;div style="text-align:justify"&gt;
            &lt;div style="margin-top:0px"&gt;
              &lt;div&gt;
                &lt;div&gt;
                  &lt;div&gt;
                    &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

                        &lt;tr&gt;
                          &lt;td style="width:36pt;vertical-align:top;font-family:'Times New Roman',Times,serif"&gt;
                            &lt;div style="margin-left:18pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;b.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                          &lt;td style="width:auto;vertical-align:top"&gt;
                            &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;Loss per share&lt;/span&gt;&lt;br/&gt;&lt;span&gt;&#160;&lt;br/&gt;Basic loss per share is computed on the basis of the net loss for the period divided by the weighted average number of ordinary shares outstanding during the period. Diluted loss per share is based upon the weighted average number of ordinary shares and of ordinary shares equivalents outstanding when dilutive. Ordinary share equivalents include outstanding stock options, restricted shares and warrants, which are included under the treasury stock method when dilutive.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                          &lt;/td&gt;
                        &lt;/tr&gt;

                    &lt;/table&gt;
                  &lt;/div&gt;
                  &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&#160;&lt;/div&gt;
                  &lt;div style="text-align:justify;margin-left:36pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The calculation of diluted loss per share does not include 3,713,296 and 4,085,416 options, restricted shares and warrants for the six and three months ended June 30, 2022 and 3,437,843 and 3,463,710 options and restricted shares for the six and the three months ended June 30, 2021, respectively, because the effect would be anti-dilutive.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/div&gt;
              &lt;/div&gt;
            &lt;/div&gt;
          &lt;/div&gt;
        &lt;/div&gt;
      </us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_20220101to20220630"
      decimals="INF"
      id="Fxbrl_20220721163539988"
      unitRef="Shares">3713296</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_20220401to20220630"
      decimals="INF"
      id="Fxbrl_20220721163551609"
      unitRef="Shares">4085416</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_20210101to20210630"
      decimals="INF"
      id="Fxbrl_20220721163630539"
      unitRef="Shares">3437843</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_20210401to20210630"
      decimals="INF"
      id="Fxbrl_20220721163648033"
      unitRef="Shares">3463710</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock contextRef="C_20220101to20220630" id="FFact_275">
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0px;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;NOTE 3 &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&#x2013;&lt;/span&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt; MARKETABLE SECURITIES:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

      &lt;p style="margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/p&gt;
      &lt;div&gt;
        &lt;div&gt;
          &lt;div style="line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:20pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The following table sets forth the Company&#x2019;s marketable securities for the indicated periods:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&#160;&lt;/div&gt;
          &lt;div style="margin-left:20pt"&gt;
            &lt;table border="0" cellpadding="0" cellspacing="0" style="color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:left;width:90%" width="100%"&gt;

                &lt;tr&gt;
                  &lt;td colspan="1" rowspan="1" style="vertical-align:top;padding-bottom:2px;font-family:Times New Roman, Times, serif" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" rowspan="1" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" rowspan="1" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;June 30,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td colspan="1" style="vertical-align:top;padding-bottom:2px;font-family:Times New Roman, Times, serif" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td colspan="1" style="vertical-align:middle;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Level 2 securities:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="6" style="vertical-align:top;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td colspan="1" style="vertical-align:middle;font-family:Times New Roman, Times, serif;width:76%" valign="bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;U.S government and agency bonds&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;font-family:Times New Roman, Times, serif;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;font-family:Times New Roman, Times, serif;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;font-family:Times New Roman, Times, serif;width:9%" valign="bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;275&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;font-family:Times New Roman, Times, serif;white-space:nowrap;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;font-family:Times New Roman, Times, serif;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;font-family:Times New Roman, Times, serif;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;font-family:Times New Roman, Times, serif;width:9%" valign="bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,174&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;font-family:Times New Roman, Times, serif;white-space:nowrap;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td colspan="1" style="vertical-align:middle;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:76%" valign="bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other foreign government bonds&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:9%" valign="bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;white-space:nowrap;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:9%" valign="bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,507&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;white-space:nowrap;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td colspan="1" style="vertical-align:middle;padding-bottom:2px;font-family:Times New Roman, Times, serif;width:76%" valign="bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Corporate bonds*&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:Times New Roman, Times, serif;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);font-family:Times New Roman, Times, serif;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:2px solid rgb(0, 0, 0);font-family:Times New Roman, Times, serif;width:9%" valign="bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,434&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:Times New Roman, Times, serif;white-space:nowrap;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:Times New Roman, Times, serif;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);font-family:Times New Roman, Times, serif;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:2px solid rgb(0, 0, 0);font-family:Times New Roman, Times, serif;width:9%" valign="bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7,165&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:Times New Roman, Times, serif;white-space:nowrap;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td colspan="1" style="vertical-align:middle;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:76%" valign="bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:9%" valign="bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,709&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;white-space:nowrap;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:9%" valign="bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;9,846&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;white-space:nowrap;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          &lt;/div&gt;
        &lt;/div&gt;
      &lt;/div&gt;
      &lt;div style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif"&gt;&#160;&lt;/div&gt;
      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-left:20pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;* &lt;span id="FN_60f774710b70e4ca22c9cb88"&gt;Investments in Corporate bonds rated A or higher.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

    &lt;p style="margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/p&gt;
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-left:20pt;text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company&#x2019;s debt securities are classified within Level 2 because it uses quoted market prices or alternative pricing sources and models utilizing market observable inputs to determine their fair value.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

      &lt;p style="margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/p&gt;
      &lt;div&gt;
        &lt;div&gt;
          &lt;div style="line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:20pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The table below sets forth a summary of the changes in the fair value of the Company&#x2019;s marketable securities for the indicated periods:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&#160;&lt;/div&gt;
          &lt;div style="margin-left:20pt"&gt;
            &lt;table border="0" cellpadding="0" cellspacing="0" style="color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:left;width:90%" width="100%"&gt;

                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="6" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Marketable securities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:top;font-family:'Times New Roman',Times,serif" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif" valign="bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;For&#160;the&#160;year&#160;ended&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif" valign="bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;For&#160;the&#160;Six&#160;Months&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:top;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,&#160;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;ended&#160;June&#160;30,&#160;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:top;font-family:'Times New Roman',Times,serif" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="vertical-align:top;font-family:'Times New Roman',Times,serif" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="vertical-align:top;font-family:'Times New Roman',Times,serif" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:top;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:76%" valign="bottom"&gt;
                    &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance at beginning of the period&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:9%" valign="bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;21,652&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;white-space:nowrap;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:9%" valign="bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,709&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;white-space:nowrap;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:76%" valign="bottom"&gt;
                    &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Additions&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;font-family:Times New Roman, Times, serif;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;font-family:Times New Roman, Times, serif;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;font-family:Times New Roman, Times, serif;width:9%" valign="bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6,716&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;font-family:Times New Roman, Times, serif;white-space:nowrap;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;font-family:Times New Roman, Times, serif;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;font-family:Times New Roman, Times, serif;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;font-family:Times New Roman, Times, serif;width:9%" valign="bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10,006&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;font-family:Times New Roman, Times, serif;white-space:nowrap;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:top;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:76%" valign="bottom"&gt;
                    &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Sale or maturity&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:9%" valign="bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(26,784&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;white-space:nowrap;width:1%" valign="bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:9%" valign="bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,734&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;white-space:nowrap;width:1%" valign="bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:top;padding-bottom:2px;font-family:Times New Roman, Times, serif;width:76%" valign="bottom"&gt;
                    &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Changes in fair value during the period&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:Times New Roman, Times, serif;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);font-family:Times New Roman, Times, serif;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:2px solid rgb(0, 0, 0);font-family:Times New Roman, Times, serif;width:9%" valign="bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;125&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:Times New Roman, Times, serif;white-space:nowrap;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:Times New Roman, Times, serif;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);font-family:Times New Roman, Times, serif;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:2px solid rgb(0, 0, 0);font-family:Times New Roman, Times, serif;width:9%" valign="bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(135&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:Times New Roman, Times, serif;white-space:nowrap;width:1%" valign="bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:top;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:76%" valign="bottom"&gt;
                    &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance at end of the period&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:9%" valign="bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,709&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;white-space:nowrap;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:9%" valign="bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;9,846&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;white-space:nowrap;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          &lt;/div&gt;
        &lt;/div&gt;
      &lt;/div&gt;


      &lt;p style="margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/p&gt;
      &lt;div&gt;
        &lt;div&gt;
          &lt;div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:20pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As of June 30, 2022, the Company&#x2019;s debt securities had the following maturity dates:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&#160;&lt;/div&gt;
          &lt;div style="margin-left:20pt"&gt;
            &lt;table border="0" cellpadding="0" cellspacing="0" style="color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:left;width:90%" width="100%"&gt;

                &lt;tr&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Market value&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif" valign="bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;June 30,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td colspan="1" style="vertical-align:middle;padding-bottom:2px;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:88%" valign="bottom"&gt;
                    &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Due within one year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:9%" valign="bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;9,041&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;white-space:nowrap;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td colspan="1" style="vertical-align:middle;padding-bottom:4px;font-family:Times New Roman, Times, serif;width:88%" valign="bottom"&gt;
                    &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Between 1-2 years&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:4px;font-family:Times New Roman, Times, serif;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0);font-family:Times New Roman, Times, serif;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:4px double rgb(0, 0, 0);font-family:Times New Roman, Times, serif;width:9%" valign="bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;805&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:4px;font-family:Times New Roman, Times, serif;white-space:nowrap;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          &lt;/div&gt;
        &lt;/div&gt;
      &lt;/div&gt;

    &lt;p style="margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/p&gt;
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-left:20pt;text-align:justify;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span&gt;&lt;span style="color:black"&gt;The carrying amount of the cash and cash equivalents, bank deposits, restricted cash, restricted long term deposits,&lt;/span&gt;&lt;/span&gt;&#160;&lt;span&gt;&lt;span style="color:black"&gt;receivables from collaborative arrangements, accrued expenses and other liabilities approximates their fair value.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
  </us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock>
    <us-gaap:MarketableSecuritiesTextBlock contextRef="C_20220101to20220630" id="FFact_261">
      &lt;p style="margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/p&gt;
      &lt;div&gt;
        &lt;div&gt;
          &lt;div style="line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:20pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The following table sets forth the Company&#x2019;s marketable securities for the indicated periods:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&#160;&lt;/div&gt;
          &lt;div style="margin-left:20pt"&gt;
            &lt;table border="0" cellpadding="0" cellspacing="0" style="color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:left;width:90%" width="100%"&gt;

                &lt;tr&gt;
                  &lt;td colspan="1" rowspan="1" style="vertical-align:top;padding-bottom:2px;font-family:Times New Roman, Times, serif" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" rowspan="1" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" rowspan="1" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;June 30,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" rowspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td colspan="1" style="vertical-align:top;padding-bottom:2px;font-family:Times New Roman, Times, serif" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td colspan="1" style="vertical-align:middle;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Level 2 securities:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="6" style="vertical-align:top;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td colspan="1" style="vertical-align:middle;font-family:Times New Roman, Times, serif;width:76%" valign="bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;U.S government and agency bonds&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;font-family:Times New Roman, Times, serif;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;font-family:Times New Roman, Times, serif;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;font-family:Times New Roman, Times, serif;width:9%" valign="bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;275&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;font-family:Times New Roman, Times, serif;white-space:nowrap;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;font-family:Times New Roman, Times, serif;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;font-family:Times New Roman, Times, serif;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;font-family:Times New Roman, Times, serif;width:9%" valign="bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,174&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;font-family:Times New Roman, Times, serif;white-space:nowrap;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td colspan="1" style="vertical-align:middle;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:76%" valign="bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Other foreign government bonds&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:9%" valign="bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;white-space:nowrap;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:9%" valign="bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,507&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;white-space:nowrap;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td colspan="1" style="vertical-align:middle;padding-bottom:2px;font-family:Times New Roman, Times, serif;width:76%" valign="bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Corporate bonds*&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:Times New Roman, Times, serif;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);font-family:Times New Roman, Times, serif;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:2px solid rgb(0, 0, 0);font-family:Times New Roman, Times, serif;width:9%" valign="bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,434&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:Times New Roman, Times, serif;white-space:nowrap;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:Times New Roman, Times, serif;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);font-family:Times New Roman, Times, serif;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:2px solid rgb(0, 0, 0);font-family:Times New Roman, Times, serif;width:9%" valign="bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7,165&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:Times New Roman, Times, serif;white-space:nowrap;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td colspan="1" style="vertical-align:middle;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:76%" valign="bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Total&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:9%" valign="bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,709&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;white-space:nowrap;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:9%" valign="bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;9,846&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;white-space:nowrap;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          &lt;/div&gt;
        &lt;/div&gt;
      &lt;/div&gt;
      &lt;div style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif"&gt;&#160;&lt;/div&gt;
      &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-left:20pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;* &lt;span id="FN_60f774710b70e4ca22c9cb88"&gt;Investments in Corporate bonds rated A or higher.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
    </us-gaap:MarketableSecuritiesTextBlock>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="C_20211231_usgaapInvestmentTypeAxis_usgaapUSGovernmentCorporationsAndAgenciesSecuritiesMember"
      decimals="-3"
      id="FFact_251"
      unitRef="usd">275000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="C_20220630_usgaapInvestmentTypeAxis_usgaapUSGovernmentCorporationsAndAgenciesSecuritiesMember"
      decimals="-3"
      id="FFact_252"
      unitRef="usd">1174000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="C_20211231_usgaapInvestmentTypeAxis_slglOtherForeignGovernmentBondsMember"
      decimals="-3"
      id="FFact_255"
      unitRef="usd">0</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="C_20220630_usgaapInvestmentTypeAxis_slglOtherForeignGovernmentBondsMember"
      decimals="-3"
      id="Fxbrl_20220721171136582"
      unitRef="usd">1507000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="C_20211231_usgaapInvestmentTypeAxis_usgaapAllOtherCorporateBondsMember"
      decimals="-3"
      id="FFact_257"
      unitRef="usd">1434000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="C_20220630_usgaapInvestmentTypeAxis_usgaapAllOtherCorporateBondsMember"
      decimals="-3"
      id="FFact_258"
      unitRef="usd">7165000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="C_20211231"
      decimals="-3"
      id="FFact_259"
      unitRef="usd">1709000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="C_20220630"
      decimals="-3"
      id="FFact_260"
      unitRef="usd">9846000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:ScheduleOfDerivativeAssetsAtFairValueTableTextBlock contextRef="C_20220101to20220630" id="FFact_272">
      &lt;p style="margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/p&gt;
      &lt;div&gt;
        &lt;div&gt;
          &lt;div style="line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:20pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The table below sets forth a summary of the changes in the fair value of the Company&#x2019;s marketable securities for the indicated periods:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&#160;&lt;/div&gt;
          &lt;div style="margin-left:20pt"&gt;
            &lt;table border="0" cellpadding="0" cellspacing="0" style="color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:left;width:90%" width="100%"&gt;

                &lt;tr&gt;
                  &lt;td style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="6" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Marketable securities&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:top;font-family:'Times New Roman',Times,serif" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif" valign="bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;For&#160;the&#160;year&#160;ended&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif" valign="bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;For&#160;the&#160;Six&#160;Months&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:top;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;December&#160;31,&#160;2021&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;ended&#160;June&#160;30,&#160;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:top;font-family:'Times New Roman',Times,serif" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="vertical-align:top;font-family:'Times New Roman',Times,serif" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="vertical-align:top;font-family:'Times New Roman',Times,serif" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:top;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:76%" valign="bottom"&gt;
                    &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance at beginning of the period&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:9%" valign="bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;21,652&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;white-space:nowrap;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:9%" valign="bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,709&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;white-space:nowrap;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:76%" valign="bottom"&gt;
                    &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Additions&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;font-family:Times New Roman, Times, serif;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;font-family:Times New Roman, Times, serif;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;font-family:Times New Roman, Times, serif;width:9%" valign="bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;6,716&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;font-family:Times New Roman, Times, serif;white-space:nowrap;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;font-family:Times New Roman, Times, serif;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;font-family:Times New Roman, Times, serif;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;font-family:Times New Roman, Times, serif;width:9%" valign="bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;10,006&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;font-family:Times New Roman, Times, serif;white-space:nowrap;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:top;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:76%" valign="bottom"&gt;
                    &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Sale or maturity&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:9%" valign="bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(26,784&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;white-space:nowrap;width:1%" valign="bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:9%" valign="bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(1,734&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;white-space:nowrap;width:1%" valign="bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:top;padding-bottom:2px;font-family:Times New Roman, Times, serif;width:76%" valign="bottom"&gt;
                    &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Changes in fair value during the period&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:Times New Roman, Times, serif;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);font-family:Times New Roman, Times, serif;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:2px solid rgb(0, 0, 0);font-family:Times New Roman, Times, serif;width:9%" valign="bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;125&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:Times New Roman, Times, serif;white-space:nowrap;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:Times New Roman, Times, serif;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);font-family:Times New Roman, Times, serif;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:2px solid rgb(0, 0, 0);font-family:Times New Roman, Times, serif;width:9%" valign="bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;(135&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:Times New Roman, Times, serif;white-space:nowrap;width:1%" valign="bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;)&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:top;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:76%" valign="bottom"&gt;
                    &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Balance at end of the period&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:9%" valign="bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;1,709&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;white-space:nowrap;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:9%" valign="bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;9,846&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;white-space:nowrap;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          &lt;/div&gt;
        &lt;/div&gt;
      &lt;/div&gt;
    </us-gaap:ScheduleOfDerivativeAssetsAtFairValueTableTextBlock>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="C_20201231"
      decimals="-3"
      id="FFact_262"
      unitRef="usd">21652000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="C_20211231"
      decimals="-3"
      id="FFact_263"
      unitRef="usd">1709000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_264"
      unitRef="usd">6716000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="FFact_265"
      unitRef="usd">10006000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_266"
      unitRef="usd">26784000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="FFact_267"
      unitRef="usd">1734000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <slgl:ChangesInFairValueOfMarketableSecurities
      contextRef="C_20210101to20211231"
      decimals="-3"
      id="FFact_268"
      unitRef="usd">125000</slgl:ChangesInFairValueOfMarketableSecurities>
    <slgl:ChangesInFairValueOfMarketableSecurities
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="Fxbrl_20220721232906325"
      unitRef="usd">-135000</slgl:ChangesInFairValueOfMarketableSecurities>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="C_20211231"
      decimals="-3"
      id="FFact_270"
      unitRef="usd">1709000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="C_20220630"
      decimals="-3"
      id="FFact_271"
      unitRef="usd">9846000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock contextRef="C_20220101to20220630" id="FFact_274">
      &lt;p style="margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/p&gt;
      &lt;div&gt;
        &lt;div&gt;
          &lt;div style="text-align:justify;line-height:1.25;font-family:Times New Roman, Times, serif;margin-left:20pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;As of June 30, 2022, the Company&#x2019;s debt securities had the following maturity dates:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
          &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&#160;&lt;/div&gt;
          &lt;div style="margin-left:20pt"&gt;
            &lt;table border="0" cellpadding="0" cellspacing="0" style="color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:left;width:90%" width="100%"&gt;

                &lt;tr&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Market value&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif" valign="bottom"&gt;
                    &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;June 30,&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;
                      &lt;div style="text-align:center;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td colspan="1" style="vertical-align:middle;padding-bottom:2px;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:88%" valign="bottom"&gt;
                    &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Due within one year&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:2px solid rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;width:9%" valign="bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;9,041&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;background-color:rgb(204, 238, 255);font-family:Times New Roman, Times, serif;white-space:nowrap;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td colspan="1" style="vertical-align:middle;padding-bottom:4px;font-family:Times New Roman, Times, serif;width:88%" valign="bottom"&gt;
                    &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Between 1-2 years&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:4px;font-family:Times New Roman, Times, serif;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;border-bottom:4px double rgb(0, 0, 0);font-family:Times New Roman, Times, serif;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;border-bottom:4px double rgb(0, 0, 0);font-family:Times New Roman, Times, serif;width:9%" valign="bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;
                      &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;805&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                    &lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:4px;font-family:Times New Roman, Times, serif;white-space:nowrap;width:1%" valign="bottom"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          &lt;/div&gt;
        &lt;/div&gt;
      &lt;/div&gt;
    </us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
      contextRef="C_20220630"
      decimals="-3"
      id="FFact_273"
      unitRef="usd">9041000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
    <slgl:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue
      contextRef="C_20220630"
      decimals="-3"
      id="Fxbrl_20220721174756543"
      unitRef="usd">805000</slgl:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue>
    <us-gaap:RevenueFromContractWithCustomerTextBlock contextRef="C_20220101to20220630" id="FFact_281">
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0px;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt;margin-top:0px"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;NOTE 4 &#x2013; COLLABORATION AGREEMENTS:&lt;br/&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;div&gt;
      &lt;div&gt;
        &lt;div&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

              &lt;tr&gt;
                &lt;td style="width:36.55pt;vertical-align:top;font-family:'Times New Roman',Times,serif"&gt;
                  &lt;div style="margin-left:20.55pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;a.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td style="width:auto;vertical-align:top;font-family:'Times New Roman',Times,serif"&gt;
                  &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In 2007, the Company granted rights to a third party for use and commercialization of a product for skin protection. Under this agreement, the Company is entitled to royalties during the years 2016 to 2024. Based on current sales, royalties are not material.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
        &lt;/div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&#160;&lt;/div&gt;
        &lt;div&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

              &lt;tr&gt;
                &lt;td style="width:36.55pt;vertical-align:top;font-family:'Times New Roman',Times,serif"&gt;
                  &lt;div style="margin-left:20.55pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;b.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td style="width:auto;vertical-align:top;font-family:'Times New Roman',Times,serif"&gt;
                  &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In 2016 through 2020, the Company entered into several collaboration agreements mainly with one Partner for the development, manufacturing and commercialization of several generic product candidates. Under the agreements, the Partner is obligated to conduct regulatory, scientific, clinical and technical activities necessary to develop the product and prepare and file ANDA, with the FDA and gain regulatory approval. The Company participates in the development of the product candidates, including participation in joint steering committees and is obligated for sourcing the active pharmaceutical ingredient (API) during the development phase.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;div style="text-align:justify;line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Upon FDA approval, the Partner has exclusive rights and is required to use diligent efforts to commercialize these products in territories defined under the agreements, including all required sales, marketing and distributing activities associated with the agreements. The Company is entitled to a share of the Partner's gross profits related to the sale of the products, as such term is defined in each of the agreements.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&#160;&lt;/div&gt;
                  &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;These Agreement are considered to be within the scope of ASC 808, as the parties are active participants and exposed to the risks and rewards of the collaborative activity.&lt;br/&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;div style="text-align:justify;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The Company recognizes collaboration revenue when the related sales occur.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&#160;&lt;/div&gt;
                  &lt;div style="text-align:justify;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In November 2021, the Company entered into a new agreement (the "New Agreement") with the Partner, to sell its rights in relation to ten generic collaborative agreements between the parties, including the agreements for two approved generic drug products. Under the New Agreement, the Company has retained collaboration rights to two generic programs related to four generic drug candidates. Following the signing of the New Agreement, the Company is no longer entitled to receive its share in profit as detailed above.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&#160;&lt;/div&gt;
                  &lt;div style="text-align:justify;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Under the terms of the New Agreement, effective as of November 1, 2021, the Company will unconditionally receive $21,500 over 24 months, in lieu of its share in future gross profits for the two approved generic drug products and its potential gross profits for eight unapproved generic programs. The Company received $1,250 as an upfront payment and $20,250 in eight equal quarterly instalments. The New Agreement also provides that effective as of November 1, 2021, the Company will cease paying any outstanding and future operational costs related to these collaborative agreements.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
        &lt;/div&gt;
        &lt;div&gt;
          &lt;div style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif"&gt;&#160;&lt;/div&gt;
        &lt;/div&gt;
      &lt;/div&gt;
    &lt;/div&gt;
  </us-gaap:RevenueFromContractWithCustomerTextBlock>
    <slgl:RoyaltiesMaturity
      contextRef="C_20070101to20071231_srtRangeAxis_srtMinimumMember"
      id="Fxbrl_20220721155340132">2016</slgl:RoyaltiesMaturity>
    <slgl:RoyaltiesMaturity
      contextRef="C_20070101to20071231_srtRangeAxis_srtMaximumMember"
      id="Fxbrl_20220721155348640">2024</slgl:RoyaltiesMaturity>
    <slgl:NumberOfGenericCollaborativeAgreementsToSellRights
      contextRef="C_20211101"
      decimals="0"
      id="Fxbrl_20220721203035246"
      unitRef="Agreement">10</slgl:NumberOfGenericCollaborativeAgreementsToSellRights>
    <slgl:NumberOfGenericProgramsRetainedForCollaborationRights
      contextRef="C_20211101"
      decimals="0"
      id="Fxbrl_20220721203021215"
      unitRef="Program">2</slgl:NumberOfGenericProgramsRetainedForCollaborationRights>
    <slgl:NumberOfGenericDrugCandidates
      contextRef="C_20211101"
      decimals="0"
      id="Fxbrl_20220721203017096"
      unitRef="Candidate">4</slgl:NumberOfGenericDrugCandidates>
    <slgl:ExpectedRevenueReceivableOverTwentyFourMonths
      contextRef="C_20211101"
      decimals="-3"
      id="Fxbrl_20220721163242015"
      unitRef="usd">21500000</slgl:ExpectedRevenueReceivableOverTwentyFourMonths>
    <slgl:NumberOfApprovedGenericDrugProducts
      contextRef="C_20211101"
      decimals="0"
      id="Fxbrl_20220802221729758"
      unitRef="Program">2</slgl:NumberOfApprovedGenericDrugProducts>
    <slgl:NumberOfUnapprovedGenericPrograms
      contextRef="C_20211101"
      decimals="0"
      id="Fxbrl_20220721163429797"
      unitRef="Program">8</slgl:NumberOfUnapprovedGenericPrograms>
    <slgl:UpfrontPaymentReceived
      contextRef="C_20211101to20211101"
      decimals="-3"
      id="Fxbrl_20220721163505699"
      unitRef="usd">1250000</slgl:UpfrontPaymentReceived>
    <slgl:PaymentReceivableInInstalments
      contextRef="C_20211101"
      decimals="-3"
      id="Fxbrl_20220721163600367"
      unitRef="usd">20250000</slgl:PaymentReceivableInInstalments>
    <slgl:NumberOfEqualQuarterlyInstalments
      contextRef="C_20211101"
      decimals="0"
      id="Fxbrl_20220721163635760"
      unitRef="Instalment">8</slgl:NumberOfEqualQuarterlyInstalments>
    <slgl:LicenseAgreementsTextBlock contextRef="C_20220101to20220630" id="FFact_285">
    &lt;div&gt;
      &lt;div&gt;
        &lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;strong&gt;&lt;span&gt;NOTE&lt;/span&gt;&lt;/strong&gt;&lt;span&gt;&#160;&lt;strong&gt;5 &lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&#x2013;&lt;/span&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;strong&gt; &lt;/strong&gt;&lt;/span&gt;&lt;strong&gt;&lt;span&gt;&lt;span style="color:black"&gt;LICENSE AGREEMENTS&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;strong&gt;&lt;span&gt;:&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-top:0pt;margin-left:24px;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif"&gt;&#160;&lt;/p&gt;
        &lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif;margin-left:20pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="color:black"&gt;In June 2021, the Company entered into two exclusive license agreements with Galderma for the commercialization of Twyneo&#xae; and Epsolay&#xae;, in the United States. According to the agreement, the Company has an option to regain commercialization rights five years following first commercialization. In the third quarter of 2021, the Company received $7.5 million for &lt;/span&gt;&lt;/span&gt;&lt;span&gt;&lt;span&gt;&lt;span style="color:black"&gt;Twyneo&#xae;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span&gt;&lt;span style="color:black"&gt; and $4 million for &lt;/span&gt;&lt;/span&gt;&lt;span&gt;&lt;span&gt;&lt;span style="color:black"&gt;Epsolay&#xae;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span&gt;&lt;span style="color:black"&gt; of upfront payments, which are refundable if FDA approval for each respective product is not received by December 31, 2021. &lt;/span&gt;&lt;/span&gt;&lt;span&gt;&lt;span style="color:black"&gt;On July 27, 2021, the Company announced that the FDA approved the Company&#x2019;s first proprietary drug product, Twyneo&#xae;&lt;/span&gt;&lt;/span&gt;&lt;span&gt;&lt;span style="color:black"&gt;.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
      &lt;/div&gt;
      &lt;div/&gt;
      &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;
      &lt;div&gt;
        &lt;div&gt;
          &lt;div style="text-align:justify;margin-left:20pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;On April 14, 2022, the Company announced that Twyneo&#xae; is available for purchase by consumers who obtain a prescription from their physician, See note 1. In March 2022, the Company has refunded the $4 million upfront payment to Galderma, since FDA approval for Epsolay&#xae; had not been received as of December 31, 2021. On April 25, 2022, the Company announced that the FDA approved the drug product, Epsolay&#xae;, which entitled the Company to $3.5 million milestone payment, according to the license agreement.&lt;span style="font-weight:bold"&gt;&#160;&lt;/span&gt;In May 2022, the Company has received the $3.5 million payment from Galderma. On June 2, 2022, the Company announced that Epsolay&#xae; is available for purchase by consumers who obtain a prescription from their physician, See note 1.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;/div&gt;
      &lt;/div&gt;
    &lt;/div&gt;
  </slgl:LicenseAgreementsTextBlock>
    <slgl:RefundableUpfrontPayment
      contextRef="C_20210930_srtProductOrServiceAxis_slglTwyneoMember_usgaapTypeOfArrangementAxis_slglLicenseAgreementsWithGaldermaMember"
      decimals="-5"
      id="Fxbrl_20220721220455933"
      unitRef="usd">7500000</slgl:RefundableUpfrontPayment>
    <slgl:RefundableUpfrontPayment
      contextRef="C_20210930_srtProductOrServiceAxis_slglEpsolayMember_usgaapTypeOfArrangementAxis_slglLicenseAgreementsWithGaldermaMember"
      decimals="-6"
      id="Fxbrl_20220721220959228"
      unitRef="usd">4000000</slgl:RefundableUpfrontPayment>
    <slgl:RefundUpFrontPayment
      contextRef="C_20220301to20220331"
      decimals="-6"
      id="Fxbrl_20220721222124939"
      unitRef="usd">4000000</slgl:RefundUpFrontPayment>
    <slgl:SalesMilestonePayments
      contextRef="C_20220401to20220425_srtProductOrServiceAxis_slglEpsolayMember_usgaapTypeOfArrangementAxis_slglLicenseAgreementsWithGaldermaMember"
      decimals="-5"
      id="Fxbrl_20220721170709301"
      unitRef="usd">3500000</slgl:SalesMilestonePayments>
    <slgl:RefundableUpfrontPayment
      contextRef="C_20220531_usgaapTypeOfArrangementAxis_slglLicenseAgreementsWithGaldermaMember"
      decimals="-5"
      id="Fxbrl_20220721170733213"
      unitRef="usd">3500000</slgl:RefundableUpfrontPayment>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="C_20220101to20220630" id="FFact_317">
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0px;margin-bottom:0pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-weight:bold"&gt;NOTE&lt;/span&gt;&lt;span&gt;&#160;&lt;span style="font-weight:bold"&gt;6 &#x2013; SHARE CAPITAL:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;div&gt;
      &lt;div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&#160;&lt;/div&gt;
        &lt;div style="text-align:justify;line-height:1.25;font-family:'Times New Roman',Times,serif;font-weight:bold;margin-left:20pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Options grants&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&#160;&lt;/div&gt;
        &lt;div style="text-align:justify;margin-left:20pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;During the six months ended June 30, 2022, the Company granted 722,488 options to employees and executive officers:&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
        &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&#160;&lt;/div&gt;
        &lt;div&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

              &lt;tr&gt;
                &lt;td style="width:20pt"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:15pt"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;i.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td style="width:auto;vertical-align:top;font-family:Times New Roman, Times, serif"&gt;
                  &lt;div style="line-height:1.25;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In March 2022, the Company granted a total of 148,907 options to several employees to purchase ordinary shares at an exercise price of $7.38 per share.&lt;/span&gt;&lt;/span&gt;&lt;br/&gt;&lt;br/&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The options vest over a period of 4 years; one quarter of the options vest on the first anniversary of the vesting commencement date (as described in each agreement) and the rest vest quarterly over the following three years. The options expire on the tenth anniversary of their grant date.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;div style="line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
        &lt;/div&gt;
        &lt;div&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

              &lt;tr&gt;
                &lt;td style="width:20pt"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:15pt"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;ii.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td style="width:auto;vertical-align:top;font-family:Times New Roman, Times, serif"&gt;
                  &lt;div style="line-height:1.25;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In March 2022, the Company granted a total of 271,517 options to several Executive Officers to purchase ordinary shares at an exercise price of $10 per share.&lt;/span&gt;&lt;/span&gt;&lt;br/&gt;&lt;br/&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The options vest over a period of 4 years; one quarter of the options vest on the first anniversary of the vesting commencement date (as described in each agreement) and the rest vest quarterly over the following three years. The options expire on the tenth anniversary of their grant date.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;div style="text-indent:38.4pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
        &lt;/div&gt;
        &lt;div&gt;
          &lt;table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"&gt;

              &lt;tr&gt;
                &lt;td style="width:20pt"&gt;&#160;&lt;/td&gt;
                &lt;td style="vertical-align:top;font-family:Times New Roman, Times, serif;width:15pt"&gt;
                  &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;iii.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
                &lt;td style="width:auto;vertical-align:top;font-family:Times New Roman, Times, serif"&gt;
                  &lt;div style="line-height:1.25;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;In March 2022, the board of directors approved and recommended the Company shareholders to approve a grant of 302,064 options to the Company's CEO to purchase ordinary shares at an exercise price of $10 per share. The Company's shareholders approved the grant in June 2022.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;div style="text-indent:38.4pt;line-height:1.25"&gt;&#160;&lt;/div&gt;
                  &lt;div style="line-height:1.25;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The options vest over a period of 4 years; one quarter of the options vest on the first anniversary of the vesting commencement date (as described in each agreement) and the rest vest quarterly over the following three years. The options expire on the tenth anniversary of their grant date.&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;
              &lt;/tr&gt;

          &lt;/table&gt;
        &lt;/div&gt;
      &lt;/div&gt;
    &lt;/div&gt;

      &lt;div&gt;
        &lt;div&gt;
          &lt;div style="text-align:justify;margin-left:20pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;
            &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The fair value of options granted in 2022 was $3,278. The underlying data used for computing the fair value of the options are as follows:&lt;/span&gt;&lt;/span&gt;
          &lt;/div&gt;
          &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&#160;&lt;/div&gt;
          &lt;div style="margin-left:20pt;margin-bottom:10pt"&gt;
            &lt;table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                &lt;tr&gt;
                  &lt;td style="vertical-align:top;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom"&gt;
                    &lt;div style="text-align:center;text-indent:20pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:top;width:88%;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom"&gt;
                    &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Value of one ordinary share&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7.72&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:top;width:88%;padding-bottom:4px;font-family:'Times New Roman',Times,serif" valign="bottom"&gt;
                    &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Dividend yield&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;font-family:'Times New Roman',Times,serif" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:top;width:88%;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom"&gt;
                    &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Expected volatility&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;62.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:top;width:88%;font-family:'Times New Roman',Times,serif;padding-bottom:4px" valign="bottom"&gt;
                    &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Risk-free interest rate&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:top;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom"&gt;
                    &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Expected term&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="vertical-align:top;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom"&gt;
                    &lt;div style="text-align:center;text-indent:20pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7 years&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          &lt;/div&gt;
        &lt;/div&gt;
      &lt;/div&gt;

    &lt;div/&gt;
    &lt;p style="margin-top:0pt;margin-left:27px;margin-bottom:0pt;text-align:left;font-size:10pt;font-family:Times New Roman, Times, serif;text-align:left"&gt;&#160;&lt;/p&gt;
    &lt;p style="margin-top:0pt;margin-bottom:0pt;text-align:justify;font-size:10pt;font-family:Times New Roman, Times, serif;margin-left:20pt"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;strong&gt;&lt;span&gt;&lt;span style="color:black"&gt;Ordinary shares&lt;/span&gt;&lt;/span&gt;&lt;/strong&gt;&lt;br/&gt;&lt;br/&gt;&lt;span&gt;&lt;span style="color:black"&gt;In July 2021, the Company entered into an ATM sales agreement with Jefferies LLC ("Jefferies"), pursuant to which the Company is entitled, at its sole discretion, to offer and sell through Jefferies, acting as sales agent, Shares having an aggregate offering price of up to $25.0&#160;million throughout the period during which the ATM facility remains in effect. The Company agreed to pay Jefferies a commission of&#160;3.0% of the gross proceeds from the sale of shares under the facility.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;
    &lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif;margin-left:20pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span&gt;&lt;span&gt;&lt;span style="color:black"&gt;From the effective date of the agreement through its expiration,&#160;41,154 shares were sold under the program for total gross proceeds of approximately $ &lt;/span&gt;&lt;/span&gt;&lt;span&gt;&lt;span style="color:black"&gt;0.5&#160;&lt;/span&gt;&lt;/span&gt;&lt;span&gt;&lt;span style="color:black"&gt;million.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;
    &lt;p style="margin-top:0pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman, Times, serif;margin-left:20pt;text-align:justify"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="color:black"&gt;In April 2022, the Company signed a new ATM agreement with Jefferies for total amount of $23 million. As of the issuance date of this report, no shares were sold under the new ATM agreement.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
  </us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_20220101to20220630_srtTitleOfIndividualAxis_slglEmployeesAndExecutiveOfficersMember"
      decimals="INF"
      id="Fxbrl_20220721173057826"
      unitRef="Shares">722488</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_20220301to20220331_srtTitleOfIndividualAxis_slglEmployeesMember"
      decimals="INF"
      id="Fxbrl_20220721173108962"
      unitRef="Shares">148907</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="C_20220331_srtTitleOfIndividualAxis_slglEmployeesMember"
      decimals="INF"
      id="Fxbrl_20220721173117602"
      unitRef="USDPShares">7.38</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="C_20220301to20220331_srtTitleOfIndividualAxis_slglEmployeesMember"
      id="Fxbrl_20220721173129398">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_20220301to20220331_srtTitleOfIndividualAxis_srtExecutiveOfficerMember"
      decimals="INF"
      id="Fxbrl_20220721173139898"
      unitRef="Shares">271517</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="C_20220331_srtTitleOfIndividualAxis_srtExecutiveOfficerMember"
      decimals="INF"
      id="Fxbrl_20220721173148339"
      unitRef="USDPShares">10</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="C_20220301to20220331_srtTitleOfIndividualAxis_srtExecutiveOfficerMember"
      id="Fxbrl_20220721173158462">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_20220301to20220331_srtTitleOfIndividualAxis_srtChiefExecutiveOfficerMember"
      decimals="INF"
      id="Fxbrl_20220721173211662"
      unitRef="Shares">302064</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="C_20220331_srtTitleOfIndividualAxis_srtChiefExecutiveOfficerMember"
      decimals="INF"
      id="Fxbrl_20220721173220544"
      unitRef="USDPShares">10</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="C_20220301to20220331_srtTitleOfIndividualAxis_srtChiefExecutiveOfficerMember"
      id="Fxbrl_20220721173231456">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock contextRef="C_20220101to20220630" id="FFact_307">
      &lt;div&gt;
        &lt;div&gt;
          &lt;div style="text-align:justify;margin-left:20pt;line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;
            &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;The fair value of options granted in 2022 was $3,278. The underlying data used for computing the fair value of the options are as follows:&lt;/span&gt;&lt;/span&gt;
          &lt;/div&gt;
          &lt;div style="line-height:1.25;font-family:'Times New Roman',Times,serif"&gt;&#160;&lt;/div&gt;
          &lt;div style="margin-left:20pt;margin-bottom:10pt"&gt;
            &lt;table border="0" cellpadding="0" cellspacing="0" style="width:90%;color:#000000;font-family:'Times New Roman', Times, serif;font-size:10pt;text-align:left"&gt;

                &lt;tr&gt;
                  &lt;td style="vertical-align:top;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="vertical-align:top;border-bottom:2px solid rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom"&gt;
                    &lt;div style="text-align:center;text-indent:20pt;line-height:1.25;font-weight:bold"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2022&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:2px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:top;width:88%;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom"&gt;
                    &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Value of one ordinary share&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;$&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7.72&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:top;width:88%;padding-bottom:4px;font-family:'Times New Roman',Times,serif" valign="bottom"&gt;
                    &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Dividend yield&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;font-family:'Times New Roman',Times,serif" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);font-family:'Times New Roman',Times,serif" valign="bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;0&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:top;width:88%;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom"&gt;
                    &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Expected volatility&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;62.6&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:top;width:88%;font-family:'Times New Roman',Times,serif;padding-bottom:4px" valign="bottom"&gt;
                    &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Risk-free interest rate&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;padding-bottom:4px" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;text-align:right;width:9%;font-family:'Times New Roman',Times,serif;border-bottom:4px double rgb(0, 0, 0)" valign="bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;2.5&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;width:1%;font-family:'Times New Roman',Times,serif;padding-bottom:4px;white-space:nowrap" valign="bottom"&gt;
                    &lt;div style="line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;%&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr&gt;
                  &lt;td style="vertical-align:top;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom"&gt;
                    &lt;div style="text-align:justify;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;Expected term&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="vertical-align:top;border-bottom:4px double rgb(0, 0, 0);background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif" valign="bottom"&gt;
                    &lt;div style="text-align:center;text-indent:20pt;line-height:1.25"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;7 years&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                  &lt;/td&gt;
                  &lt;td colspan="1" style="vertical-align:bottom;padding-bottom:4px;background-color:rgb(204, 238, 255);font-family:'Times New Roman',Times,serif;white-space:nowrap" valign="bottom"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;

            &lt;/table&gt;
          &lt;/div&gt;
        &lt;/div&gt;
      &lt;/div&gt;
    </us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
      contextRef="C_20220101to20220630"
      decimals="-3"
      id="FFact_297"
      unitRef="usd">3278000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:SharePrice
      contextRef="C_20220630"
      decimals="INF"
      id="FFact_298"
      unitRef="USDPShares">7.72</us-gaap:SharePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="C_20220101to20220630"
      decimals="INF"
      id="FFact_300"
      unitRef="pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="C_20220101to20220630"
      decimals="3"
      id="FFact_301"
      unitRef="pure">0.626</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="C_20220101to20220630"
      decimals="3"
      id="FFact_303"
      unitRef="pure">0.025</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="C_20220101to20220630" id="FFact_306">P7Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <slgl:AggregateOfferingPrice
      contextRef="C_20210701to20210731_usgaapRelatedPartyTransactionsByRelatedPartyAxis_slglJefferiesLlcMember"
      decimals="-6"
      id="Fxbrl_20220726213802308"
      unitRef="usd">25000000</slgl:AggregateOfferingPrice>
    <slgl:PercentageOfGrossProceedsFromSaleOfShares
      contextRef="C_20210701to20210731_usgaapRelatedPartyTransactionsByRelatedPartyAxis_slglJefferiesLlcMember"
      decimals="3"
      id="Fxbrl_20220721184050637"
      unitRef="pure">0.03</slgl:PercentageOfGrossProceedsFromSaleOfShares>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="C_20210701to20210731_usgaapRelatedPartyTransactionsByRelatedPartyAxis_slglJefferiesLlcMember"
      decimals="INF"
      id="Fxbrl_20220721184154893"
      unitRef="Shares">41154</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="C_20210701to20210731_usgaapRelatedPartyTransactionsByRelatedPartyAxis_slglJefferiesLlcMember"
      decimals="-5"
      id="Fxbrl_20220721184235909"
      unitRef="usd">500000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_20220401to20220430_usgaapRelatedPartyTransactionsByRelatedPartyAxis_slglJefferiesLlcMember"
      decimals="-6"
      id="Fxbrl_20220721184533343"
      unitRef="usd">23000000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="C_20220101to20220630" id="FFact_318">
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0px;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-weight:bold"&gt;NOTE 7&#x2009;&lt;/span&gt;&lt;span&gt;&#x2013;&lt;/span&gt;&lt;span style="font-weight:bold"&gt;&#x2009;RELATED PARTIES:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:0pt;margin-left:35pt;text-indent:-16pt;margin-bottom:0pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span style="font-weight:normal"&gt;a.&lt;/span&gt;&lt;span style="padding-left:9pt"&gt;Related parties include the controlling shareholder and companies under his control, the board of directors and the executive officers of the Company.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="margin:0pt"&gt;&#160;&lt;/p&gt;
    &lt;p style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;margin-bottom:0pt;margin-left:35pt;text-indent:-16pt"&gt;&lt;span style="font-family:Times New Roman,Times,serif"&gt;&lt;span style="font-size:10pt"&gt;&lt;span&gt;b.&lt;/span&gt;&lt;span style="padding-left:9pt"&gt;&lt;span&gt;As to options granted to executive officers, see note 6.&#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
  </us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#Fxbrl_20220802203330582"
          xlink:label="Fxbrl_20220802203330582"
          xlink:type="locator"/>
        <link:footnote id="FN20220802204601537" xlink:label="FN20220802204601537" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">less than $1 thousand.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20220802203330582"
          xlink:to="FN20220802204601537"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20220802203340661"
          xlink:label="Fxbrl_20220802203340661"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20220802203340661"
          xlink:to="FN20220802204601537"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20220802203405739"
          xlink:label="Fxbrl_20220802203405739"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20220802203405739"
          xlink:to="FN20220802204601537"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20220802203425221"
          xlink:label="Fxbrl_20220802203425221"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20220802203425221"
          xlink:to="FN20220802204601537"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20220802203547323"
          xlink:label="Fxbrl_20220802203547323"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20220802203547323"
          xlink:to="FN20220802204601537"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20220802203910105"
          xlink:label="Fxbrl_20220802203910105"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20220802203910105"
          xlink:to="FN20220802204601537"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_257"
          xlink:label="FFact_257"
          xlink:type="locator"/>
        <link:footnote id="FN20220721214244043" xlink:label="FN20220721214244043" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Investments in Corporate bonds rated A or higher.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_257"
          xlink:to="FN20220721214244043"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#FFact_258"
          xlink:label="FFact_258"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="FFact_258"
          xlink:to="FN20220721214244043"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>35
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
M.7\N?<^E[[GT/:'2MS<C?6?!TXM;WD9N6\3[KC':US0N*&-7<LW(QU2ODRG8
M.9_ [/UH/I[Q[?K9)(2OFEDM(Q:02X&S022X_(O*\"K$">AD6R4)RU3393>*
M$IY"&V[I4_5*E=?EK[DHN#Q;Y.FOH70^+,_Y/%_GM,T+,T.W<DOJMI2^M28X
M2O2QS'!.'LL,.V<\DAVV=Z =-?OV77;D(Z4P4Y=#N!I"O@-MNIW<.CB>F)&Y
M"M-2D&_#^>G%>!KB.=D$N7V85VWGV-'1^^?!4;"C[SR6'<>(\J(A[J&&F,_#
M0X=Y>U^89Y7&4#04;6RL)"Q&MV"XU_$L%.!D8"V@!X.O40+R4E5@,5O& RN0
MHGQ,C$7H<.>77%_CT9+CVZ9EM6ZO*7<9;2)2.<)IF!-GJ\K>9;'!51W/55OR
ML+YJ/;053L_^6:W(GPP13A8+$DACE!>F2J+S&5.^YRM)Q%4XOT4SMA*7&+SC
MYL=Q3E.X$G:V#P(RN;LYJ7IE,6>F\M\M# DL6XA9$N)-7>W5YYN<KGHB=OJ7
M=\%@\OUPR4</Y3OG7_1=0ZY^]MWC^FZ3.TA,G'G%$0%T10(CE1P&%A<RY%#N
MDI &$P'-E,E$\ *"9*8<@)CZ"[WR#+DI%<ZM/CE_12R#ADY>TB42%(JP# 4A
M%W+C[^^3:G>,U_HL@6V$5#)DU1?*0XG!/3-R0]A4)?.NVB8+A=OB5,V[&KXF
M8$O#>FZ=+2?_VU[4/;07/4;SHYG@'K.'<YMZN,)%K/]8UA[Y,M\Y<-LZW@->
MYA,L0Z1^P7V*BH 1JV*^NJ]/^26<.[1[\8$@F_S6VZ3VW> ,?-2K6J5D*Q$_
M2P=\'Y(&8XQ;]#1?CQ1BK::QK<;:,0QY@%CS#*%F.-^'19H:,]6+K#F-"F]!
MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MU^B?L^1E,@\DH4,6_.FOQ?:ZY;3 FFY(&H@%>[FE>4*6BN>Q(,G^@Y?<%K:
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M+W-H965T-"YX;6RUF/V3HC88Q_^5#+WIW,W<+80W<:O.(,1=.@J.Z%X[G?[
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M?J;EUE9YD2?[8N_F,<GS)"I.MSC8X)0*R/]/29*_7M &Z@W&T3]02P,$%
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MATS;XA<'I79(*9JK"HWENW)$4.Y"^BA(.53O%:+N/!#DK8[2DFY+29;"RNY
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M1ZA<,D"-FJL"T*4$4$#Q&%!@&D$J"Q)S-(9I+G; 9<%SYNK5&750!VBK($/
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M_02EDM-GQ?,*3SP\ZE+';J[O0X-O!SRHA:]\DG&Y1)\LMWU1LV7XWT"Z.2;
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M7$G0N!P'TVAXTW/R7N OCI796X.+9*'4#[>Y3\=!QSF$ A/K$!C]O>(M"N&
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M*!PF!8FZI&#CVT_,\(S*>Y-@/ *1B ]B.D758>/CQW/V*MA^!Z_;U".FHIP
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M4Y8&GE^6U)RHG0#=;Y2RW<89Z/^SS/X'4$L#!!0    (  U,!%5+3\#3#00
M -@)   9    >&PO=V]R:W-H965T<R]S:&5E=#$U+GAM;*U646_B.!!^]Z^P
MLJM5=\66))# LH $E&I[M]55I=U[.-V#209B-;%9VT#Y]S=V($WO:'0GW0O8
MSLPWWW@^CSW<2_6D,P!#GXM<Z)&7&;,9M-LZR:!@^E)N0."7E50%,SA5Z[;>
M*&"I<RKR=NC[<;M@7'CCH5N[4^.AW)J<"[A35&^+@JG#%'*Y'WF!=UJXY^O,
MV(7V>+AA:UB >=S<*9RU*Y24%R TEX(J6(V\23"8QM;>&?S@L->U,;69+*5\
MLI.;=.3YEA#DD!B+P/!O!S/(<PN$-'X>,;TJI'6LCT_HURYWS&7)-,QD_CM/
M33;R^AY-8<6VN;F7^V]PS">R>(G,M?NE^](V0N-DJXTLCL[(H."B_&?/QWVH
M.?3]-QS"HT/H>)>!',LK9MAXJ.2>*FN-:';@4G7>2(X+6Y2%4?B5HY\9WT[N
M?YT_3*;?YW0QGSW>WSS<S!<#>O' ECGHC\.VP2#6M)T< :<E8/@&8$QOI3"9
MIG.10OK:OXWD*H;AB>$T; 3\92LN:<=OT= /PP:\3I5QQ^%UWL"[$3O0!G5E
M=(M>P=)0)E(Z_[GEYD 7D&P5-QPT_6.RU$:A:OX\MPEEC.[Y&/8D#?2&)3#R
M\*AH4#OPQA_>!;'_M2&#;I5!MPE]O,"3F6YSH')%;YEZ F.+5>-^CG SY$,&
M="5S/*)<K&F)I\%H7%0FHP8_SV2Q8>+PX5T_#'I?-8JPBJQ?=@WMG347*4^8
M@91N0'&9Z@&Y@@2*)2C:"5H$JPJVJ@2K&MB?D'R''>0TK*$-R./E@J[E#I2P
M!7.5PE8AD@-=2I%J$O8B$K2"7I?\AE&5#8_G4-1]2L//:!;Y/3*3:B,5$BO7
M/^%RM],EO5801^1!&I;C2L__0KZT^MV8?J(UN6!2]&_^5+D<)Q33SK !@+IL
M*'!4%3AJ+G#9(6U]9QD3:W"AKQE7] ?+M_^M\(VASBO5JJ&$7MJN75<".[5O
MR\$6.GDA:*<K2W)W(OF_Z.;VG .Y/CH<@"D*MM=42PO^?&Q"KS1'G=2<*3W)
MSS45,F4Y$PE0AFJ!-1?"'H(C_9(&>4_"H!5'(0Y*?4S2E-M[19.XU0MB$O@M
MO ?)@MESJ3!+8YD>R$6(W_M=\I%<H&/'#FHUK6U7BO;V[+W$#,((G3H1NM08
M8@+_X.8HT?='T38H,*X4&/_K%N-Z9+/&&L'.:VRB+?:K.K3.ZB6UX6M*R5A:
M*JUJ5Z>]IBD*IQ),N:VO&DU(KG"C]]QDN/52E.+!3?.[ 9F"V0,(&GP.W;(F
M?3\ZNY7MVFU;@%J[-X6FB=P*4UZ\U6KU;)F4M_6+>?GF0:8H-TUS6*&K?]G#
MPZK*=T0Y,7+C[NZE-/@2<,,,GUZ@K %^7TEI3A,;H'K,C?\"4$L#!!0    (
M  U,!%6:_31>TP(  .8%   9    >&PO=V]R:W-H965T<R]S:&5E=#$V+GAM
M;'U4VV[:0!!]]U>,W/0FI=@QMX@"$DF(DJJI$"3I0]6'!8_QBO6NL[N&\/>=
MM<&E*N'%>YMSYASOSO0W2J],BFCA-1/2#/S4VKP7!&:18L9,0^4HZ211.F.6
MEGH9F%PCBTM0)H(H##M!QKCTA_UR;Z*'?558P25.-)@BRYC>7J%0FX%_X>\W
MIGR96K<1#/LY6^(,[5,^T;0*:I:89R@-5Q(T)@-_=-&[:KGX,N"9X\8<S,$Y
MF2NU<HO[>."'3A *7%C'P&A8XS4*X8A(QLN.TZ]3.N#A?,]^6WHG+W-F\%J)
MGSRVZ<"_]"'&A!7"3M7F#G=^VHYOH80IO["I8MN1#XO"6)7MP*0@X[(:V>ON
M/QP +L,W -$.$)6ZJT2ERAMFV;"OU0:TBR8V-RFMEF@2QZ6[E)G5=,H)9X>S
MN]%T#->CR?WCZ'L//CVRN4#SN1]8(G<AP6)'=%4116\0=>!!29L:&,L8XW_Q
M 8FJE45[95?12<)OA6Q ,SR'*(RB$WS-VFFSY&N^Y=2JQ2I5(D9M/L+XI>!V
M"S^41?@UFANKZ7W\/F:[8FT=9W4UTS,Y6^# IZ(PJ-?H#S^\N^B$7T]H;M6:
M6Z?8AS.JP;@0""J!D:'"R=U3-O!D, :K8&PLIY>)<,NXAF<F"CQFX622XQ8>
M4X3$D:X=J<NO=KF7FDE+Z;DL;P8VS,!9\SSJ7C; H0JZ?RVV7"XAIA<)A=-*
MW0,6*LL+Z_;M?^1N9Y^ :03B3)2@CF%ZGLOB/=<R) TZYI):")B4@KTSK]OH
M1MX-7_,890Q;CB+V0N^]-W[-J?HI_UH)9KF@*_<Z4:-#1U-N5E\2C4A&+))O
M"YK^I!<UVH= .LJ\+FR1:0/';C0XJ+T,];+L,(;,%M)695COUDUL5-7NW_"J
M SXPO>3T P0F! T;W;8/NNHJU<*JO*SDN;+4%\II2HT8M0N@\T31<]XM7(*Z
MM0__ %!+ P04    "  -3 15L%&@GE\"  ! !0  &0   'AL+W=O<FMS:&5E
M=',O<VAE970Q-RYX;6RM5-MNVS ,_17"*X86Z"I?>@DZQT":M&@'K F2=GL8
M]J#83"Q4ECQ)3KI]_239-5(@+?:PEUBD> [)$U+I5JHG72(:>*ZXT,.@-*:^
M)$3G)594G\@:A;U925518TVU)KI62 L/JCB)P_"<5)2)($N];Z:R5#:&,X$S
M!;JI*JI^7R&7VV$0!2^..5N7QCE(EM9TC0LTC_5,68OT+ 6K4&@F!2A<#8-1
M=#E.7+P/^,9PJW?.X#I92OGDC+MB&(2N(.28&\= [6>#8^3<$=DR?G6<09_2
M 7?/+^PWOG?;RY)J'$O^G16F' :#  I<T8:;N=S>8M?/F>/+)=?^%[9=;!A
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MS:8FG:G)]]X64"7HF_=D<J'R9M+/_VIPR_];2RYW/+N9C6O[Y.M< -_778Y
M":NH;#XRW6K72"WJ_J&WOG2GJZ8?^H^FZ<[4YU=5$X%RV"E*YSI4DGC3\303
MR<JZ!]@RJ3J*>IBI)A&X#E#/=XS)UXG>H&L[HW\!4$L#!!0    (  U,!%5$
MEIT/60(  -P$   9    >&PO=V]R:W-H965T<R]S:&5E=#(Q+GAM;'U4;6^;
M,!#^*Q:KME;J"B%IUV4$*6_3LJU2%=KMP[0/#KD$JV!3^PC-O]_94)1M:;_
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M:W-H965T<R]S:&5E=#(S+GAM;,69VV[C-A"&7X50%T4"M-'!AR2N;2"QV&V
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M24BY/D&]OV1,/NSH :I_ YC^!U!+ P04    "  -3 15@K"P&-D"  #^!@
M&0   'AL+W=O<FMS:&5E=',O<VAE970R-2YX;6R-55%OVC 0_BNG;)I::24A
M+80QB!0H53NU$H*U>YCV8,@!5ITXLPV4?[^S QF3TF@OB>W<?=]W=[[+8"_5
MJ]X@&GC+1*Z'WL:8HN_[>KG!C.F6+#"G+RNI,F9HJ]:^+A2RU#EEP@^#H.MG
MC.=>/'!G4Q4/Y-8(GN-4@=YF&5.'$0JY'WIM[W0PX^N-L0=^/"C8&N=HGHNI
MHIU?H:0\PUQSF8/"U=!+VOU1S]H[@Q>.>WVV!AO)0LI7NWE(AUY@!:' I;$(
MC%X['*,0%HAD_#YB>A6E=3Q?G]#O7.P4RX)I'$OQ@Z=F,_1Z'J2X8EMA9G)_
MC\=X.A9O*85V3]B7MM$7#Y9;;61V="8%&<_+-WL[YN',(>R\XQ >'4*GNR1R
M*F^98?% R3TH:TUH=N%"==XDCN>V*'.CZ"LG/Q//[Y/9!,;)].%[\MB'BSE5
M/=T*!+F"1%.I"IL\#<\:4S 2)MIPR@7"'>,*7IC8XB5<W*)A7.C+@6](DT7V
MET?^4<D?OL/?A2>9FXV&29YB^J^_3[%4 86G@$9A(^"W;=Z"Z^ SA$$8PD?P
M06^80MT ?5WEZMI!7[^7*PMT9>] "F.945]HYJY6HA3+UTAWU<#B .=V4W9P
MQ\F>J11^/A(D/!C,]*^Z7)7\-_7\MC_[NF!+''K4@!K5#KWXTX=V-_C:$-U-
M%=U-$WKL:FG++DFB5"G/J4G+Y-5)+<%Z#LQV_BZ.6E$X\'<U$CJ5A$ZCA%N^
MXRGF*1PXBK2.M?1O!V>T03UGM^+L-G).W@H:$%2IG1143<'-H8ZX!&FWSXE;
MW;!;3QY5Y%$C^8SKUZN50@2>&Z2:&E#47'4"HCH!0=BI%]"K!/3^+WIBS^IH
MF]TC."!3M;WEG\VD#-7:35X-2[G-33F>JM-JN"?E3/MK7OX9GIA:<YI! E?D
M&K0BN@6JG+;EQLC"3;B%-#0OW7)#/RA4UH"^KZ0TIXTEJ'YY\1]02P,$%
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ME,4/VK&@7?R@/0O:QP\ZL*!#_"!(N8RI@*0%U@*T!LXU"/ :.-@@0&S@9(,
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MG\SM6ABI[,&?=?\E9I]02P$"% ,4    "  -3 15!T%-8H$   "Q    $
M            @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    (  U,
M!%5Y,T0([P   "L"   1              "  :\   !D;V-0<F]P<R]C;W)E
M+GAM;%!+ 0(4 Q0    (  U,!%697)PC$ 8  )PG   3              "
M <T!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ #4P$5<+9_TI&
M P  * L  !@              ("!#@@  'AL+W=O<FMS:&5E=',O<VAE970Q
M+GAM;%!+ 0(4 Q0    (  U,!%4>;OLH= 8  )L:   8              "
M@8H+  !X;"]W;W)K<VAE971S+W-H965T,BYX;6Q02P$"% ,4    "  -3 15
M9OG8?K "  !9!P  &               @($T$@  >&PO=V]R:W-H965T<R]S
M:&5E=#,N>&UL4$L! A0#%     @ #4P$54Q_FC/:!   ;!0  !@
M     ("!&A4  'AL+W=O<FMS:&5E=',O<VAE970T+GAM;%!+ 0(4 Q0    (
M  U,!%6SHFX]8P<  .8Q   8              " @2H:  !X;"]W;W)K<VAE
M971S+W-H965T-2YX;6Q02P$"% ,4    "  -3 15P.W'7C0)   /.P  &
M            @('#(0  >&PO=V]R:W-H965T<R]S:&5E=#8N>&UL4$L! A0#
M%     @ #4P$5;P"C&7;"   [!0  !@              ("!+2L  'AL+W=O
M<FMS:&5E=',O<VAE970W+GAM;%!+ 0(4 Q0    (  U,!%4W5'2[O ,  &T(
M   8              " @3XT  !X;"]W;W)K<VAE971S+W-H965T."YX;6Q0
M2P$"% ,4    "  -3 15'%8_(Z4$   \"@  &               @($P.
M>&PO=V]R:W-H965T<R]S:&5E=#DN>&UL4$L! A0#%     @ #4P$5<BF?(Q&
M!@  50\  !D              ("!"ST  'AL+W=O<FMS:&5E=',O<VAE970Q
M,"YX;6Q02P$"% ,4    "  -3 15FG?S6P0$  !Q"0  &0
M@(&(0P  >&PO=V]R:W-H965T<R]S:&5E=#$Q+GAM;%!+ 0(4 Q0    (  U,
M!%4(UG+HE@4  %8/   9              " @<-'  !X;"]W;W)K<VAE971S
M+W-H965T,3(N>&UL4$L! A0#%     @ #4P$5:@;H?^+ @  K 4  !D
M         ("!D$T  'AL+W=O<FMS:&5E=',O<VAE970Q,RYX;6Q02P$"% ,4
M    "  -3 15MKP]#L(#  "_"   &0              @(%24   >&PO=V]R
M:W-H965T<R]S:&5E=#$T+GAM;%!+ 0(4 Q0    (  U,!%5+3\#3#00  -@)
M   9              " @4M4  !X;"]W;W)K<VAE971S+W-H965T,34N>&UL
M4$L! A0#%     @ #4P$59K]-%[3 @  Y@4  !D              ("!CU@
M 'AL+W=O<FMS:&5E=',O<VAE970Q-BYX;6Q02P$"% ,4    "  -3 15L%&@
MGE\"  ! !0  &0              @(&96P  >&PO=V]R:W-H965T<R]S:&5E
M=#$W+GAM;%!+ 0(4 Q0    (  U,!%704LZ)J@(  -0'   9
M  " @2]>  !X;"]W;W)K<VAE971S+W-H965T,3@N>&UL4$L! A0#%     @
M#4P$53V01HK  P  WQ$  !D              ("!$&$  'AL+W=O<FMS:&5E
M=',O<VAE970Q.2YX;6Q02P$"% ,4    "  -3 15%RP:9'<#  """@  &0
M            @($'90  >&PO=V]R:W-H965T<R]S:&5E=#(P+GAM;%!+ 0(4
M Q0    (  U,!%5$EIT/60(  -P$   9              " @;5H  !X;"]W
M;W)K<VAE971S+W-H965T,C$N>&UL4$L! A0#%     @ #4P$55N]>Z/_ P
MVP\  !D              ("!16L  'AL+W=O<FMS:&5E=',O<VAE970R,BYX
M;6Q02P$"% ,4    "  -3 153&;U:/D#   Y&   &0              @(%[
M;P  >&PO=V]R:W-H965T<R]S:&5E=#(S+GAM;%!+ 0(4 Q0    (  U,!%5
MR 6, @8  !(P   9              " @:MS  !X;"]W;W)K<VAE971S+W-H
M965T,C0N>&UL4$L! A0#%     @ #4P$58*PL!C9 @  _@8  !D
M     ("!Y'D  'AL+W=O<FMS:&5E=',O<VAE970R-2YX;6Q02P$"% ,4
M"  -3 154\" @D4#  !($P  #0              @ 'T?   >&PO<W1Y;&5S
M+GAM;%!+ 0(4 Q0    (  U,!%67BKL<P    !,"   +              "
M 62   !?<F5L<R\N<F5L<U!+ 0(4 Q0    (  U,!%5W96_BUP(  (81   /
M              "  4V!  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    "  -
M3 15?ME0(CP!  "R#P  &@              @ %1A   >&PO7W)E;',O=V]R
M:V)O;VLN>&UL+G)E;'-02P$"% ,4    "  -3 15*]!RCG(!  "?$   $P
M            @ '%A0  6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     (0 A
+ -X(  !HAP     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>73</ContextCount>
  <ElementCount>123</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>18</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>9</UnitCount>
  <MyReports>
    <Report instance="zk2228238.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sol-gel.co/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="zk2228238.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sol-gel.co/role/CondensedConsolidatedBalanceSheets</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="zk2228238.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sol-gel.co/role/CondensedConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="zk2228238.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfOperations</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="zk2228238.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="zk2228238.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfCashFlows</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="zk2228238.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0007 - Disclosure - NATURE OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sol-gel.co/role/NatureOfOperations</Role>
      <ShortName>NATURE OF OPERATIONS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="zk2228238.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0008 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES:</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sol-gel.co/role/SignificantAccountingPolicies</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES:</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="zk2228238.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0009 - Disclosure - MARKETABLE SECURITIES:</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sol-gel.co/role/MarketableSecurities</Role>
      <ShortName>MARKETABLE SECURITIES:</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="zk2228238.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0010 - Disclosure - COLLABORATION AGREEMENTS:</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sol-gel.co/role/CollaborationAgreements</Role>
      <ShortName>COLLABORATION AGREEMENTS:</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="zk2228238.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0011 - Disclosure - LICENSE AGREEMENTS:</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sol-gel.co/role/LicenseAgreements</Role>
      <ShortName>LICENSE AGREEMENTS:</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="zk2228238.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0012 - Disclosure - SHARE CAPITAL:</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sol-gel.co/role/ShareCapital</Role>
      <ShortName>SHARE CAPITAL:</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="zk2228238.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0013 - Disclosure - RELATED PARTIES:</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sol-gel.co/role/RelatedParties</Role>
      <ShortName>RELATED PARTIES:</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="zk2228238.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0015 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES: (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sol-gel.co/role/SignificantAccountingPoliciesPolicies</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES: (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="zk2228238.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0016 - Disclosure - MARKETABLE SECURITIES: (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sol-gel.co/role/MarketableSecuritiesTables</Role>
      <ShortName>MARKETABLE SECURITIES: (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.sol-gel.co/role/MarketableSecurities</ParentRole>
      <Position>15</Position>
    </Report>
    <Report instance="zk2228238.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0017 - Disclosure - SHARE CAPITAL: (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sol-gel.co/role/ShareCapitalTables</Role>
      <ShortName>SHARE CAPITAL: (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.sol-gel.co/role/ShareCapital</ParentRole>
      <Position>16</Position>
    </Report>
    <Report instance="zk2228238.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0018 - Disclosure - NATURE OF OPERATIONS (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sol-gel.co/role/NatureOfOperationsDetails</Role>
      <ShortName>NATURE OF OPERATIONS (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.sol-gel.co/role/NatureOfOperations</ParentRole>
      <Position>17</Position>
    </Report>
    <Report instance="zk2228238.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>0019 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES: (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sol-gel.co/role/SignificantAccountingPoliciesNarrativeDetails</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES: (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.sol-gel.co/role/SignificantAccountingPoliciesPolicies</ParentRole>
      <Position>18</Position>
    </Report>
    <Report instance="zk2228238.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>0020 - Disclosure - MARKETABLE SECURITIES: (Schedule of Company's Marketable Securities) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sol-gel.co/role/MarketableSecuritiesScheduleOfCompanysMarketableSecuritiesDetails</Role>
      <ShortName>MARKETABLE SECURITIES: (Schedule of Company's Marketable Securities) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.sol-gel.co/role/MarketableSecuritiesTables</ParentRole>
      <Position>19</Position>
    </Report>
    <Report instance="zk2228238.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>0021 - Disclosure - MARKETABLE SECURITIES: (Schedule of Changes in Fair Value of Company's Marketable Securities) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sol-gel.co/role/MarketableSecuritiesSummaryOfChangesInFairValueOfCompanysMarketableSecuritiesDetails</Role>
      <ShortName>MARKETABLE SECURITIES: (Schedule of Changes in Fair Value of Company's Marketable Securities) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.sol-gel.co/role/MarketableSecuritiesTables</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="zk2228238.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>0022 - Disclosure - MARKETABLE SECURITIES: (Schedule of Company's debt marketable securities) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sol-gel.co/role/MarketableSecuritiesScheduleOfCompanysDebtMarketableSecuritiesDetails</Role>
      <ShortName>MARKETABLE SECURITIES: (Schedule of Company's debt marketable securities) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.sol-gel.co/role/MarketableSecuritiesTables</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="zk2228238.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>0023 - Disclosure - COLLABORATION AGREEMENTS: (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sol-gel.co/role/CollaborationAgreementsDetails</Role>
      <ShortName>COLLABORATION AGREEMENTS: (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.sol-gel.co/role/CollaborationAgreements</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="zk2228238.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>0024 - Disclosure - LICENSE AGREEMENTS: (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sol-gel.co/role/LicenseAgreementsDetails</Role>
      <ShortName>LICENSE AGREEMENTS: (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.sol-gel.co/role/LicenseAgreements</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="zk2228238.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>0025 - Disclosure - SHARE CAPITAL: (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sol-gel.co/role/ShareCapitalNarrativeDetails</Role>
      <ShortName>SHARE CAPITAL: (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.sol-gel.co/role/ShareCapitalTables</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="zk2228238.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>0026 - Disclosure - SHARE CAPITAL: (Schedule of Assumptions Used to Estimate Fair Value) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sol-gel.co/role/ShareCapitalScheduleOfAssumptionsUsedToEstimateFairValueDetails</Role>
      <ShortName>SHARE CAPITAL: (Schedule of Assumptions Used to Estimate Fair Value) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.sol-gel.co/role/ShareCapitalTables</ParentRole>
      <Position>25</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="6-K" isDefinitelyFs="true" isUsgaap="true" original="zk2228238.htm">zk2228238.htm</File>
    <File doctype="6-K" isDefinitelyFs="true" isUsgaap="true" original="exhibit_99-2.htm">exhibit_99-2.htm</File>
    <File>slgl-20220630.xsd</File>
    <File>slgl-20220630_cal.xml</File>
    <File>slgl-20220630_def.xml</File>
    <File>slgl-20220630_lab.xml</File>
    <File>slgl-20220630_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="274">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="13">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>40
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "zk2228238.htm exhibit_99-2.htm": {
   "nsprefix": "slgl",
   "nsuri": "http://www.sol-gel.co/20220630",
   "dts": {
    "inline": {
     "local": [
      "exhibit_99-2.htm",
      "zk2228238.htm"
     ]
    },
    "schema": {
     "local": [
      "slgl-20220630.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/currency/2022/currency-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd",
      "https://xbrl.sec.gov/exch/2022/exch-2022.xsd",
      "https://xbrl.sec.gov/naics/2022/naics-2022.xsd",
      "https://xbrl.sec.gov/sic/2022/sic-2022.xsd",
      "https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "slgl-20220630_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "slgl-20220630_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "slgl-20220630_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "slgl-20220630_pre.xml"
     ]
    }
   },
   "keyStandard": 99,
   "keyCustom": 24,
   "axisStandard": 7,
   "axisCustom": 0,
   "memberStandard": 10,
   "memberCustom": 8,
   "hidden": {
    "total": 13,
    "http://fasb.org/us-gaap/2022": 7,
    "http://xbrl.sec.gov/dei/2022": 6
   },
   "contextCount": 73,
   "entityCount": 1,
   "segmentCount": 18,
   "elementCount": 213,
   "unitCount": 9,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2022": 274,
    "http://xbrl.sec.gov/dei/2022": 13
   },
   "report": {
    "R1": {
     "role": "http://www.sol-gel.co/role/DocumentAndEntityInformation",
     "longName": "0001 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "C_20220101to20220630",
      "name": "dei:DocumentFiscalYearFocus",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "span",
       "span",
       "span",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2228238.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20220101to20220630",
      "name": "dei:DocumentFiscalYearFocus",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "span",
       "span",
       "span",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2228238.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://www.sol-gel.co/role/CondensedConsolidatedBalanceSheets",
     "longName": "0002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "2",
     "firstAnchor": {
      "contextRef": "C_20220630",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-2.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20220630",
      "name": "us-gaap:DepositsAssetsCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-2.htm",
      "unique": true
     }
    },
    "R3": {
     "role": "http://www.sol-gel.co/role/CondensedConsolidatedBalanceSheetsParenthetical",
     "longName": "0003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "C_20220630",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "unitRef": "ILSPerShare",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "us-gaap:CommonStockParOrStatedValuePerShare",
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-2.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20220630",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "unitRef": "ILSPerShare",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "us-gaap:CommonStockParOrStatedValuePerShare",
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-2.htm",
      "first": true,
      "unique": true
     }
    },
    "R4": {
     "role": "http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfOperations",
     "longName": "0004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "C_20220401to20220630",
      "name": "us-gaap:Revenues",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-2.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20220401to20220630",
      "name": "us-gaap:Revenues",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-2.htm",
      "first": true,
      "unique": true
     }
    },
    "R5": {
     "role": "http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity",
     "longName": "0005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (Unaudited)",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (Unaudited)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "C_20201231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember",
      "name": "us-gaap:StockholdersEquity",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-2.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20201231_usgaapStatementEquityComponentsAxis_usgaapCommonStockMember",
      "name": "us-gaap:StockholdersEquity",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-2.htm",
      "first": true,
      "unique": true
     }
    },
    "R6": {
     "role": "http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfCashFlows",
     "longName": "0006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "C_20220401to20220630",
      "name": "us-gaap:ProfitLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-2.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20220101to20220630",
      "name": "us-gaap:Depreciation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-2.htm",
      "unique": true
     }
    },
    "R7": {
     "role": "http://www.sol-gel.co/role/NatureOfOperations",
     "longName": "0007 - Disclosure - NATURE OF OPERATIONS",
     "shortName": "NATURE OF OPERATIONS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "7",
     "firstAnchor": {
      "contextRef": "C_20220101to20220630",
      "name": "us-gaap:NatureOfOperations",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-2.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20220101to20220630",
      "name": "us-gaap:NatureOfOperations",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-2.htm",
      "first": true,
      "unique": true
     }
    },
    "R8": {
     "role": "http://www.sol-gel.co/role/SignificantAccountingPolicies",
     "longName": "0008 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES:",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES:",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "8",
     "firstAnchor": {
      "contextRef": "C_20220101to20220630",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-2.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20220101to20220630",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-2.htm",
      "first": true,
      "unique": true
     }
    },
    "R9": {
     "role": "http://www.sol-gel.co/role/MarketableSecurities",
     "longName": "0009 - Disclosure - MARKETABLE SECURITIES:",
     "shortName": "MARKETABLE SECURITIES:",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "C_20220101to20220630",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-2.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20220101to20220630",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-2.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://www.sol-gel.co/role/CollaborationAgreements",
     "longName": "0010 - Disclosure - COLLABORATION AGREEMENTS:",
     "shortName": "COLLABORATION AGREEMENTS:",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "C_20220101to20220630",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-2.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20220101to20220630",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-2.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://www.sol-gel.co/role/LicenseAgreements",
     "longName": "0011 - Disclosure - LICENSE AGREEMENTS:",
     "shortName": "LICENSE AGREEMENTS:",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "C_20220101to20220630",
      "name": "slgl:LicenseAgreementsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-2.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20220101to20220630",
      "name": "slgl:LicenseAgreementsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-2.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://www.sol-gel.co/role/ShareCapital",
     "longName": "0012 - Disclosure - SHARE CAPITAL:",
     "shortName": "SHARE CAPITAL:",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "C_20220101to20220630",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-2.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20220101to20220630",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-2.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://www.sol-gel.co/role/RelatedParties",
     "longName": "0013 - Disclosure - RELATED PARTIES:",
     "shortName": "RELATED PARTIES:",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "C_20220101to20220630",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-2.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20220101to20220630",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-2.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://www.sol-gel.co/role/SignificantAccountingPoliciesPolicies",
     "longName": "0015 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES: (Policies)",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES: (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "14",
     "firstAnchor": {
      "contextRef": "C_20220101to20220630",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-2.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20220101to20220630",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-2.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://www.sol-gel.co/role/MarketableSecuritiesTables",
     "longName": "0016 - Disclosure - MARKETABLE SECURITIES: (Tables)",
     "shortName": "MARKETABLE SECURITIES: (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "15",
     "firstAnchor": {
      "contextRef": "C_20220101to20220630",
      "name": "us-gaap:MarketableSecuritiesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-2.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20220101to20220630",
      "name": "us-gaap:MarketableSecuritiesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-2.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://www.sol-gel.co/role/ShareCapitalTables",
     "longName": "0017 - Disclosure - SHARE CAPITAL: (Tables)",
     "shortName": "SHARE CAPITAL: (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "16",
     "firstAnchor": {
      "contextRef": "C_20220101to20220630",
      "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-2.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20220101to20220630",
      "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-2.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://www.sol-gel.co/role/NatureOfOperationsDetails",
     "longName": "0018 - Disclosure - NATURE OF OPERATIONS (Narrative) (Details)",
     "shortName": "NATURE OF OPERATIONS (Narrative) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "17",
     "firstAnchor": {
      "contextRef": "C_20220630",
      "name": "us-gaap:RetainedEarningsAccumulatedDeficit",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-2.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R18": {
     "role": "http://www.sol-gel.co/role/SignificantAccountingPoliciesNarrativeDetails",
     "longName": "0019 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES: (Narrative) (Details)",
     "shortName": "SIGNIFICANT ACCOUNTING POLICIES: (Narrative) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "18",
     "firstAnchor": {
      "contextRef": "C_20220401to20220630",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-2.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20220401to20220630",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-2.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://www.sol-gel.co/role/MarketableSecuritiesScheduleOfCompanysMarketableSecuritiesDetails",
     "longName": "0020 - Disclosure - MARKETABLE SECURITIES: (Schedule of Company's Marketable Securities) (Details)",
     "shortName": "MARKETABLE SECURITIES: (Schedule of Company's Marketable Securities) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "19",
     "firstAnchor": {
      "contextRef": "C_20220630",
      "name": "us-gaap:MarketableSecuritiesCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-2.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20220630_usgaapInvestmentTypeAxis_usgaapUSGovernmentCorporationsAndAgenciesSecuritiesMember",
      "name": "us-gaap:MarketableSecuritiesCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "us-gaap:MarketableSecuritiesTextBlock",
       "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-2.htm",
      "unique": true
     }
    },
    "R20": {
     "role": "http://www.sol-gel.co/role/MarketableSecuritiesSummaryOfChangesInFairValueOfCompanysMarketableSecuritiesDetails",
     "longName": "0021 - Disclosure - MARKETABLE SECURITIES: (Schedule of Changes in Fair Value of Company's Marketable Securities) (Details)",
     "shortName": "MARKETABLE SECURITIES: (Schedule of Changes in Fair Value of Company's Marketable Securities) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "20",
     "firstAnchor": {
      "contextRef": "C_20211231",
      "name": "us-gaap:MarketableSecuritiesCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-2.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R21": {
     "role": "http://www.sol-gel.co/role/MarketableSecuritiesScheduleOfCompanysDebtMarketableSecuritiesDetails",
     "longName": "0022 - Disclosure - MARKETABLE SECURITIES: (Schedule of Company's debt marketable securities) (Details)",
     "shortName": "MARKETABLE SECURITIES: (Schedule of Company's debt marketable securities) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "21",
     "firstAnchor": {
      "contextRef": "C_20220630",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-2.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20220630",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-2.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://www.sol-gel.co/role/CollaborationAgreementsDetails",
     "longName": "0023 - Disclosure - COLLABORATION AGREEMENTS: (Narrative) (Details)",
     "shortName": "COLLABORATION AGREEMENTS: (Narrative) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "22",
     "firstAnchor": {
      "contextRef": "C_20211101",
      "name": "slgl:NumberOfGenericCollaborativeAgreementsToSellRights",
      "unitRef": "Agreement",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-2.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20211101",
      "name": "slgl:NumberOfGenericCollaborativeAgreementsToSellRights",
      "unitRef": "Agreement",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-2.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://www.sol-gel.co/role/LicenseAgreementsDetails",
     "longName": "0024 - Disclosure - LICENSE AGREEMENTS: (Narrative) (Details)",
     "shortName": "LICENSE AGREEMENTS: (Narrative) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "23",
     "firstAnchor": {
      "contextRef": "C_20220301to20220331",
      "name": "slgl:RefundUpFrontPayment",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "span",
       "span",
       "span",
       "div",
       "div",
       "div",
       "div",
       "slgl:LicenseAgreementsTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-2.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20220301to20220331",
      "name": "slgl:RefundUpFrontPayment",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "span",
       "span",
       "span",
       "div",
       "div",
       "div",
       "div",
       "slgl:LicenseAgreementsTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-2.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://www.sol-gel.co/role/ShareCapitalNarrativeDetails",
     "longName": "0025 - Disclosure - SHARE CAPITAL: (Narrative) (Details)",
     "shortName": "SHARE CAPITAL: (Narrative) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "24",
     "firstAnchor": {
      "contextRef": "C_20220101to20220630",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-2.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20220101to20220630",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "div",
       "div",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-2.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://www.sol-gel.co/role/ShareCapitalScheduleOfAssumptionsUsedToEstimateFairValueDetails",
     "longName": "0026 - Disclosure - SHARE CAPITAL: (Schedule of Assumptions Used to Estimate Fair Value) (Details)",
     "shortName": "SHARE CAPITAL: (Schedule of Assumptions Used to Estimate Fair Value) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "25",
     "firstAnchor": {
      "contextRef": "C_20220630",
      "name": "us-gaap:SharePrice",
      "unitRef": "USDPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-2.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_20220630",
      "name": "us-gaap:SharePrice",
      "unitRef": "USDPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exhibit_99-2.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "us-gaap_AccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "AccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "AccountsPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.sol-gel.co/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.sol-gel.co/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts payable",
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r295"
     ]
    },
    "us-gaap_AccountsReceivableNetNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "AccountsReceivableNetNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.sol-gel.co/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0,
       "order": 40.0
      }
     },
     "presentation": [
      "http://www.sol-gel.co/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Receivable, after Allowance for Credit Loss, Noncurrent",
        "terseLabel": "Long-term receivables from collaborative arrangements",
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r120",
      "r247",
      "r252"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "AdditionalPaidInCapitalCommonStock",
     "crdr": "credit",
     "calculation": {
      "http://www.sol-gel.co/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.sol-gel.co/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional paid-in capital",
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "AdditionalPaidInCapitalMember",
     "presentation": [
      "http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Paid-In Capital [Member]",
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r197",
      "r198",
      "r199",
      "r306",
      "r307",
      "r308",
      "r321"
     ]
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments required to reconcile loss to net cash used in operating activities:"
       }
      }
     },
     "auth_ref": []
    },
    "slgl_AggregateOfferingPrice": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sol-gel.co/20220630",
     "localname": "AggregateOfferingPrice",
     "crdr": "debit",
     "presentation": [
      "http://www.sol-gel.co/role/ShareCapitalNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the amount of aggregate offering price.",
        "label": "Aggregate Offering Price",
        "terseLabel": "Aggregate offering price"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AllOtherCorporateBondsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "AllOtherCorporateBondsMember",
     "presentation": [
      "http://www.sol-gel.co/role/MarketableSecuritiesScheduleOfCompanysMarketableSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Corporate bonds [Member]",
        "documentation": "Investments in corporate fixed maturity debt securities classified as other."
       }
      }
     },
     "auth_ref": [
      "r34"
     ]
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.sol-gel.co/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "presentation": [
      "http://www.sol-gel.co/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Anti-dilutive shares",
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r101"
     ]
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "presentation": [
      "http://www.sol-gel.co/role/LicenseAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]",
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://www.sol-gel.co/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.sol-gel.co/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Default Label]",
        "totalLabel": "TOTAL ASSETS",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events."
       }
      }
     },
     "auth_ref": [
      "r47",
      "r52",
      "r67",
      "r80",
      "r108",
      "r111",
      "r115",
      "r122",
      "r128",
      "r129",
      "r130",
      "r131",
      "r132",
      "r133",
      "r134",
      "r135",
      "r136",
      "r203",
      "r207",
      "r213",
      "r295",
      "r314",
      "r315",
      "r326"
     ]
    },
    "us-gaap_AssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "AssetsAbstract",
     "presentation": [
      "http://www.sol-gel.co/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "AssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.sol-gel.co/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.sol-gel.co/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current",
        "totalLabel": "TOTAL CURRENT ASSETS",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events."
       }
      }
     },
     "auth_ref": [
      "r64",
      "r68",
      "r80",
      "r122",
      "r128",
      "r129",
      "r130",
      "r131",
      "r132",
      "r133",
      "r134",
      "r135",
      "r136",
      "r203",
      "r207",
      "r213",
      "r295",
      "r314",
      "r315",
      "r326"
     ]
    },
    "us-gaap_AssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "AssetsCurrentAbstract",
     "presentation": [
      "http://www.sol-gel.co/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "CURRENT ASSETS:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "AssetsNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.sol-gel.co/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.sol-gel.co/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Noncurrent",
        "totalLabel": "TOTAL NON-CURRENT ASSETS",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r80",
      "r122",
      "r128",
      "r129",
      "r130",
      "r131",
      "r132",
      "r133",
      "r134",
      "r135",
      "r136",
      "r203",
      "r207",
      "r213",
      "r314",
      "r315",
      "r326"
     ]
    },
    "us-gaap_AssetsNoncurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "AssetsNoncurrentAbstract",
     "presentation": [
      "http://www.sol-gel.co/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "NON-CURRENT ASSETS:"
       }
      }
     },
     "auth_ref": []
    },
    "slgl_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sol-gel.co/20220630",
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue",
     "crdr": "debit",
     "presentation": [
      "http://www.sol-gel.co/role/MarketableSecuritiesScheduleOfCompanysDebtMarketableSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), maturing in two fiscal year following latest fiscal year. Excludes interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.",
        "label": "Available For Sale Securities Debt Maturities After One Through Two Years Fair Value",
        "verboseLabel": "Between 1-2 years"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue",
     "crdr": "debit",
     "presentation": [
      "http://www.sol-gel.co/role/MarketableSecuritiesScheduleOfCompanysDebtMarketableSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Due within one year",
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r35",
      "r121",
      "r250"
     ]
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "presentation": [
      "http://www.sol-gel.co/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basis of presentation",
        "verboseLabel": "Basis of Presentation",
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "calculation": {
      "http://www.sol-gel.co/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 0.0
      },
      "http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.sol-gel.co/role/CondensedConsolidatedBalanceSheets",
      "http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Cash and Cash equivalents",
        "label": "Cash and cash equivalents",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r27",
      "r66",
      "r280"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AT END OF THE PERIODS",
        "periodStartLabel": "CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AT BEGINNING OF THE PERIOD",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "terseLabel": "CASH AND CASH EQUIVALENTS AND RESTRICTED CASH SHOWN IN STATEMENT OF CASH FLOWS",
        "totalLabel": "CASH AND CASH EQUIVALENTS AND RESTRICTED CASH SHOWN IN STATEMENT OF CASH FLOWS",
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r27",
      "r28"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "crdr": "debit",
     "calculation": {
      "http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS AND RESTRICTED CASH",
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r45"
     ]
    },
    "slgl_ChangesInAccruedLiabilityForEmployeeRightsUponRetirement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sol-gel.co/20220630",
     "localname": "ChangesInAccruedLiabilityForEmployeeRightsUponRetirement",
     "crdr": "credit",
     "calculation": {
      "http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 70.0
      }
     },
     "presentation": [
      "http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Changes in accrued liability for employee rights upon retirement.",
        "negatedLabel": "Changes in accrued liability for employee rights upon retirement, net",
        "label": "Changes In Accrued Liability For Employee Rights Upon Retirement"
       }
      }
     },
     "auth_ref": []
    },
    "slgl_ChangesInFairValueOfMarketableSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sol-gel.co/20220630",
     "localname": "ChangesInFairValueOfMarketableSecurities",
     "crdr": "credit",
     "calculation": {
      "http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 80.0
      }
     },
     "presentation": [
      "http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfCashFlows",
      "http://www.sol-gel.co/role/MarketableSecuritiesSummaryOfChangesInFairValueOfCompanysMarketableSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash inflow from changes in fair value of marketable securities.",
        "negatedLabel": "Changes in fair value of marketable securities",
        "label": "Changes In Fair Value Of Marketable Securities",
        "terseLabel": "Change in fair value during the period"
       }
      }
     },
     "auth_ref": []
    },
    "srt_ChiefExecutiveOfficerMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2022",
     "localname": "ChiefExecutiveOfficerMember",
     "presentation": [
      "http://www.sol-gel.co/role/ShareCapitalNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Chief Executive Officer [Member]"
       }
      }
     },
     "auth_ref": [
      "r309"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
     "presentation": [
      "http://www.sol-gel.co/role/ShareCapitalNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants to purchase ordinary shares",
        "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares."
       }
      }
     },
     "auth_ref": [
      "r149"
     ]
    },
    "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems",
     "presentation": [
      "http://www.sol-gel.co/role/LicenseAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "slgl_CollabrationsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sol-gel.co/20220630",
     "localname": "CollabrationsMember",
     "presentation": [
      "http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for collabrations.",
        "label": "Collabrations [Member]",
        "verboseLabel": "COLLABORATION REVENUES [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingencies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "CommitmentsAndContingencies",
     "crdr": "credit",
     "calculation": {
      "http://www.sol-gel.co/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://www.sol-gel.co/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "COMMITMENTS",
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r49",
      "r57"
     ]
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "CommonStockMember",
     "presentation": [
      "http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ordinary shares [Member]",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r306",
      "r307",
      "r321"
     ]
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "CommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://www.sol-gel.co/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ordinary shares, par value per share",
        "documentation": "Face amount or stated value per share of common stock."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "CommonStockSharesAuthorized",
     "presentation": [
      "http://www.sol-gel.co/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ordinary shares, shares authorized",
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_CommonStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "CommonStockSharesIssued",
     "presentation": [
      "http://www.sol-gel.co/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ordinary shares, shares issued",
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://www.sol-gel.co/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Balance, shares",
        "periodStartLabel": "Balance, shares",
        "label": "Ordinary shares, shares outstanding",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r39"
     ]
    },
    "us-gaap_CommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "CommonStockValue",
     "crdr": "credit",
     "calculation": {
      "http://www.sol-gel.co/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.sol-gel.co/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ordinary Shares, NIS 0.1 par value - authorized: 50,000,000 as of December 31, 2021 and June 30, 2022; issued and outstanding: 23,000,782 and 23,029,951 as of December 31, 2021 and June 30, 2022, respectively.",
        "terseLabel": "Ordinary Shares, NIS 0.1 par value \u2013 authorized: 50,000,000 as of December 31, 2021 and June 30, 2022; issued and outstanding: 23,126,804 and 23,129,469 as of December 31, 2021 and June 30, 2022, respectively.",
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r295"
     ]
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://www.sol-gel.co/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedBenefitPlanBenefitObligation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "DefinedBenefitPlanBenefitObligation",
     "crdr": "credit",
     "calculation": {
      "http://www.sol-gel.co/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.sol-gel.co/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liability for employee rights upon retirement",
        "documentation": "Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan."
       }
      }
     },
     "auth_ref": [
      "r161"
     ]
    },
    "us-gaap_DefinedBenefitPlanFairValueOfPlanAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "DefinedBenefitPlanFairValueOfPlanAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.sol-gel.co/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://www.sol-gel.co/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Funds in respect of employee rights upon retirement",
        "documentation": "Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee."
       }
      }
     },
     "auth_ref": [
      "r162",
      "r164",
      "r165",
      "r166",
      "r288",
      "r289",
      "r290"
     ]
    },
    "us-gaap_DepositsAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "DepositsAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.sol-gel.co/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 40.0
      }
     },
     "presentation": [
      "http://www.sol-gel.co/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Bank deposits",
        "documentation": "Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment within one year or during the operating cycle, if shorter."
       }
      }
     },
     "auth_ref": [
      "r300"
     ]
    },
    "us-gaap_Depreciation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "Depreciation",
     "crdr": "debit",
     "calculation": {
      "http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Depreciation",
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r37"
     ]
    },
    "srt_DirectorMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2022",
     "localname": "DirectorMember",
     "presentation": [
      "http://www.sol-gel.co/role/ShareCapitalNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Director [Member]"
       }
      }
     },
     "auth_ref": [
      "r309"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://www.sol-gel.co/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://www.sol-gel.co/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.sol-gel.co/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "DocumentType",
     "presentation": [
      "http://www.sol-gel.co/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareBasic": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "EarningsPerShareBasic",
     "presentation": [
      "http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic",
        "terseLabel": "BASIC LOSS PER ORDINARY SHARE",
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r75",
      "r86",
      "r87",
      "r88",
      "r89",
      "r90",
      "r94",
      "r96",
      "r98",
      "r99",
      "r100",
      "r102",
      "r211",
      "r212",
      "r248",
      "r253",
      "r283"
     ]
    },
    "us-gaap_EarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "EarningsPerShareDiluted",
     "presentation": [
      "http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "BASIC AND DILUTED LOSS PER ORDINARY SHARE",
        "terseLabel": "DILUTED LOSS PER ORDINARY SHARE",
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r75",
      "r86",
      "r87",
      "r88",
      "r89",
      "r90",
      "r96",
      "r98",
      "r99",
      "r100",
      "r102",
      "r211",
      "r212",
      "r248",
      "r253",
      "r283"
     ]
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "EarningsPerSharePolicyTextBlock",
     "presentation": [
      "http://www.sol-gel.co/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loss per share",
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements."
       }
      }
     },
     "auth_ref": [
      "r30",
      "r31"
     ]
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
     "crdr": "debit",
     "calculation": {
      "http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 30.0
      }
     },
     "presentation": [
      "http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "EFFECT OF EXCHANGE RATE ON CASH AND CASH EQUIVALENTS",
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r323"
     ]
    },
    "slgl_EmployeesAndExecutiveOfficersMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sol-gel.co/20220630",
     "localname": "EmployeesAndExecutiveOfficersMember",
     "presentation": [
      "http://www.sol-gel.co/role/ShareCapitalNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employees And Executive Officers [Member]",
        "label": "Employees And Executive Officers [Member]",
        "terseLabel": "Employees and Director [Member]",
        "verboseLabel": "Employees And Executive Officers [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "slgl_EmployeesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sol-gel.co/20220630",
     "localname": "EmployeesMember",
     "presentation": [
      "http://www.sol-gel.co/role/ShareCapitalNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employees Member [Member]",
        "label": "Employees [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.sol-gel.co/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.sol-gel.co/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://www.sol-gel.co/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.sol-gel.co/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.sol-gel.co/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r298"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.sol-gel.co/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.sol-gel.co/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r298"
     ]
    },
    "slgl_EpsolayMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sol-gel.co/20220630",
     "localname": "EpsolayMember",
     "presentation": [
      "http://www.sol-gel.co/role/LicenseAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Epsolay",
        "label": "Epsolay [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r39",
      "r62",
      "r71",
      "r72",
      "r73",
      "r81",
      "r82",
      "r83",
      "r85",
      "r91",
      "r93",
      "r103",
      "r123",
      "r150",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r210",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r224",
      "r255",
      "r256",
      "r257"
     ]
    },
    "srt_ExecutiveOfficerMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2022",
     "localname": "ExecutiveOfficerMember",
     "presentation": [
      "http://www.sol-gel.co/role/ShareCapitalNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Executive Officer [Member]",
        "terseLabel": "Executive Officers [Member]"
       }
      }
     },
     "auth_ref": [
      "r309"
     ]
    },
    "slgl_ExpectedRevenueReceivableOverTwentyFourMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sol-gel.co/20220630",
     "localname": "ExpectedRevenueReceivableOverTwentyFourMonths",
     "crdr": "debit",
     "presentation": [
      "http://www.sol-gel.co/role/CollaborationAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the value of expected revenue receivable over twenty four months.",
        "label": "Expected Revenue Receivable Over Twenty Four Months",
        "terseLabel": "Expected revenue receivable over twenty four months"
       }
      }
     },
     "auth_ref": []
    },
    "slgl_FinanceExpensesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sol-gel.co/20220630",
     "localname": "FinanceExpensesNet",
     "crdr": "debit",
     "calculation": {
      "http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 40.0
      }
     },
     "presentation": [
      "http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance expenses, net.",
        "label": "Finance Expenses Net",
        "terseLabel": "Financial expenses (income), net"
       }
      }
     },
     "auth_ref": []
    },
    "slgl_FinancialIncomeExpensesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sol-gel.co/20220630",
     "localname": "FinancialIncomeExpensesNet",
     "crdr": "credit",
     "calculation": {
      "http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial expenses (income), net.",
        "negatedLabel": "FINANCIAL INCOME, net",
        "label": "Financial Income Expenses Net",
        "terseLabel": "FINANCIAL INCOME, net"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ForeignGovernmentDebtMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ForeignGovernmentDebtMember",
     "presentation": [
      "http://www.sol-gel.co/role/MarketableSecuritiesScheduleOfCompanysMarketableSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Canada government bonds [Member]",
        "documentation": "Debt securities (such as bonds) issued by a national, local, or municipal government not within the country of domicile of the entity."
       }
      }
     },
     "auth_ref": [
      "r34"
     ]
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "GeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "GENERAL AND ADMINISTRATIVE EXPENSES",
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 60.0
      }
     },
     "presentation": [
      "http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts payable, accrued expenses and other",
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid."
       }
      }
     },
     "auth_ref": [
      "r24"
     ]
    },
    "us-gaap_IncreaseDecreaseInLongTermReceivablesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "IncreaseDecreaseInLongTermReceivablesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Receivables from collaborative arrangements (including long-term)",
        "label": "Increase (Decrease) in Long-Term Receivables, Current",
        "documentation": "The increase (decrease) during the reporting period in the amount due within one year (or one business cycle) of receivables that were originally due beyond one year (or one business cycle)."
       }
      }
     },
     "auth_ref": [
      "r24"
     ]
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "presentation": [
      "http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changes in operating asset and liabilities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInPrepaidExpensesOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "IncreaseDecreaseInPrepaidExpensesOther",
     "crdr": "credit",
     "calculation": {
      "http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 50.0
      }
     },
     "presentation": [
      "http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Prepaid expenses and other current assets",
        "label": "Increase (Decrease) in Prepaid Expenses, Other",
        "documentation": "Amount of increase (decrease) of consideration paid in advance for other costs that provide economic benefits in future periods."
       }
      }
     },
     "auth_ref": [
      "r24"
     ]
    },
    "slgl_IncreaseInOperatingLeaseRouAssetsAndLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sol-gel.co/20220630",
     "localname": "IncreaseInOperatingLeaseRouAssetsAndLiabilities",
     "crdr": "debit",
     "presentation": [
      "http://www.sol-gel.co/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase in Operating lease ROU assets and liabilities.",
        "label": "Increase in Operating lease ROU assets and liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InvestmentTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "InvestmentTypeAxis",
     "presentation": [
      "http://www.sol-gel.co/role/MarketableSecuritiesScheduleOfCompanysMarketableSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Type [Axis]",
        "documentation": "Information by type of investments."
       }
      }
     },
     "auth_ref": [
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274"
     ]
    },
    "us-gaap_InvestmentTypeCategorizationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "InvestmentTypeCategorizationMember",
     "presentation": [
      "http://www.sol-gel.co/role/MarketableSecuritiesScheduleOfCompanysMarketableSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset obtained to generate income or appreciate in value."
       }
      }
     },
     "auth_ref": [
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274"
     ]
    },
    "us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
     "presentation": [
      "http://www.sol-gel.co/role/MarketableSecuritiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Debt Securities",
        "documentation": "Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "InvestmentsDebtAndEquitySecuritiesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments, Debt and Equity Securities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
     "presentation": [
      "http://www.sol-gel.co/role/MarketableSecurities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "MARKETABLE SECURITIES",
        "documentation": "The entire disclosure for investments in certain debt and equity securities."
       }
      }
     },
     "auth_ref": [
      "r36",
      "r46",
      "r51",
      "r60",
      "r279"
     ]
    },
    "slgl_JefferiesLlcMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sol-gel.co/20220630",
     "localname": "JefferiesLlcMember",
     "presentation": [
      "http://www.sol-gel.co/role/ShareCapitalNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Jefferies Llc.",
        "label": "Jefferies Llc [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "LesseeLeasesPolicyTextBlock",
     "presentation": [
      "http://www.sol-gel.co/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases",
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee."
       }
      }
     },
     "auth_ref": [
      "r223"
     ]
    },
    "us-gaap_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.sol-gel.co/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.sol-gel.co/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities",
        "totalLabel": "TOTAL LIABILITIES",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r80",
      "r122",
      "r128",
      "r129",
      "r130",
      "r131",
      "r132",
      "r133",
      "r134",
      "r135",
      "r136",
      "r204",
      "r207",
      "r208",
      "r213",
      "r284",
      "r314",
      "r326",
      "r327"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.sol-gel.co/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.sol-gel.co/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity",
        "totalLabel": "TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r48",
      "r54",
      "r295",
      "r305",
      "r310",
      "r322"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "presentation": [
      "http://www.sol-gel.co/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and shareholders' equity"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "LiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.sol-gel.co/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.sol-gel.co/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current",
        "totalLabel": "TOTAL CURRENT LIABILITIES",
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r65",
      "r80",
      "r122",
      "r128",
      "r129",
      "r130",
      "r131",
      "r132",
      "r133",
      "r134",
      "r135",
      "r136",
      "r204",
      "r207",
      "r208",
      "r213",
      "r295",
      "r314",
      "r326",
      "r327"
     ]
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "LiabilitiesCurrentAbstract",
     "presentation": [
      "http://www.sol-gel.co/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "CURRENT LIABILITIES:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "LiabilitiesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.sol-gel.co/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.sol-gel.co/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Noncurrent",
        "totalLabel": "TOTAL LONG-TERM LIABILITIES",
        "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r80",
      "r122",
      "r128",
      "r129",
      "r130",
      "r131",
      "r132",
      "r133",
      "r134",
      "r135",
      "r136",
      "r204",
      "r207",
      "r208",
      "r213",
      "r314",
      "r326",
      "r327"
     ]
    },
    "us-gaap_LiabilitiesNoncurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "LiabilitiesNoncurrentAbstract",
     "presentation": [
      "http://www.sol-gel.co/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "LONG-TERM LIABILITIES -",
        "terseLabel": "LONG-TERM LIABILITIES"
       }
      }
     },
     "auth_ref": []
    },
    "slgl_LicenseAgreementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.sol-gel.co/20220630",
     "localname": "LicenseAgreementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "License Agreements [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "slgl_LicenseAgreementsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.sol-gel.co/20220630",
     "localname": "LicenseAgreementsTextBlock",
     "presentation": [
      "http://www.sol-gel.co/role/LicenseAgreements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for license agreements information.",
        "label": "License Agreements Text Block",
        "verboseLabel": "LICENSE AGREEMENTS:"
       }
      }
     },
     "auth_ref": []
    },
    "slgl_LicenseAgreementsWithGaldermaMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sol-gel.co/20220630",
     "localname": "LicenseAgreementsWithGaldermaMember",
     "presentation": [
      "http://www.sol-gel.co/role/LicenseAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "License Agreements With Galderma",
        "label": "License Agreements With Galderma [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LicenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "LicenseMember",
     "presentation": [
      "http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "License [Member]",
        "verboseLabel": "LICENSE REVENUES [Member]",
        "documentation": "Right to use intangible asset. Intangible asset includes, but is not limited to, patent, copyright, technology, manufacturing process, software or trademark."
       }
      }
     },
     "auth_ref": [
      "r318"
     ]
    },
    "us-gaap_MarketableSecuritiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "MarketableSecuritiesAbstract",
     "presentation": [
      "http://www.sol-gel.co/role/MarketableSecuritiesScheduleOfCompanysMarketableSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Level 2 securities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MarketableSecuritiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "MarketableSecuritiesCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.sol-gel.co/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://www.sol-gel.co/role/CondensedConsolidatedBalanceSheets",
      "http://www.sol-gel.co/role/MarketableSecuritiesScheduleOfCompanysMarketableSecuritiesDetails",
      "http://www.sol-gel.co/role/MarketableSecuritiesSummaryOfChangesInFairValueOfCompanysMarketableSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Balance at end of the period",
        "periodStartLabel": "Balance at beginning of the period",
        "label": "Marketable securities",
        "documentation": "Amount of investment in marketable security, classified as current."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MarketableSecuritiesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "MarketableSecuritiesTextBlock",
     "presentation": [
      "http://www.sol-gel.co/role/MarketableSecuritiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Marketable Securities",
        "documentation": "Tabular disclosure of marketable securities. This may consist of investments in certain debt and equity securities, short-term investments and other assets."
       }
      }
     },
     "auth_ref": []
    },
    "srt_MaximumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2022",
     "localname": "MaximumMember",
     "presentation": [
      "http://www.sol-gel.co/role/CollaborationAgreementsDetails",
      "http://www.sol-gel.co/role/ShareCapitalScheduleOfAssumptionsUsedToEstimateFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]"
       }
      }
     },
     "auth_ref": [
      "r124",
      "r125",
      "r126",
      "r127",
      "r168",
      "r233",
      "r254",
      "r277",
      "r278",
      "r286",
      "r291",
      "r297",
      "r316",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333"
     ]
    },
    "srt_MinimumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2022",
     "localname": "MinimumMember",
     "presentation": [
      "http://www.sol-gel.co/role/CollaborationAgreementsDetails",
      "http://www.sol-gel.co/role/ShareCapitalScheduleOfAssumptionsUsedToEstimateFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]"
       }
      }
     },
     "auth_ref": [
      "r124",
      "r125",
      "r126",
      "r127",
      "r168",
      "r233",
      "r254",
      "r277",
      "r278",
      "r286",
      "r291",
      "r297",
      "r316",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333"
     ]
    },
    "us-gaap_NatureOfOperations": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "NatureOfOperations",
     "presentation": [
      "http://www.sol-gel.co/role/NatureOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "NATURE OF OPERATIONS",
        "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward."
       }
      }
     },
     "auth_ref": [
      "r104",
      "r105"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by financing activities",
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "CASH FLOWS FROM FINANCING ACTIVITIES:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash provided by (used in) investing activities",
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "CASH FLOWS FROM INVESTING ACTIVITIES:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "calculation": {
      "http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash used in operating activities",
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r23",
      "r26"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "CASH FLOWS FROM OPERATING ACTIVITIES:"
       }
      }
     },
     "auth_ref": []
    },
    "slgl_NetChangesInOperatingLeases": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sol-gel.co/20220630",
     "localname": "NetChangesInOperatingLeases",
     "crdr": "credit",
     "calculation": {
      "http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 90.0
      }
     },
     "presentation": [
      "http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net changes in operating leases.",
        "negatedLabel": "Net changes in operating leases",
        "label": "Net Changes In Operating Leases"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfOperations": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTotalLabel": "LOSS FOR THE PERIOD",
        "label": "Loss",
        "terseLabel": "Loss for the period",
        "totalLabel": "LOSS FOR THE PERIOD",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r26",
      "r50",
      "r58",
      "r63",
      "r69",
      "r70",
      "r73",
      "r80",
      "r84",
      "r86",
      "r87",
      "r88",
      "r89",
      "r92",
      "r93",
      "r97",
      "r108",
      "r110",
      "r114",
      "r116",
      "r122",
      "r128",
      "r129",
      "r130",
      "r131",
      "r132",
      "r133",
      "r134",
      "r135",
      "r136",
      "r212",
      "r213",
      "r285",
      "r314"
     ]
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "presentation": [
      "http://www.sol-gel.co/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Newly issued and recently adopted accounting pronouncements:",
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact."
       }
      }
     },
     "auth_ref": []
    },
    "slgl_NumberOfApprovedGenericDrugProducts": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.sol-gel.co/20220630",
     "localname": "NumberOfApprovedGenericDrugProducts",
     "presentation": [
      "http://www.sol-gel.co/role/CollaborationAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the number of approved generic drug products.",
        "label": "Number Of Approved Generic Drug Products",
        "terseLabel": "Number of approved generic drug products"
       }
      }
     },
     "auth_ref": []
    },
    "slgl_NumberOfEqualQuarterlyInstalments": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.sol-gel.co/20220630",
     "localname": "NumberOfEqualQuarterlyInstalments",
     "presentation": [
      "http://www.sol-gel.co/role/CollaborationAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the number of equal quarterly instalments.",
        "label": "Number Of Equal Quarterly Instalments",
        "terseLabel": "Number of equal quarterly instalments"
       }
      }
     },
     "auth_ref": []
    },
    "slgl_NumberOfGenericCollaborativeAgreementsToSellRights": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.sol-gel.co/20220630",
     "localname": "NumberOfGenericCollaborativeAgreementsToSellRights",
     "presentation": [
      "http://www.sol-gel.co/role/CollaborationAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of generic collaborative agreements to sell the rights.",
        "label": "Number Of Generic Collaborative Agreements To Sell Rights",
        "terseLabel": "Number of generic collaborative agreements to sell rights"
       }
      }
     },
     "auth_ref": []
    },
    "slgl_NumberOfGenericDrugCandidates": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.sol-gel.co/20220630",
     "localname": "NumberOfGenericDrugCandidates",
     "presentation": [
      "http://www.sol-gel.co/role/CollaborationAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of generic drug candidates.",
        "label": "Number Of Generic Drug Candidates",
        "terseLabel": "Number of generic drug candidates"
       }
      }
     },
     "auth_ref": []
    },
    "slgl_NumberOfGenericProgramsRetainedForCollaborationRights": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.sol-gel.co/20220630",
     "localname": "NumberOfGenericProgramsRetainedForCollaborationRights",
     "presentation": [
      "http://www.sol-gel.co/role/CollaborationAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of generic programs retained for collaboration rights.",
        "label": "Number Of Generic Programs Retained For Collaboration Rights",
        "terseLabel": "Number of generic programs retained for collaboration rights"
       }
      }
     },
     "auth_ref": []
    },
    "slgl_NumberOfUnapprovedGenericPrograms": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.sol-gel.co/20220630",
     "localname": "NumberOfUnapprovedGenericPrograms",
     "presentation": [
      "http://www.sol-gel.co/role/CollaborationAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the number of unapproved generic programs.",
        "label": "Number Of Unapproved Generic Programs",
        "terseLabel": "Number of unapproved generic programs"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "OperatingIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTotalLabel": "TOTAL OPERATING LOSS",
        "label": "Operating Income (Loss)",
        "totalLabel": "TOTAL OPERATING LOSS",
        "documentation": "The net result for the period of deducting operating expenses from operating revenues."
       }
      }
     },
     "auth_ref": [
      "r108",
      "r110",
      "r114",
      "r116",
      "r285"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "OperatingLeaseLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.sol-gel.co/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.sol-gel.co/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current maturities of operating leases",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current."
       }
      }
     },
     "auth_ref": [
      "r222"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.sol-gel.co/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.sol-gel.co/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating leases liabilities",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r222"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "OperatingLeaseRightOfUseAsset",
     "crdr": "debit",
     "calculation": {
      "http://www.sol-gel.co/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0,
       "order": 30.0
      }
     },
     "presentation": [
      "http://www.sol-gel.co/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating lease right-of-use assets",
        "documentation": "Amount of lessee's right to use underlying asset under operating lease."
       }
      }
     },
     "auth_ref": [
      "r221"
     ]
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "OtherAccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.sol-gel.co/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://www.sol-gel.co/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other accounts payable",
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "slgl_OtherForeignGovernmentBondsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sol-gel.co/20220630",
     "localname": "OtherForeignGovernmentBondsMember",
     "presentation": [
      "http://www.sol-gel.co/role/MarketableSecuritiesScheduleOfCompanysMarketableSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other foreign government bonds [Member]",
        "label": "Other foreign government bonds [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "slgl_PaymentReceivableInInstalments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sol-gel.co/20220630",
     "localname": "PaymentReceivableInInstalments",
     "crdr": "debit",
     "presentation": [
      "http://www.sol-gel.co/role/CollaborationAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the value of payment receivable in instalments.",
        "label": "Payment Receivable In Instalments",
        "terseLabel": "Payment receivable in instalments"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsToAcquireMarketableSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "PaymentsToAcquireMarketableSecurities",
     "crdr": "credit",
     "calculation": {
      "http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfCashFlows",
      "http://www.sol-gel.co/role/MarketableSecuritiesSummaryOfChangesInFairValueOfCompanysMarketableSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Investment in marketable securities",
        "label": "Additions",
        "documentation": "Amount of cash outflow for purchase of marketable security."
       }
      }
     },
     "auth_ref": [
      "r33"
     ]
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchase of property and equipment",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets."
       }
      }
     },
     "auth_ref": [
      "r20"
     ]
    },
    "slgl_PercentageOfGrossProceedsFromSaleOfShares": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.sol-gel.co/20220630",
     "localname": "PercentageOfGrossProceedsFromSaleOfShares",
     "presentation": [
      "http://www.sol-gel.co/role/ShareCapitalNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the of Percentage of gross proceeds from sale of shares.",
        "label": "Percentage Of Gross Proceeds From Sale Of Shares",
        "terseLabel": "Percentage of gross proceeds from sale of shares"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.sol-gel.co/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.sol-gel.co/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid expenses and other current assets",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r301"
     ]
    },
    "us-gaap_PrivatePlacementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "PrivatePlacementMember",
     "presentation": [
      "http://www.sol-gel.co/role/ShareCapitalNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Private Placement [Member]",
        "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromInterestReceived": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ProceedsFromInterestReceived",
     "crdr": "debit",
     "presentation": [
      "http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest received",
        "documentation": "Interest received on loans and other debt instruments during the current period."
       }
      }
     },
     "auth_ref": [
      "r303"
     ]
    },
    "us-gaap_ProceedsFromIssuanceInitialPublicOffering": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ProceedsFromIssuanceInitialPublicOffering",
     "crdr": "debit",
     "presentation": [
      "http://www.sol-gel.co/role/ShareCapitalNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Procceds from Initial public offering, net of issuance costs",
        "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public."
       }
      }
     },
     "auth_ref": [
      "r21"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "crdr": "debit",
     "presentation": [
      "http://www.sol-gel.co/role/ShareCapitalNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from Issuance of Common Stock",
        "terseLabel": "Net proceeds",
        "documentation": "The cash inflow from the additional capital contribution to the entity."
       }
      }
     },
     "auth_ref": [
      "r21"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfPrivatePlacement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ProceedsFromIssuanceOfPrivatePlacement",
     "crdr": "debit",
     "presentation": [
      "http://www.sol-gel.co/role/ShareCapitalNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from private placement",
        "documentation": "The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement."
       }
      }
     },
     "auth_ref": [
      "r21"
     ]
    },
    "slgl_ProceedsFromLongTermDeposits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sol-gel.co/20220630",
     "localname": "ProceedsFromLongTermDeposits",
     "crdr": "debit",
     "calculation": {
      "http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 40.0
      }
     },
     "presentation": [
      "http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the amount of proceeds from long-term deposits.",
        "label": "Proceeds From Long Term Deposits",
        "terseLabel": "Proceeds from long-term deposits"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ProceedsFromSaleAndMaturityOfMarketableSecurities",
     "crdr": "debit",
     "calculation": {
      "http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfCashFlows",
      "http://www.sol-gel.co/role/MarketableSecuritiesSummaryOfChangesInFairValueOfCompanysMarketableSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Sale or maturity",
        "label": "Proceeds from sales and maturity of marketable securities",
        "documentation": "The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period."
       }
      }
     },
     "auth_ref": []
    },
    "slgl_ProceedsFromShortTermDeposits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sol-gel.co/20220630",
     "localname": "ProceedsFromShortTermDeposits",
     "crdr": "debit",
     "calculation": {
      "http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 30.0
      }
     },
     "presentation": [
      "http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the amount of proceeds from short term deposits.",
        "label": "Proceeds From Short Term Deposits",
        "terseLabel": "Proceeds from short-term deposits"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ProceedsFromStockOptionsExercised",
     "crdr": "debit",
     "calculation": {
      "http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceed from exercise of options",
        "terseLabel": "Proceeds from exercise of options",
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r21",
      "r43"
     ]
    },
    "srt_ProductOrServiceAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2022",
     "localname": "ProductOrServiceAxis",
     "presentation": [
      "http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfOperations",
      "http://www.sol-gel.co/role/LicenseAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]"
       }
      }
     },
     "auth_ref": [
      "r117",
      "r234",
      "r287",
      "r296",
      "r312",
      "r313",
      "r317",
      "r338"
     ]
    },
    "srt_ProductsAndServicesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2022",
     "localname": "ProductsAndServicesDomain",
     "presentation": [
      "http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfOperations",
      "http://www.sol-gel.co/role/LicenseAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]"
       }
      }
     },
     "auth_ref": [
      "r117",
      "r234",
      "r287",
      "r296",
      "r312",
      "r313",
      "r317",
      "r338"
     ]
    },
    "us-gaap_ProfitLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ProfitLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfCashFlows",
      "http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTotalLabel": "LOSS FOR THE PERIOD",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Loss for the period",
        "totalLabel": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Total",
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r63",
      "r69",
      "r70",
      "r76",
      "r80",
      "r84",
      "r92",
      "r93",
      "r108",
      "r110",
      "r114",
      "r116",
      "r122",
      "r128",
      "r129",
      "r130",
      "r131",
      "r132",
      "r133",
      "r134",
      "r135",
      "r136",
      "r202",
      "r205",
      "r206",
      "r212",
      "r213",
      "r249",
      "r285",
      "r293",
      "r294",
      "r302",
      "r314"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "PropertyPlantAndEquipmentNet",
     "crdr": "debit",
     "calculation": {
      "http://www.sol-gel.co/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.sol-gel.co/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property and equipment, net",
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r38",
      "r56",
      "r251",
      "r295"
     ]
    },
    "srt_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2022",
     "localname": "RangeAxis",
     "presentation": [
      "http://www.sol-gel.co/role/CollaborationAgreementsDetails",
      "http://www.sol-gel.co/role/ShareCapitalScheduleOfAssumptionsUsedToEstimateFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Range [Axis]",
        "verboseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r124",
      "r125",
      "r126",
      "r127",
      "r163",
      "r168",
      "r193",
      "r194",
      "r195",
      "r232",
      "r233",
      "r254",
      "r277",
      "r278",
      "r286",
      "r291",
      "r297",
      "r311",
      "r316",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333"
     ]
    },
    "srt_RangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2022",
     "localname": "RangeMember",
     "presentation": [
      "http://www.sol-gel.co/role/CollaborationAgreementsDetails",
      "http://www.sol-gel.co/role/ShareCapitalScheduleOfAssumptionsUsedToEstimateFairValueDetails"
     ],
     "auth_ref": [
      "r124",
      "r125",
      "r126",
      "r127",
      "r163",
      "r168",
      "r193",
      "r194",
      "r195",
      "r232",
      "r233",
      "r254",
      "r277",
      "r278",
      "r286",
      "r291",
      "r297",
      "r311",
      "r316",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333"
     ]
    },
    "us-gaap_ReceivablesNetCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ReceivablesNetCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.sol-gel.co/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 30.0
      }
     },
     "presentation": [
      "http://www.sol-gel.co/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Receivables from collaborative arrangements",
        "documentation": "The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value."
       }
      }
     },
     "auth_ref": [
      "r55",
      "r59",
      "r295"
     ]
    },
    "slgl_RefundUpFrontPayment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sol-gel.co/20220630",
     "localname": "RefundUpFrontPayment",
     "crdr": "debit",
     "presentation": [
      "http://www.sol-gel.co/role/LicenseAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of refund upfront payment.",
        "label": "Refund Up Front Payment",
        "verboseLabel": "Refunded Upfront Payment To Galderma"
       }
      }
     },
     "auth_ref": []
    },
    "slgl_RefundableUpfrontPayment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sol-gel.co/20220630",
     "localname": "RefundableUpfrontPayment",
     "crdr": "credit",
     "presentation": [
      "http://www.sol-gel.co/role/LicenseAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represent the amount of refundable upfront payment",
        "label": "Refundable Upfront Payment",
        "verboseLabel": "Refundable upfront payment"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "RelatedPartyDomain",
     "presentation": [
      "http://www.sol-gel.co/role/ShareCapitalNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party [Domain]",
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests."
       }
      }
     },
     "auth_ref": [
      "r167",
      "r227",
      "r228"
     ]
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "RelatedPartyTransactionsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "presentation": [
      "http://www.sol-gel.co/role/ShareCapitalNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party [Axis]",
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests."
       }
      }
     },
     "auth_ref": [
      "r167",
      "r227",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r325"
     ]
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "presentation": [
      "http://www.sol-gel.co/role/RelatedParties"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "RELATED PARTIES:",
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates."
       }
      }
     },
     "auth_ref": [
      "r225",
      "r226",
      "r228",
      "r229",
      "r230"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ResearchAndDevelopmentExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "RESEARCH AND DEVELOPMENT EXPENSES",
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use."
       }
      }
     },
     "auth_ref": [
      "r44",
      "r61",
      "r334"
     ]
    },
    "us-gaap_RestrictedCash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "RestrictedCash",
     "crdr": "debit",
     "calculation": {
      "http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Restricted cash",
        "label": "Restricted Cash",
        "documentation": "Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits."
       }
      }
     },
     "auth_ref": [
      "r299",
      "r304",
      "r335",
      "r337"
     ]
    },
    "us-gaap_RestrictedCashAndInvestmentsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "RestrictedCashAndInvestmentsNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.sol-gel.co/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.sol-gel.co/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted long-term deposits and cash",
        "documentation": "The noncurrent cash, cash equivalents and investments that is restricted as to withdrawal or usage. Restrictions may include legally restricted deposits held as compensating balances against borrowing arrangements, contracts entered into with others, or entity statements of intention with regard to particular deposits classified as long-term; that is not expected to be released from such existing restrictions within one year of the balance sheet date or operating cycle, whichever is longer. Excludes compensating balance arrangements that are not agreements which legally restrict the use of cash amounts shown on the balance sheet. Includes noncurrent cash equivalents and investments that are similarly restricted as to withdrawal, usage or disposal."
       }
      }
     },
     "auth_ref": [
      "r275",
      "r276"
     ]
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "calculation": {
      "http://www.sol-gel.co/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://www.sol-gel.co/role/CondensedConsolidatedBalanceSheets",
      "http://www.sol-gel.co/role/NatureOfOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Accumulated deficit",
        "label": "Accumulated deficit",
        "terseLabel": "Accumulated deficit",
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r40",
      "r53",
      "r258",
      "r259",
      "r295"
     ]
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated Deficit [Member]",
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit."
       }
      }
     },
     "auth_ref": [
      "r62",
      "r81",
      "r82",
      "r83",
      "r85",
      "r91",
      "r93",
      "r123",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r210",
      "r255",
      "r257"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "RevenueFromContractWithCustomerAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "presentation": [
      "http://www.sol-gel.co/role/CollaborationAgreements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "COLLABORATION AGREEMENTS:",
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts."
       }
      }
     },
     "auth_ref": [
      "r151",
      "r152",
      "r153",
      "r154",
      "r155",
      "r156",
      "r157",
      "r158",
      "r159",
      "r160"
     ]
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "RevenueRecognitionPolicyTextBlock",
     "presentation": [
      "http://www.sol-gel.co/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue recognition",
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources."
       }
      }
     },
     "auth_ref": [
      "r281",
      "r282"
     ]
    },
    "us-gaap_Revenues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "Revenues",
     "crdr": "credit",
     "calculation": {
      "http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfOperations": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues",
        "terseLabel": "TOTAL REVENUES",
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss)."
       }
      }
     },
     "auth_ref": [
      "r74",
      "r80",
      "r106",
      "r107",
      "r109",
      "r112",
      "r113",
      "r117",
      "r118",
      "r119",
      "r122",
      "r128",
      "r129",
      "r130",
      "r131",
      "r132",
      "r133",
      "r134",
      "r135",
      "r136",
      "r213",
      "r249",
      "r314"
     ]
    },
    "slgl_RoyaltiesCompanyIsEligibleToReceive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sol-gel.co/20220630",
     "localname": "RoyaltiesCompanyIsEligibleToReceive",
     "crdr": "debit",
     "presentation": [
      "http://www.sol-gel.co/role/LicenseAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Royalties company is eligible to receive.",
        "label": "Royalties company is eligible to receive"
       }
      }
     },
     "auth_ref": []
    },
    "slgl_RoyaltiesMaturity": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.sol-gel.co/20220630",
     "localname": "RoyaltiesMaturity",
     "presentation": [
      "http://www.sol-gel.co/role/CollaborationAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Royalties Maturity.",
        "label": "Royalties Maturity",
        "terseLabel": "Royalties maturity"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "SaleOfStockNameOfTransactionDomain",
     "presentation": [
      "http://www.sol-gel.co/role/ShareCapitalNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "presentation": [
      "http://www.sol-gel.co/role/ShareCapitalNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale of Stock, Number of Shares Issued in Transaction",
        "terseLabel": "Issuance of share",
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction."
       }
      }
     },
     "auth_ref": []
    },
    "slgl_SalesMilestonePayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sol-gel.co/20220630",
     "localname": "SalesMilestonePayments",
     "crdr": "credit",
     "presentation": [
      "http://www.sol-gel.co/role/LicenseAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represent of amount the sales milestone payments",
        "label": "Sales Milestone Payments",
        "verboseLabel": "Sales milestone payments"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable",
     "presentation": [
      "http://www.sol-gel.co/role/LicenseAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]",
        "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r320"
     ]
    },
    "us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ScheduleOfDerivativeAssetsAtFairValueTableTextBlock",
     "presentation": [
      "http://www.sol-gel.co/role/MarketableSecuritiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Summary of Changes in Fair Value of Marketable Securities",
        "documentation": "Tabular disclosure of derivative assets at fair value."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "presentation": [
      "http://www.sol-gel.co/role/ShareCapitalNarrativeDetails",
      "http://www.sol-gel.co/role/ShareCapitalScheduleOfAssumptionsUsedToEstimateFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "documentation": "Disclosure of information about share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r169",
      "r170",
      "r171",
      "r172",
      "r173",
      "r174",
      "r175",
      "r176",
      "r177",
      "r178",
      "r179",
      "r180",
      "r181",
      "r182",
      "r183",
      "r184",
      "r185",
      "r186",
      "r187",
      "r188",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196"
     ]
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "presentation": [
      "http://www.sol-gel.co/role/ShareCapitalTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Assumptions Used to Estimate Fair Value",
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions."
       }
      }
     },
     "auth_ref": [
      "r42"
     ]
    },
    "us-gaap_ShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ShareBasedCompensation",
     "crdr": "debit",
     "calculation": {
      "http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 30.0
      }
     },
     "presentation": [
      "http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfCashFlows",
      "http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based compensation",
        "terseLabel": "Share-based compensation expenses",
        "documentation": "Amount of noncash expense for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r24"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "presentation": [
      "http://www.sol-gel.co/role/ShareCapitalNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Option vesting period",
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition."
       }
      }
     },
     "auth_ref": [
      "r292"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "presentation": [
      "http://www.sol-gel.co/role/ShareCapitalScheduleOfAssumptionsUsedToEstimateFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend yield",
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term."
       }
      }
     },
     "auth_ref": [
      "r194"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "presentation": [
      "http://www.sol-gel.co/role/ShareCapitalScheduleOfAssumptionsUsedToEstimateFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expected volatility",
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period."
       }
      }
     },
     "auth_ref": [
      "r193"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "presentation": [
      "http://www.sol-gel.co/role/ShareCapitalScheduleOfAssumptionsUsedToEstimateFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk-free interest rate",
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": [
      "r195"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "presentation": [
      "http://www.sol-gel.co/role/ShareCapitalNarrativeDetails",
      "http://www.sol-gel.co/role/ShareCapitalScheduleOfAssumptionsUsedToEstimateFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "presentation": [
      "http://www.sol-gel.co/role/ShareCapitalNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Option grants",
        "documentation": "Gross number of share options (or share units) granted during the period."
       }
      }
     },
     "auth_ref": [
      "r178"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://www.sol-gel.co/role/ShareCapitalNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise price",
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r174",
      "r175"
     ]
    },
    "us-gaap_SharePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "SharePrice",
     "presentation": [
      "http://www.sol-gel.co/role/ShareCapitalScheduleOfAssumptionsUsedToEstimateFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of one ordinary share",
        "documentation": "Price of a single share of a number of saleable stocks of a company."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage",
     "presentation": [
      "http://www.sol-gel.co/role/ShareCapitalNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Percentage of option vesting",
        "documentation": "Percentage of vesting of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r319"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "presentation": [
      "http://www.sol-gel.co/role/ShareCapitalNarrativeDetails",
      "http://www.sol-gel.co/role/ShareCapitalScheduleOfAssumptionsUsedToEstimateFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expected term",
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r192"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1",
     "crdr": "credit",
     "presentation": [
      "http://www.sol-gel.co/role/ShareCapitalNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair value of options granted",
        "documentation": "Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock."
       }
      }
     },
     "auth_ref": [
      "r189"
     ]
    },
    "us-gaap_SharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "SharesIssued",
     "presentation": [
      "http://www.sol-gel.co/role/ShareCapitalNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ordinary shares issued",
        "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "us-gaap_SharesIssuedPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "SharesIssuedPricePerShare",
     "presentation": [
      "http://www.sol-gel.co/role/ShareCapitalNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Per share price",
        "documentation": "Per share or per unit amount of equity securities issued."
       }
      }
     },
     "auth_ref": []
    },
    "slgl_ShortTermDeposits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sol-gel.co/20220630",
     "localname": "ShortTermDeposits",
     "crdr": "credit",
     "calculation": {
      "http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 50.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Short-term deposits.",
        "negatedLabel": "short-term deposits",
        "label": "Short Term Deposits"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "SignificantAccountingPoliciesTextBlock",
     "presentation": [
      "http://www.sol-gel.co/role/SignificantAccountingPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SIGNIFICANT ACCOUNTING POLICIES:",
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r29",
      "r78"
     ]
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r39",
      "r62",
      "r71",
      "r72",
      "r73",
      "r81",
      "r82",
      "r83",
      "r85",
      "r91",
      "r93",
      "r103",
      "r123",
      "r150",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r210",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r224",
      "r255",
      "r256",
      "r257"
     ]
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "StatementLineItems",
     "presentation": [
      "http://www.sol-gel.co/role/CollaborationAgreementsDetails",
      "http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity",
      "http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfOperations",
      "http://www.sol-gel.co/role/MarketableSecuritiesScheduleOfCompanysMarketableSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "StatementOfStockholdersEquityAbstract",
     "auth_ref": []
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "StatementTable",
     "presentation": [
      "http://www.sol-gel.co/role/CollaborationAgreementsDetails",
      "http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity",
      "http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfOperations",
      "http://www.sol-gel.co/role/MarketableSecuritiesScheduleOfCompanysMarketableSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Table]",
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed."
       }
      }
     },
     "auth_ref": [
      "r81",
      "r82",
      "r83",
      "r103",
      "r234"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "StockIssuedDuringPeriodSharesEmployeeBenefitPlan",
     "presentation": [
      "http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise of options granted to an employee, shares",
        "documentation": "Number of shares issued during the period to an employee benefit plan, such as a defined contribution or defined benefit plan."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "presentation": [
      "http://www.sol-gel.co/role/ShareCapitalNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares issued",
        "documentation": "Number of new stock issued during the period."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r6",
      "r39",
      "r40"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardGross",
     "presentation": [
      "http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vesting of restricted shares units, shares",
        "documentation": "Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards."
       }
      }
     },
     "auth_ref": [
      "r39",
      "r40"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "presentation": [
      "http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise of options, shares",
        "documentation": "Number of share options (or share units) exercised during the current period."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r6",
      "r39",
      "r40",
      "r179"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "crdr": "credit",
     "presentation": [
      "http://www.sol-gel.co/role/ShareCapitalNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Issued During Period, Value, New Issues",
        "terseLabel": "Available balance",
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r6",
      "r39",
      "r40"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardGross",
     "crdr": "credit",
     "presentation": [
      "http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vesting of restricted shares units",
        "documentation": "Aggregate value of stock related to Restricted Stock Awards issued during the period."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r6",
      "r39",
      "r40"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "crdr": "credit",
     "presentation": [
      "http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise of options",
        "documentation": "Value of stock issued as a result of the exercise of stock options."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r39",
      "r40"
     ]
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.sol-gel.co/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.sol-gel.co/role/CondensedConsolidatedBalanceSheets",
      "http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Balance",
        "periodStartLabel": "Balance",
        "label": "Stockholders' Equity Attributable to Parent",
        "totalLabel": "TOTAL SHAREHOLDERS' EQUITY",
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r9",
      "r10",
      "r32",
      "r295",
      "r305",
      "r310",
      "r322"
     ]
    },
    "us-gaap_StockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "StockholdersEquityAbstract",
     "presentation": [
      "http://www.sol-gel.co/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SHAREHOLDERS' EQUITY:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityNoteAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "StockholdersEquityNoteAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Note [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "presentation": [
      "http://www.sol-gel.co/role/ShareCapital"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SHARE CAPITAL:",
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income."
       }
      }
     },
     "auth_ref": [
      "r41",
      "r79",
      "r137",
      "r138",
      "r139",
      "r140",
      "r141",
      "r142",
      "r143",
      "r144",
      "r145",
      "r146",
      "r147",
      "r148",
      "r150",
      "r209"
     ]
    },
    "us-gaap_SubsequentEventMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "SubsequentEventMember",
     "presentation": [
      "http://www.sol-gel.co/role/LicenseAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event [Member]",
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r220",
      "r231"
     ]
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "SubsequentEventTypeAxis",
     "presentation": [
      "http://www.sol-gel.co/role/LicenseAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event Type [Axis]",
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r220",
      "r231"
     ]
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "SubsequentEventTypeDomain",
     "presentation": [
      "http://www.sol-gel.co/role/LicenseAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event Type [Domain]",
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r220",
      "r231"
     ]
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "SubsidiarySaleOfStockAxis",
     "presentation": [
      "http://www.sol-gel.co/role/ShareCapitalNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsidiary Sale Of Stock [Axis]",
        "verboseLabel": "Sale of Stock [Axis]",
        "documentation": "Information by type of sale of the entity's stock."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "SupplementalCashFlowInformationAbstract",
     "presentation": [
      "http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SUPPLEMENTARY INFORMATION:"
       }
      }
     },
     "auth_ref": []
    },
    "srt_TitleOfIndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2022",
     "localname": "TitleOfIndividualAxis",
     "presentation": [
      "http://www.sol-gel.co/role/ShareCapitalNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Axis]"
       }
      }
     },
     "auth_ref": [
      "r309",
      "r324"
     ]
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2022",
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "presentation": [
      "http://www.sol-gel.co/role/ShareCapitalNarrativeDetails"
     ],
     "auth_ref": []
    },
    "slgl_TwyneoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sol-gel.co/20220630",
     "localname": "TwyneoMember",
     "presentation": [
      "http://www.sol-gel.co/role/LicenseAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Twyneo",
        "label": "Twyneo [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TypeOfArrangementAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "TypeOfArrangementAxis",
     "presentation": [
      "http://www.sol-gel.co/role/LicenseAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r320"
     ]
    },
    "us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "USGovernmentCorporationsAndAgenciesSecuritiesMember",
     "presentation": [
      "http://www.sol-gel.co/role/MarketableSecuritiesScheduleOfCompanysMarketableSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "U.S government and agency bonds [Member]",
        "documentation": "This category includes information about debt issued by US Government Corporations and Agencies. Investments in such US Government Corporations may include debt securities issued by the Government National Mortgage Association (Ginnie Mae) and by the Federal National Mortgage Association (Fannie Mae) and the Federal Home Loan Mortgage Corporation (Freddie Mac)."
       }
      }
     },
     "auth_ref": [
      "r336"
     ]
    },
    "slgl_UnderwrittenPublicOfferingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sol-gel.co/20220630",
     "localname": "UnderwrittenPublicOfferingMember",
     "presentation": [
      "http://www.sol-gel.co/role/ShareCapitalNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Underwritten Public Offering Member",
        "label": "Underwritten Public Offering [member]"
       }
      }
     },
     "auth_ref": []
    },
    "slgl_UpfrontPaymentReceived": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sol-gel.co/20220630",
     "localname": "UpfrontPaymentReceived",
     "crdr": "credit",
     "presentation": [
      "http://www.sol-gel.co/role/CollaborationAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the value of upfront payment received.",
        "label": "Upfront Payment Received",
        "terseLabel": "Upfront payment received"
       }
      }
     },
     "auth_ref": []
    },
    "slgl_UpfrontPayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sol-gel.co/20220630",
     "localname": "UpfrontPayments",
     "crdr": "credit",
     "presentation": [
      "http://www.sol-gel.co/role/LicenseAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Upfront payments.",
        "label": "Upfront payments",
        "terseLabel": "Upfront payments"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "presentation": [
      "http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING USED IN COMPUTATION OF DILUTED LOSS PER SHARE",
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
       }
      }
     },
     "auth_ref": [
      "r95",
      "r100"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "presentation": [
      "http://www.sol-gel.co/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING USED IN COMPUTATION OF BASIC AND DILUTED LOSS PER SHARE",
        "terseLabel": "WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING USED IN COMPUTATION OF BASIC LOSS PER SHARE",
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period."
       }
      }
     },
     "auth_ref": [
      "r94",
      "r100"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 201.5-02(24))",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 201.5-02(25))",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 201.5-02(26))",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(23))",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.20)",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.21)",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.25)",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.4)",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "24",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "25",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "28",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "235",
   "URI": "https://asc.fasb.org/topic&trid=2122369"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "310",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "320",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "11",
   "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26853-111562"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "320",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1B",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL6283291-111563"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "320",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "320",
   "URI": "https://asc.fasb.org/topic&trid=2196928"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "URI": "https://asc.fasb.org/topic&trid=2208762"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2A",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=SL79508275-113901"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "730",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "830",
   "SubTopic": "230",
   "Section": "45",
   "Paragraph": "1",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "940",
   "SubTopic": "320",
   "URI": "https://asc.fasb.org/subtopic&trid=2176304"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03.17)",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "220",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "320",
   "URI": "https://asc.fasb.org/subtopic&trid=2209399"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "944",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "944",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "944",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "944",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(5))",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "944",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r57": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "944",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r58": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "944",
   "SubTopic": "220",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r59": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "946",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-06(3))",
   "URI": "https://asc.fasb.org/extlink&oid=120401414&loc=d3e604059-122996"
  },
  "r60": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "946",
   "SubTopic": "320",
   "URI": "https://asc.fasb.org/subtopic&trid=2324412"
  },
  "r61": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "985",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r62": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "105",
   "SubTopic": "10",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r63": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "205",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "7",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r64": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "1",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r65": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "5",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765"
  },
  "r66": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r67": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r68": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r69": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
  },
  "r70": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580"
  },
  "r71": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r72": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r73": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "6",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r74": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(1))",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r75": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(25))",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r76": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "2",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585"
  },
  "r77": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "24",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585"
  },
  "r78": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "235",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790"
  },
  "r79": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "235",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r80": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "235",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r81": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "250",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r82": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "250",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "24",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r83": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "250",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r84": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "250",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r85": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "250",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r86": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "250",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r87": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "250",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r88": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "250",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r89": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "250",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r90": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "250",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r91": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "250",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r92": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "250",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r93": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "250",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r94": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "10",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256"
  },
  "r95": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "16",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256"
  },
  "r96": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "2",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256"
  },
  "r97": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
  },
  "r98": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
  },
  "r99": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "7",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256"
  },
  "r100": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r101": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r102": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "15",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258"
  },
  "r103": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "272",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "1",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r104": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r105": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "URI": "https://asc.fasb.org/topic&trid=2134479"
  },
  "r106": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r107": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r108": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "22",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r109": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r110": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r111": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r112": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r113": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r114": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r115": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r116": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r117": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "40",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "42",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "310",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "2",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "320",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "323",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "326",
   "SubTopic": "10",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "450",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "450",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "450",
   "SubTopic": "20",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "450",
   "SubTopic": "20",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r133": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r134": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r135": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r136": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r137": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r138": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(g)",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r139": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r140": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(i)",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r141": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "13",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r142": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644"
  },
  "r143": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644"
  },
  "r144": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(c)",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644"
  },
  "r145": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644"
  },
  "r146": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
  },
  "r147": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
  },
  "r148": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(d)",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "606",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "10",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "606",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "606",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "606",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(c)",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "606",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(d)",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "606",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(e)",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "606",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)(2)",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "606",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "15",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130558-203045"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "606",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130550-203045"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "606",
   "URI": "https://asc.fasb.org/topic&trid=49130388"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(n)",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "80",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "35",
   "Paragraph": "1D",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "35",
   "Paragraph": "3",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(f)(1)",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(f)(2)",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "19",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(a)(1)",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(1)",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "40",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "40",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "40",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(4)",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "40",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "830",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "17",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "830",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "830",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "830",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "830",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "830",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "1",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "830",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "2",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "842",
   "SubTopic": "20",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "842",
   "SubTopic": "20",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "842",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918666-209980"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "848",
   "SubTopic": "10",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "850",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "850",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "850",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "850",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "850",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "6",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "850",
   "URI": "https://asc.fasb.org/topic&trid=2122745"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "855",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "860",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "910",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "924",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "932",
   "SubTopic": "235",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "932",
   "SubTopic": "235",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "932",
   "SubTopic": "235",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "932",
   "SubTopic": "235",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "932",
   "SubTopic": "235",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "932",
   "SubTopic": "235",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "932",
   "SubTopic": "235",
   "Section": "50",
   "Paragraph": "33",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "932",
   "SubTopic": "235",
   "Section": "50",
   "Paragraph": "33",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "932",
   "SubTopic": "235",
   "Section": "50",
   "Paragraph": "35A",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "932",
   "SubTopic": "235",
   "Section": "50",
   "Paragraph": "35A",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "932",
   "SubTopic": "235",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(1)",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "932",
   "SubTopic": "235",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(2)",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(9))",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "220",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "235",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "320",
   "Section": "50",
   "Paragraph": "3A",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=SL120269850-112803"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "360",
   "Section": "50",
   "Paragraph": "1",
   "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "944",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(5))",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "944",
   "SubTopic": "220",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "944",
   "SubTopic": "40",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "944",
   "SubTopic": "40",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "944",
   "SubTopic": "40",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "944",
   "SubTopic": "40",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "944",
   "SubTopic": "40",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "944",
   "SubTopic": "40",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "946",
   "SubTopic": "320",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 1))",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "946",
   "SubTopic": "320",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 6))",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "946",
   "SubTopic": "320",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 7))",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "946",
   "SubTopic": "320",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 1))",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "946",
   "SubTopic": "320",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 6))",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "946",
   "SubTopic": "320",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 7))",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "946",
   "SubTopic": "320",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 1))",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "946",
   "SubTopic": "320",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 6))",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "946",
   "SubTopic": "320",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 7))",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "946",
   "SubTopic": "320",
   "Section": "S99",
   "Paragraph": "5D",
   "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "946",
   "SubTopic": "320",
   "Section": "S99",
   "Paragraph": "5D",
   "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "946",
   "SubTopic": "320",
   "Section": "S99",
   "Paragraph": "7",
   "Subparagraph": "(SX 210.12-15(Column A))",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "946",
   "SubTopic": "320",
   "Section": "S99",
   "Paragraph": "7",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "946",
   "SubTopic": "320",
   "Section": "S99",
   "Paragraph": "7",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "946",
   "SubTopic": "320",
   "Section": "S99",
   "Paragraph": "7",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "954",
   "SubTopic": "210",
   "Section": "45",
   "Paragraph": "4",
   "URI": "https://asc.fasb.org/extlink&oid=120413173&loc=SL6242262-115580"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "954",
   "SubTopic": "210",
   "Section": "50",
   "Paragraph": "2",
   "URI": "https://asc.fasb.org/extlink&oid=127002003&loc=SL6242269-115581"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "976",
   "SubTopic": "310",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "978",
   "SubTopic": "310",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1403",
   "Paragraph": "(b)"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "235",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "235",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(f)",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "52",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "31",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "606",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "17",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "80",
   "Section": "55",
   "Paragraph": "8",
   "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "4J",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "4K",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "852",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "10",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "944",
   "SubTopic": "40",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "944",
   "SubTopic": "40",
   "Section": "55",
   "Paragraph": "29F",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r299": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(8))",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r301": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r302": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "6",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r303": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "16",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3337-108585"
  },
  "r304": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586"
  },
  "r305": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "235",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r306": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "250",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r307": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "250",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "24",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r308": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "250",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r309": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "310",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "13",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522"
  },
  "r310": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "323",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r311": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "410",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(c)",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859"
  },
  "r312": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "450",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r313": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "450",
   "SubTopic": "20",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751"
  },
  "r314": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r315": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r316": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r317": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "606",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045"
  },
  "r318": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "606",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r319": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r320": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "808",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "URI": "https://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
  },
  "r321": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "40",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r322": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r323": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "830",
   "SubTopic": "230",
   "Section": "45",
   "Paragraph": "1",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r324": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "850",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864"
  },
  "r325": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "850",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
  },
  "r326": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "852",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r327": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "852",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r328": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "860",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r329": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "860",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r330": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "860",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r331": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "860",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r332": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "860",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r333": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "860",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r334": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "912",
   "SubTopic": "730",
   "Section": "25",
   "Paragraph": "1",
   "URI": "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433"
  },
  "r335": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r336": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "320",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62557-112803"
  },
  "r337": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "944",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r338": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Publisher": "FASB",
   "Name": "Accounting Standards Codification",
   "Topic": "944",
   "SubTopic": "40",
   "Section": "50",
   "Paragraph": "4H",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>41
<FILENAME>0001178913-22-002936-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001178913-22-002936-xbrl.zip
M4$L#!!0    (  U,!%6AU,"MY"8  "L? @ 0    97AH:6)I=%\Y.2TQ+FAT
M;>U]:7?;N)+V]SEG_@->=_=T?(922(K:XG3.*+:2>,:Q?2VG[_1\@TC0X@U%
MJKG847[]6P6 BR1ZEVS*1N[M1*)(+(6JIU: [R?)U/_P[_]&R/L)HP[_!)\3
M+_'9A_=OQ;_RXO]K-,B19[,@9@Y)PG?D_QK_0S[[X9CZX@[^YR"TTRD+$F)'
MC"9P9QI[P07Y&(74B3SG@I'3LQ/7\QDQS6:W:3;;>J=5>GX_G,TC[V*2$*/?
M;Y,&,773+#_>:(CQOI4#?C\.G3D97]BA'T9_[/SB\C\[)$[F/OMCQPV#I.'2
MJ>?/WY'?S[TIB\DQNR)GX90&OVN$7]%(S"+/W2/\[MC[R=X10Y\E>R1A/Y(&
M];V+X!WQF0M7>#_OR"\Z_[.W(T;C>)<9G281X0_\L0.T2EB4#V4<1@Z#1X,P
M8'M$?&N,PR0)I]#=[ >)0]]SR-BG]O?\]R2<O2/6\H\3AB3B@_Q1#$E,'1Z%
M>RZB, V<QO)/Y?F(X>V1*8TNO*"!TWM':)J$^:5(],*O[63S@ZEF,RJWQN^%
MN\C[],-[I./""ES) 8]#WX&;AC\FWMA+2+_?--Z_Q3N V^"Y<93U\K9$T>*C
M[-YS_M@Y&)U^.J47[ NP 1#Y0\%#Y1'Z7L :.;6:9ALZAUYN^KG4T-N%GM^N
MC..Z5G9NHT#%$D47XS=FNZV1[*_=?&'Q)UTC^/]=R:/7<[1@Z I^MI"?Q04<
M%O)A-*6^O'9)(X\&27&5KVT2T2!VX8KDVIT/H]!O?&9EB2?GS)X$,-(+#T9R
MQF9AE,1DQ.PP<,@_4AH!DPDI_N0%-+ ]ZL-=<>K#711N.8W"2\^!1_?#")X%
MT"#?9@[^DW%&SA55BU!>KX2. 5ALYOOQC-J .W_LZ#O\^XPZ3O9]/<@@183+
MIV&6KF02W<%K5YZ33/ 1_;>[@ FQ?1K'@KF/O#@YQPGM<'[_V3/[5MMRW*YE
M,\LU6*_O=,;ML>GJ)H-/3IES"2E_1LI$'Q:OX#4G(X4<)2!R&P=]R:+$LZF?
MC17FN$>6Q'RYM46)6( 42[2Z*FL+W.@ET(,-+?_'+SW3[.PMKG0ADHESAYD(
M%*N:QVTC+Z_1O](X\=SYW8=^&K'8CKQ9XH4!N0S]%'DJ"0GG9B]P8##P(4ZB
M$%1B.DOH=P8,Y@$+T@COBU/;9G'LICX!3)O2!*5J3GR:!O:$Q7<F"5R*KN$&
M^ EY2@G4SD_F&&V;6LQI4=T:FZS?ZXTM9G:=-C7L<==\.0)E=/2]K1"K;+"K
MZG-Y4E(/D8C9S+L$3ONUU6P3X#T?90_^97$"&HO,Z)R;HVX43H$[IE,6<0TT
M [T4@&+Z3'TN:N0+Z&6T5$<#\H;32M_+?N-?C;U=J8_N.D30FZM$P3^?#@:$
MSF:@]V @H4N&IZ.3H\%?N2&DI'R-4JZ[_6ZO:YE]UW0MG?;[X[Y)NV-C;%MZ
MU];'+T?*MT"^JX<N91EG8'3W8F+3>$*B-+BB<\)^S)B=<(\3/B<,#,9D H;S
MQ03^902_@P2!>=E2<K->N>F:/==JM5S#[EIMQ^J;X[[!^F/;[;7&8Y<JN7E^
MN?E\WF@;.A<-=.5A.;T 1T"2"'6<3_%B,O%B,F<T>AH!N<FU)C>[<C<]>CP<
MC<C_'9X<#S2A?P_CB#)?(X/T NA&+(W[F(V&^#4S#\J^J4:.$J<I?G]S/!@=
M#/[QCHR./A_M:H0N&-Q@)\QH, >JVRE&N\"B  \UP-4!J=;@WDOFAS/^N; I
MO)]H/X119EO@MS$XT ZT@([N!<.+-O(%7R0G2B\(6 %.:H,K#-8"(EI!Z@0#
M:-QV 8"+OWL!<;R8T1@G0H,@!)^ PZ(#*.GFGG4D/6O9'. )]\/_EGXXXZ/Y
M[Q0LHY8N2,;'-A-.. P4)I2YX2EWPYOW"GQ(X^A>:RO-K7\R/I0PC5:M,QHQ
ME*\YF?E( JX.(AYJ@%G2A$\U<Y/ T^+?OS5'3:2=&)(TLN!+U]KC'9W_\Z_C
MX0EO^B+$Q;H"Y);4X'[<&$: ]J7PYR8T)F/& NF_:=(JA*\\SCGPX9X1+'#C
MB%W.-7(Z.=#(_L1C8-_]8'::@)5:+.Z)ZWHV- _#DZPJ&9-(8E2XDNA&TO=Q
M.LMHN0(X/&2#Z+E(Y05U$D^I[[,(R&Z\?PN-?0"HC='UG'%J(O6!8USD=QN=
M5N (Z;"NNJ3 H_1?H)[#:-XLU@H)10.2!K"*V)>/RQ51^SL2,XRXPEZ6&@\8
M^I(BC;A8"/ZE=B!8(@IC:C.ZL+!X'7HJ2,K71D2;*3@ /Q:[P4G .O$8%7KD
M$79%G9 3& ;/&0 ZO:*1 _(58T=SE)X4V ,T-+V 6=C(*Y3[Z"2\9$+";"!9
MS+ W_(9 JP$G2<.%! R<! K>B)S(G/K)'"8"(^/4Q94"M9U,LD6^B,*K9-*4
MW+5QV3N(F@77 D$  [2,!T^ %P+@*101H C,D ,BEQB@(74N*?((LDQI_6;>
MC/%9@6G!$I1&N'=1,P&"\2EG"FSF Z!)&X\K,GJ+*M,X-;E). .3!L; N3<-
MO$0N, P;6"XIV ,M,EQK: S<KI0)CQ#'GN$ M"A!(D?E)UH&4A4CKXJ@XAC/
M& ;N2]'2 Z&-4%7$6V2PBHOKC.<8G6ZWU>ETF.Y:CFWV]';+L2S;;'7<7J?3
M>KS%VNILP%XU>M7FZBVFZ8/8,']TTW9MU71. F%XF,+NT$K:O3!G $+I)?5\
M.O9\CR-E!OFE2 EY,V;!SW#NDQF+PA^@JWBZ<:J1]F^[N>FS8$!Y@>O3*>HO
M,"( C@$).**55 MUT')JYIUX7 F ;16!?<DMD\"?$]ES560G'TQFX14C0/L*
MU!.W6GP/!)8W/4ZG,Z$8@(NG7HS&2VE,)<,L)A&=>0Y&BR\"#VP'&H@QQ6#\
M4@_!DS?L-C=AY4LD63#?^=4)*(@PGE 'EEQ^V,FRG\C=1>YS-24I19ID:5&>
MRLQ9!K]D?J(7+"4IRP!3SE&N)F<W8"X=_N//PP&WQ33@9^ (CLRWY@K+.<N/
MP!??!_!73A\;S-H(H3^9+$&G7@6=>'$EY;G20][Z#*XTQGBI0=T$B4W]*SJ/
ME\2X>CD7LM<-N28B[[PZ:)&KUDNK)Y ](ZY9SE?G'' M<^Q\N(VNKT>]689M
MFZ9K]GO,LJQ.E^INM]]F74;[S&[W7:7>BD>?2;T-9I'G$[.=*;@L"E'HMVM"
M_\W\5G2>+B) =V$.YRJ2!SM_V#XX.* \^#IP.[?L2+%"=16.DG0K![<E2*Z@
M8YE, 74TK])OV1BYY9R/#/0.E:/EVEO.3N,JU4:'CWL)W.#/O;?RL"GW<>E%
MQ!@?R9@E5^C+<1U^%<IHC)>Y4-R'Q$A%#%S%RY'@&BC7=#E2<0,WO,P0\-HA
MQ[8<EYE6U^PY;<MLLW[+[3HF,YBKM]OTI5G4SX(:GT+?#Z\P^(#L#KZR\#Q1
M(@ >I&LZGI=L91'L&@1!"A#RE;&$1QU%]&$PQ0@C!22R07=/YWC]H C;:.0K
MC>P)(%3#[*-\?@P1!.#RH JLSO_Z)_:.R#"E:&/G0@M6C[32?98)/LIU%6K
MTGQGB9+--<MFI]_ONO98[S$7,YF,CJG;'>M.VVAU&3,-)9N/EDVA.C^&4G')
MF&<AECP&55)Y90_UBD4H,# 4KDX)UM>%:8R!4)"D*7,\2L(T\46$#-P\$'V-
MH*L7\G9IZG@A/CBE_P)_=LQ@:B"_X&+&/(8E0I%PHQ<XX )B9#P=^UA@Q#U;
M_&6ADRK)] *P)WC1P_OTP\#WTXAA%29T>4%_ CTTO'Z*833NS9: !&_COYY/
M6.DZL&C^RU?FH-O!\Q--0 X-?Y%&6_KA"X.U"?%Z_L!I-K5]G-IA$',;IV@/
M1&X"N",#XV,<]AES@;YH7;SY>GJVRP>/,X?;#S"Y<HY^.&]"P<^:X<=TVGK?
M[INFY5++:;5HVQQWG4[;[E%;[UF=+8.?R@AL_1 IT]$8,.?F/P /V,UQG(?2
M>;3]MO!Y%CW/GP:(@]_A*^ 02RB@267P/DX +HH$FXB,3:CO(O+Q3 &V_D2R
M]KAP^DHM\L8S+6?"2>'FU((OEL4K2SE:!+>%)*U6^&;<^\+[]T66NBB;6:EN
M*T*LFDP,\RQ7UL USNAM;I8F/+)(^'R_ZLU^L6S9G#"**>>;9Z+IE*'^\D)4
M6C@K@UQ-/-"HTO7,^P,< LL2DQO<UY7MB&BH!^(,(%GV.D5Z#7K,$NQY3AW4
MIP?_9-GD4^I0T%&;3V@#2S%N:..8G2(]PY."0,E8F >_FDWKGERP0/E.L[_R
M> 65FP2UM,,P1"X2E;]:)?83YKV'L6V: %R,4TE7NOA,JZFOKC,W74(7,$2D
MUO()EM:G(K_&+9S%YHW2D*#5Z%82EGJ8 8^@=053D&O-' %N=%K%&6 ] 76Q
MN"&6+(@F1Q!>@9WE\4PW[T]8;I)KM&+RH>L"..)O82 J!\H#+%+ZN62N NOF
M>? S3IF*>@;J3 '!>08<)6J)"XUFYS%<:#;U!W*A7F+_:[GPRA-#<,(KA)5B
M%6#1&RMAI$;&%?D<<4AEMA/<N'GZ%P7*F)GFE35^&,=RXL8JR18+=411H[E
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M:Y>D4\-[]4-<S M,-08<B^6D)&T7\/];P&T([MK"#(8ILA(NES@S2'@;;WY
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MH1B[9N-3H%\'N>B;-3R$0$E&C4>W-:S]\B!_\Y[18W?VK<,1.CK<Q]*ANKE
M:A^0V@=TE_8K86?S ZLAV-4A$JH$6 GP/=MO:>T-)C&4$"LA5D*LM+ 28"7
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M$>OG]PM;F\UUXC[0<U.+M)@8-M6 OR[?H/T?5E[V(?P5[Z.VZ5KTB#HL5_[
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M!(?#9%(&?AEM.5>?^<Y:L#"P7/V=Q3!S]<7T< KL5X45L@D0"GR^)F=%Q,C
M<D5T%L/,%1'3PRFR[Q&)V:A@D7M$N2<.,#&P7!&=Q3!S1<3T<,;4LQR37=^&
MD[ZA:C\TU97U9<&(V5PWWS&VNX;:>\.*ZV@_X,Z)IF"+;6 F)2!BVQ74@-C=
MLI-$;-G)M@Z5<TC(%N5@@1,.-RLU*/@@%RJ,E5PZ+6<=S0H[?' IOBU<4OF
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MC+,2Q?JAHIB>60*B* A"6461A^'28>%OLO4=>^F]]J+8. _!G=1_/1&I9P7
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MSZ?T*I-*:=:6QM""@9>M=P^ZD]?-/(7WMH,K=XQJA"L7WF"^PI07V;4TI"H
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M9B9?JEKV^,F9MH.E*2@^0&4)L!>2Z-QF!0K0]67A>]X.QJ6##Q!O1SG:P9+
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M0#)Y)8LE2AZZ3PU[Q8+$CE2I-X[(QRX73A:<EY-7TRC,L!54*91% Y1.1 Y
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MB$&#LPCN?J&(+=EZPR1Y*\U&6VC7FA'<[TTF6'&&D]Z;,I6-%_PH.WAH$%5
M_B/%<Z&UI(C8([8=2U,<K)(+74,-GUBYLV\HNDL \%:SYZ8MZU^@0^?P!!P3
MU:$9+E;];95,X_1[U/$JBTQEK3#9M[E#5*&(+1F>;C.<(]O&,0F@F1CDM4*4
M\^(1W9U"<QKCNS^X>>QU1SWTZVW/^_4;ZF\QO.G)Q]YH_-B_&?>\ZPSR%X_*
M\*A,5LHELL#F*#7R !\T55 F%I9M?(N]?Q?*955A>4KL=)7.I0/J%)4QN,/A
MBL,5VW"5,+8@M>L=]M KTW4U8KTBU<X.QPK&OD5>-%.2(/Q>!C_JCM'GWI?^
M8$!6W@SOT/AK#SWT'OO#6P9]@2+$9@I%[#D$DL*ZLPVV<%UJ1L)*1^G.&%4H
MB#5)3"<!I%)K%6*+NZ*G,A=!8 M%[#F@BQ=)D"+IPVGCB9@:GM3$2DTZJSFY
MDQ<=K>=1=/0TUJ57A71O&[,'IT/6923O@QVV2S*8;(1P@#2DFB[9%:E409"_
M,N[4)XU1E75\MFG"R(Y)J6O"%&=8*](ANT>S&5&J%RLRSF&5PRJ'U<2P&MG)
M*FU832]QI5GIE">9_#A4+6<<.YNP-5F=2+;]I#_PDE<9]!"*$'PI%+%G%"F*
MK#CTL7H-H;O.C6Q9[X!$?\BZB[.U@\6*V. A9C;HY\1RX(@%CLA2DD.!(SU+
MKU%I-7DDN1Q)RIGP\](!H=4G&.0,GJ_'\_6R0NQ(T>JP/YZM30<FW=DERS$2
MVN0@PD$D-1")9"KM!)$T=Z7G(+(D/W\;KWZ"0KXL)JF.O@[_.2"+V4;C[KCW
M#>XCR03+"O+LVY4'CQP;:F/#C$LAFG3DK-*Y5\:4TEUFPB?TT\:,(EG&' 8Y
M#!84!CM\ IYER"B::5\ &WWT]/!P3ZWM[N._P?J^&SY^ZX[[PP'?EHEA0DJ]
MG4[YAX\90DK-1TQ$<PJ[+5,?+!<++!MD805K/[#*GC[@^Y*PTB*^+\DQ;D=]
MZS9,@2 ^^G)XHH)"C79I8BQ\"Z;\Z>=0QZ&.0-W6+9@20%TV5?%+M?W&*0,I
M/RU.RL\Z]LXO^F7Y8]%1GU:Z;)4O5Z1*P80+/FY?+KVURZ*!DZ I^7P] Q$;
M3S&2%<6<P<,D#109I@-WRQ:<!H&#-KQ8LH[FLN60G52=*;8QB(KLJAK-TS,-
M%1NV]XNBE$Q.^WM%P8.V R=F)(AYN4425OMP)ELOFE%US/D5M.NC?^BSI1"L
M7$_2MAV#I>A8MH@<3#]N_:;7O0M.W3K>V:VB7U!-)?$O OT3XA&#0)/N+_,G
M-_MG+J[O4!4UDRRA7VW;7'[!U6<+R]^K\@2:=B7KK_*['=(+GZ96<+NOM#P\
M$0 ](MU+)PO(%1]S!.'GC[YD$+0)-RR"/?Z%"_1AA=S0T"80RO^XMJ--WC=(
MY6FJ(01<N6LT/FT<F>*AS&AX7_W2NT?CWLW7P?!^^*7?&Z'[\>TV3$@2U$[2
MPE@<V+=#H>&R9W[T!]W!3;][OT@N&<&U#_(UREKPHP,U&(ZA&\=#=#,<W/8&
M(Y( ,QQ 7_=ONR0;9D'K,A-FD?SR;($@>0SYZ]/EZ!*IIJ[+E@V0#R!ONK9L
MJ'8%X3<%SQUD3SV%H*(YMOPC0'HY4L"/\6'<YW-9E.M\"A3GMLJ'*P?Q%E#&
MFG*SG>69M@-W!D\I<?72&@U1:-0[D53F@>RX%AY.]BN+C\$(GY-QM5R\IH!#
M2BAJ/<<9V3'G#M03[. J00 DHO_SES9T_D<TZ(Z?'GLDVVWXT'NDLV^[L]TR
M%]&$?>VSKXXG8 \0[F5,>$>F7OV"=33&RM0 D^1%@WOO'?42_0H6BH[)%FQ8
M?T>OFC-%FF,C"JNV^VQKJB9;[Q5B/*,;S]+^#6DV,;#[MB5C70M. _HJIC4W
M+6I% Q2+G4YKNY(LU!!F:%:-EYU+^Q8I\''B[Q(7Y 4C>XZ)0^*\HSFHKQGX
MJRYUAY'O^X!GK[C$D3$-</EA),TYW>O6(*[-;$:V<8;&_H^< \"E3X*].Y,=
MR@KTT')?R(ZYJJN MX-6"*+RV?IH(S")U<4M2(&74X?)\[>>9?)Y=TX"'7 5
M;IM;&G: ==!,4RP3&P"'MJM3 (6/Z\!O<,U^M\'#JE '3(-Q  +!4:-/>/?#
MZV>RBLG9N06=,-<<REZVI@/=(4+15+:1\VHB>4ZV_H6;2*/L*_2K]AL:O[X;
MV 3^:-4_5A X_LH4O<+]?F\1M\^T*),[X#4XQ.DCWY05 Z,?KOXB6Y3GU<5$
M$)!E?<>48MDE1H>E_<]KW/,[?0^5H#O35.ECMZ[U@KKJ#(;5=CPU@GXEMUW<
MW78O?B,#]W<7!+#6JB 2P:8/_:H!Y;TYN*;R>T"ZO$(@(1EDE!1*0_T^LDP;
M. -NF,I.<CKA^^3K71@O'=4:]/.U2]0G!$'C"3$AZ4?4.J$2[IBTO\'.TET;
M/H9@3(A#C>07"WN.LX<H7V2=\MNBDU>YTJ,&.GMUC&C[UYI.K3OH6(-Z[R/"
M"#:I#X>IWX\:EV@8M$.L>^T(4RX;!CAE"CQ,NRCT/3*\/V1-)Q$<2N;<M13@
M*$SZB; G,1R@.5,3F<^.#+3(A"-MQ=+H;NEH8IDS\C4-'IV^VQHTSJ 4>=V8
M@)Y0<[,B",:5!,OH'63\IJ3W0 86DATB<2'\"[G7:)ET2C)>2MH+-JA9M;BM
MJ[PKNOE#LRJH#Y(^(QK&H(,*/C68X6L/K, ))7$ ;YT]PWU+]E/BV \0=\%K
M'JL]R*K\HI%6F, :ND[AB,:HJ7M@81^"2-NQL:"#:$'YF>@NPL<K_/N,G5>,
M/<XC@22-\)P6U(KW>F%Y]P)$" S! 3T-GP-Z(WVU!KE/!HB(-QZ@*A;O##>>
M0)R%R6C3J-6"9FB0WT9?)E?Z]\629[;7<#)L)A#I6F$JEKV_(D_UYXCR+KP.
MW]<&]D)1H', V4YC%3]J]G<J)T\ #!89Z41[U1=F!#*THD8@EGC%"J5B/K5,
M]V7J@; DQ*$PD2F"(XKBSEQ/2%0\ ;BD%L!?M\WC1"H /OJRV9,M ^#![BY?
M>NN],\MTV)4=)-I2I=V*3NA0SB*(*"\V78;V ^(]$XR;N(9*+0;- %,$U RY
MDP9,IB91X'9E'7/ >C)<[%E&4>7O@0F0;@*@$TNQ3F]LA,TV_ ;6K8=<P19T
MY#>,(\ 4:9$&'2<;Q*2QL0PZD+[$-]PH\"_5BF+:3@CK2 M,X\6DEN7"@3]G
M8,LH3VIA552 ?PQP6NC(@!'CCZGG>\!0R?K[_S"MD4 &%%21XO,/]0& R\B=
MEJS9U&3U7PH>"F%.<HJ:-:HVF8 5 %_PWP"LYA+.(-_S?= PK\(=<_<9>!01
M4\K2?I [2.TM<*I,\C(BKH2.#W!=Q<]., \$IRO!>6)0$!JH3-C(7:ALGY=_
ML=%P#H+TC=K<: 0BC+IA^^3OF'Z,N-_W-Y=PYZ*O%G) ;,'P2Y6@8IBR5C&L
M J3.39M*M!'8^M1BM#&(CR?@T"D 9"$$!%K -))UW7P-82&Q#EP?(GQQ@>;.
M=7F)I$ <>(*VXYLJ;PX2:V@&@SRU%R;GRM1:S&P:<(7MR@2KB<G!(P0'1 C
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M_CJEV2LETW7NX$M_D ^-"4F\HD>*?.@7LL"Z^;I:S4-&MCN;D0J^?E'CE4U
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M@=O 8]E)8.K#^^N3(;LJ6(=J[+*2$^U$O/CI__AI6\I7.Y(R^(A_8,/%I"9
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M6_$9W.^?7VPP6$W;)FV:: [I$SV0;W*;3>O[AF2"1.]M9+O*U)LTT)8-A_[
M,ISW'UBA[  &S6#E#TM\ZTVGC"E#=8..HM8BX*JMJ=AGS.=%.AX=#\6<TP'I
MCFY06VC3L:"#0R#)-S<#1 E0RO!9'K_-37LYMI9F?_<N6/A5ME1[,:T4GKCQ
MV._],D&X()W^WF>D,QB952&RL&*^&/!&>TUC6U[@"KU.L3<R@>!0>4:F @Y!
ML;D^YU$ NVI@_J#.%[&IQ"TVE0R&Q.L2;="OY,X+\MZ%8%W\M@1,'_HJB)IC
M@,44]SS-0$T(W1OBI?NYK>"3( E2HU9OAOQ/<!"![N'DBV=PW:P*U((F>VR.
MX/./],NQ!23 05U)CE@V)DB1$%93)(10AD35Q@K)DG@U0;"Q<7'M8".2(+$P
M"-<D?FF-/OO94RL0LZK)PBCOV:BOIJ^*87B"]ZN6^[+0'ZNV9FB0PD-,-+>%
M'9EJEC7A6\16D@T0_"TVM@W0@V6^6/+,?O2_=V=:-ZM?3#Q&_HL.&Z%7<_,(
MS7T*5Q5TLL:++:&SE3MO87!N%G9N@D8N;CZHF1,P?C>WDW+*JE]RMUA$3/4?
M(-;*_JA;V ?,$L.DN0W :J%X&,U3P%3J/9/(B["!^4.4J4I8@-P*@__C(,N:
M0WA@FB_$G!B*]H9! V,;>P:+3&]9H+Y8B0'^5PT VS6([TDW[@);^GTQI']-
MD.+6E&IU<-C#<-![FV.2"^-/1STN4EF&X#B/7X'.]SM@VV_0\FD2"3EJ-\^&
M($3E SH%]& =S2@)!(.1KF&7=%B(D2>NX\*OL%$?Q YV=$\;_JJ)K5JGU6C'
M D;7Q_45X'CP03T/;-RN9CPO#_Z=FPZ1?Q+_B/1*(H:I0X]T6K$]\F3(X3X)
M-$G&_4%E/-HCKA'IDT!QA)U#7V+4A"+3$!K-3B?4 T_SB04M]/<S>O3?MZG9
M?E'<M*1$K-0:,4(BDT%'KD<9V"OOGD]E)&UF4Q"D9GB@0^TCB- W^H;MR#JU
M>+*% B&^E2#ER5HC-5I-(99M>_]U9?T?+AATV-+?]VO0\NXT.1<3BM!_ Y*@
MD0N:/,X-:0T$7S():_\ 1YDXP+)SB!Y1L$S".;*76@EG3=>!SQIJ$(?QT11\
M;L\.I(%;.Q(FL2,^\YZ1CTRF>W;4/,DB&R1"27RFR%KZY?:<D;"FOM<4DC"Z
MXD0=FR*R.;4A<09S7';QH;EBF68=KZ0!TBR12'9>*-_7.]= *\E[6W)KMV2]
M[-%X/VEE]TO32<#VVA5M8:@_-N<\W_=O2&+<2E+-IK3'T NO(I>W9M\D849O
MQK >EY&4+G=&\IOS$I33%,%*EJ/?-[PZ63L"520VLIR,T#TH6PV@T!C5%UD'
MOVDF+\SVV#F]\>N[@4T8C5;](]55O;EMZO*[=Z82S&T]&21#$(T<SYON*@HH
M8NI-F^'H333X FTUYT$DS,)T?BU*BA^+F9 6>5DER[)?$\VRG>@SEZCO$>?E
MQ?A*GS0JVG_[&*KP=[W1Z$CAY4N@#EQ#)=HR;++&[M_0D022^^%[-4-KA*T?
M,$Q>3@B\S>MU+R?D3]<F.8SC]SD&UVBYO&%Q<T17D=3&8'3]O))X0[$9,A0;
M.PS%UF5T[1,"UM9)-U$O)XK4NY>=K/#79L#?\H*D=C?\W6ET:K5V=J/FB\:)
MAZVY8]BBFTX=/6@A##ALU$ *UQPH -S7J:9,Z=R2M1@7I$U"\ZZ4:#K]9V%[
M[IOBP3PZC<8Y2VE^?D>W\)O:YY)OH%]N;G(LJ4,"NN JU%IQ!KYL&*9K*,1&
M)][!(E,@\(_C"AEZ> 4WS"T-.R0O836B4$%;9&('K<G6*LUCS&;?*B5R1%6'
MBL-6_JFL^C-;Q20*?!D37\;$ES'Q94Q\&=,9+&.*<V,S7P->F&A,..?G-!V2
M8M!E07ZR]_]*/ SM_V_OVGK;-K+P^_X*(FC1%E!47G1M@0!J8G>]<&K#=K//
MLD3;1"51RZ'2Z-_O.6>&%,D9BB.9%"F7 9*BNE!#GOOM.ZL-<*2$5%WDMB6\
MM+0/IS\KKI?$S<<SV&$>G+"/#7SQ"3C-"\/J*9#"L\YX*G>!@RP1P@C%$.M-
M,,.N5@P2L!<.<\(,0A#?\!^Q/8,F9%PV"SR>G2"P 0X.L'[9,F_F(2/?NS1W
MX1H6I1L^3^&BBI/Q+A.,:41,H!6QPM_>V!DK(M8_UY?[HU5JR1 Y:2=W04QI
MD62V&!;Z<7X)I-S#?5=2$)>*(@G-'6.W1^P#B@,X7F-1Q' Q)]A]#4Y0AF7I
MH"N3U^*AZ*ZA(W%MN#>=.M_0'&+&P$I1#X%MV&</_@G]E2O(IU[(UXOIU[/[
M#<P[%*6+G'WIHF7T""*.(:R.=,Y02EQV"P924_:#A'&;*XJ"OS1%$8GI.+9U
M=,K/-ON.=1ZDB428]%WTXR1P//>L(6YIR:Y>\^JT"1]>+ZP0KN60<7;'DG;<
MWX?^[*\7'TG#+OZW\<+M'_ @/GELMO#9)GCUNI*FS;-7.,">2JPE$(CROS6(
M)][O_SVYNS ^3FZO'B;7!3Z<UH1[I9.3E33T24."IRF7W9!B8'P*>C_48IW/
MM=!5KKES\M-NV(MYWT33'VXE!46>OY GGCW7L9N.V1^.[(&DP3!S05/->%$P
M>E2Q2]C$W[:[CPBS.L'I$4'YWXGP5ZM;%]>F_HX-=\6Z#IVH!_3G;IZN5D Y
M;[Z9+G9>U'*]\+>NRR:K^<4W=[;!RL+-TQ/8Y(!)QI=.QY)6]^J/RZ("&CS(
MWFBDZ+H4[ R.CQN=0HS2B'. %\P/LG^I43M^G?ASU/BUG3+7!4/'!9/&^PVF
MN*N^M VJF)25* /OY)/8!5FA0_O?905<U<107I0?*<8I2'((42Z$KEHZTC)'
MXX%=EXY,)0HT=60I^M#JC3IC<[A7'T8SY3N]""_& 00%C%A I4PXPYW:0%'0
MFL',HPE:T)E(!:T0SX&_ [-T,MSLFCW_2]SJSB=X3\_NA3CG+1Y339KC"?+G
M_:?;HXQ4UU%8J+C:D%425+@0_Y8O:]B1&S$#+FWD\PE3L2T](5][D%N KO;8
M&8]*HRO]\P5. Q3ELF65+E?9UN;Y)L"NIT0.+H:OH6ZH7PG$(='B%$I/CO="
M\=X#B-?!J0@($T%\^"N_(=Y&!:$\Y0!P.,KXD<:5,!Q_3 Q?QUF9GSCP LVF
MPJ7IQW8-UD2P]);&\ 6^R8_->ZZC<[K?UAZV08NN+;CVB^*D7L#U+!VNC,&I
M@G&HZINF6S_J3?E1K2-5GR,%>KY$35^1(Q6$V?BR%'?*'EJ=OJ7G3L4',*((
MMTJ_JC=R=E6LYOM5&O0YUKNR%(-6Y^U;]4>]$D.7LGVK?%*V'E9U'A89$&\U
MA^O_XHRZ/6630.MTM4Y7B4Y7ZW4=[74]^J!T4?;GH!QFH1^P7:,$QVWB*FN>
M:80@HR7*D(3]Q;\$-H2K#UVO#<>(FY_^"L*/+Y[[5(GKYIAVQQPH^FL2KEOB
MR?_ C(\7-Q5Z;-BOT.N=D\>F1YMJW+8DY,$/+"T6J8XC+A;>;HK/KL>Z-D,3
ME>. VA!>],NK+Y;O@.[ES-8++=,++=EK5'4)[6O4,>5&G=F+.]\@7ZBYC1IY
MA';$Y76<2QG;+/EK#WBZUW;S5-WO>S2Z\N%C *7HG-UJ+^0T/]E*POD>GZ;Q
M-TB#VEARP(BQ3&PD\6.QSGG,,8^H==QYY+#$^PS5^B=#]A)P8)R./90K/UQR
M"6IV0?@E.&V",+8<8ABTR)K#QX;2DTVJ)II:B6:VLTT,*8'<PYP5()[E@Z(K
M1^&R#,R#2#YW%\>/&O&D6/R)'83RX.!Q<68FN)3B#T7,D[OF-S]"5.PVUB="
ME;M::SN8G7<P?%Q:>\M?<4[%X7+UN9CU2GJ/>]1YU;C_J+IT?=^Z^4.Q';7B
M/=OY'!7OQE;M>SUTS7B%W'92D.LOL3%?92/A4_)8M#&W!M*4J$GCN]#;=ETW
MSYV$P;X[)1M):\>C->$M10JVC O/7%T SL\MI3WHXQNGAO:QN\'/2_V<C3U\
MB[;N$Z:7W-7<V'KN8MX4_CI+T]6,0[]6W;]A5>Z89FF)W3B?DDBO17C<D4S=
M$=C\ =F6]29P#[,2<B'A[$182_TW@[6^?]7#;<.V:JD3B9_QU<==* LOW#9%
M&-IPK?8;:\.@5]I.:0MZ);;S2RR[1UI/4:QX;R<-:5&Q8F!W!XVUI*</MIK!
MC VTMOJ/6:;C&5G2.X_]]?X)R^T> 4&ST A &FL1B'(?>1664O^$6I:F)BM8
M^5TT0ZGLLW!.I18.A>H29.I*B-0I[9NM0.@Y.VEN3=>K"^QM>(BMDVZPK+%6
MW*QX\(!^@Z9&1D<T)51I6E2=?.J&TF.:N_;%3@_ V%KM7;EMHD-UF^A;DI9*
MJDW_RGP@W04J3P_EMH5*F'%&+I#^/P[;WFJQ[5ML^Q;;_L"?:['M6VS[\\2V
M/PMD^T&[9U V[@*2/@5HV@RT^SRL>[U%A<.B184TAWVT,I=Z[K,PO_^ C85Z
MY+])CZ?F\586\6+/%:^BM5S[=R'"MR</GPV&N.N[63:^ ?$_N,LW\."-Z^N/
MQH_OXO]_]U,')VO99LJA[#D8?/(W/!9CPW=PUI:6H_L0:,\]-@M<C/(Z^$T?
MKT@VC;F+!8[$^9OGQ"\C[#F-STQ9?$9"0^<=B,;+]"M?$@RO/^-RQ-#EU\17
MXZ'>S5H/E'Y@6\[(M!TSO01O$EWZ1EPYKU72,H?1CFUS&..9W_$EQ;?3(-P^
M0#S,^,^SW[;)=V*LL_C>KQ>S$M?<V7+"M&MR>8R0S<73]S=\(8"8,YUS$-P=
MC9%?GJ8SJFD:@;N<>BOR6/CFY_2"<^(HVL^\GFX3##6E^4J/,;Y&4^B%XM'K
M4<_L0\B?60[N!NC, &?</-$<^VW@S^!GV67@+W&C@!@O5*[5KIQDK\AR.UVY
M'>K[:'3L&>\4]S/0K<8@\"0F^!DQZ$ZC:6+ZC-/LH"5X>G#M^GJ\-*5]JBGL
MM .1IVTOHZ>_6W\^Y[HHO=XUUG"H$&G.E_)DG0,$P.KW1F.YLL/9'.=EH^WR
MG.>O&-O@U&2"C6L1@V-:QGM6!^Y6AA80K/TWF#&T*O,$DX,\/ ?3)5_:2]AH
M&3D!BA#FP#?XB= % _G=@?LNM8AD._VQ*4%Z)?42TF6ZF@'10%<N_161KF$V
MI6A/AJFHPJ675.D]4F& 6L5T=,B;=?W$[A\).)#!J0@W< 4714.>Z_+M!&BZ
M]#<<K48''&74ZSN.TY,5%/(W5T8<5I^/<5/J'^Z0WBE<]..8S?*IG-PU,5UC
MPB+M[PE13Y@$#W?LK/T /-F5OT^?273*$Q+B^.;N:)%FCO(H^.:VM%20G92V
MM!A#3*28Z41*87(ELQR*+G!W<4TIR]O)W</5Q7U>+N(X)5P&'3*P&ZJTAM./
MOB)*IN^M08VYY%0QZ-V':5=%D*A*2#<PQ@L) 8' *0A1(7LK2O*05D!Y"'Q0
M-!"8)>"4*)">D:KW8M<?=8WX?#Z<F4"ND?=I1#I,&)"]VJ<6?I#E4F7=B]FC
M.F;X\*A)<?[I":&996%7</6)1!Q\.F+)UZ"K=+SJ-A+JC_UZFBHM%5DE%(7=
MR;+54WPHKJ)'A&-2D',5O8N<9F7>BFHDF1JK*,D]T1]%V52\D5N9(?X@O$7Q
M O4Y\E?DYVC\K+;.44GVT9]OX3\OX7+QP?@_4$L#!!0    (  U,!%4M9COC
M80L  !-H   1    <VQG;"TR,#(R,#8S,"YX<V3M'%UWXC;VO;_"RTO3!T(^
M.K--3C(]#C$9N@12<':F3SW"%J!3([F2G(3]]7ME;/"GL$G:<79YF;&M^WVO
M[KT24JY^?EEZQA/F@C!ZW3H]/FD9F#K,)71^W0KDK/U3Z^=/WUT)9X&7R !@
M*BZ%-_>N6PLI_<M.Y_GY^5@PKSW'WK'#.F<G9V<G'\^!3 B; GL^/V9\#B G
MIYVO]X-)2#,"O/0(_2,%_3+E7@Q_WE'#4R1P#*Y&7;E!2 )_Z*P'-Z">AN[7
M 1!.$B4:8$*%1-39"I$3.E+Q].+BHA..QJ 4SY'$;BGQBPYG'NY$8#$6Q[-2
MC(\=&(T!7>QS[.S@@+@3,IDA1[;QB^\ABB3CJQZ\;PA)WI8K'XMB.C#<4</*
MSR?MD]/VV>E6!))VA\#.\9P]=6 @#(L8T&$!E7Q5#!P-IA$"SB$HRS"BT10*
M?G$6Q>!J) 5*$7%$,6PXE (6Q"D&A8$TH/1Y"22,I$ #D;'X#(EI:.UX)$V9
MRSPD?,P"E1'=#&6%F"/D%\J@!B)@B?@<RR%:8N$C!^_. MC#2TQEC_'E+9ZA
MP /A_PR01V8$POS3=X9Q]8]VV^@/;>NN_]68K@SK/^VO-^.!T6Z'HV3I,RX-
M6LBR;'JNT]6 P8P(\UHIBGIKQWAM]:E]>M8^/SU^$6ZK4U> ;9*J)T",5U.
MXJ17D76,H'A^V$?=;,:JPM?C/(6EF%\HA4\_ODJ$BFHGV,M7L]9GTZKB)*E8
M6R(UI2O)MT5"B#)P]=!6#[49IG-V):9)E/AE3^;I]%^->Q)G\[8?_T0]J<1[
M Q\^[<<S69<J,=TBK!_W8[NM<968QN#J84^&VU)9C6,,'SY5YEE6;[4\"PMD
M!WM2;,C4%V!;QJOQCN'7?%5EWX?E'DKG&>^I<;J]>(7%U9?*['?WM&62[,(,
MWT5"!D0IDR$1]:H^^#ZA,[9^@W=5_"]5#; !TU /C^-^66,5UHI;Y@2JJ3*I
M:U%)Y*H/]/@R9-(R""P!M! QYYBWBV>$DE#"$UB:&6TC1D\^(NH::UI&@MA5
M)TLB0SP0V!W13^$S+%$$D H1U;(K0HY -(A;\K70'.0Y@:=G%WV,[?\*KW09
M=3$%XO  8\15#<X-\E1G.5E@+,7:-Q7@]!XZ [=,P(HX<E%W-+RUAA/K5CU-
M1H/^K6G#RXTY,(==RYA\MBQ[8AP]4A2X!'C]<'!:#:<](&@.Y )+ I)5]6 :
M2>_.\]>ZTSA*L3NX=X=[-\86H]G(QSP41C<Y2Q#T;OVQFELG-OQW;PW!I:.>
M,7JPQJ;=!X##?-W/H=T%HG,L^G2R@$FQ8)Z+N;#^#*!N5?2PCH+>Y1_V<7GW
MLSF\LR9&?PA3VQQ;GT>#6VL\^=ZP?GWLV[\=XF#/.$!BT?/8<]5YO877^_CC
M7CXV)Y^-WF#TY3"MB]TY1#+@.)^."[[KW?-/U;(2X7A, "*\#$W[<6RE<^O!
M\!O#3\B<DAFT#;!6<,)]&$+G#S!!'((C'^A!].[X*>N.2?]NV._UN^;0-LQN
M=_0XM/O#.^,!)DZW;TTN#Z[9N.8>\3^P1%,/3[ 3<! W]DCAB-X1%UE'W)OC
M?UFV>3. CM+J@BSVP?R9"N-Y:,K6:<><<[RN%'$Y*1[4.N'T).N$[F@P,&]&
MZ[1DF'=C:UTS#G[8^F% '%6XLQ[(?];;_C1K>T@XJFX?K%Y<%U3OVT4^D?&B
M-_5%;^NS7-97C2UT00]]VQP<S+PU\QA[JA&%]?LVNV>^Z4U]GC7UV!J$#>B#
M.3YD]!J]3HV>IUKO<_JA;N]C',64#TL#?1MDJU=-,Q2-Z_WSL5I+9!RMJ1U\
M4EP=DKXH^*[W06ZYEJX4!]M762K?0O@3KW3%' _K/9%;J14MG(VC(>**[!/^
MP3B*"!^<4['$;&R7<E@]%+T3<ZN\W27GX-#:U4>=6W4##R99ERU]1%>B""KE
MY->3T3K^++>R+*ME,5.#S8R([??"V#(VMIP/ 5$Y((+E$O%5XJ>#'B+\W\@+
M7ATCKZ6L#YO<HKA2V*Q%,0@UE#!&*,TAGO[2!'.+I_*-DLPN4OJ(R2WMZR4:
M%Y@;RVUTB$-T[+,)F7+[#AB]/W/[!Z5;DH=6H>Y&9<I+I:-Z__Q88=ORX)D:
MR]62)EP'H?=0?ILGLX0].*>R<[;5RA0B6/KA^O41&-O,$I(LD<2;_J?4?_L0
MT;LXMU.4=7&RV"68&HJK(9D1\TTT3/\WP:#^47=;QGAFA#?B+M4)V>N6($O?
M4S?IPF^+\*:;NEC8CN\._0ZJ'K\LO1A$D==<I F#*6N=B'%,(KILH;^Q!T28
MC\/-]TXL_/HL[ULH!6ZHJU3:<\U3";J/NBH!"O::J0T$?%UM,G/DK76ZZB2.
MC,-+ZD#Y573!+CSD?MTRY]!@J*M5H]D,<[63Q(FZ$*>2I-+S]S* M7G""["7
M2T8A-?%57^*EFM M TV%Y,B1UZT9\L)+N"$@2$R8:X>H;L"C ^@B &@B _5V
MQUG@QW0)T&L9E*A^51E$\F!#:KH^/@MT\)3(Z.Q\1K<G2)<*L\?X!*77+FI-
M(Z,W<R8Q'U%L+X#Y?&$_L]\PXF*3])/6>#.2K[;?^A*B_.O,ITZXF=15_ZG3
MC$^@+K2A\&6,03CB2!R.31;LF?;IYHQ;[BA=:+BW(/8.3!;ONIB. YCN@* I
M\8A<0;A8D$C8"N,QF2^D>/09'6-)>(B>--3>)!HS(QV.W5T&2FQ+E9];2AMD
M)\J[,$"X^(Y^:;G'RRGF25V+1M=J;>[97[ILB0@M4BPIS%OH5:3 [KM$H29Z
ML*2GU/2G\V^E3CRE5"JR7B"8U,(+2AW4.)[W3R7H9OEK(W*Y,O4%?_,95"BY
M#TL_M,K+G?[>,'._^%@5LS%^PC2 ML[!4.P 9_2$N?T,@)#( W[/J%PDLUQ-
MO.:7PAZA"D3I10460YPL<D6#C<G>NW0BR.M3ARVUNA4#-49'384"L3F&U42?
M1D<"Z'R@WL<L,(7 8=,6-R7I2ET;LS'F*'=Y7XA P8QFX9:14N&+VI^#YC7J
M[6$]] 3=ZH.'G&POMP]R8VRB"Y':>JWA7F6:F$2J=PB_?;,*54&)8.H1)UXZ
M0PX8S6*D+A.RID5V$OL?"9X=>NX33!5)-BBX?L&AM%@,/"?7 Q4--JL1ROU^
M94;L$UIH8)JS0L@):>,7>>,QYP^=)@F@K%]D//3-0BLG[1<B%W=(75Q=HERL
M58)N6/ Q.K>Q^@MB/A,DE6;S0^\A:4+&VNR#I)NKI&Y:J'>A9J"B:30S?9^S
M)^S>80H".+<\F#]PY@9.RI65H)-J$RKQ'/._8Z&DT\Y2?\_NUP!QB;FWZBL&
M7N*F4DHW#6P#-8L\D#AA\I3,B6R"/6^]>5F@:AWDYNJNHJ^+J!O>&->HF85K
MKD8PE^8<+<58_?Q,L=MC/'6$:)=#J^(WT */%*5S2ZQ+@;8:V 9I-I(+S,$#
MF,SI'0C+J1J\8=3-;Q!6@&W8EN$#6JFW[>Y9GQ:GUUV S=]?>\#<42<7YK#J
M ;I"0+@Y&+NBQ]E2_309+X:26E?'R3K67Z-^.\\6B#Z#]BVZ_ C5 <0OZ!%J
MXC5.[82#-$VM'JPQG9\FFI.!N&!<5E"T .Y]:*IBS:3N!/.G]%F+@K'FK(/7
MN1(KR]L+PL/[QJM'?\89E5$Z3:A2";HQ[M(L2<9X%E!7X6IT+0-I2AG9J=^C
MW]/IEAUNC./*YUDLN-9GC0U(C5YLA3SU\TET2:(O+(_,"9"R633IDFI6@6Y*
ME%90.CIAM2I2<3M6+6G^+05<M1?BGL _$BP;!5JRHI4!-"84-;E#5ZF;7)TU
M*MG/*XI9;BF4_MRLS<Y'ZF+^#)$O,4W_SI%38S=HPQ9TZ00=92PWJ5$)P'N(
MM;3LHE2K9DZ=J\[Z3UY_^B]02P,$%     @ #4P$5;\9_V-#"   J6<  !4
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MH1R\7U<8:7.?QGR94G+B_?SYOZWY\C]02P,$%     @ #4P$573#0<R #P
M3.L  !4   !S;&=L+3(P,C(P-C,P7V1E9BYX;6SM75MSXK@2?M]?D9/SS##
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MF+]5_C5KZ*? I9H4];<:SE2WQGX*;:I8@R]\<_B7-D/)*OOM_U!+ P04
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M_6D8VIG+3\/0SDS-)7NV/PZ<<*./1<2QO&YG_FX74SNS>KN8VIGOV\74CB<
MP938$1D'TRW!F#=8W^&_YV$RB"+"MGFR=;=B:=-0S/*Z'6]@"GT['F$<10E.
M$]/5_9--69SWLTVI'<11NATZHS"[QV3FVXYRIZ2YI.5U.[[!J [OV_$M9G5H
MQS<U_S*G:T\33K=\WXZ?ZX\^[?C(_NC3CG_5^'[RZ'M.=C()+FNZRIB&812?
MHEF-Y.7[=OQUOW5LR?^?C.1D.]62OWS?4L3P:O1M)\;X"V$?(M&=[Z@W&JJ4
MR_?MQ @G8?BN'1]_YSD8.@_6E+#9,%J0K_%'D/"+#(N<8_E=.SZ[74SM^-UV
M,;7C.RM?^-F+GS[9ODOHQE8;E ;K\KMV/.*Y4;;CT^["8+T L3=D&T:>W$,=
MTBV_:\??'/_]=N;_X[_?SGP,\WU^#+B_V)1"4; LOVMGAFX9U??MS-EMHVIG
MUIXD.!ZGJ\%V2\-GXGXB ;@LYX8FZQD-W<21&Y4&Z_+[=N;Q<Z-L9V8_-\IV
M9O;L4Z-?$]O_6V+3F%!_-\:'##Z;KNLP2AF7W[<SJY\383OS_CD1MN,9L@^E
MAL1O 80X@SR7@YOPGO@^OW54!UE?TO+[EKR+41U:\D4F=?BA)<^U_V6<E(9V
MX'JN'2M\EXII^4.[WJM-9.UZK#:1M>NETH^ >UE3>Q/-26Q[ 7%O0UHRK3!H
M9)1ZPI8_M.O)3&K2KL<SJ4F[GO$AL/=#F0Q&'6HIX_*'=CWC.1"VZ_?.@; =
MKS:-GP@%0R+>.O@$WZ$!.I^/8>#6W'JJ95S^V([/.B?"=GS7S-ZAY.+2RSC0
M""#57,L?V_%>Y\'6CO\Z#[9V/-*,4 ?DV6L"TR\-HP@&GD.(&]W2<(,/A[*-
M="E,70'+']OQ/%TB;L?#=(FX'8\C^N#*B\$C^_PY,WZT;H>@D9#EC^UX(A/(
MV_%0Y3[5W255\2P_M..7VL?5DC=J'5=+GJ@\-I]"&C<%5F%:?FC)#YT!64M>
MZ S(6O(V?)0/ O>>T&?%6_ *X?)#2][C! 3M> ,>@A!LY\631]V93>/=PW9%
MPR!.HQ09)@W6Y8=V9OYSHVQGEI^351*X&,[I0A/3+R_?M3.]MPBHG7F]14#M
M3.C\ P_;6VTP^[0 I)WYNP4@[4S7+0!I9W:>ASO;QRO!PW"SM8/=.!KYWMH#
M6UB$Z:"6XJIG!9CM3.%GA]G2/)]]*TT/L:L%E1$"A)8F\5,@M#1#GP"AI8?\
MN+R(/GOPGS@,2#IHI'&0F!K M#,?MP2FG;FX)3#MS,?:D6HU.KULZ4G\21#:
MF8-/@M#._+IXV04D5.^2EFG@P^W,F$=\N)UY\B%P"7V!22<FP?Z%5C68.CX
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M&D9G:2+YUZ#-^A%-ZVLQ3>(HM@-\UO\SP5""N(-G0B&0R$Y19]1SSC(VFR&
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MS$3EI_:I,"N79F82.D)KT?2JV='5?N8;]1CSXV%S=C>$B>"O)5_1$.!TPH'
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MW8' /_T;_ /^'X]6__3_ 5!+ P04    "  -3 15>=1ACC0>  !3Z0$ %0
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MZX>KU W.X4*JOW&NSL&&+%M4DC&'"VK[5A[;)E33XF=BVCF]6OESFW!P!SR
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M,MASP1+SK+3YR@'Q :A7):8E@^9#4+-*?#/C[".T+IO*2!#.M_:&J5=O$EC
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M_M+W2#PFBY>2K'28>8^\73.;6J@VOTR"(&8G\R6Y>*)\P%_F,Y[W3QY$7VJ
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M7_W07R=K+DVE-F:H<E_%5!7;&'=>M<57_*#%Y+B+MFZ0QB1WMTB6[5!KJ(F
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MF:B?,MRC?WO%."Q.9/"R[-UKF=0JK0=W)EJ4O@F![,H)?\$-8W05WJ:I%;_
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ML3MC)Z[CGJ.-B9,W/057K); LR'P5P1;K>:$"(PDM$:^^O3^--?V7$%<H0V
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MLI^LPO1,ZKD>GK438^7=U844U7 @#3X3 D.PMA#LCHCP$&9$R6/D.8XWDVI
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MVLOR,7P(?_6D('_Y"+[D[RJUT/\!4$L! A0#%     @ #4P$5:'4P*WD)@
M*Q\" !               ( !     &5X:&EB:71?.3DM,2YH=&U02P$"% ,4
M    "  -3 15!'ETQ*=U  #OOP@ $               @ $2)P  97AH:6)I
M=%\Y.2TR+FAT;5!+ 0(4 Q0    (  U,!%4M9COC80L  !-H   1
M      "  >><  !S;&=L+3(P,C(P-C,P+GAS9%!+ 0(4 Q0    (  U,!%6_
M&?]C0P@  *EG   5              "  7>H  !S;&=L+3(P,C(P-C,P7V-A
M;"YX;6Q02P$"% ,4    "  -3 15=,-!S( /  !,ZP  %0
M@ 'ML   <VQG;"TR,#(R,#8S,%]D968N>&UL4$L! A0#%     @ #4P$5<)B
M>)@A2P  +VL# !4              ( !H,   '-L9VPM,C R,C V,S!?;&%B
M+GAM;%!+ 0(4 Q0    (  U,!%5YU&&.-!X  %/I 0 5              "
M ?0+ 0!S;&=L+3(P,C(P-C,P7W!R92YX;6Q02P$"% ,4    "  -3 151#[4
M\- +  ""3@  #0              @ %;*@$ >FLR,C(X,C,X+FAT;5!+!08
1    "  (  ("  !6-@$    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
